<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en" class="win-std-desktop-val"><head>
<META http-equiv="Content-Type" content="text/html">
<title>Source View: https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-1049-0</title><meta name="robots" content="noindex,nofollow"><meta name="SortSite-IgnoreRule-Page" content="AccHtmlLinkTextReused,AccAdvancedReadingLevel,Section508-m-3,BugHtmlColgroup,BugIeCssMinMaxWidthHeight,ErrSpellingError,SeoBingTitleLength,SeoPage150k,UseGov5.1,UseGov9.2.3,UseGov10.11,UseGov11.7,UseGov14.3,UseGov17.4,UseGunningFog,W3cTitleTooLong"><link rel="icon" href="https://www-powermapper-com.azureedge.net/favicon.ico"><link rel="stylesheet" href="../Report/report-min-20200618.css"><script type="text/javascript" src="../Report/report-min-20210409.js"></script><!--[if lte IE 8]>
            <script>
                document.createElement('header');
                document.createElement('aside');
            </script>
            <![endif]--></head><body class="source"><a class="accessible" href="#content">Skip to Content</a><header><h1>
                        HTML Document
                    </h1><table><tr><th>
                        URL:
                    </th><td><a rel="nofollow" target="_top" href="https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-1049-0">https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-1049-0</a></td></tr><tr><th>
                        HTTP Status:
                    </th><td>200 OK</td></tr><tr><th>
                        MIME Type:
                    </th><td>text/html </td></tr><tr><th>
                        Last Modified:
                    </th><td>Mon, 01 Jan 1601 00:00:00 GMT</td></tr><tr><th>
                        Download Time:
                    </th><td>1 seconds
                            </td></tr><tr><th>
                        Cookies:
                    </th><td>
                                None
                            </td></tr><tr><th>
                        Size:
                    </th><td>428 KB
                        </td></tr><tr><th>
                                Depth:
                            </th><td>4 clicks from home page
                            </td></tr><tr><th>
                                Charset:
                            </th><td>utf-8</td></tr><tr><th>
                                Forms:
                            </th><td>1 forms containing 2 controls
                            </td></tr><tr><th>
                        HTTP Headers:
                    </th><td><button class="chevron toggleChevron" data-toggleid="HttpHeaders"><img width="20" height="20" alt="View Headers" id="chevHttpHeaders" src="../Report/chevron-down.svg"></button>&nbsp;<span>24&nbsp;headers</span><div class="links" id="expand-HttpHeaders">Accept-Ranges: bytes<br>Age: 1<br>Cache-Control: public, max-age=600, stale-while-revalidate=601, stale-if-error=601<br>Connection: keep-alive<br>Date: Wed, 27 Sep 2023 21:57:02 GMT<br>Server: Oscar Platform 0.1068.0<br>Strict-Transport-Security: max-age=31536000;includeSubDomains;preload<br>Traceparent: 00-66446a21b10d4ec372d2753ea9a34f52-558d22e7e00ac3b8-01<br>Tracestate: gorouter=e56fca1e409a4835<br>Vary: x-cdn,x-forwarded-host,x-geo-jp,x-oscar-cache-mode,X-Frame-Options<br>Via: 1.1 google, 1.1 varnish<br>X-Cache: MISS, MISS<br>X-Cache-Hits: 0<br>X-Cdn-Origin: SNPaaS<br>X-Content-Type-Options: nosniff<br>X-Forwarded-Host: breast-cancer-research.biomedcentral.com<br>X-Frame-Options: DENY<br>X-Geo-Jp: 0<br>X-Served-By: cache-a529f83a-internal, cache-mnl9729-MNL<br>X-Sn-Servicetimems: 116<br>X-Timer: S1695851821.244567,VS0,VE1218<br>X-Vcap-Request-Id: 66446a21-b10d-4ec3-72d2-753ea9a34f52<br>X-Xss-Protection: 1; mode=block<br>alt-svc: h3=":443";ma=86400,h3-29=":443";ma=86400,h3-27=":443";ma=86400<br></div></td></tr><tr><th>
                        Links In:
                    </th><td><button class="chevron toggleChevron" data-toggleid="LinksIn"><img width="20" height="20" alt="View Links" id="chevLinksIn" src="../Report/chevron-down.svg"></button>&nbsp;<span>1&nbsp;pages</span><div class="links" id="expand-LinksIn"><a class="viewsource" rel="nofollow" target="_top" href="https://content.montefioreeinstein.org/cancer/research/cdtmi/cdtmi-research" data-pageid="6651" data-line="0" data-col="0">https://content.montefioreeinstein.org/cancer/research/cdtmi/cdtmi-research</a><br></div></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td></tr><tr class="middle"><th><img alt="OK" width="20" height="20" src="../Report/bench-better.svg">
                                Issues:
                            </th><td>
                                No issues found
                            </td></tr></table></header><main id="content" class="pre"><p><code>1</code><code>&lt;!DOCTYPE html&gt;</code></p><p><code>2</code><code>          </code></p><p><code>3</code><code>&lt;html lang="en" class="no-js"&gt;</code></p><p><code>4</code><code>          </code></p><p><code>5</code><code>    &lt;head&gt;</code></p><p><code>6</code><code>          </code></p><p><code>7</code><code>        &lt;meta charset="UTF-8"&gt;</code></p><p><code>8</code><code>          </code></p><p><code>9</code><code>        &lt;meta http-equiv="X-UA-Compatible" content="IE=edge"&gt;</code></p><p><code>10</code><code>          </code></p><p><code>11</code><code>        &lt;meta name="applicable-device" content="pc,mobile"&gt;</code></p><p><code>12</code><code>          </code></p><p><code>13</code><code>        &lt;meta name="viewport" content="width=device-width, initial-scale=1"&gt;</code></p><p><code>14</code><code>          </code></p><p><code>15</code><code>          </code></p><p><code>16</code><code>        &lt;title&gt;</code></p><p><code>17</code><code>NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients | Breast Cancer Research | Full Text&lt;/title&gt;</code></p><p><code>18</code><code>          </code></p><p><code>19</code><code>          </code></p><p><code>20</code><code>        </code></p><p><code>21</code><code>    </code></p><p><code>22</code><code>    &lt;meta name="citation_abstract" content="The presence of disseminated tumor cells (DTCs) in bone marrow (BM) is an independent prognostic factor in early breast cancer but does not uniformly predict outcome. Tumor cells can persist in a quiescent state over time, but clinical studies of markers predicting the awakening potential of DTCs are lacking. Recently, experiments have shown that NR2F1 (COUP-TF1) plays a key role in dormancy signaling. We analyzed the NR2F1 expression in DTCs by double immunofluorescence (DIF) staining of extra cytospins prepared from 114 BM samples from 86 selected DTC-positive breast cancer patients. Samples collected at two or more time points were available for 24 patients. Fifteen samples were also analyzed for the proliferation marker Ki67. Of the patients with detectable DTCs by DIF, 27% had &amp;#8805;&amp;#8201;50% NR2F1high DTCs, chosen a priori as the cut-off for &amp;#8220;dormant profile&amp;#8221; classification. All patients with systemic relapse within 12&amp;#160;months after BM aspiration carried &amp;#8804;&amp;#8201;1% NR2F1high DTCs, including patients who transitioned from having NR2F1high-expressing DTCs in previous BM samples. Of the patients with serial samples, half of those with no relapse at follow-up had &amp;#8805;&amp;#8201;50% NR2F1high DTCs in the last BM aspiration analyzed. Among the 18 relapse-free patients at the time of the last DTC-positive BM aspiration with no subsequent BM analysis performed, distant disease-free intervals were favorable for patients carrying &amp;#8805;&amp;#8201;50% NR2F1high DTCs compared with those with predominantly NR2F1low DTCs (p&amp;#8201;=&amp;#8201;0.007, log-rank). No survival difference was observed by classification according to Ki67-expressing DTCs (p&amp;#8201;=&amp;#8201;0.520). Our study translates findings from basic biological analysis of DTC dormancy to the clinical situation and supports further clinical studies of NR2F1 as a marker of dormancy."/&gt;</code></p><p><code>23</code><code>          </code></p><p><code>24</code><code>    &lt;meta name="journal_id" content="13058"/&gt;</code></p><p><code>25</code><code>          </code></p><p><code>26</code><code>    &lt;meta name="dc.title" content="NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients"/&gt;</code></p><p><code>27</code><code>          </code></p><p><code>28</code><code>    &lt;meta name="dc.source" content="Breast Cancer Research 2018 20:1"/&gt;</code></p><p><code>29</code><code>          </code></p><p><code>30</code><code>    &lt;meta name="dc.format" content="text/html"/&gt;</code></p><p><code>31</code><code>          </code></p><p><code>32</code><code>    &lt;meta name="dc.publisher" content="BioMed Central"/&gt;</code></p><p><code>33</code><code>          </code></p><p><code>34</code><code>    &lt;meta name="dc.date" content="2018-10-16"/&gt;</code></p><p><code>35</code><code>          </code></p><p><code>36</code><code>    &lt;meta name="dc.type" content="OriginalPaper"/&gt;</code></p><p><code>37</code><code>          </code></p><p><code>38</code><code>    &lt;meta name="dc.language" content="En"/&gt;</code></p><p><code>39</code><code>          </code></p><p><code>40</code><code>    &lt;meta name="dc.copyright" content="2018 The Author(s)."/&gt;</code></p><p><code>41</code><code>          </code></p><p><code>42</code><code>    &lt;meta name="dc.rights" content="2018 The Author(s)."/&gt;</code></p><p><code>43</code><code>          </code></p><p><code>44</code><code>    &lt;meta name="dc.rightsAgent" content="reprints@biomedcentral.com"/&gt;</code></p><p><code>45</code><code>          </code></p><p><code>46</code><code>    &lt;meta name="dc.description" content="The presence of disseminated tumor cells (DTCs) in bone marrow (BM) is an independent prognostic factor in early breast cancer but does not uniformly predict outcome. Tumor cells can persist in a quiescent state over time, but clinical studies of markers predicting the awakening potential of DTCs are lacking. Recently, experiments have shown that NR2F1 (COUP-TF1) plays a key role in dormancy signaling. We analyzed the NR2F1 expression in DTCs by double immunofluorescence (DIF) staining of extra cytospins prepared from 114 BM samples from 86 selected DTC-positive breast cancer patients. Samples collected at two or more time points were available for 24 patients. Fifteen samples were also analyzed for the proliferation marker Ki67. Of the patients with detectable DTCs by DIF, 27% had &amp;#8805;&amp;#8201;50% NR2F1high DTCs, chosen a priori as the cut-off for &amp;#8220;dormant profile&amp;#8221; classification. All patients with systemic relapse within 12&amp;amp;nbsp;months after BM aspiration carried &amp;#8804;&amp;#8201;1% NR2F1high DTCs, including patients who transitioned from having NR2F1high-expressing DTCs in previous BM samples. Of the patients with serial samples, half of those with no relapse at follow-up had &amp;#8805;&amp;#8201;50% NR2F1high DTCs in the last BM aspiration analyzed. Among the 18 relapse-free patients at the time of the last DTC-positive BM aspiration with no subsequent BM analysis performed, distant disease-free intervals were favorable for patients carrying &amp;#8805;&amp;#8201;50% NR2F1high DTCs compared with those with predominantly NR2F1low DTCs (p&amp;#8201;=&amp;#8201;0.007, log-rank). No survival difference was observed by classification according to Ki67-expressing DTCs (p&amp;#8201;=&amp;#8201;0.520). Our study translates findings from basic biological analysis of DTC dormancy to the clinical situation and supports further clinical studies of NR2F1 as a marker of dormancy."/&gt;</code></p><p><code>47</code><code>          </code></p><p><code>48</code><code>    &lt;meta name="prism.issn" content="1465-542X"/&gt;</code></p><p><code>49</code><code>          </code></p><p><code>50</code><code>    &lt;meta name="prism.publicationName" content="Breast Cancer Research"/&gt;</code></p><p><code>51</code><code>          </code></p><p><code>52</code><code>    &lt;meta name="prism.publicationDate" content="2018-10-16"/&gt;</code></p><p><code>53</code><code>          </code></p><p><code>54</code><code>    &lt;meta name="prism.volume" content="20"/&gt;</code></p><p><code>55</code><code>          </code></p><p><code>56</code><code>    &lt;meta name="prism.number" content="1"/&gt;</code></p><p><code>57</code><code>          </code></p><p><code>58</code><code>    &lt;meta name="prism.section" content="OriginalPaper"/&gt;</code></p><p><code>59</code><code>          </code></p><p><code>60</code><code>    &lt;meta name="prism.startingPage" content="1"/&gt;</code></p><p><code>61</code><code>          </code></p><p><code>62</code><code>    &lt;meta name="prism.endingPage" content="13"/&gt;</code></p><p><code>63</code><code>          </code></p><p><code>64</code><code>    &lt;meta name="prism.copyright" content="2018 The Author(s)."/&gt;</code></p><p><code>65</code><code>          </code></p><p><code>66</code><code>    &lt;meta name="prism.rightsAgent" content="reprints@biomedcentral.com"/&gt;</code></p><p><code>67</code><code>          </code></p><p><code>68</code><code>    &lt;meta name="prism.url" content="https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-1049-0"/&gt;</code></p><p><code>69</code><code>          </code></p><p><code>70</code><code>    &lt;meta name="prism.doi" content="doi:10.1186/s13058-018-1049-0"/&gt;</code></p><p><code>71</code><code>          </code></p><p><code>72</code><code>    &lt;meta name="citation_pdf_url" content="https://breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/s13058-018-1049-0"/&gt;</code></p><p><code>73</code><code>          </code></p><p><code>74</code><code>    &lt;meta name="citation_fulltext_html_url" content="https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-1049-0"/&gt;</code></p><p><code>75</code><code>          </code></p><p><code>76</code><code>    &lt;meta name="citation_journal_title" content="Breast Cancer Research"/&gt;</code></p><p><code>77</code><code>          </code></p><p><code>78</code><code>    &lt;meta name="citation_journal_abbrev" content="Breast Cancer Res"/&gt;</code></p><p><code>79</code><code>          </code></p><p><code>80</code><code>    &lt;meta name="citation_publisher" content="BioMed Central"/&gt;</code></p><p><code>81</code><code>          </code></p><p><code>82</code><code>    &lt;meta name="citation_issn" content="1465-542X"/&gt;</code></p><p><code>83</code><code>          </code></p><p><code>84</code><code>    &lt;meta name="citation_title" content="NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients"/&gt;</code></p><p><code>85</code><code>          </code></p><p><code>86</code><code>    &lt;meta name="citation_volume" content="20"/&gt;</code></p><p><code>87</code><code>          </code></p><p><code>88</code><code>    &lt;meta name="citation_issue" content="1"/&gt;</code></p><p><code>89</code><code>          </code></p><p><code>90</code><code>    &lt;meta name="citation_publication_date" content="2018/12"/&gt;</code></p><p><code>91</code><code>          </code></p><p><code>92</code><code>    &lt;meta name="citation_online_date" content="2018/10/16"/&gt;</code></p><p><code>93</code><code>          </code></p><p><code>94</code><code>    &lt;meta name="citation_firstpage" content="1"/&gt;</code></p><p><code>95</code><code>          </code></p><p><code>96</code><code>    &lt;meta name="citation_lastpage" content="13"/&gt;</code></p><p><code>97</code><code>          </code></p><p><code>98</code><code>    &lt;meta name="citation_article_type" content="Short report"/&gt;</code></p><p><code>99</code><code>          </code></p><p><code>100</code><code>    &lt;meta name="citation_fulltext_world_readable" content=""/&gt;</code></p><p><code>101</code><code>          </code></p><p><code>102</code><code>    &lt;meta name="citation_language" content="en"/&gt;</code></p><p><code>103</code><code>          </code></p><p><code>104</code><code>    &lt;meta name="dc.identifier" content="doi:10.1186/s13058-018-1049-0"/&gt;</code></p><p><code>105</code><code>          </code></p><p><code>106</code><code>    &lt;meta name="DOI" content="10.1186/s13058-018-1049-0"/&gt;</code></p><p><code>107</code><code>          </code></p><p><code>108</code><code>    &lt;meta name="size" content="227497"/&gt;</code></p><p><code>109</code><code>          </code></p><p><code>110</code><code>    &lt;meta name="citation_doi" content="10.1186/s13058-018-1049-0"/&gt;</code></p><p><code>111</code><code>          </code></p><p><code>112</code><code>    &lt;meta name="citation_springer_api_url" content="http://api.springer.com/xmldata/jats?q=doi:10.1186/s13058-018-1049-0&amp;amp;api_key="/&gt;</code></p><p><code>113</code><code>          </code></p><p><code>114</code><code>    &lt;meta name="description" content="The presence of disseminated tumor cells (DTCs) in bone marrow (BM) is an independent prognostic factor in early breast cancer but does not uniformly predict outcome. Tumor cells can persist in a quiescent state over time, but clinical studies of markers predicting the awakening potential of DTCs are lacking. Recently, experiments have shown that NR2F1 (COUP-TF1) plays a key role in dormancy signaling. We analyzed the NR2F1 expression in DTCs by double immunofluorescence (DIF) staining of extra cytospins prepared from 114 BM samples from 86 selected DTC-positive breast cancer patients. Samples collected at two or more time points were available for 24 patients. Fifteen samples were also analyzed for the proliferation marker Ki67. Of the patients with detectable DTCs by DIF, 27% had &amp;#8805;&amp;#8201;50% NR2F1high DTCs, chosen a priori as the cut-off for &amp;#8220;dormant profile&amp;#8221; classification. All patients with systemic relapse within 12&amp;amp;nbsp;months after BM aspiration carried &amp;#8804;&amp;#8201;1% NR2F1high DTCs, including patients who transitioned from having NR2F1high-expressing DTCs in previous BM samples. Of the patients with serial samples, half of those with no relapse at follow-up had &amp;#8805;&amp;#8201;50% NR2F1high DTCs in the last BM aspiration analyzed. Among the 18 relapse-free patients at the time of the last DTC-positive BM aspiration with no subsequent BM analysis performed, distant disease-free intervals were favorable for patients carrying &amp;#8805;&amp;#8201;50% NR2F1high DTCs compared with those with predominantly NR2F1low DTCs (p&amp;#8201;=&amp;#8201;0.007, log-rank). No survival difference was observed by classification according to Ki67-expressing DTCs (p&amp;#8201;=&amp;#8201;0.520). Our study translates findings from basic biological analysis of DTC dormancy to the clinical situation and supports further clinical studies of NR2F1 as a marker of dormancy."/&gt;</code></p><p><code>115</code><code>          </code></p><p><code>116</code><code>    &lt;meta name="dc.creator" content="Borgen, Elin"/&gt;</code></p><p><code>117</code><code>          </code></p><p><code>118</code><code>    &lt;meta name="dc.creator" content="Rypdal, Maria C."/&gt;</code></p><p><code>119</code><code>          </code></p><p><code>120</code><code>    &lt;meta name="dc.creator" content="Sosa, Maria Soledad"/&gt;</code></p><p><code>121</code><code>          </code></p><p><code>122</code><code>    &lt;meta name="dc.creator" content="Renolen, Anne"/&gt;</code></p><p><code>123</code><code>          </code></p><p><code>124</code><code>    &lt;meta name="dc.creator" content="Schlichting, Ellen"/&gt;</code></p><p><code>125</code><code>          </code></p><p><code>126</code><code>    &lt;meta name="dc.creator" content="L&amp;#248;nning, Per E."/&gt;</code></p><p><code>127</code><code>          </code></p><p><code>128</code><code>    &lt;meta name="dc.creator" content="Synnestvedt, Marit"/&gt;</code></p><p><code>129</code><code>          </code></p><p><code>130</code><code>    &lt;meta name="dc.creator" content="Aguirre-Ghiso, Julio A."/&gt;</code></p><p><code>131</code><code>          </code></p><p><code>132</code><code>    &lt;meta name="dc.creator" content="Naume, Bj&amp;#248;rn"/&gt;</code></p><p><code>133</code><code>          </code></p><p><code>134</code><code>    &lt;meta name="dc.subject" content="Cancer Research"/&gt;</code></p><p><code>135</code><code>          </code></p><p><code>136</code><code>    &lt;meta name="dc.subject" content="Oncology"/&gt;</code></p><p><code>137</code><code>          </code></p><p><code>138</code><code>    &lt;meta name="dc.subject" content="Surgical Oncology"/&gt;</code></p><p><code>139</code><code>          </code></p><p><code>140</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Adv Cancer Res; citation_title=The relationship between dormant cancer cells and their microenvironment; citation_author=N Linde, G Fluegen, JA Aguirre-Ghiso; citation_volume=132; citation_publication_date=2016; citation_pages=45-71; citation_doi=10.1016/bs.acr.2016.07.002; citation_id=CR1"/&gt;</code></p><p><code>141</code><code>          </code></p><p><code>142</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Nat Med; citation_title=Metastasis awakening: targeting dormant cancer; citation_author=JA Aguirre-Ghiso, P Bragado, MS Sosa; citation_volume=19; citation_issue=3; citation_publication_date=2013; citation_pages=276-277; citation_doi=10.1038/nm.3120; citation_id=CR2"/&gt;</code></p><p><code>143</code><code>          </code></p><p><code>144</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=N Engl J Med; citation_title=A pooled analysis of bone marrow micrometastasis in breast cancer; citation_author=S Braun, FD Vogl, B Naume, W Janni, MP Osborne, RC Coombes, G Schlimok, IJ Diel, B Gerber, G Gebauer; citation_volume=353; citation_issue=8; citation_publication_date=2005; citation_pages=793-802; citation_doi=10.1056/NEJMoa050434; citation_id=CR3"/&gt;</code></p><p><code>145</code><code>          </code></p><p><code>146</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Clin Cancer Res; citation_title=Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse&amp;#8212;a European pooled analysis; citation_author=W Janni, FD Vogl, G Wiedswang, M Synnestvedt, T Fehm, J Juckstock, E Borgen, B Rack, S Braun, H Sommer; citation_volume=17; citation_issue=9; citation_publication_date=2011; citation_pages=2967-2976; citation_doi=10.1158/1078-0432.CCR-10-2515; citation_id=CR4"/&gt;</code></p><p><code>147</code><code>          </code></p><p><code>148</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence; citation_author=AP Adam, A George, D Schewe, P Bragado, BV Iglesias, AC Ranganathan, A Kourtidis, DS Conklin, JA Aguirre-Ghiso; citation_volume=69; citation_issue=14; citation_publication_date=2009; citation_pages=5664-5672; citation_doi=10.1158/0008-5472.CAN-08-3820; citation_id=CR5"/&gt;</code></p><p><code>149</code><code>          </code></p><p><code>150</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Nat Commun; citation_title=NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes; citation_author=MS Sosa, F Parikh, AG Maia, Y Estrada, A Bosch, P Bragado, E Ekpin, A George, Y Zheng, HM Lam; citation_volume=6; citation_publication_date=2015; citation_pages=6170; citation_doi=10.1038/ncomms7170; citation_id=CR6"/&gt;</code></p><p><code>151</code><code>          </code></p><p><code>152</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Mol Cell Oncol; citation_title=Dormancy programs as emerging antimetastasis therapeutic alternatives; citation_author=MS Sosa; citation_volume=3; citation_issue=1; citation_publication_date=2016; citation_pages=e1029062; citation_doi=10.1080/23723556.2015.1029062; citation_id=CR7"/&gt;</code></p><p><code>153</code><code>          </code></p><p><code>154</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Nat Cell Biol; citation_title=Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments; citation_author=G Fluegen, A Avivar-Valderas, Y Wang, MR Padgen, JK Williams, AR Nobre, V Calvo, JF Cheung, JJ Bravo-Cordero, D Entenberg; citation_volume=19; citation_issue=2; citation_publication_date=2017; citation_pages=120-132; citation_doi=10.1038/ncb3465; citation_id=CR8"/&gt;</code></p><p><code>155</code><code>          </code></p><p><code>156</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Breast Cancer Res; citation_title=Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival; citation_author=RR Mathiesen, E Borgen, A Renolen, E Lokkevik, JM Nesland, G Anker, B Ostenstad, S Lundgren, T Risberg, I Mjaaland; citation_volume=14; citation_issue=4; citation_publication_date=2012; citation_pages=R117; citation_doi=10.1186/bcr3242; citation_id=CR9"/&gt;</code></p><p><code>157</code><code>          </code></p><p><code>158</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=J Clin Oncol; citation_title=Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer; citation_author=G Wiedswang, E Borgen, R Karesen, G Kvalheim, JM Nesland, H Qvist, E Schlichting, T Sauer, J Janbu, T Harbitz; citation_volume=21; citation_issue=18; citation_publication_date=2003; citation_pages=3469-3478; citation_doi=10.1200/JCO.2003.02.009; citation_id=CR10"/&gt;</code></p><p><code>159</code><code>          </code></p><p><code>160</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Clin Cancer Res; citation_title=Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome; citation_author=G Wiedswang, E Borgen, R Karesen, H Qvist, J Janbu, G Kvalheim, JM Nesland, B Naume; citation_volume=10; citation_issue=16; citation_publication_date=2004; citation_pages=5342-5348; citation_doi=10.1158/1078-0432.CCR-04-0245; citation_id=CR11"/&gt;</code></p><p><code>161</code><code>          </code></p><p><code>162</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=J Clin Oncol; citation_title=Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer; citation_author=B Naume, M Synnestvedt, RS Falk, G Wiedswang, K Weyde, T Risberg, C Kersten, I Mjaaland, L Vindi, HH Sommer; citation_volume=32; citation_issue=34; citation_publication_date=2014; citation_pages=3848-3857; citation_doi=10.1200/JCO.2014.56.9327; citation_id=CR12"/&gt;</code></p><p><code>163</code><code>          </code></p><p><code>164</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=PLoS One; citation_title=CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer; citation_author=R Chrisanthar, S Knappskog, E Lokkevik, G Anker, B Ostenstad, S Lundgren, EO Berge, T Risberg, I Mjaaland, L Maehle; citation_volume=3; citation_issue=8; citation_publication_date=2008; citation_pages=e3062; citation_doi=10.1371/journal.pone.0003062; citation_id=CR13"/&gt;</code></p><p><code>165</code><code>          </code></p><p><code>166</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=PLoS One; citation_title=Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel; citation_author=R Chrisanthar, S Knappskog, E Lokkevik, G Anker, B Ostenstad, S Lundgren, T Risberg, I Mjaaland, G Skjonsberg, T Aas; citation_volume=6; citation_issue=4; citation_publication_date=2011; citation_pages=e19249; citation_doi=10.1371/journal.pone.0019249; citation_id=CR14"/&gt;</code></p><p><code>167</code><code>          </code></p><p><code>168</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Cytotherapy; citation_title=Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. Establishment of objective criteria for the evaluation of immunostained cells; citation_author=E Borgen, B Naume, JM Nesland, G Kvalheim, K Beiske, O Fodstad, I Diel, EF Solomayer, P Theocharous, RC Coombes; citation_volume=1; citation_issue=5; citation_publication_date=1999; citation_pages=377-388; citation_doi=10.1080/0032472031000141283; citation_id=CR15"/&gt;</code></p><p><code>169</code><code>          </code></p><p><code>170</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Cancer; citation_title=A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation; citation_author=T Fehm, S Braun, V Muller, W Janni, G Gebauer, C Marth, C Schindlbeck, D Wallwiener, E Borgen, B Naume; citation_volume=107; citation_issue=5; citation_publication_date=2006; citation_pages=885-892; citation_doi=10.1002/cncr.22076; citation_id=CR16"/&gt;</code></p><p><code>171</code><code>          </code></p><p><code>172</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=BMC Cancer; citation_title=Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study; citation_author=M Synnestvedt, E Borgen, E Wist, G Wiedswang, K Weyde, T Risberg, C Kersten, I Mjaaland, L Vindi, C Schirmer; citation_volume=12; citation_publication_date=2012; citation_pages=616; citation_doi=10.1186/1471-2407-12-616; citation_id=CR17"/&gt;</code></p><p><code>173</code><code>          </code></p><p><code>174</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Nat Cell Biol; citation_title=TGF-beta2 dictates disseminated tumour cell fate in target organs through TGF-beta-RIII and p38alpha/beta signalling; citation_author=P Bragado, Y Estrada, F Parikh, S Krause, C Capobianco, HG Farina, DM Schewe, JA Aguirre-Ghiso; citation_volume=15; citation_issue=11; citation_publication_date=2013; citation_pages=1351-1361; citation_doi=10.1038/ncb2861; citation_id=CR18"/&gt;</code></p><p><code>175</code><code>          </code></p><p><code>176</code><code>    &lt;meta name="citation_reference" content="Harper KL, Sosa MS, Entenberg D, Hosseini H, Cheung JF, Nobre R, Avivar-Valderas A, Nagi C, Girnius N, Davis RJ, et al. Mechanism of early dissemination and metastasis in Her2+ mammary cancer. Nature. 2016. </code></p><p><code>177</code><code>                    https://doi.org/10.1038/nature20609</code></p><p><code>178</code><code>                    </code></p><p><code>179</code><code>                  ."/&gt;</code></p><p><code>180</code><code>          </code></p><p><code>181</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Nat Rev Cancer; citation_title=Mechanisms of disseminated cancer cell dormancy: an awakening field; citation_author=MS Sosa, P Bragado, JA Aguirre-Ghiso; citation_volume=14; citation_issue=9; citation_publication_date=2014; citation_pages=611-622; citation_doi=10.1038/nrc3793; citation_id=CR20"/&gt;</code></p><p><code>182</code><code>          </code></p><p><code>183</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Cell; citation_title=Metastatic latency and immune evasion through autocrine inhibition of WNT; citation_author=S Malladi, DG Macalinao, X Jin, L He, H Basnet, Y Zou, E de Stanchina, J Massague; citation_volume=165; citation_issue=1; citation_publication_date=2016; citation_pages=45-60; citation_doi=10.1016/j.cell.2016.02.025; citation_id=CR21"/&gt;</code></p><p><code>184</code><code>          </code></p><p><code>185</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Cell; citation_title=The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites; citation_author=H Gao, G Chakraborty, AP Lee-Lim, Q Mo, M Decker, A Vonica, R Shen, E Brogi, AH Brivanlou, FG Giancotti; citation_volume=150; citation_issue=4; citation_publication_date=2012; citation_pages=764-779; citation_doi=10.1016/j.cell.2012.06.035; citation_id=CR22"/&gt;</code></p><p><code>186</code><code>          </code></p><p><code>187</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Cell; citation_title=Vitamin A-retinoic acid signaling regulates hematopoietic stem cell dormancy; citation_author=N Cabezas-Wallscheid, F Buettner, P Sommerkamp, D Klimmeck, L Ladel, FB Thalheimer, D Pastor-Flores, LP Roma, S Renders, P Zeisberger; citation_volume=169; citation_issue=5; citation_publication_date=2017; citation_pages=807-823.e819; citation_doi=10.1016/j.cell.2017.04.018; citation_id=CR23"/&gt;</code></p><p><code>188</code><code>          </code></p><p><code>189</code><code>    &lt;meta name="citation_reference" content="Thompson VC, Day TK, Bianco-Miotto T, Selth LA, Han G, Thomas M, Buchanan G, Scher HI, Nelson CC, Greenberg NM, et al. A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease. Int J Cancer. 2012;131(3):662&amp;#8211;72."/&gt;</code></p><p><code>190</code><code>          </code></p><p><code>191</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=Transforming growth factor beta 2 (TGF-beta 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen; citation_author=A Kopp, W Jonat, M Schmahl, C Knabbe; citation_volume=55; citation_issue=20; citation_publication_date=1995; citation_pages=4512-4515; citation_id=CR25"/&gt;</code></p><p><code>192</code><code>          </code></p><p><code>193</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Breast Cancer Res Treat; citation_title=TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells; citation_author=MB Buck, JK Coller, TE Murdter, M Eichelbaum, C Knabbe; citation_volume=107; citation_issue=1; citation_publication_date=2008; citation_pages=15-24; citation_doi=10.1007/s10549-007-9526-7; citation_id=CR26"/&gt;</code></p><p><code>194</code><code>          </code></p><p><code>195</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=J Cell Physiol; citation_title=The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells; citation_author=MS Lucia, MB Sporn, AB Roberts, LV Stewart, D Danielpour; citation_volume=175; citation_issue=2; citation_publication_date=1998; citation_pages=184-192; citation_doi=10.1002/(SICI)1097-4652(199805)175:2&amp;lt;184::AID-JCP8&amp;gt;3.0.CO;2-K; citation_id=CR27"/&gt;</code></p><p><code>196</code><code>          </code></p><p><code>197</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Clin Cancer Res; citation_title=The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells; citation_author=B Naume, G Wiedswang, E Borgen, G Kvalheim, R Karesen, H Qvist, J Janbu, T Harbitz, JM Nesland; citation_volume=10; citation_issue=9; citation_publication_date=2004; citation_pages=3091-3097; citation_doi=10.1158/1078-0432.CCR-03-0373; citation_id=CR28"/&gt;</code></p><p><code>198</code><code>          </code></p><p><code>199</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Int J Cancer; citation_title=Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation; citation_author=B Naume, E Borgen, JM Nesland, K Beiske, E Gilen, A Renolen, G Ravnas, H Qvist, R Karesen, G Kvalheim; citation_volume=78; citation_issue=5; citation_publication_date=1998; citation_pages=556-560; citation_doi=10.1002/(SICI)1097-0215(19981123)78:5&amp;lt;556::AID-IJC5&amp;gt;3.0.CO;2-G; citation_id=CR29"/&gt;</code></p><p><code>200</code><code>          </code></p><p><code>201</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Expert Rev Mol Diagn; citation_title=Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution; citation_author=NH Stoecklein, JC Fischer, D Niederacher, LW Terstappen; citation_volume=16; citation_issue=2; citation_publication_date=2016; citation_pages=147-164; citation_doi=10.1586/14737159.2016.1123095; citation_id=CR30"/&gt;</code></p><p><code>202</code><code>          </code></p><p><code>203</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=PLoS One; citation_title=The use of a new cell collector to isolate circulating tumor cells from the blood of patients with different stages of prostate cancer and clinical outcomes&amp;#8212;a proof-of-concept study; citation_author=G Theil, K Fischer, E Weber, R Medek, R Hoda, K Lucke, P Fornara; citation_volume=11; citation_issue=8; citation_publication_date=2016; citation_pages=e0158354; citation_doi=10.1371/journal.pone.0158354; citation_id=CR31"/&gt;</code></p><p><code>204</code><code>          </code></p><p><code>205</code><code>    &lt;meta name="citation_reference" content="citation_journal_title=Clin Cancer Res; citation_title=Enumeration and molecular characterization of tumor cells in lung cancer patients using a novel in vivo device for capturing circulating tumor cells; citation_author=TM Gorges, N Penkalla, T Schalk, SA Joosse, S Riethdorf, J Tucholski, K Lucke, H Wikman, S Jackson, N Brychta; citation_volume=22; citation_issue=9; citation_publication_date=2016; citation_pages=2197-2206; citation_doi=10.1158/1078-0432.CCR-15-1416; citation_id=CR32"/&gt;</code></p><p><code>206</code><code>          </code></p><p><code>207</code><code>    &lt;meta name="citation_author" content="Borgen, Elin"/&gt;</code></p><p><code>208</code><code>          </code></p><p><code>209</code><code>    &lt;meta name="citation_author_institution" content="Department of Pathology, Oslo University Hospital, Oslo, Norway"/&gt;</code></p><p><code>210</code><code>          </code></p><p><code>211</code><code>    &lt;meta name="citation_author" content="Rypdal, Maria C."/&gt;</code></p><p><code>212</code><code>          </code></p><p><code>213</code><code>    &lt;meta name="citation_author_institution" content="Department of Pathology, Oslo University Hospital, Oslo, Norway"/&gt;</code></p><p><code>214</code><code>          </code></p><p><code>215</code><code>    &lt;meta name="citation_author" content="Sosa, Maria Soledad"/&gt;</code></p><p><code>216</code><code>          </code></p><p><code>217</code><code>    &lt;meta name="citation_author_institution" content="Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, USA"/&gt;</code></p><p><code>218</code><code>          </code></p><p><code>219</code><code>    &lt;meta name="citation_author_institution" content="Division of Hematology and Oncology, Department of Medicine, Department of Otolaryngology, Tisch Cancer Institute, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, USA"/&gt;</code></p><p><code>220</code><code>          </code></p><p><code>221</code><code>    &lt;meta name="citation_author" content="Renolen, Anne"/&gt;</code></p><p><code>222</code><code>          </code></p><p><code>223</code><code>    &lt;meta name="citation_author_institution" content="Department of Pathology, Oslo University Hospital, Oslo, Norway"/&gt;</code></p><p><code>224</code><code>          </code></p><p><code>225</code><code>    &lt;meta name="citation_author" content="Schlichting, Ellen"/&gt;</code></p><p><code>226</code><code>          </code></p><p><code>227</code><code>    &lt;meta name="citation_author_institution" content="Department of Surgery, Oslo University Hospital, Oslo, Norway"/&gt;</code></p><p><code>228</code><code>          </code></p><p><code>229</code><code>    &lt;meta name="citation_author" content="L&amp;#248;nning, Per E."/&gt;</code></p><p><code>230</code><code>          </code></p><p><code>231</code><code>    &lt;meta name="citation_author_institution" content="Department of Oncology, Haukeland University Hospital, Bergen, Norway"/&gt;</code></p><p><code>232</code><code>          </code></p><p><code>233</code><code>    &lt;meta name="citation_author_institution" content="Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway"/&gt;</code></p><p><code>234</code><code>          </code></p><p><code>235</code><code>    &lt;meta name="citation_author" content="Synnestvedt, Marit"/&gt;</code></p><p><code>236</code><code>          </code></p><p><code>237</code><code>    &lt;meta name="citation_author_institution" content="Department of Oncology, Oslo University Hospital, Oslo, Norway"/&gt;</code></p><p><code>238</code><code>          </code></p><p><code>239</code><code>    &lt;meta name="citation_author" content="Aguirre-Ghiso, Julio A."/&gt;</code></p><p><code>240</code><code>          </code></p><p><code>241</code><code>    &lt;meta name="citation_author_institution" content="Division of Hematology and Oncology, Department of Medicine, Department of Otolaryngology, Tisch Cancer Institute, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, USA"/&gt;</code></p><p><code>242</code><code>          </code></p><p><code>243</code><code>    &lt;meta name="citation_author" content="Naume, Bj&amp;#248;rn"/&gt;</code></p><p><code>244</code><code>          </code></p><p><code>245</code><code>    &lt;meta name="citation_author_institution" content="Department of Oncology, Oslo University Hospital, Oslo, Norway"/&gt;</code></p><p><code>246</code><code>          </code></p><p><code>247</code><code>    &lt;meta name="citation_author_institution" content="Institute of Clinical Medicine, University of Oslo, Oslo, Norway"/&gt;</code></p><p><code>248</code><code>          </code></p><p><code>249</code><code>    </code></p><p><code>250</code><code>          </code></p><p><code>251</code><code>          </code></p><p><code>252</code><code>        &lt;meta name="format-detection" content="telephone=no"&gt;</code></p><p><code>253</code><code>          </code></p><p><code>254</code><code>        </code></p><p><code>255</code><code>          </code></p><p><code>256</code><code>        &lt;link rel="apple-touch-icon" sizes="180x180" href=/static/img/favicons/bmc/apple-touch-icon-582ef1d0f5.png&gt;</code></p><p><code>257</code><code>          </code></p><p><code>258</code><code>&lt;link rel="icon" type="image/png" sizes="32x32" href=/static/img/favicons/bmc/favicon-32x32-5d7879efe1.png&gt;</code></p><p><code>259</code><code>          </code></p><p><code>260</code><code>&lt;link rel="icon" type="image/png" sizes="16x16" href=/static/img/favicons/bmc/favicon-16x16-c241ac1a2f.png&gt;</code></p><p><code>261</code><code>          </code></p><p><code>262</code><code>&lt;link rel="shortcut icon" data-test="shortcut-icon" href=/static/img/favicons/bmc/favicon-1886637b78.ico&gt;</code></p><p><code>263</code><code>          </code></p><p><code>264</code><code>          </code></p><p><code>265</code><code>&lt;link rel="manifest" href=/static/app-bmc/manifest-3bb9ad383b.json&gt;</code></p><p><code>266</code><code>          </code></p><p><code>267</code><code>&lt;meta name="msapplication-config" content=/static/app-bmc/browserconfig-ecd9aa8205.xml&gt;</code></p><p><code>268</code><code>          </code></p><p><code>269</code><code>&lt;meta name="msapplication-TileColor" content="#1b3051"&gt;</code></p><p><code>270</code><code>          </code></p><p><code>271</code><code>&lt;meta name="msapplication-TileImage" content=/static/img/favicons/bmc/app-icon-144x144.png&gt;</code></p><p><code>272</code><code>          </code></p><p><code>273</code><code>          </code></p><p><code>274</code><code>&lt;meta name="theme-color" content="#1b3051"&gt;</code></p><p><code>275</code><code>          </code></p><p><code>276</code><code>          </code></p><p><code>277</code><code>          </code></p><p><code>278</code><code>        </code></p><p><code>279</code><code>        &lt;script&gt;</code></p><p><code>280</code><code>(function(H){H.className=H.className.replace(/\bno-js\b/,'js')})(document.documentElement)&lt;/script&gt;</code></p><p><code>281</code><code>          </code></p><p><code>282</code><code>          </code></p><p><code>283</code><code>        </code></p><p><code>284</code><code>          </code></p><p><code>285</code><code>          </code></p><p><code>286</code><code>    &lt;link rel="stylesheet" media="screen" href=/static/app-bmc/css/core-article-f3872e738d.css&gt;</code></p><p><code>287</code><code>          </code></p><p><code>288</code><code>          </code></p><p><code>289</code><code>          </code></p><p><code>290</code><code>          </code></p><p><code>291</code><code>    &lt;link rel="stylesheet" media="screen" href=/static/app-bmc/css/core-eac3097aa4.css&gt;</code></p><p><code>292</code><code>          </code></p><p><code>293</code><code>          </code></p><p><code>294</code><code>          </code></p><p><code>295</code><code>&lt;link rel="stylesheet" media="print" href=/static/app-bmc/css/print-b8af42253b.css&gt;</code></p><p><code>296</code><code>          </code></p><p><code>297</code><code>          </code></p><p><code>298</code><code>          </code></p><p><code>299</code><code>          </code></p><p><code>300</code><code>          </code></p><p><code>301</code><code>    &lt;!-- This template is only used by BMC for now --&gt;</code></p><p><code>302</code><code>          </code></p><p><code>303</code><code>          </code></p><p><code>304</code><code>          </code></p><p><code>305</code><code>    &lt;style&gt;</code></p><p><code>306</code><code>@media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) { button{line-height:inherit}html,label{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;margin:0;max-width:100%;min-height:100%}button,div,form,input,p{margin:0;padding:0}body{padding:0}a{color:#004b83;text-decoration:underline;text-decoration-skip-ink:auto}a&gt;</code></p><p><code>307</code><code>img{vertical-align:middle}h1,h2{color:#1b3051;font-style:normal;font-weight:700}h1{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:28px;line-height:1.4}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h2{font-size:26px;margin-bottom:.5em}h2,h3{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;line-height:1.4}h3{color:#1b3051;font-size:18px;font-style:normal;margin-bottom:.7em}.c-navbar{background:#f2f2f2;border-bottom:1px solid #d9d9d9;border-top:1px solid #d9d9d9;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.61803;padding:16px 0}.c-navbar--with-submit-button{padding-bottom:24px}@media only screen and (min-width:540px){.c-navbar--with-submit-button{padding-bottom:16px}}.c-navbar__container{display:flex;flex-wrap:wrap;justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}.c-navbar__content{display:flex;flex:0 1 auto}.c-navbar__nav{align-items:center;display:flex;flex-wrap:wrap;gap:16px 16px;list-style:none;margin:0;padding:0}.c-navbar__item{flex:0 0 auto}.c-navbar__link{background:0 0;border:0;color:currentcolor;display:block;text-decoration:none;text-transform:capitalize}.c-navbar__link--is-shown{text-decoration:underline}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}.c-ad--728x90 iframe{height:90px;max-width:970px}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad iframe{border:0;overflow:auto;vertical-align:top}.c-ad__label{color:#333;font-weight:400;line-height:1.5;margin-bottom:4px}.c-ad__label,.c-skip-link{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem}.c-skip-link{background:#dceaf6;bottom:auto;color:#004b83;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:link{color:#004b83}.c-dropdown__button:after{border-color:transparent transparent transparent #fff;border-style:solid;border-width:4px 0 4px 14px;content:"";display:block;height:0;margin-left:3px;width:0}.c-dropdown{display:inline-block;position:relative}.c-dropdown__button{background-color:transparent;border:0;display:inline-block;padding:0;white-space:nowrap}.c-dropdown__button:after{border-color:currentcolor transparent transparent;border-width:5px 4px 0 5px;display:inline-block;margin-left:8px;vertical-align:middle}.c-dropdown__menu{background-color:#fff;border:1px solid #d9d9d9;border-radius:3px;box-shadow:0 2px 6px rgba(0,0,0,.1);font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.4;list-style:none;margin:0;padding:8px 0;position:absolute;top:100%;transform:translateY(8px);width:180px;z-index:100}.c-dropdown__menu:after,.c-dropdown__menu:before{border-style:solid;bottom:100%;content:"";display:block;height:0;left:16px;position:absolute;width:0}.c-dropdown__menu:before{border-color:transparent transparent #d9d9d9;border-width:0 9px 9px;transform:translateX(-1px)}.c-dropdown__menu:after{border-color:transparent transparent #fff;border-width:0 8px 8px}.c-dropdown__menu--right{left:auto;right:0}.c-dropdown__menu--right:after,.c-dropdown__menu--right:before{left:auto;right:16px}.c-dropdown__menu--right:before{transform:translateX(1px)}.c-dropdown__link{background-color:transparent;color:#004b83;display:block;padding:4px 16px}.c-header{background-color:#1b3051;border-bottom:4px solid #1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;padding:16px 0}.c-header__container,.c-header__menu{align-items:center;display:flex;flex-wrap:wrap}@supports (gap:2em){.c-header__container,.c-header__menu{gap:2em 2em}}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:#fff}@supports not (gap:2em){.c-header__item{margin-left:24px}}.c-header__container{justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}@supports not (gap:2em){.c-header__brand{margin-right:48px}}.c-header__brand a{display:block;text-decoration:none}.c-header__link{color:#fff}.c-journal-title a{text-decoration:none}html.webfonts-loaded .c-journal-title{font-family:Europa,Trebuchet MS}.c-form-field{margin-bottom:1em}.c-form-field__label{color:#666;display:block;font-size:14px;margin-bottom:.4em}.c-form-field__input{border:1px solid #a6a6a6;border-radius:3px;box-shadow:inset 0 1px 3px 0 rgba(0,0,0,.21);font-size:14px;line-height:1.28571;padding:.75em 1em;vertical-align:middle;width:100%}.c-popup-search{background-color:#25426f;box-shadow:0 3px 3px -3px rgba(0,0,0,.21);padding:16px 0;position:relative;z-index:10}@media only screen and (min-width:1024px){.js .c-popup-search{position:absolute;top:100%;width:100%}.c-popup-search__container{margin:auto;max-width:70%}}.c-logo img{display:block}.ctx-search .c-form-field{margin-bottom:0}.ctx-search .c-form-field__label{color:#fff}.ctx-search .c-form-field__input{border-bottom-right-radius:0;border-top-right-radius:0;margin-right:0}.c-journal-header{overflow:hidden}.c-journal-header__inner{padding-bottom:8px;padding-top:8px}@media only screen and (min-width:540px){.c-journal-header__inner{display:flex;justify-content:space-between}}.c-journal-header__identity{background-size:auto 80px;min-height:16px;padding:6px 0}@media only screen and (min-width:540px){.c-journal-header__identity{background-position:0}}.c-journal-header__identity--default{background:url(/static/images/bmc/identities/patterns/default-7e3a6b1388.svg) 0 0 no-repeat #04caa8}.c-journal-title{color:#1b3051;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:26px;font-style:normal;font-weight:700;line-height:1.4;margin-bottom:0}.c-journal-title&gt;</code></p><p><code>308</code><code>a{color:#0061a9;color:#1b3051;display:flex;text-decoration:none}.c-journal-title__text{align-self:center;display:block;flex:0 1 auto}.c-logo,.c-logo&gt;</code></p><p><code>309</code><code>a{align-items:baseline;display:flex}.c-logo__strapline{display:none}@media only screen and (min-width:540px){.c-logo__strapline{display:block;margin:0 0 0 16px;transform:translateY(1px)}}.c-logo{display:block}html.webfonts-loaded .u-h3,html.webfonts-loaded .u-h4{font-family:Europa,Trebuchet MS}.u-button{align-items:center;background-color:#f2f2f2;background-image:linear-gradient(#fff,#f2f2f2);border:1px solid #ccc;border-radius:2px;cursor:pointer;display:inline-flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:auto}.u-button svg,.u-button--primary svg,.u-button--tertiary svg{fill:currentcolor}.u-button{color:#004b83}.u-button--primary,.u-button--tertiary{background-color:#33629d;background-image:linear-gradient(#4d76a9,#33629d);border:1px solid rgba(0,59,132,.5);color:#fff}.u-button--tertiary{font-weight:400}.u-button--full-width{display:flex;width:100%}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-color-open-access{color:#b74616}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-flex{display:flex;width:100%}.u-align-items-center{align-items:center}.u-justify-content-space-between{justify-content:space-between}.u-flex-static{flex:0 0 auto}.u-display-none{display:none}.js .u-js-hide{display:none;visibility:hidden}@media print{.u-hide-print{display:none}}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-position-relative{position:relative}.u-mt-32{margin-top:32px}.u-mr-24{margin-right:24px}.u-mr-48{margin-right:48px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-button-reset{background-color:transparent;border:0;padding:0}.u-text-sm{font-size:14px}.u-h3,.u-h4{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;line-height:1.4}.u-h3{color:#1b3051;font-size:18px;font-style:normal;margin-bottom:.7em}.u-h4{color:#1b3051;font-size:18px;font-style:italic;font-weight:700;margin-bottom:.7em}.u-vh-full{min-height:100vh}.u-hide{display:none;visibility:hidden}.u-hide:first-child+*{margin-block-start:0}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}}@media only screen and (max-width:1023px){.u-hide-at-lt-lg{display:none;visibility:hidden}.u-hide-at-lt-lg:first-child+*{margin-block-start:0}}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.u-button--tertiary{font-size:.875rem;padding:8px 16px}@media only screen and (max-width:539px){.u-button--alt-colour-on-mobile{background-color:#f2f2f2;background-image:linear-gradient(#fff,#f2f2f2);border:1px solid #ccc;color:#004b83}}body{font-size:1.125rem}.c-header__navigation{display:flex;gap:.5rem .5rem} }&lt;/style&gt;</code></p><p><code>310</code><code>          </code></p><p><code>311</code><code>    &lt;style&gt;</code></p><p><code>312</code><code>@media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) { button{line-height:inherit}html,label{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;margin:0;max-width:100%;min-height:100%}button,div,form,input,p{margin:0;padding:0}body{padding:0}a{color:#004b83;overflow-wrap:break-word;text-decoration:underline;text-decoration-skip-ink:auto;word-break:break-word}a&gt;</code></p><p><code>313</code><code>img{vertical-align:middle}h1,h2{color:#1b3051;font-style:normal;font-weight:700}h1{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:28px;line-height:1.4}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h2{font-size:26px;margin-bottom:.5em}h2,h3{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;line-height:1.4}h3{color:#1b3051;font-size:18px;font-style:normal;margin-bottom:.7em}p{overflow-wrap:break-word;word-break:break-word}.u-h3{font-size:1.5rem}.u-h3,.u-h4{font-weight:700}.u-h4{font-size:1.25rem}.c-reading-companion__figure-title{font-size:1.25rem;font-weight:700}body{font-size:1.125rem}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list svg{margin-left:4px}.c-article-author-list__show-more{display:none;margin-right:4px}.c-article-author-list__button,.js .c-article-author-list__item--hide,.js .c-article-author-list__show-more{display:none}.js .c-article-author-list--long .c-article-author-list__show-more,.js .c-article-author-list--long+.c-article-author-list__button{display:inline}@media only screen and (max-width:539px){.js .c-article-author-list__item--hide-small-screen{display:none}.js .c-article-author-list--short .c-article-author-list__show-more,.js .c-article-author-list--short+.c-article-author-list__button{display:inline}}#uptodate-client,.js .c-article-author-list--expanded .c-article-author-list__show-more{display:none!important}.js .c-article-author-list--expanded .c-article-author-list__item--hide-small-screen{display:inline!important}.c-article-author-list__button,.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-article-author-list__button svg,.c-button-author-list svg{margin:1px 4px 0 0}.c-article-author-list__button:hover,.c-button-author-list:hover{background:#173962;border-color:transparent;color:#fff}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Georgia,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;margin:0;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-associated-content__container .c-article-associated-content__title{margin-bottom:8px}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;margin-top:0;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article__sub-heading{color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;font-style:normal;font-weight:400;line-height:1.3;margin:24px 0 8px}@media only screen and (min-width:768px){.c-article__sub-heading{font-size:1.5rem;line-height:1.24}}.c-article__sub-heading:first-child{margin-top:0}.c-article-authors-search{margin-bottom:24px;margin-top:0}.c-article-authors-search__item,.c-article-authors-search__title{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-article-authors-search__title{color:#626262;font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-authors-search__item{font-size:1rem}.c-article-authors-search__text{margin:0}.c-article-share-box__no-sharelink-info{font-size:.813rem;font-weight:700;margin-bottom:24px;padding-top:4px}.c-article-share-box__only-read-input{border:1px solid #d5d5d5;box-sizing:content-box;display:inline-block;font-size:.875rem;font-weight:700;height:24px;margin-bottom:8px;padding:8px 10px}.c-article-share-box__button--link-like{background-color:transparent;border:0;color:#0067c5;cursor:pointer;font-size:.875rem;margin-bottom:8px;margin-left:10px}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title{line-height:1.3}.c-context-bar{box-shadow:0 0 10px 0 rgba(51,51,51,.2);position:relative;width:100%}.c-context-bar__title{display:none}.c-reading-companion{clear:both;min-height:389px}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs&gt;</code></p><p><code>314</code><code>li{flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#0067c5;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__figures-list,.c-reading-companion__references-list{list-style:none;min-height:389px;padding:0}.c-reading-companion__references-list--numeric{list-style:decimal inside}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1.5;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__figure-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:16px 8px 16px 0}.c-reading-companion__figure-item:first-child{border-top:none;padding-top:8px}.c-reading-companion__reference-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:8px 8px 8px 16px}.c-reading-companion__reference-item:first-child{border-top:none}.c-reading-companion__reference-item a{word-break:break-word}.c-reading-companion__reference-citation{display:inline}.c-reading-companion__reference-links{font-size:.813rem;font-weight:700;list-style:none;margin:8px 0 0;padding:0;text-align:right}.c-reading-companion__reference-links&gt;</code></p><p><code>315</code><code>a{display:inline-block;padding-left:8px}.c-reading-companion__reference-links&gt;</code></p><p><code>316</code><code>a:first-child{display:inline-block;padding-left:0}.c-reading-companion__figure-title{display:block;margin:0 0 8px}.c-reading-companion__figure-links{display:flex;justify-content:space-between;margin:8px 0 0}.c-reading-companion__figure-links&gt;</code></p><p><code>317</code><code>a{align-items:center;display:flex}.c-reading-companion__figure-full-link svg{height:.8em;margin-left:2px}.c-reading-companion__panel{border-top:none;display:none;margin-top:0;padding-top:0}.c-reading-companion__panel--active{display:block}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{display:flex;flex:1 1 0%;padding:13px 24px!important}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}.c-pdf-container{display:flex;justify-content:flex-end}@media only screen and (max-width:539px){.c-pdf-container .c-pdf-download{display:flex;flex-basis:100%}}.c-article-associated-content__container a,.c-card__summary a{text-decoration:underline}.u-display-none{display:none}.js .u-js-hide,.u-hide{display:none;visibility:hidden}.u-hide:first-child+*{margin-block-start:0}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media print{.u-hide-print{display:none}}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.hide{display:none;visibility:hidden}.c-article-associated-content__container .c-article-associated-content__collection.collection~.c-article-associated-content__collection.collection .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__collection.section~.c-article-associated-content__collection.section .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__title{display:none}.c-article-associated-content__container .c-article-associated-content__collection.collection .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__collection.section .c-article-associated-content__collection-label{display:block}.c-article-associated-content__container .c-article-associated-content__collection.collection,.c-article-associated-content__container .c-article-associated-content__collection.section{margin-bottom:5px}.c-article-associated-content__container .c-article-associated-content__collection.section~.c-article-associated-content__collection.collection{margin-top:28px}.c-article-associated-content__container .c-article-associated-content__collection:first-child{margin-top:0}.c-article-associated-content__container .c-article-associated-content__collection:last-child{margin-bottom:2.4rem}.c-article-associated-content__container .c-article-associated-content__collection-label{color:#1b3051}.c-article-associated-content__container .c-article-associated-content__collection-title{font-size:1.063rem;font-weight:400}.webfonts-loaded .c-article__sub-heading{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif} }&lt;/style&gt;</code></p><p><code>318</code><code>          </code></p><p><code>319</code><code>          </code></p><p><code>320</code><code>    &lt;link rel="stylesheet" data-test="critical-css-handler" data-inline-css-source="critical-css" href="/static/app-bmc/css/enhanced-9cdfca5fd8.css"</code></p><p><code>321</code><code>          media="print" onload="this.media='only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)';this.onload=null"&gt;</code></p><p><code>322</code><code>          </code></p><p><code>323</code><code>          </code></p><p><code>324</code><code>    &lt;link rel="stylesheet" data-test="critical-css-handler" data-inline-css-source="critical-css" href="/static/app-bmc/css/enhanced-article-be8d5ca42d.css"</code></p><p><code>325</code><code>          media="print" onload="this.media='only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)';this.onload=null"&gt;</code></p><p><code>326</code><code>          </code></p><p><code>327</code><code>          </code></p><p><code>328</code><code>          </code></p><p><code>329</code><code>          </code></p><p><code>330</code><code>        </code></p><p><code>331</code><code>          </code></p><p><code>332</code><code>        </code></p><p><code>333</code><code>    &lt;script type="text/javascript"&gt;</code></p><p><code>334</code><code>          </code></p><p><code>335</code><code>        config = {</code></p><p><code>336</code><code>            env: 'live',</code></p><p><code>337</code><code>            site: 'breast-cancer-research.biomedcentral.com',</code></p><p><code>338</code><code>            siteWithPath: 'breast-cancer-research.biomedcentral.com' + window.location.pathname,</code></p><p><code>339</code><code>            twitterHashtag: '',</code></p><p><code>340</code><code>            cmsPrefix: 'https://studio-cms.springernature.com/studio/',</code></p><p><code>341</code><code>            </code></p><p><code>342</code><code>            doi: '10.1186/s13058-018-1049-0',</code></p><p><code>343</code><code>            figshareScriptUrl: 'https://widgets.figshare.com/static/figshare.js',</code></p><p><code>344</code><code>            hasFigshareInvoked: false,</code></p><p><code>345</code><code>            publisherBrand: 'BioMed Central',</code></p><p><code>346</code><code>            mustardcut: false</code></p><p><code>347</code><code>        };</code></p><p><code>348</code><code>    &lt;/script&gt;</code></p><p><code>349</code><code>          </code></p><p><code>350</code><code>          </code></p><p><code>351</code><code>        </code></p><p><code>352</code><code>    &lt;script type="text/javascript" data-test="dataLayer"&gt;</code></p><p><code>353</code><code>          </code></p><p><code>354</code><code>        window.dataLayer = [{"content":{"article":{"doi":"10.1186/s13058-018-1049-0","articleType":"Short report","peerReviewType":"Closed","supplement":null,"keywords":"Disseminated tumor cells;DTC;Dormancy;NR2F1;Bone marrow;Breast cancer;Occult disease;Micrometastasis"},"contentInfo":{"imprint":"BioMed Central","title":"NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients","publishedAt":1539648000000,"publishedAtDate":"2018-10-16","author":["Elin Borgen","Maria C. Rypdal","Maria Soledad Sosa","Anne Renolen","Ellen Schlichting","Per E. Lønning","Marit Synnestvedt","Julio A. Aguirre-Ghiso","Bjørn Naume"],"collection":[]},"attributes":{"deliveryPlatform":"oscar","template":"rebrand","cms":null,"copyright":{"creativeCommonsType":"CC BY + CC0","openAccess":true},"environment":"live"},"journal":{"siteKey":"breast-cancer-research.biomedcentral.com","volume":"20","issue":"1","title":"Breast Cancer Research","type":"BioMed","journalID":13058,"section":[]},"category":{"pmc":{"primarySubject":"Biomedicine"},"contentType":"Short report","publishingSegment":"BioMed2"}},"session":{"authentication":{"authenticationID":[]}},"version":"1.0.0","page":{"category":{"pageType":"article"},"attributes":{"featureFlags":[],"environment":"live","darwin":false,"journalTranche":null}},"japan":false,"event":"dataLayerCreated"}];</code></p><p><code>355</code><code>    &lt;/script&gt;</code></p><p><code>356</code><code>          </code></p><p><code>357</code><code>          </code></p><p><code>358</code><code>        </code></p><p><code>359</code><code>          </code></p><p><code>360</code><code>        </code></p><p><code>361</code><code>        </code></p><p><code>362</code><code>            &lt;script&gt;</code></p><p><code>363</code><code>          </code></p><p><code>364</code><code>                window.dataLayer = window.dataLayer || [];</code></p><p><code>365</code><code>                window.dataLayer.push({</code></p><p><code>366</code><code>                    ga4MeasurementId: 'G-PJCTJWPV25',</code></p><p><code>367</code><code>                    ga360TrackingId: 'UA-54492316-9',</code></p><p><code>368</code><code>                    twitterId: 'o47a2',</code></p><p><code>369</code><code>                    ga4ServerUrl: 'https://collect.biomedcentral.com',</code></p><p><code>370</code><code>                    imprint: 'biomedcentral'</code></p><p><code>371</code><code>                });</code></p><p><code>372</code><code>            &lt;/script&gt;</code></p><p><code>373</code><code>          </code></p><p><code>374</code><code>        </code></p><p><code>375</code><code>        </code></p><p><code>376</code><code>          </code></p><p><code>377</code><code>        </code></p><p><code>378</code><code>          </code></p><p><code>379</code><code>        &lt;script&gt;</code></p><p><code>380</code><code>          </code></p><p><code>381</code><code>    (function(w, d) {</code></p><p><code>382</code><code>        w.config = w.config || {};</code></p><p><code>383</code><code>        w.config.mustardcut = false;</code></p><p><code>384</code><code>          </code></p><p><code>385</code><code>        </code></p><p><code>386</code><code>        if (w.matchMedia &amp;&amp; w.matchMedia('only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)').matches) {</code></p><p><code>387</code><code>            w.config.mustardcut = true;</code></p><p><code>388</code><code>            d.classList.add('js');</code></p><p><code>389</code><code>            d.classList.remove('grade-c');</code></p><p><code>390</code><code>            d.classList.remove('no-js');</code></p><p><code>391</code><code>        }</code></p><p><code>392</code><code>    })(window, document.documentElement);</code></p><p><code>393</code><code>&lt;/script&gt;</code></p><p><code>394</code><code>          </code></p><p><code>395</code><code>          </code></p><p><code>396</code><code>          </code></p><p><code>397</code><code>        </code></p><p><code>398</code><code>&lt;script&gt;</code></p><p><code>399</code><code>          </code></p><p><code>400</code><code>    (function () {</code></p><p><code>401</code><code>        if ( typeof window.CustomEvent === "function" ) return false;</code></p><p><code>402</code><code>        function CustomEvent ( event, params ) {</code></p><p><code>403</code><code>            params = params || { bubbles: false, cancelable: false, detail: null };</code></p><p><code>404</code><code>            var evt = document.createEvent( 'CustomEvent' );</code></p><p><code>405</code><code>            evt.initCustomEvent( event, params.bubbles, params.cancelable, params.detail );</code></p><p><code>406</code><code>            return evt;</code></p><p><code>407</code><code>        }</code></p><p><code>408</code><code>          </code></p><p><code>409</code><code>        CustomEvent.prototype = window.Event.prototype;</code></p><p><code>410</code><code>          </code></p><p><code>411</code><code>        window.CustomEvent = CustomEvent;</code></p><p><code>412</code><code>    })();</code></p><p><code>413</code><code>&lt;/script&gt;</code></p><p><code>414</code><code>          </code></p><p><code>415</code><code>          </code></p><p><code>416</code><code>        &lt;script class="js-entry"&gt;</code></p><p><code>417</code><code>          </code></p><p><code>418</code><code>    if (window.config.mustardcut) {</code></p><p><code>419</code><code>        (function(w, d) {</code></p><p><code>420</code><code>            </code></p><p><code>421</code><code>            </code></p><p><code>422</code><code>            </code></p><p><code>423</code><code>                window.Component = {};</code></p><p><code>424</code><code>                window.suppressShareButton = true;</code></p><p><code>425</code><code>                window.onArticlePage = true;</code></p><p><code>426</code><code>            </code></p><p><code>427</code><code>          </code></p><p><code>428</code><code>            var currentScript = d.currentScript || d.head.querySelector('script.js-entry');</code></p><p><code>429</code><code>          </code></p><p><code>430</code><code>            </code></p><p><code>431</code><code>            function catchNoModuleSupport() {</code></p><p><code>432</code><code>                var scriptEl = d.createElement('script');</code></p><p><code>433</code><code>                return (!('noModule' in scriptEl) &amp;&amp; 'onbeforeload' in scriptEl)</code></p><p><code>434</code><code>            }</code></p><p><code>435</code><code>          </code></p><p><code>436</code><code>            var headScripts = [</code></p><p><code>437</code><code>                {'src': '/static/js/polyfill-es5-bundle-17b14d8af4.js', 'async': false},</code></p><p><code>438</code><code>                {'src': '/static/js/airbrake-es5-bundle-5528e2c21f.js', 'async': false},</code></p><p><code>439</code><code>            ];</code></p><p><code>440</code><code>          </code></p><p><code>441</code><code>            var bodyScripts = [</code></p><p><code>442</code><code>                </code></p><p><code>443</code><code>                    {'src': '/static/js/app-es5-bundle-2833b90dac.js', 'async': false, 'module': false},</code></p><p><code>444</code><code>                    {'src': '/static/js/app-es6-bundle-3db91a8d4f.js', 'async': false, 'module': true}</code></p><p><code>445</code><code>                </code></p><p><code>446</code><code>                </code></p><p><code>447</code><code>                </code></p><p><code>448</code><code>                    , {'src': '/static/js/global-article-es5-bundle-9b6e6039c4.js', 'async': false, 'module': false},</code></p><p><code>449</code><code>                    {'src': '/static/js/global-article-es6-bundle-c370cc61ea.js', 'async': false, 'module': true}</code></p><p><code>450</code><code>                </code></p><p><code>451</code><code>            ];</code></p><p><code>452</code><code>          </code></p><p><code>453</code><code>            function createScript(script) {</code></p><p><code>454</code><code>                var scriptEl = d.createElement('script');</code></p><p><code>455</code><code>                scriptEl.src = script.src;</code></p><p><code>456</code><code>                scriptEl.async = script.async;</code></p><p><code>457</code><code>                if (script.module === true) {</code></p><p><code>458</code><code>                    scriptEl.type = "module";</code></p><p><code>459</code><code>                    if (catchNoModuleSupport()) {</code></p><p><code>460</code><code>                        scriptEl.src = '';</code></p><p><code>461</code><code>                    }</code></p><p><code>462</code><code>                } else if (script.module === false) {</code></p><p><code>463</code><code>                    scriptEl.setAttribute('nomodule', true)</code></p><p><code>464</code><code>                }</code></p><p><code>465</code><code>                if (script.charset) {</code></p><p><code>466</code><code>                    scriptEl.setAttribute('charset', script.charset);</code></p><p><code>467</code><code>                }</code></p><p><code>468</code><code>          </code></p><p><code>469</code><code>                return scriptEl;</code></p><p><code>470</code><code>            }</code></p><p><code>471</code><code>          </code></p><p><code>472</code><code>            for (var i = 0; i &lt; headScripts.length; ++i) {</code></p><p><code>473</code><code>                var scriptEl = createScript(headScripts[i]);</code></p><p><code>474</code><code>                currentScript.parentNode.insertBefore(scriptEl, currentScript.nextSibling);</code></p><p><code>475</code><code>            }</code></p><p><code>476</code><code>          </code></p><p><code>477</code><code>            d.addEventListener('DOMContentLoaded', function() {</code></p><p><code>478</code><code>                for (var i = 0; i &lt; bodyScripts.length; ++i) {</code></p><p><code>479</code><code>                    var scriptEl = createScript(bodyScripts[i]);</code></p><p><code>480</code><code>                    d.body.appendChild(scriptEl);</code></p><p><code>481</code><code>                }</code></p><p><code>482</code><code>            });</code></p><p><code>483</code><code>          </code></p><p><code>484</code><code>            // Webfont repeat view</code></p><p><code>485</code><code>            var config = w.config;</code></p><p><code>486</code><code>            if (config &amp;&amp; config.publisherBrand &amp;&amp; sessionStorage.fontsLoaded === 'true') {</code></p><p><code>487</code><code>                d.documentElement.className += ' webfonts-loaded';</code></p><p><code>488</code><code>            }</code></p><p><code>489</code><code>        })(window, document);</code></p><p><code>490</code><code>    }</code></p><p><code>491</code><code>&lt;/script&gt;</code></p><p><code>492</code><code>          </code></p><p><code>493</code><code>          </code></p><p><code>494</code><code>          </code></p><p><code>495</code><code>        </code></p><p><code>496</code><code>            </code></p><p><code>497</code><code>            </code></p><p><code>498</code><code>                &lt;script data-test="gtm-head"&gt;</code></p><p><code>499</code><code>          </code></p><p><code>500</code><code>    window.initGTM = function() {</code></p><p><code>501</code><code>        if (window.config.mustardcut) {</code></p><p><code>502</code><code>            (function (w, d, s, l, i) {</code></p><p><code>503</code><code>                w[l] = w[l] || [];</code></p><p><code>504</code><code>                w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});</code></p><p><code>505</code><code>                var f = d.getElementsByTagName(s)[0],</code></p><p><code>506</code><code>                        j = d.createElement(s),</code></p><p><code>507</code><code>                        dl = l != 'dataLayer' ? '&amp;l=' + l : '';</code></p><p><code>508</code><code>                j.async = true;</code></p><p><code>509</code><code>                j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl;</code></p><p><code>510</code><code>                f.parentNode.insertBefore(j, f);</code></p><p><code>511</code><code>            })(window, document, 'script', 'dataLayer', 'GTM-MRVXSHQ');</code></p><p><code>512</code><code>        }</code></p><p><code>513</code><code>    }</code></p><p><code>514</code><code>&lt;/script&gt;</code></p><p><code>515</code><code>          </code></p><p><code>516</code><code>            </code></p><p><code>517</code><code>            </code></p><p><code>518</code><code>        </code></p><p><code>519</code><code>          </code></p><p><code>520</code><code>        &lt;script&gt;</code></p><p><code>521</code><code>          </code></p><p><code>522</code><code>(function (w, d, t) {</code></p><p><code>523</code><code>    function cc() {</code></p><p><code>524</code><code>        var h = w.location.hostname;</code></p><p><code>525</code><code>        var e = d.createElement(t),</code></p><p><code>526</code><code>        s = d.getElementsByTagName(t)[0];</code></p><p><code>527</code><code>          </code></p><p><code>528</code><code>        </code></p><p><code>529</code><code>        if (h.indexOf('springer.com') &gt;</code></p><p><code>530</code><code> -1 &amp;&amp; h.indexOf('biomedcentral.com') === -1 &amp;&amp; h.indexOf('springeropen.com') === -1) {</code></p><p><code>531</code><code>            if (h.indexOf('link-qa.springer.com') &gt;</code></p><p><code>532</code><code> -1 || h.indexOf('test-www.springer.com') &gt;</code></p><p><code>533</code><code> -1) {</code></p><p><code>534</code><code>                e.src = 'https://cmp-static.springer.com/production_live/en/consent-bundle-17-36.js';</code></p><p><code>535</code><code>                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");</code></p><p><code>536</code><code>            } else {</code></p><p><code>537</code><code>                e.src = 'https://cmp-static.springer.com/production_live/en/consent-bundle-17-36.js';</code></p><p><code>538</code><code>                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");</code></p><p><code>539</code><code>            }</code></p><p><code>540</code><code>        } else if (h.indexOf('biomedcentral.com') &gt;</code></p><p><code>541</code><code> -1) {</code></p><p><code>542</code><code>            if (h.indexOf('biomedcentral.com.qa') &gt;</code></p><p><code>543</code><code> -1) {</code></p><p><code>544</code><code>                e.src = 'https://cmp.biomedcentral.com/production_live/en/consent-bundle-15-25.js';</code></p><p><code>545</code><code>                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");</code></p><p><code>546</code><code>            } else {</code></p><p><code>547</code><code>                e.src = 'https://cmp.biomedcentral.com/production_live/en/consent-bundle-15-25.js';</code></p><p><code>548</code><code>                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");</code></p><p><code>549</code><code>            }</code></p><p><code>550</code><code>        } else if (h.indexOf('springeropen.com') &gt;</code></p><p><code>551</code><code> -1) {</code></p><p><code>552</code><code>            if (h.indexOf('springeropen.com.qa') &gt;</code></p><p><code>553</code><code> -1) {</code></p><p><code>554</code><code>                e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-16-26.js';</code></p><p><code>555</code><code>                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");</code></p><p><code>556</code><code>            } else {</code></p><p><code>557</code><code>                e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-16-26.js';</code></p><p><code>558</code><code>                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");</code></p><p><code>559</code><code>            }</code></p><p><code>560</code><code>        } else if (h.indexOf('springernature.com') &gt;</code></p><p><code>561</code><code> -1) {</code></p><p><code>562</code><code>            if (h.indexOf('beta-qa.springernature.com') &gt;</code></p><p><code>563</code><code> -1) {</code></p><p><code>564</code><code>                e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-49-28.js';</code></p><p><code>565</code><code>                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-NK22KLS')");</code></p><p><code>566</code><code>            } else {</code></p><p><code>567</code><code>                e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-49-28.js';</code></p><p><code>568</code><code>                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-NK22KLS')");</code></p><p><code>569</code><code>            }</code></p><p><code>570</code><code>        } else {</code></p><p><code>571</code><code>            e.src = '/static/js/cookie-consent-es5-bundle-2b0f06c1e4.js';</code></p><p><code>572</code><code>            e.setAttribute('data-consent', h);</code></p><p><code>573</code><code>        }</code></p><p><code>574</code><code>        s.insertAdjacentElement('afterend', e);</code></p><p><code>575</code><code>    }</code></p><p><code>576</code><code>          </code></p><p><code>577</code><code>    cc();</code></p><p><code>578</code><code>})(window, document, 'script');</code></p><p><code>579</code><code>&lt;/script&gt;</code></p><p><code>580</code><code>          </code></p><p><code>581</code><code>          </code></p><p><code>582</code><code>          </code></p><p><code>583</code><code>        </code></p><p><code>584</code><code>    </code></p><p><code>585</code><code>        </code></p><p><code>586</code><code>    </code></p><p><code>587</code><code>          </code></p><p><code>588</code><code>          </code></p><p><code>589</code><code>        </code></p><p><code>590</code><code>    </code></p><p><code>591</code><code>    &lt;link rel="canonical" href="https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-1049-0"/&gt;</code></p><p><code>592</code><code>          </code></p><p><code>593</code><code>    </code></p><p><code>594</code><code>          </code></p><p><code>595</code><code>        </code></p><p><code>596</code><code>        </code></p><p><code>597</code><code>        </code></p><p><code>598</code><code>    </code></p><p><code>599</code><code>    &lt;meta property="og:url" content="https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-1049-0"/&gt;</code></p><p><code>600</code><code>          </code></p><p><code>601</code><code>    &lt;meta property="og:type" content="article"/&gt;</code></p><p><code>602</code><code>          </code></p><p><code>603</code><code>    &lt;meta property="og:site_name" content="BioMed Central"/&gt;</code></p><p><code>604</code><code>          </code></p><p><code>605</code><code>    &lt;meta property="og:title" content="NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients - Breast Cancer Research"/&gt;</code></p><p><code>606</code><code>          </code></p><p><code>607</code><code>    &lt;meta property="og:description" content="Background The presence of disseminated tumor cells (DTCs) in bone marrow (BM) is an independent prognostic factor in early breast cancer but does not uniformly predict outcome. Tumor cells can persist in a quiescent state over time, but clinical studies of markers predicting the awakening potential of DTCs are lacking. Recently, experiments have shown that NR2F1 (COUP-TF1) plays a key role in dormancy signaling. Methods We analyzed the NR2F1 expression in DTCs by double immunofluorescence (DIF) staining of extra cytospins prepared from 114 BM samples from 86 selected DTC-positive breast cancer patients. Samples collected at two or more time points were available for 24 patients. Fifteen samples were also analyzed for the proliferation marker Ki67. Results Of the patients with detectable DTCs by DIF, 27% had &amp;#8805;&amp;#8201;50% NR2F1high DTCs, chosen a priori as the cut-off for &amp;#8220;dormant profile&amp;#8221; classification. All patients with systemic relapse within 12 months after BM aspiration carried &amp;#8804;&amp;#8201;1% NR2F1high DTCs, including patients who transitioned from having NR2F1high-expressing DTCs in previous BM samples. Of the patients with serial samples, half of those with no relapse at follow-up had &amp;#8805;&amp;#8201;50% NR2F1high DTCs in the last BM aspiration analyzed. Among the 18 relapse-free patients at the time of the last DTC-positive BM aspiration with no subsequent BM analysis performed, distant disease-free intervals were favorable for patients carrying &amp;#8805;&amp;#8201;50% NR2F1high DTCs compared with those with predominantly NR2F1low DTCs (p&amp;#8201;=&amp;#8201;0.007, log-rank). No survival difference was observed by classification according to Ki67-expressing DTCs (p&amp;#8201;=&amp;#8201;0.520). Conclusions Our study translates findings from basic biological analysis of DTC dormancy to the clinical situation and supports further clinical studies of NR2F1 as a marker of dormancy."/&gt;</code></p><p><code>608</code><code>          </code></p><p><code>609</code><code>    &lt;meta property="og:image" content="https://media.springernature.com/w200/springer-static/cover/journal/13058.jpg"/&gt;</code></p><p><code>610</code><code>          </code></p><p><code>611</code><code>    </code></p><p><code>612</code><code>          </code></p><p><code>613</code><code>        </code></p><p><code>614</code><code>          </code></p><p><code>615</code><code>        </code></p><p><code>616</code><code>    &lt;script type="application/ld+json"&gt;</code></p><p><code>617</code><code>{"mainEntity":{"headline":"NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients","description":"The presence of disseminated tumor cells (DTCs) in bone marrow (BM) is an independent prognostic factor in early breast cancer but does not uniformly predict outcome. Tumor cells can persist in a quiescent state over time, but clinical studies of markers predicting the awakening potential of DTCs are lacking. Recently, experiments have shown that NR2F1 (COUP-TF1) plays a key role in dormancy signaling. We analyzed the NR2F1 expression in DTCs by double immunofluorescence (DIF) staining of extra cytospins prepared from 114 BM samples from 86 selected DTC-positive breast cancer patients. Samples collected at two or more time points were available for 24 patients. Fifteen samples were also analyzed for the proliferation marker Ki67. Of the patients with detectable DTCs by DIF, 27% had ≥ 50% NR2F1high DTCs, chosen a priori as the cut-off for “dormant profile” classification. All patients with systemic relapse within 12 months after BM aspiration carried ≤ 1% NR2F1high DTCs, including patients who transitioned from having NR2F1high-expressing DTCs in previous BM samples. Of the patients with serial samples, half of those with no relapse at follow-up had ≥ 50% NR2F1high DTCs in the last BM aspiration analyzed. Among the 18 relapse-free patients at the time of the last DTC-positive BM aspiration with no subsequent BM analysis performed, distant disease-free intervals were favorable for patients carrying ≥ 50% NR2F1high DTCs compared with those with predominantly NR2F1low DTCs (p = 0.007, log-rank). No survival difference was observed by classification according to Ki67-expressing DTCs (p = 0.520). Our study translates findings from basic biological analysis of DTC dormancy to the clinical situation and supports further clinical studies of NR2F1 as a marker of dormancy.","datePublished":"2018-10-16","dateModified":"2018-10-16","pageStart":"1","pageEnd":"13","license":"http://creativecommons.org/publicdomain/zero/1.0/","sameAs":"https://doi.org/10.1186/s13058-018-1049-0","keywords":"Cancer Research,Oncology,Surgical Oncology","image":"https://static-content.springer.com/image/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_Fig1_HTML.png","isPartOf":{"name":"Breast Cancer Research","issn":["1465-542X"],"volumeNumber":"20","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"BioMed Central","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Elin Borgen","affiliation":[{"name":"Oslo University Hospital","address":{"name":"Department of Pathology, Oslo University Hospital, Oslo, Norway","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Maria C. Rypdal","affiliation":[{"name":"Oslo University Hospital","address":{"name":"Department of Pathology, Oslo University Hospital, Oslo, Norway","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Maria Soledad Sosa","affiliation":[{"name":"Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai","address":{"name":"Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, USA","@type":"PostalAddress"},"@type":"Organization"},{"name":"Icahn School of Medicine at Mount Sinai","address":{"name":"Division of Hematology and Oncology, Department of Medicine, Department of Otolaryngology, Tisch Cancer Institute, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Anne Renolen","affiliation":[{"name":"Oslo University Hospital","address":{"name":"Department of Pathology, Oslo University Hospital, Oslo, Norway","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Ellen Schlichting","affiliation":[{"name":"Oslo University Hospital","address":{"name":"Department of Surgery, Oslo University Hospital, Oslo, Norway","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Per E. Lønning","affiliation":[{"name":"Haukeland University Hospital","address":{"name":"Department of Oncology, Haukeland University Hospital, Bergen, Norway","@type":"PostalAddress"},"@type":"Organization"},{"name":"University of Bergen","address":{"name":"Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Marit Synnestvedt","affiliation":[{"name":"Oslo University Hospital","address":{"name":"Department of Oncology, Oslo University Hospital, Oslo, Norway","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Julio A. Aguirre-Ghiso","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai","address":{"name":"Division of Hematology and Oncology, Department of Medicine, Department of Otolaryngology, Tisch Cancer Institute, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, USA","@type":"PostalAddress"},"@type":"Organization"}],"email":"julio.aguirre-ghiso@mssm.edu","@type":"Person"},{"name":"Bjørn Naume","affiliation":[{"name":"Oslo University Hospital","address":{"name":"Department of Oncology, Oslo University Hospital, Oslo, Norway","@type":"PostalAddress"},"@type":"Organization"},{"name":"University of Oslo","address":{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway","@type":"PostalAddress"},"@type":"Organization"}],"email":"BNA@ous-hf.no","@type":"Person"}],"isAccessibleForFree":true,"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}&lt;/script&gt;</code></p><p><code>618</code><code>          </code></p><p><code>619</code><code>          </code></p><p><code>620</code><code>        </code></p><p><code>621</code><code>          </code></p><p><code>622</code><code>    &lt;/head&gt;</code></p><p><code>623</code><code>          </code></p><p><code>624</code><code>          </code></p><p><code>625</code><code>    &lt;body class="journal journal-fulltext"</code></p><p><code>626</code><code>    </code></p><p><code>627</code><code>          &gt;</code></p><p><code>628</code><code>          </code></p><p><code>629</code><code>        </code></p><p><code>630</code><code>    </code></p><p><code>631</code><code>        </code></p><p><code>632</code><code>            &lt;!-- Google Tag Manager (noscript) --&gt;</code></p><p><code>633</code><code>          </code></p><p><code>634</code><code>            &lt;noscript&gt;</code></p><p><code>635</code><code>          </code></p><p><code>636</code><code>                &lt;iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MRVXSHQ"</code></p><p><code>637</code><code>                        height="0" width="0" style="display:none;visibility:hidden"&gt;</code></p><p><code>638</code><code>&lt;/iframe&gt;</code></p><p><code>639</code><code>          </code></p><p><code>640</code><code>            &lt;/noscript&gt;</code></p><p><code>641</code><code>          </code></p><p><code>642</code><code>            &lt;!-- End Google Tag Manager (noscript) --&gt;</code></p><p><code>643</code><code>          </code></p><p><code>644</code><code>        </code></p><p><code>645</code><code>    </code></p><p><code>646</code><code>          </code></p><p><code>647</code><code>        &lt;div class="u-visually-hidden" aria-hidden="true"&gt;</code></p><p><code>648</code><code>          </code></p><p><code>649</code><code>    </code></p><p><code>650</code><code>    &lt;?xml version="1.0" encoding="UTF-8"?&gt;</code></p><p><code>651</code><code>&lt;!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd"&gt;</code></p><p><code>652</code><code>&lt;svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"&gt;</code></p><p><code>653</code><code>&lt;defs&gt;</code></p><p><code>654</code><code>&lt;path id="a" d="M0 .74h56.72v55.24H0z"/&gt;</code></p><p><code>655</code><code>&lt;/defs&gt;</code></p><p><code>656</code><code>&lt;symbol id="icon-access" viewBox="0 0 18 18"&gt;</code></p><p><code>657</code><code>&lt;path d="m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z" fill-rule="evenodd"/&gt;</code></p><p><code>658</code><code>&lt;/symbol&gt;</code></p><p><code>659</code><code>&lt;symbol id="icon-account" viewBox="0 0 18 18"&gt;</code></p><p><code>660</code><code>&lt;path d="m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/&gt;</code></p><p><code>661</code><code>&lt;/symbol&gt;</code></p><p><code>662</code><code>&lt;symbol id="icon-alert" viewBox="0 0 18 18"&gt;</code></p><p><code>663</code><code>&lt;path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill-rule="evenodd"/&gt;</code></p><p><code>664</code><code>&lt;/symbol&gt;</code></p><p><code>665</code><code>&lt;symbol id="icon-arrow-broad" viewBox="0 0 16 16"&gt;</code></p><p><code>666</code><code>&lt;path d="m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 14 15)"/&gt;</code></p><p><code>667</code><code>&lt;/symbol&gt;</code></p><p><code>668</code><code>&lt;symbol id="icon-arrow-down" viewBox="0 0 16 16"&gt;</code></p><p><code>669</code><code>&lt;path d="m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z" fill-rule="evenodd"/&gt;</code></p><p><code>670</code><code>&lt;/symbol&gt;</code></p><p><code>671</code><code>&lt;symbol id="icon-arrow-left" viewBox="0 0 16 16"&gt;</code></p><p><code>672</code><code>&lt;path d="m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z" fill-rule="evenodd"/&gt;</code></p><p><code>673</code><code>&lt;/symbol&gt;</code></p><p><code>674</code><code>&lt;symbol id="icon-arrow-right" viewBox="0 0 16 16"&gt;</code></p><p><code>675</code><code>&lt;path d="m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z" fill-rule="evenodd"/&gt;</code></p><p><code>676</code><code>&lt;/symbol&gt;</code></p><p><code>677</code><code>&lt;symbol id="icon-arrow-sub" viewBox="0 0 16 16"&gt;</code></p><p><code>678</code><code>&lt;path d="m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z" fill-rule="evenodd"/&gt;</code></p><p><code>679</code><code>&lt;/symbol&gt;</code></p><p><code>680</code><code>&lt;symbol id="icon-arrow-up" viewBox="0 0 16 16"&gt;</code></p><p><code>681</code><code>&lt;path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule="evenodd"/&gt;</code></p><p><code>682</code><code>&lt;/symbol&gt;</code></p><p><code>683</code><code>&lt;symbol id="icon-article" viewBox="0 0 18 18"&gt;</code></p><p><code>684</code><code>&lt;path d="m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z" fill-rule="evenodd"/&gt;</code></p><p><code>685</code><code>&lt;/symbol&gt;</code></p><p><code>686</code><code>&lt;symbol id="icon-audio" viewBox="0 0 18 18"&gt;</code></p><p><code>687</code><code>&lt;path d="m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z" fill-rule="evenodd"/&gt;</code></p><p><code>688</code><code>&lt;/symbol&gt;</code></p><p><code>689</code><code>&lt;symbol id="icon-block" viewBox="0 0 24 24"&gt;</code></p><p><code>690</code><code>&lt;path d="m0 0h24v24h-24z" fill-rule="evenodd"/&gt;</code></p><p><code>691</code><code>&lt;/symbol&gt;</code></p><p><code>692</code><code>&lt;symbol id="icon-book" viewBox="0 0 18 18"&gt;</code></p><p><code>693</code><code>&lt;path d="m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/&gt;</code></p><p><code>694</code><code>&lt;/symbol&gt;</code></p><p><code>695</code><code>&lt;symbol id="icon-broad" viewBox="0 0 24 24"&gt;</code></p><p><code>696</code><code>&lt;path d="m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 20.182742 24.805206)"/&gt;</code></p><p><code>697</code><code>&lt;/symbol&gt;</code></p><p><code>698</code><code>&lt;symbol id="icon-calendar" viewBox="0 0 18 18"&gt;</code></p><p><code>699</code><code>&lt;path d="m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z" fill-rule="evenodd"/&gt;</code></p><p><code>700</code><code>&lt;/symbol&gt;</code></p><p><code>701</code><code>&lt;symbol id="icon-cart" viewBox="0 0 18 18"&gt;</code></p><p><code>702</code><code>&lt;path d="m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z"/&gt;</code></p><p><code>703</code><code>&lt;/symbol&gt;</code></p><p><code>704</code><code>&lt;symbol id="icon-chevron-less" viewBox="0 0 10 10"&gt;</code></p><p><code>705</code><code>&lt;path d="m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 -1 -1 0 9 9)"/&gt;</code></p><p><code>706</code><code>&lt;/symbol&gt;</code></p><p><code>707</code><code>&lt;symbol id="icon-chevron-more" viewBox="0 0 10 10"&gt;</code></p><p><code>708</code><code>&lt;path d="m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"/&gt;</code></p><p><code>709</code><code>&lt;/symbol&gt;</code></p><p><code>710</code><code>&lt;symbol id="icon-chevron-right" viewBox="0 0 10 10"&gt;</code></p><p><code>711</code><code>&lt;path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/&gt;</code></p><p><code>712</code><code>&lt;/symbol&gt;</code></p><p><code>713</code><code>&lt;symbol id="icon-circle-fill" viewBox="0 0 16 16"&gt;</code></p><p><code>714</code><code>&lt;path d="m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"/&gt;</code></p><p><code>715</code><code>&lt;/symbol&gt;</code></p><p><code>716</code><code>&lt;symbol id="icon-circle" viewBox="0 0 16 16"&gt;</code></p><p><code>717</code><code>&lt;path d="m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"/&gt;</code></p><p><code>718</code><code>&lt;/symbol&gt;</code></p><p><code>719</code><code>&lt;symbol id="icon-citation" viewBox="0 0 18 18"&gt;</code></p><p><code>720</code><code>&lt;path d="m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z" fill-rule="evenodd"/&gt;</code></p><p><code>721</code><code>&lt;/symbol&gt;</code></p><p><code>722</code><code>&lt;symbol id="icon-close" viewBox="0 0 16 16"&gt;</code></p><p><code>723</code><code>&lt;path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"/&gt;</code></p><p><code>724</code><code>&lt;/symbol&gt;</code></p><p><code>725</code><code>&lt;symbol id="icon-collections" viewBox="0 0 18 18"&gt;</code></p><p><code>726</code><code>&lt;path d="m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/&gt;</code></p><p><code>727</code><code>&lt;/symbol&gt;</code></p><p><code>728</code><code>&lt;symbol id="icon-compare" viewBox="0 0 18 18"&gt;</code></p><p><code>729</code><code>&lt;path d="m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z" fill-rule="evenodd"/&gt;</code></p><p><code>730</code><code>&lt;/symbol&gt;</code></p><p><code>731</code><code>&lt;symbol id="icon-download-file" viewBox="0 0 18 18"&gt;</code></p><p><code>732</code><code>&lt;path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z" fill-rule="evenodd"/&gt;</code></p><p><code>733</code><code>&lt;/symbol&gt;</code></p><p><code>734</code><code>&lt;symbol id="icon-download" viewBox="0 0 16 16"&gt;</code></p><p><code>735</code><code>&lt;path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"/&gt;</code></p><p><code>736</code><code>&lt;/symbol&gt;</code></p><p><code>737</code><code>&lt;symbol id="icon-editors" viewBox="0 0 18 18"&gt;</code></p><p><code>738</code><code>&lt;path d="m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z" fill-rule="evenodd"/&gt;</code></p><p><code>739</code><code>&lt;/symbol&gt;</code></p><p><code>740</code><code>&lt;symbol id="icon-email" viewBox="0 0 18 18"&gt;</code></p><p><code>741</code><code>&lt;path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z" fill-rule="evenodd"/&gt;</code></p><p><code>742</code><code>&lt;/symbol&gt;</code></p><p><code>743</code><code>&lt;symbol id="icon-error" viewBox="0 0 18 18"&gt;</code></p><p><code>744</code><code>&lt;path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill-rule="evenodd"/&gt;</code></p><p><code>745</code><code>&lt;/symbol&gt;</code></p><p><code>746</code><code>&lt;symbol id="icon-ethics" viewBox="0 0 18 18"&gt;</code></p><p><code>747</code><code>&lt;path d="m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z" fill-rule="evenodd"/&gt;</code></p><p><code>748</code><code>&lt;/symbol&gt;</code></p><p><code>749</code><code>&lt;symbol id="icon-expand"&gt;</code></p><p><code>750</code><code>&lt;path d="M7.498 11.918a.997.997 0 0 0-.003-1.411.995.995 0 0 0-1.412-.003l-4.102 4.102v-3.51A1 1 0 0 0 .98 10.09.992.992 0 0 0 0 11.092V17c0 .554.448 1.002 1.002 1.002h5.907c.554 0 1.002-.45 1.002-1.003 0-.539-.45-.978-1.006-.978h-3.51zm3.005-5.835a.997.997 0 0 0 .003 1.412.995.995 0 0 0 1.411.003l4.103-4.103v3.51a1 1 0 0 0 1.001 1.006A.992.992 0 0 0 18 6.91V1.002A1 1 0 0 0 17 0h-5.907a1.003 1.003 0 0 0-1.002 1.003c0 .539.45.978 1.006.978h3.51z" fill-rule="evenodd"/&gt;</code></p><p><code>751</code><code>&lt;/symbol&gt;</code></p><p><code>752</code><code>&lt;symbol id="icon-explore" viewBox="0 0 18 18"&gt;</code></p><p><code>753</code><code>&lt;path d="m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z" fill-rule="evenodd"/&gt;</code></p><p><code>754</code><code>&lt;/symbol&gt;</code></p><p><code>755</code><code>&lt;symbol id="icon-filter" viewBox="0 0 16 16"&gt;</code></p><p><code>756</code><code>&lt;path d="m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z"/&gt;</code></p><p><code>757</code><code>&lt;/symbol&gt;</code></p><p><code>758</code><code>&lt;symbol id="icon-home" viewBox="0 0 18 18"&gt;</code></p><p><code>759</code><code>&lt;path d="m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z" fill-rule="evenodd"/&gt;</code></p><p><code>760</code><code>&lt;/symbol&gt;</code></p><p><code>761</code><code>&lt;symbol id="icon-image" viewBox="0 0 18 18"&gt;</code></p><p><code>762</code><code>&lt;path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z" fill-rule="evenodd"/&gt;</code></p><p><code>763</code><code>&lt;/symbol&gt;</code></p><p><code>764</code><code>&lt;symbol id="icon-info" viewBox="0 0 18 18"&gt;</code></p><p><code>765</code><code>&lt;path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"/&gt;</code></p><p><code>766</code><code>&lt;/symbol&gt;</code></p><p><code>767</code><code>&lt;symbol id="icon-institution" viewBox="0 0 18 18"&gt;</code></p><p><code>768</code><code>&lt;path d="m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z" fill-rule="evenodd"/&gt;</code></p><p><code>769</code><code>&lt;/symbol&gt;</code></p><p><code>770</code><code>&lt;symbol id="icon-location" viewBox="0 0 18 18"&gt;</code></p><p><code>771</code><code>&lt;path d="m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z" fill-rule="evenodd"/&gt;</code></p><p><code>772</code><code>&lt;/symbol&gt;</code></p><p><code>773</code><code>&lt;symbol id="icon-minus" viewBox="0 0 16 16"&gt;</code></p><p><code>774</code><code>&lt;path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/&gt;</code></p><p><code>775</code><code>&lt;/symbol&gt;</code></p><p><code>776</code><code>&lt;symbol id="icon-newsletter" viewBox="0 0 18 18"&gt;</code></p><p><code>777</code><code>&lt;path d="m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z" fill-rule="evenodd"/&gt;</code></p><p><code>778</code><code>&lt;/symbol&gt;</code></p><p><code>779</code><code>&lt;symbol id="icon-orcid" viewBox="0 0 18 18"&gt;</code></p><p><code>780</code><code>&lt;path d="m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z" fill-rule="evenodd"/&gt;</code></p><p><code>781</code><code>&lt;/symbol&gt;</code></p><p><code>782</code><code>&lt;symbol id="icon-plus" viewBox="0 0 16 16"&gt;</code></p><p><code>783</code><code>&lt;path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/&gt;</code></p><p><code>784</code><code>&lt;/symbol&gt;</code></p><p><code>785</code><code>&lt;symbol id="icon-print" viewBox="0 0 18 18"&gt;</code></p><p><code>786</code><code>&lt;path d="m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z" fill-rule="evenodd"/&gt;</code></p><p><code>787</code><code>&lt;/symbol&gt;</code></p><p><code>788</code><code>&lt;symbol id="icon-search" viewBox="0 0 22 22"&gt;</code></p><p><code>789</code><code>&lt;path d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z" fill-rule="evenodd"/&gt;</code></p><p><code>790</code><code>&lt;/symbol&gt;</code></p><p><code>791</code><code>&lt;symbol id="icon-social-facebook" viewBox="0 0 24 24"&gt;</code></p><p><code>792</code><code>&lt;path d="m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z" fill-rule="evenodd"/&gt;</code></p><p><code>793</code><code>&lt;/symbol&gt;</code></p><p><code>794</code><code>&lt;symbol id="icon-social-twitter" viewBox="0 0 24 24"&gt;</code></p><p><code>795</code><code>&lt;path d="m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z" fill-rule="evenodd"/&gt;</code></p><p><code>796</code><code>&lt;/symbol&gt;</code></p><p><code>797</code><code>&lt;symbol id="icon-social-youtube" viewBox="0 0 24 24"&gt;</code></p><p><code>798</code><code>&lt;path d="m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z" fill-rule="evenodd"/&gt;</code></p><p><code>799</code><code>&lt;/symbol&gt;</code></p><p><code>800</code><code>&lt;symbol id="icon-subject-medicine" viewBox="0 0 18 18"&gt;</code></p><p><code>801</code><code>&lt;path d="m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/&gt;</code></p><p><code>802</code><code>&lt;/symbol&gt;</code></p><p><code>803</code><code>&lt;symbol id="icon-success" viewBox="0 0 18 18"&gt;</code></p><p><code>804</code><code>&lt;path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z" fill-rule="evenodd"/&gt;</code></p><p><code>805</code><code>&lt;/symbol&gt;</code></p><p><code>806</code><code>&lt;symbol id="icon-table" viewBox="0 0 18 18"&gt;</code></p><p><code>807</code><code>&lt;path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z" fill-rule="evenodd"/&gt;</code></p><p><code>808</code><code>&lt;/symbol&gt;</code></p><p><code>809</code><code>&lt;symbol id="icon-tick-circle" viewBox="0 0 24 24"&gt;</code></p><p><code>810</code><code>&lt;path d="m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z" fill-rule="evenodd"/&gt;</code></p><p><code>811</code><code>&lt;/symbol&gt;</code></p><p><code>812</code><code>&lt;symbol id="icon-tick" viewBox="0 0 16 16"&gt;</code></p><p><code>813</code><code>&lt;path d="m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z" fill-rule="evenodd"/&gt;</code></p><p><code>814</code><code>&lt;/symbol&gt;</code></p><p><code>815</code><code>&lt;symbol id="icon-update" viewBox="0 0 18 18"&gt;</code></p><p><code>816</code><code>&lt;path d="m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z" fill-rule="evenodd"/&gt;</code></p><p><code>817</code><code>&lt;/symbol&gt;</code></p><p><code>818</code><code>&lt;symbol id="icon-upload" viewBox="0 0 18 18"&gt;</code></p><p><code>819</code><code>&lt;path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z" fill-rule="evenodd"/&gt;</code></p><p><code>820</code><code>&lt;/symbol&gt;</code></p><p><code>821</code><code>&lt;symbol id="icon-video" viewBox="0 0 18 18"&gt;</code></p><p><code>822</code><code>&lt;path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z" fill-rule="evenodd"/&gt;</code></p><p><code>823</code><code>&lt;/symbol&gt;</code></p><p><code>824</code><code>&lt;symbol id="icon-warning" viewBox="0 0 18 18"&gt;</code></p><p><code>825</code><code>&lt;path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/&gt;</code></p><p><code>826</code><code>&lt;/symbol&gt;</code></p><p><code>827</code><code>&lt;symbol id="icon-facebook-bordered" viewBox="463.812 263.868 32 32"&gt;</code></p><p><code>828</code><code>&lt;path d="M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z</code></p><p><code>829</code><code>	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z"/&gt;</code></p><p><code>830</code><code>&lt;path d="M483.025,280.48l0.32-2.477h-2.453v-1.582c0-0.715,0.199-1.207,1.227-1.207h1.311v-2.213</code></p><p><code>831</code><code>	c-0.227-0.029-1.003-0.098-1.907-0.098c-1.894,0-3.186,1.154-3.186,3.271v1.826h-2.142v2.477h2.142v6.354h2.557v-6.354</code></p><p><code>832</code><code>	L483.025,280.48L483.025,280.48z"/&gt;</code></p><p><code>833</code><code>&lt;/symbol&gt;</code></p><p><code>834</code><code>&lt;symbol id="icon-twitter-bordered" viewBox="463.812 263.868 32 32"&gt;</code></p><p><code>835</code><code>&lt;g&gt;</code></p><p><code>836</code><code>&lt;path d="M486.416,276.191c-0.483,0.215-1.007,0.357-1.554,0.429c0.558-0.338,0.991-0.868,1.19-1.502</code></p><p><code>837</code><code>		c-0.521,0.308-1.104,0.536-1.72,0.657c-0.494-0.526-1.2-0.854-1.979-0.854c-1.496,0-2.711,1.213-2.711,2.71</code></p><p><code>838</code><code>		c0,0.212,0.023,0.419,0.069,0.616c-2.252-0.111-4.25-1.19-5.586-2.831c-0.231,0.398-0.365,0.866-0.365,1.361</code></p><p><code>839</code><code>		c0,0.94,0.479,1.772,1.204,2.257c-0.441-0.015-0.861-0.138-1.227-0.339v0.031c0,1.314,0.937,2.41,2.174,2.656</code></p><p><code>840</code><code>		c-0.227,0.062-0.47,0.098-0.718,0.098c-0.171,0-0.343-0.018-0.511-0.049c0.35,1.074,1.347,1.859,2.531,1.883</code></p><p><code>841</code><code>		c-0.928,0.726-2.095,1.16-3.366,1.16c-0.22,0-0.433-0.014-0.644-0.037c1.2,0.768,2.621,1.215,4.155,1.215</code></p><p><code>842</code><code>		c4.983,0,7.71-4.129,7.71-7.711c0-0.115-0.004-0.232-0.006-0.351C485.592,277.212,486.054,276.734,486.416,276.191z"/&gt;</code></p><p><code>843</code><code>&lt;/g&gt;</code></p><p><code>844</code><code>&lt;path d="M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z</code></p><p><code>845</code><code>	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z"/&gt;</code></p><p><code>846</code><code>&lt;/symbol&gt;</code></p><p><code>847</code><code>&lt;symbol id="icon-weibo-bordered" viewBox="463.812 263.868 32 32"&gt;</code></p><p><code>848</code><code>&lt;path d="M479.812,263.868c-8.838,0-16,7.163-16,16s7.162,16,16,16c8.837,0,16-7.163,16-16S488.649,263.868,479.812,263.868z</code></p><p><code>849</code><code>	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14c7.731,0,14,6.269,14,14S487.545,293.868,479.812,293.868z"/&gt;</code></p><p><code>850</code><code>&lt;g&gt;</code></p><p><code>851</code><code>&lt;path d="M478.552,285.348c-2.616,0.261-4.876-0.926-5.044-2.649c-0.167-1.722,1.814-3.33,4.433-3.588</code></p><p><code>852</code><code>		c2.609-0.263,4.871,0.926,5.041,2.647C483.147,283.479,481.164,285.089,478.552,285.348 M483.782,279.63</code></p><p><code>853</code><code>		c-0.226-0.065-0.374-0.109-0.259-0.403c0.25-0.639,0.276-1.188,0.005-1.581c-0.515-0.734-1.915-0.693-3.521-0.021</code></p><p><code>854</code><code>		c0,0-0.508,0.224-0.378-0.181c0.247-0.798,0.209-1.468-0.178-1.852c-0.87-0.878-3.194,0.032-5.183,2.027</code></p><p><code>855</code><code>		c-1.489,1.494-2.357,3.082-2.357,4.453c0,2.619,3.354,4.213,6.631,4.213c4.297,0,7.154-2.504,7.154-4.493</code></p><p><code>856</code><code>		C485.697,280.594,484.689,279.911,483.782,279.63"/&gt;</code></p><p><code>857</code><code>&lt;path d="M486.637,274.833c-1.039-1.154-2.57-1.592-3.982-1.291l0,0c-0.325,0.068-0.532,0.391-0.465,0.72</code></p><p><code>858</code><code>		c0.068,0.328,0.391,0.537,0.72,0.466c1.005-0.215,2.092,0.104,2.827,0.92c0.736,0.818,0.938,1.939,0.625,2.918l0,0</code></p><p><code>859</code><code>		c-0.102,0.318,0.068,0.661,0.39,0.762c0.32,0.104,0.658-0.069,0.763-0.391v-0.001C487.953,277.558,487.674,275.985,486.637,274.833</code></p><p><code>860</code><code>		"/&gt;</code></p><p><code>861</code><code>&lt;path d="M485.041,276.276c-0.504-0.562-1.25-0.774-1.938-0.63c-0.279,0.06-0.461,0.339-0.396,0.621</code></p><p><code>862</code><code>		c0.062,0.281,0.335,0.461,0.617,0.398l0,0c0.336-0.071,0.702,0.03,0.947,0.307s0.312,0.649,0.207,0.979l0,0</code></p><p><code>863</code><code>		c-0.089,0.271,0.062,0.565,0.336,0.654c0.274,0.09,0.564-0.062,0.657-0.336C485.686,277.604,485.549,276.837,485.041,276.276"/&gt;</code></p><p><code>864</code><code>&lt;path d="M478.694,282.227c-0.09,0.156-0.293,0.233-0.451,0.166c-0.151-0.062-0.204-0.235-0.115-0.389</code></p><p><code>865</code><code>		c0.093-0.155,0.284-0.229,0.44-0.168C478.725,281.892,478.782,282.071,478.694,282.227 M477.862,283.301</code></p><p><code>866</code><code>		c-0.253,0.405-0.795,0.58-1.202,0.396c-0.403-0.186-0.521-0.655-0.27-1.051c0.248-0.39,0.771-0.566,1.176-0.393</code></p><p><code>867</code><code>		C477.979,282.423,478.109,282.889,477.862,283.301 M478.812,280.437c-1.244-0.326-2.65,0.294-3.19,1.396</code></p><p><code>868</code><code>		c-0.553,1.119-0.021,2.369,1.236,2.775c1.303,0.42,2.84-0.225,3.374-1.436C480.758,281.989,480.1,280.77,478.812,280.437"/&gt;</code></p><p><code>869</code><code>&lt;/g&gt;</code></p><p><code>870</code><code>&lt;/symbol&gt;</code></p><p><code>871</code><code>&lt;symbol id="icon-arrow-left-bullet" viewBox="0 0 8 16"&gt;</code></p><p><code>872</code><code>&lt;path d="M3 8l5 5v3L0 8l8-8v3L3 8z"/&gt;</code></p><p><code>873</code><code>&lt;/symbol&gt;</code></p><p><code>874</code><code>&lt;symbol id="icon-chevron-down" viewBox="0 0 16 16"&gt;</code></p><p><code>875</code><code>&lt;path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 3)"/&gt;</code></p><p><code>876</code><code>&lt;/symbol&gt;</code></p><p><code>877</code><code>&lt;symbol id="icon-download-rounded"&gt;</code></p><p><code>878</code><code>&lt;path d="M0 13c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H1.002A1.006 1.006 0 010 13zM7 1v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L1.115 6.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L5 7.8V1c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z"/&gt;</code></p><p><code>879</code><code>&lt;/symbol&gt;</code></p><p><code>880</code><code>&lt;symbol id="icon-ext-link" viewBox="0 0 16 16"&gt;</code></p><p><code>881</code><code>&lt;path d="M12.9 16H3.1C1.4 16 0 14.6 0 12.9V3.2C0 1.4 1.4 0 3.1 0h3.7v1H3.1C2 1 1 2 1 3.2v9.7C1 14 2 15 3.1 15h9.7c1.2 0 2.1-1 2.1-2.1V8.7h1v4.2c.1 1.7-1.3 3.1-3 3.1z"/&gt;</code></p><p><code>882</code><code>&lt;path d="M12.8 2.5l.7.7-9 8.9-.7-.7 9-8.9z"/&gt;</code></p><p><code>883</code><code>&lt;path d="M9.7 0L16 6.2V0z"/&gt;</code></p><p><code>884</code><code>&lt;/symbol&gt;</code></p><p><code>885</code><code>&lt;symbol id="icon-remove" viewBox="-296 388 18 18"&gt;</code></p><p><code>886</code><code>&lt;path d="M-291.7 396.1h9v2h-9z"/&gt;</code></p><p><code>887</code><code>&lt;path d="M-287 405.5c-4.7 0-8.5-3.8-8.5-8.5s3.8-8.5 8.5-8.5 8.5 3.8 8.5 8.5-3.8 8.5-8.5 8.5zm0-16c-4.1 0-7.5 3.4-7.5 7.5s3.4 7.5 7.5 7.5 7.5-3.4 7.5-7.5-3.4-7.5-7.5-7.5z"/&gt;</code></p><p><code>888</code><code>&lt;/symbol&gt;</code></p><p><code>889</code><code>&lt;symbol id="icon-rss" viewBox="0 0 18 18"&gt;</code></p><p><code>890</code><code>&lt;path d="m.97480857 6.01583891.11675372.00378391c5.75903295.51984988 10.34261021 5.10537458 10.85988231 10.86480098.0494035.5500707-.3564674 1.0360406-.906538 1.0854441-.5500707.0494036-1.0360406-.3564673-1.08544412-.906538-.43079083-4.7965248-4.25151132-8.61886853-9.04770289-9.05180573-.55004837-.04965115-.95570047-.53580366-.90604933-1.08585203.04610464-.5107592.46858035-.89701345.96909831-.90983323zm1.52519143 6.95474179c1.38071187 0 2.5 1.1192881 2.5 2.5s-1.11928813 2.5-2.5 2.5-2.5-1.1192881-2.5-2.5 1.11928813-2.5 2.5-2.5zm-1.43253846-12.96884168c9.09581416.53242539 16.37540296 7.8163886 16.90205336 16.91294558.0319214.5513615-.389168 1.0242056-.9405294 1.056127-.5513615.0319214-1.0242057-.389168-1.0561271-.9405294-.4679958-8.08344784-6.93949306-14.55883389-15.02226722-15.03196077-.55134101-.03227286-.97212889-.50538538-.93985602-1.05672639.03227286-.551341.50538538-.97212888 1.05672638-.93985602z" fill-rule="evenodd"/&gt;</code></p><p><code>891</code><code>&lt;/symbol&gt;</code></p><p><code>892</code><code>&lt;symbol id="icon-springer-arrow-left"&gt;</code></p><p><code>893</code><code>&lt;path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"/&gt;</code></p><p><code>894</code><code>&lt;/symbol&gt;</code></p><p><code>895</code><code>&lt;symbol id="icon-springer-arrow-right"&gt;</code></p><p><code>896</code><code>&lt;path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"/&gt;</code></p><p><code>897</code><code>&lt;/symbol&gt;</code></p><p><code>898</code><code>&lt;symbol id="icon-springer-collections" viewBox="3 3 32 32"&gt;</code></p><p><code>899</code><code>&lt;path fill-rule="evenodd" d="M25.583333,30.1249997 L25.583333,7.1207574 C25.583333,7.10772495 25.579812,7.10416665 25.5859851,7.10416665 L6.10400517,7.10571021 L6.10400517,30.1355179 C6.10400517,31.1064087 6.89406744,31.8958329 7.86448169,31.8958329 L26.057145,31.8958329 C25.7558021,31.374901 25.583333,30.7700915 25.583333,30.1249997 Z M4.33333333,30.1355179 L4.33333333,7.10571021 C4.33333333,6.12070047 5.12497502,5.33333333 6.10151452,5.33333333 L25.5859851,5.33333333 C26.5617372,5.33333333 27.3541664,6.13359035 27.3541664,7.1207574 L27.3541664,12.4166666 L32.6666663,12.4166666 L32.6666663,30.1098941 C32.6666663,32.0694626 31.0857174,33.6666663 29.1355179,33.6666663 L7.86448169,33.6666663 C5.91736809,33.6666663 4.33333333,32.0857174 4.33333333,30.1355179 Z M27.3541664,14.1874999 L27.3541664,30.1249997 C27.3541664,31.1030039 28.1469954,31.8958329 29.1249997,31.8958329 C30.1030039,31.8958329 30.8958329,31.1030039 30.8958329,30.1249997 L30.8958329,14.1874999 L27.3541664,14.1874999 Z M9.64583326,10.6458333 L22.0416665,10.6458333 L22.0416665,17.7291665 L9.64583326,17.7291665 L9.64583326,10.6458333 Z M11.4166666,12.4166666 L11.4166666,15.9583331 L20.2708331,15.9583331 L20.2708331,12.4166666 L11.4166666,12.4166666 Z M9.64583326,19.4999998 L22.0416665,19.4999998 L22.0416665,21.2708331 L9.64583326,21.2708331 L9.64583326,19.4999998 Z M9.64583326,23.0416665 L22.0416665,23.0416665 L22.0416665,24.8124997 L9.64583326,24.8124997 L9.64583326,23.0416665 Z M9.64583326,26.583333 L22.0416665,26.583333 L22.0416665,28.3541664 L9.64583326,28.3541664 L9.64583326,26.583333 Z"/&gt;</code></p><p><code>900</code><code>&lt;/symbol&gt;</code></p><p><code>901</code><code>&lt;symbol id="icon-springer-download" viewBox="-301 390 9 14"&gt;</code></p><p><code>902</code><code>&lt;path d="M-301 395.6l4.5 5.1 4.5-5.1h-3V390h-3v5.6h-3zm0 6.5h9v1.9h-9z"/&gt;</code></p><p><code>903</code><code>&lt;/symbol&gt;</code></p><p><code>904</code><code>&lt;symbol id="icon-springer-info" viewBox="0 0 24 24"&gt;</code></p><p><code>905</code><code>&lt;!--Generator: Sketch 63.1 (92452) - https://sketch.com--&gt;</code></p><p><code>906</code><code>&lt;g id="V&amp;amp;I" stroke="none" stroke-width="1" fill-rule="evenodd"&gt;</code></p><p><code>907</code><code>&lt;g id="info" fill-rule="nonzero"&gt;</code></p><p><code>908</code><code>&lt;path d="M12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 Z M12.5540543,9.1 L11.5540543,9.1 C11.0017696,9.1 10.5540543,9.54771525 10.5540543,10.1 L10.5540543,10.1 L10.5540543,18.1 C10.5540543,18.6522847 11.0017696,19.1 11.5540543,19.1 L11.5540543,19.1 L12.5540543,19.1 C13.1063391,19.1 13.5540543,18.6522847 13.5540543,18.1 L13.5540543,18.1 L13.5540543,10.1 C13.5540543,9.54771525 13.1063391,9.1 12.5540543,9.1 L12.5540543,9.1 Z M12,5 C11.5356863,5 11.1529412,5.14640523 10.8517647,5.43921569 C10.5505882,5.73202614 10.4,6.11546841 10.4,6.58954248 C10.4,7.06361656 10.5505882,7.45054466 10.8517647,7.7503268 C11.1529412,8.05010893 11.5356863,8.2 12,8.2 C12.4768627,8.2 12.8627451,8.05010893 13.1576471,7.7503268 C13.452549,7.45054466 13.6,7.06361656 13.6,6.58954248 C13.6,6.11546841 13.452549,5.73202614 13.1576471,5.43921569 C12.8627451,5.14640523 12.4768627,5 12,5 Z" id="Combined-Shape"/&gt;</code></p><p><code>909</code><code>&lt;/g&gt;</code></p><p><code>910</code><code>&lt;/g&gt;</code></p><p><code>911</code><code>&lt;/symbol&gt;</code></p><p><code>912</code><code>&lt;symbol id="icon-springer-tick-circle" viewBox="0 0 24 24"&gt;</code></p><p><code>913</code><code>&lt;g id="Page-1" stroke="none" stroke-width="1" fill-rule="evenodd"&gt;</code></p><p><code>914</code><code>&lt;g id="springer-tick-circle" fill-rule="nonzero"&gt;</code></p><p><code>915</code><code>&lt;path d="M12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 Z M7.657,10.79 C7.45285634,10.6137568 7.18569967,10.5283283 6.91717333,10.5534259 C6.648647,10.5785236 6.40194824,10.7119794 6.234,10.923 C5.87705269,11.3666969 5.93445559,12.0131419 6.364,12.387 L10.261,15.754 C10.6765468,16.112859 11.3037113,16.0695601 11.666,15.657 L17.759,8.713 C18.120307,8.27302248 18.0695334,7.62621189 17.644,7.248 C17.4414817,7.06995024 17.1751516,6.9821166 16.9064461,7.00476032 C16.6377406,7.02740404 16.3898655,7.15856958 16.22,7.368 L10.768,13.489 L7.657,10.79 Z" id="path-1"/&gt;</code></p><p><code>916</code><code>&lt;/g&gt;</code></p><p><code>917</code><code>&lt;/g&gt;</code></p><p><code>918</code><code>&lt;/symbol&gt;</code></p><p><code>919</code><code>&lt;symbol id="icon-updates" viewBox="0 0 18 18"&gt;</code></p><p><code>920</code><code>&lt;g fill-rule="nonzero"&gt;</code></p><p><code>921</code><code>&lt;path d="M16.98 3.484h-.48c-2.52-.058-5.04 1.161-7.44 2.903-2.46-1.8-4.74-2.903-8.04-2.903-.3 0-.54.29-.54.58v9.813c0 .29.24.523.54.581 2.76.348 4.86 1.045 7.62 2.903.24.116.54.116.72 0 2.76-1.858 4.86-2.555 7.62-2.903.3-.058.54-.29.54-.58V4.064c0-.29-.24-.523-.54-.581zm-15.3 1.22c2.34 0 4.86 1.509 6.72 2.786v8.478c-2.34-1.394-4.38-2.09-6.72-2.439V4.703zm14.58 8.767c-2.34.348-4.38 1.045-6.72 2.439V7.374C12 5.632 14.1 4.645 16.26 4.645v8.826z"/&gt;</code></p><p><code>922</code><code>&lt;path d="M9 .058c-1.56 0-2.76 1.22-2.76 2.671C6.24 4.181 7.5 5.4 9 5.4c1.5 0 2.76-1.22 2.76-2.671 0-1.452-1.2-2.67-2.76-2.67zm0 4.413c-.96 0-1.8-.755-1.8-1.742C7.2 1.8 7.98.987 9 .987s1.8.755 1.8 1.742c0 .93-.84 1.742-1.8 1.742z"/&gt;</code></p><p><code>923</code><code>&lt;/g&gt;</code></p><p><code>924</code><code>&lt;/symbol&gt;</code></p><p><code>925</code><code>&lt;symbol id="icon-checklist-banner" viewBox="0 0 56.69 56.69"&gt;</code></p><p><code>926</code><code>&lt;path style="fill:none" d="M0 0h56.69v56.69H0z"/&gt;</code></p><p><code>927</code><code>&lt;clipPath id="b"&gt;</code></p><p><code>928</code><code>&lt;use xlink:href="#a" style="overflow:visible"/&gt;</code></p><p><code>929</code><code>&lt;/clipPath&gt;</code></p><p><code>930</code><code>&lt;path d="M21.14 34.46c0-6.77 5.48-12.26 12.24-12.26s12.24 5.49 12.24 12.26-5.48 12.26-12.24 12.26c-6.76-.01-12.24-5.49-12.24-12.26zm19.33 10.66 10.23 9.22s1.21 1.09 2.3-.12l2.09-2.32s1.09-1.21-.12-2.3l-10.23-9.22m-19.29-5.92c0-4.38 3.55-7.94 7.93-7.94s7.93 3.55 7.93 7.94c0 4.38-3.55 7.94-7.93 7.94-4.38-.01-7.93-3.56-7.93-7.94zm17.58 12.99 4.14-4.81" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round"/&gt;</code></p><p><code>931</code><code>&lt;path d="M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5m14.42-5.2V4.86s0-2.93-2.93-2.93H4.13s-2.93 0-2.93 2.93v37.57s0 2.93 2.93 2.93h15.01M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round;stroke-linejoin:round"/&gt;</code></p><p><code>932</code><code>&lt;/symbol&gt;</code></p><p><code>933</code><code>&lt;symbol id="icon-submit-closed" viewBox="0 0 18 18"&gt;</code></p><p><code>934</code><code>&lt;path d="m15 0c1.1045695 0 2 .8954305 2 2v4.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-4.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h4.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-4.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-2.5 7c3.0375661 0 5.5 2.46243388 5.5 5.5 0 3.0375661-2.4624339 5.5-5.5 5.5-3.03756612 0-5.5-2.4624339-5.5-5.5 0-3.03756612 2.46243388-5.5 5.5-5.5zm0 1c-2.4852814 0-4.5 2.0147186-4.5 4.5s2.0147186 4.5 4.5 4.5 4.5-2.0147186 4.5-4.5-2.0147186-4.5-4.5-4.5zm2.3087379 2.1912621c.2550161.2550162.2550161.668479 0 .9234952l-1.3859024 1.3845831 1.3859024 1.3859023c.2550161.2550162.2550161.668479 0 .9234952-.2550162.2550161-.668479.2550161-.9234952 0l-1.3859023-1.3859024-1.3845831 1.3859024c-.2550162.2550161-.668479.2550161-.9234952 0-.25501614-.2550162-.25501614-.668479 0-.9234952l1.3845831-1.3859023-1.3845831-1.3845831c-.25501614-.2550162-.25501614-.668479 0-.9234952.2550162-.25501614.668479-.25501614.9234952 0l1.3845831 1.3845831 1.3859023-1.3845831c.2550162-.25501614.668479-.25501614.9234952 0zm-9.8087379-8.7782621-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1z"/&gt;</code></p><p><code>935</code><code>&lt;/symbol&gt;</code></p><p><code>936</code><code>&lt;symbol id="icon-submit-open" viewBox="0 0 18 18"&gt;</code></p><p><code>937</code><code>&lt;path d="m15 0c1.1045695 0 2 .8954305 2 2v5.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-5.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h7.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-7.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-.5442863 8.18867991 3.3545404 3.35454039c.2508994.2508994.2538696.6596433.0035959.909917-.2429543.2429542-.6561449.2462671-.9065387-.0089489l-2.2609825-2.3045251.0010427 7.2231989c0 .3569916-.2898381.6371378-.6473715.6371378-.3470771 0-.6473715-.2852563-.6473715-.6371378l-.0010428-7.2231995-2.2611222 2.3046654c-.2531661.2580415-.6562868.2592444-.9065605.0089707-.24295423-.2429542-.24865597-.6576651.0036132-.9099343l3.3546673-3.35466731c.2509089-.25090888.6612706-.25227691.9135302-.00001728zm-.9557137-3.18867991c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm-8.5-3.587-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1zm8.5 1.587c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z"/&gt;</code></p><p><code>938</code><code>&lt;/symbol&gt;</code></p><p><code>939</code><code>&lt;symbol id="icon-submit-upcoming" viewBox="0 0 18 18"&gt;</code></p><p><code>940</code><code>&lt;path d="m15 0c1.1045695 0 2 .8954305 2 2v4.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-4.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h4.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-4.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-2.5 7c3.0375661 0 5.5 2.46243388 5.5 5.5 0 3.0375661-2.4624339 5.5-5.5 5.5-3.03756612 0-5.5-2.4624339-5.5-5.5 0-1.6607442.73606908-3.14957021 1.89976608-4.15803695l-1.51549374.02214397c-.27613212.00263356-.49998143-.22483432-.49998143-.49020681 0-.24299316.17766103-.44509007.40961587-.48700057l.08928713-.00797472h2.66407569c.2449213 0 .4486219.17766776.490865.40963137l.008038.08929051v2.6642143c0 .275547-.2296028.4989219-.4949753.4989219-.24299317 0-.44342617-.1744719-.4830969-.4093269l-.00710993-.0906783.01983146-1.46576707c-.96740882.82538117-1.58082193 2.05345007-1.58082193 3.42478927 0 2.4852814 2.0147186 4.5 4.5 4.5s4.5-2.0147186 4.5-4.5-2.0147186-4.5-4.5-4.5c-.7684937 0-.7684937-1 0-1zm0 2.85c.3263501 0 .5965265.2405082.6429523.5539478l.0070477.0960522v1.731l.8096194.8093806c.2284567.2284567.2513024.5846637.068537.8386705l-.068537.0805683c-.2284567.2284567-.5846637.2513024-.8386705.068537l-.0805683-.068537-.9707107-.9707107c-.1125218-.1125218-.1855975-.257116-.2103268-.412296l-.0093431-.1180341v-1.9585786c0-.3589851.2910149-.65.65-.65zm-7.5-8.437-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1z"/&gt;</code></p><p><code>941</code><code>&lt;/symbol&gt;</code></p><p><code>942</code><code>&lt;/svg&gt;</code></p><p><code>943</code><code>          </code></p><p><code>944</code><code>&lt;/div&gt;</code></p><p><code>945</code><code>          </code></p><p><code>946</code><code>          </code></p><p><code>947</code><code>          </code></p><p><code>948</code><code>        </code></p><p><code>949</code><code>          </code></p><p><code>950</code><code>        </code></p><p><code>951</code><code>          </code></p><p><code>952</code><code>    &lt;div class="u-vh-full"&gt;</code></p><p><code>953</code><code>          </code></p><p><code>954</code><code>        &lt;a class="c-skip-link" href="#main-content"&gt;</code></p><p><code>955</code><code>Skip to main content&lt;/a&gt;</code></p><p><code>956</code><code>          </code></p><p><code>957</code><code>        </code></p><p><code>958</code><code>            </code></p><p><code>959</code><code>    </code></p><p><code>960</code><code>        &lt;div class="u-hide u-show-following-ad"&gt;</code></p><p><code>961</code><code>&lt;/div&gt;</code></p><p><code>962</code><code>          </code></p><p><code>963</code><code>    </code></p><p><code>964</code><code>    &lt;aside class="adsbox c-ad c-ad--728x90" data-component-mpu&gt;</code></p><p><code>965</code><code>          </code></p><p><code>966</code><code>        &lt;div class="c-ad__inner" &gt;</code></p><p><code>967</code><code>          </code></p><p><code>968</code><code>            &lt;p class="c-ad__label"&gt;</code></p><p><code>969</code><code>Advertisement&lt;/p&gt;</code></p><p><code>970</code><code>          </code></p><p><code>971</code><code>            &lt;div id="div-gpt-ad-LB1"</code></p><p><code>972</code><code>                data-ad-type="LB1"</code></p><p><code>973</code><code>                data-test="LB1-ad"</code></p><p><code>974</code><code>                data-pa11y-ignore</code></p><p><code>975</code><code>                data-gpt</code></p><p><code>976</code><code>                data-gpt-unitpath="/270604982/bmc/breast-cancer-research/articles"</code></p><p><code>977</code><code>                data-gpt-sizes="728x90,970x90"</code></p><p><code>978</code><code>                data-gpt-targeting="pos=LB1;doi=10.1186/s13058-018-1049-0;type=article;kwrd=Disseminated tumor cells,DTC,Dormancy,NR2F1,Bone marrow,Breast cancer,Occult disease,Micrometastasis;pmc=B11001,H33160,H59150;"</code></p><p><code>979</code><code>            &gt;</code></p><p><code>980</code><code>          </code></p><p><code>981</code><code>                &lt;noscript&gt;</code></p><p><code>982</code><code>          </code></p><p><code>983</code><code>                    &lt;a href="//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/breast-cancer-research/articles&amp;amp;sz=728x90,970x90&amp;amp;pos=LB1&amp;amp;doi=10.1186/s13058-018-1049-0&amp;amp;type=article&amp;amp;kwrd=Disseminated tumor cells,DTC,Dormancy,NR2F1,Bone marrow,Breast cancer,Occult disease,Micrometastasis&amp;amp;pmc=B11001,H33160,H59150&amp;amp;"&gt;</code></p><p><code>984</code><code>          </code></p><p><code>985</code><code>                        &lt;img data-test="gpt-advert-fallback-img"</code></p><p><code>986</code><code>                            src="//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/breast-cancer-research/articles&amp;amp;sz=728x90,970x90&amp;amp;pos=LB1&amp;amp;doi=10.1186/s13058-018-1049-0&amp;amp;type=article&amp;amp;kwrd=Disseminated tumor cells,DTC,Dormancy,NR2F1,Bone marrow,Breast cancer,Occult disease,Micrometastasis&amp;amp;pmc=B11001,H33160,H59150&amp;amp;"</code></p><p><code>987</code><code>                            alt="Advertisement"</code></p><p><code>988</code><code>                            width="728"</code></p><p><code>989</code><code>                            height="90"&gt;</code></p><p><code>990</code><code>          </code></p><p><code>991</code><code>                    &lt;/a&gt;</code></p><p><code>992</code><code>          </code></p><p><code>993</code><code>                &lt;/noscript&gt;</code></p><p><code>994</code><code>          </code></p><p><code>995</code><code>            &lt;/div&gt;</code></p><p><code>996</code><code>          </code></p><p><code>997</code><code>        &lt;/div&gt;</code></p><p><code>998</code><code>          </code></p><p><code>999</code><code>    &lt;/aside&gt;</code></p><p><code>1000</code><code>          </code></p><p><code>1001</code><code>          </code></p><p><code>1002</code><code>        </code></p><p><code>1003</code><code>        </code></p><p><code>1004</code><code>          </code></p><p><code>1005</code><code>         </code></p><p><code>1006</code><code>    </code></p><p><code>1007</code><code>        &lt;div id="membership-message-loader-desktop" class="placeholder" data-placeholder="/placeholder/v1/membership/message"&gt;</code></p><p><code>1008</code><code>&lt;/div&gt;</code></p><p><code>1009</code><code>          </code></p><p><code>1010</code><code>    </code></p><p><code>1011</code><code>    </code></p><p><code>1012</code><code>        &lt;div id="top" class="u-position-relative"&gt;</code></p><p><code>1013</code><code>          </code></p><p><code>1014</code><code>    &lt;header class="c-header" data-test="publisher-header"&gt;</code></p><p><code>1015</code><code>          </code></p><p><code>1016</code><code>        &lt;div class="c-header__container"&gt;</code></p><p><code>1017</code><code>          </code></p><p><code>1018</code><code>            &lt;div class="c-header__brand u-mr-48" itemscope itemtype="http://schema.org/Organization" data-test="navbar-logo-header"&gt;</code></p><p><code>1019</code><code>          </code></p><p><code>1020</code><code>                &lt;div class="c-logo"&gt;</code></p><p><code>1021</code><code>          </code></p><p><code>1022</code><code>    &lt;a href="https://www.biomedcentral.com" itemprop="url"&gt;</code></p><p><code>1023</code><code>          </code></p><p><code>1024</code><code>        &lt;img alt="BMC" itemprop="logo" width="76" height="18" role="img" src=/static/images/bmc/logos/logo-bmc-white-aj-be532aa3f0.svg&gt;</code></p><p><code>1025</code><code>          </code></p><p><code>1026</code><code>        &lt;div class="c-logo__strapline"&gt;</code></p><p><code>1027</code><code>          </code></p><p><code>1028</code><code>            &lt;img alt="Part of Springer Nature" width="173" height="16" role="img" src=/static/images/bmc/logos/logo-bmc-white-strapline-sn-f224388d67.svg&gt;</code></p><p><code>1029</code><code>          </code></p><p><code>1030</code><code>        &lt;/div&gt;</code></p><p><code>1031</code><code>          </code></p><p><code>1032</code><code>    &lt;/a&gt;</code></p><p><code>1033</code><code>          </code></p><p><code>1034</code><code>&lt;/div&gt;</code></p><p><code>1035</code><code>          </code></p><p><code>1036</code><code>          </code></p><p><code>1037</code><code>            &lt;/div&gt;</code></p><p><code>1038</code><code>          </code></p><p><code>1039</code><code>            &lt;div class="c-header__navigation"&gt;</code></p><p><code>1040</code><code>          </code></p><p><code>1041</code><code>                &lt;button</code></p><p><code>1042</code><code>                    type="button"</code></p><p><code>1043</code><code>                    class="c-header__link u-button-reset u-mr-24"</code></p><p><code>1044</code><code>                    data-expander</code></p><p><code>1045</code><code>                    data-expander-target="#publisher-header-search"</code></p><p><code>1046</code><code>                    data-expander-autofocus="firstTabbable"</code></p><p><code>1047</code><code>                    data-test="header-search-button"</code></p><p><code>1048</code><code>                    aria-controls="publisher-header-search"</code></p><p><code>1049</code><code>                    aria-expanded="false"&gt;</code></p><p><code>1050</code><code>          </code></p><p><code>1051</code><code>                    &lt;span class="u-display-flex u-align-items-center"&gt;</code></p><p><code>1052</code><code>          </code></p><p><code>1053</code><code>                        &lt;span&gt;</code></p><p><code>1054</code><code>Search&lt;/span&gt;</code></p><p><code>1055</code><code>          </code></p><p><code>1056</code><code>                        &lt;svg class="u-icon u-flex-static u-ml-8" aria-hidden="true" focusable="false"&gt;</code></p><p><code>1057</code><code>          </code></p><p><code>1058</code><code>                            &lt;use xlink:href="#icon-search"&gt;</code></p><p><code>1059</code><code>&lt;/use&gt;</code></p><p><code>1060</code><code>          </code></p><p><code>1061</code><code>                        &lt;/svg&gt;</code></p><p><code>1062</code><code>          </code></p><p><code>1063</code><code>                    &lt;/span&gt;</code></p><p><code>1064</code><code>          </code></p><p><code>1065</code><code>                &lt;/button&gt;</code></p><p><code>1066</code><code>          </code></p><p><code>1067</code><code>                &lt;nav&gt;</code></p><p><code>1068</code><code>          </code></p><p><code>1069</code><code>                    &lt;ul class="c-header__menu" data-enhanced-menu data-test="publisher-navigation"&gt;</code></p><p><code>1070</code><code>          </code></p><p><code>1071</code><code>                        </code></p><p><code>1072</code><code>                            </code></p><p><code>1073</code><code>                                &lt;li class="c-header__item u-hide-at-lt-lg"&gt;</code></p><p><code>1074</code><code>          </code></p><p><code>1075</code><code>                                    &lt;a class="c-header__link"</code></p><p><code>1076</code><code>                                       href="//www.biomedcentral.com/journals"&gt;</code></p><p><code>1077</code><code>          </code></p><p><code>1078</code><code>                                        Explore journals</code></p><p><code>1079</code><code>                                    &lt;/a&gt;</code></p><p><code>1080</code><code>          </code></p><p><code>1081</code><code>                                &lt;/li&gt;</code></p><p><code>1082</code><code>          </code></p><p><code>1083</code><code>                            </code></p><p><code>1084</code><code>                                &lt;li class="c-header__item u-hide-at-lt-lg"&gt;</code></p><p><code>1085</code><code>          </code></p><p><code>1086</code><code>                                    &lt;a class="c-header__link"</code></p><p><code>1087</code><code>                                       href="//www.biomedcentral.com/getpublished"&gt;</code></p><p><code>1088</code><code>          </code></p><p><code>1089</code><code>                                        Get published</code></p><p><code>1090</code><code>                                    &lt;/a&gt;</code></p><p><code>1091</code><code>          </code></p><p><code>1092</code><code>                                &lt;/li&gt;</code></p><p><code>1093</code><code>          </code></p><p><code>1094</code><code>                            </code></p><p><code>1095</code><code>                                &lt;li class="c-header__item u-hide-at-lt-lg"&gt;</code></p><p><code>1096</code><code>          </code></p><p><code>1097</code><code>                                    &lt;a class="c-header__link"</code></p><p><code>1098</code><code>                                       href="//www.biomedcentral.com/about"&gt;</code></p><p><code>1099</code><code>          </code></p><p><code>1100</code><code>                                        About BMC</code></p><p><code>1101</code><code>                                    &lt;/a&gt;</code></p><p><code>1102</code><code>          </code></p><p><code>1103</code><code>                                &lt;/li&gt;</code></p><p><code>1104</code><code>          </code></p><p><code>1105</code><code>                            </code></p><p><code>1106</code><code>                        </code></p><p><code>1107</code><code>                        &lt;li class="c-header__item"&gt;</code></p><p><code>1108</code><code>          </code></p><p><code>1109</code><code>                            &lt;a data-enhanced-account</code></p><p><code>1110</code><code>                               class="c-header__link"</code></p><p><code>1111</code><code>                               href="https://www.biomedcentral.com/account"</code></p><p><code>1112</code><code>                               data-test="login-link"&gt;</code></p><p><code>1113</code><code>          </code></p><p><code>1114</code><code>                                My account</code></p><p><code>1115</code><code>                            &lt;/a&gt;</code></p><p><code>1116</code><code>          </code></p><p><code>1117</code><code>                        &lt;/li&gt;</code></p><p><code>1118</code><code>          </code></p><p><code>1119</code><code>                    &lt;/ul&gt;</code></p><p><code>1120</code><code>          </code></p><p><code>1121</code><code>                &lt;/nav&gt;</code></p><p><code>1122</code><code>          </code></p><p><code>1123</code><code>            &lt;/div&gt;</code></p><p><code>1124</code><code>          </code></p><p><code>1125</code><code>        &lt;/div&gt;</code></p><p><code>1126</code><code>          </code></p><p><code>1127</code><code>    &lt;/header&gt;</code></p><p><code>1128</code><code>          </code></p><p><code>1129</code><code>    &lt;div class="c-popup-search u-js-hide" id="publisher-header-search"&gt;</code></p><p><code>1130</code><code>          </code></p><p><code>1131</code><code>        &lt;div class="u-container"&gt;</code></p><p><code>1132</code><code>          </code></p><p><code>1133</code><code>            &lt;div class="c-popup-search__container"&gt;</code></p><p><code>1134</code><code>          </code></p><p><code>1135</code><code>                &lt;div class="ctx-search"&gt;</code></p><p><code>1136</code><code>          </code></p><p><code>1137</code><code>    &lt;form role="search" class="c-form-field js-skip-validation" method="GET" action="//www.biomedcentral.com/search" data-track="submit"</code></p><p><code>1138</code><code>        data-track-category="Search and Results" data-track-action="Submit search" data-dynamic-track-label data-track-label="" data-test="global-search"&gt;</code></p><p><code>1139</code><code>          </code></p><p><code>1140</code><code>        &lt;label for="publisherSearch" class="c-form-field__label"&gt;</code></p><p><code>1141</code><code>Search all BMC articles&lt;/label&gt;</code></p><p><code>1142</code><code>          </code></p><p><code>1143</code><code>        &lt;div class="u-display-flex"&gt;</code></p><p><code>1144</code><code>          </code></p><p><code>1145</code><code>            &lt;input id="publisherSearch" class="c-form-field__input" data-search-input autocomplete="off" role="textbox" data-test="search-input" name="query" type="text" value=""/&gt;</code></p><p><code>1146</code><code>          </code></p><p><code>1147</code><code>            &lt;div&gt;</code></p><p><code>1148</code><code>          </code></p><p><code>1149</code><code>                &lt;button class="u-button" type="submit" data-test="search-submit-button"&gt;</code></p><p><code>1150</code><code>          </code></p><p><code>1151</code><code>    &lt;span class="u-visually-hidden"&gt;</code></p><p><code>1152</code><code>Search&lt;/span&gt;</code></p><p><code>1153</code><code>          </code></p><p><code>1154</code><code>    &lt;svg class="u-icon u-flex-static" width="16" height="16" aria-hidden="true" focusable="false"&gt;</code></p><p><code>1155</code><code>          </code></p><p><code>1156</code><code>        &lt;use xlink:href="#icon-search"&gt;</code></p><p><code>1157</code><code>&lt;/use&gt;</code></p><p><code>1158</code><code>          </code></p><p><code>1159</code><code>    &lt;/svg&gt;</code></p><p><code>1160</code><code>          </code></p><p><code>1161</code><code>&lt;/button&gt;</code></p><p><code>1162</code><code>          </code></p><p><code>1163</code><code>          </code></p><p><code>1164</code><code>          </code></p><p><code>1165</code><code>            &lt;/div&gt;</code></p><p><code>1166</code><code>          </code></p><p><code>1167</code><code>        &lt;/div&gt;</code></p><p><code>1168</code><code>          </code></p><p><code>1169</code><code>        &lt;input type="hidden" name="searchType" value="publisherSearch"/&gt;</code></p><p><code>1170</code><code>          </code></p><p><code>1171</code><code>    &lt;/form&gt;</code></p><p><code>1172</code><code>          </code></p><p><code>1173</code><code>&lt;/div&gt;</code></p><p><code>1174</code><code>          </code></p><p><code>1175</code><code>          </code></p><p><code>1176</code><code>            &lt;/div&gt;</code></p><p><code>1177</code><code>          </code></p><p><code>1178</code><code>        &lt;/div&gt;</code></p><p><code>1179</code><code>          </code></p><p><code>1180</code><code>    &lt;/div&gt;</code></p><p><code>1181</code><code>          </code></p><p><code>1182</code><code>&lt;/div&gt;</code></p><p><code>1183</code><code>          </code></p><p><code>1184</code><code>          </code></p><p><code>1185</code><code>    </code></p><p><code>1186</code><code>          </code></p><p><code>1187</code><code>        </code></p><p><code>1188</code><code>            &lt;header class="c-journal-header c-journal-header--breast-cancer-research ctx-journal-header"&gt;</code></p><p><code>1189</code><code>          </code></p><p><code>1190</code><code>                &lt;div class="u-container"&gt;</code></p><p><code>1191</code><code>          </code></p><p><code>1192</code><code>                    &lt;div class="c-journal-header__inner "&gt;</code></p><p><code>1193</code><code>          </code></p><p><code>1194</code><code>                        </code></p><p><code>1195</code><code>                        &lt;div class="c-journal-title" id="journalTitle"&gt;</code></p><p><code>1196</code><code>          </code></p><p><code>1197</code><code>                            &lt;a href="/"&gt;</code></p><p><code>1198</code><code>          </code></p><p><code>1199</code><code>    </code></p><p><code>1200</code><code>        </code></p><p><code>1201</code><code>    </code></p><p><code>1202</code><code>    &lt;span class="c-journal-title__text "&gt;</code></p><p><code>1203</code><code>Breast Cancer Research&lt;/span&gt;</code></p><p><code>1204</code><code>          </code></p><p><code>1205</code><code>    </code></p><p><code>1206</code><code>&lt;/a&gt;</code></p><p><code>1207</code><code>          </code></p><p><code>1208</code><code>                        &lt;/div&gt;</code></p><p><code>1209</code><code>          </code></p><p><code>1210</code><code>                        </code></p><p><code>1211</code><code>                    &lt;/div&gt;</code></p><p><code>1212</code><code>          </code></p><p><code>1213</code><code>                &lt;/div&gt;</code></p><p><code>1214</code><code>          </code></p><p><code>1215</code><code>                &lt;div class="c-navbar c-navbar--with-submit-button"&gt;</code></p><p><code>1216</code><code>          </code></p><p><code>1217</code><code>                    &lt;div class="c-navbar__container"&gt;</code></p><p><code>1218</code><code>          </code></p><p><code>1219</code><code>                        </code></p><p><code>1220</code><code>                            &lt;div class="c-navbar__content"&gt;</code></p><p><code>1221</code><code>          </code></p><p><code>1222</code><code>                                &lt;nav class="c-navbar__nav"&gt;</code></p><p><code>1223</code><code>          </code></p><p><code>1224</code><code>                                    &lt;ul class="c-navbar__nav c-navbar__nav--journal" role="menu" data-test="site-navigation"&gt;</code></p><p><code>1225</code><code>          </code></p><p><code>1226</code><code>                                        </code></p><p><code>1227</code><code>                                            &lt;li class="c-navbar__item" role="menuitem"&gt;</code></p><p><code>1228</code><code>          </code></p><p><code>1229</code><code>                                                &lt;a class="c-navbar__link" data-track="click" data-track-category="Home" data-track-action="Clicked journal navigation link" href='/'&gt;</code></p><p><code>1230</code><code>Home&lt;/a&gt;</code></p><p><code>1231</code><code>          </code></p><p><code>1232</code><code>                                            &lt;/li&gt;</code></p><p><code>1233</code><code>          </code></p><p><code>1234</code><code>                                        </code></p><p><code>1235</code><code>                                            &lt;li class="c-navbar__item" role="menuitem"&gt;</code></p><p><code>1236</code><code>          </code></p><p><code>1237</code><code>                                                &lt;a class="c-navbar__link" data-track="click" data-track-category="About" data-track-action="Clicked journal navigation link" href='/about'&gt;</code></p><p><code>1238</code><code>About&lt;/a&gt;</code></p><p><code>1239</code><code>          </code></p><p><code>1240</code><code>                                            &lt;/li&gt;</code></p><p><code>1241</code><code>          </code></p><p><code>1242</code><code>                                        </code></p><p><code>1243</code><code>                                            &lt;li class="c-navbar__item" role="menuitem"&gt;</code></p><p><code>1244</code><code>          </code></p><p><code>1245</code><code>                                                &lt;a class="c-navbar__link c-navbar__link--is-shown" data-track="click" data-track-category="Articles" data-track-action="Clicked journal navigation link" href='/articles'&gt;</code></p><p><code>1246</code><code>Articles&lt;/a&gt;</code></p><p><code>1247</code><code>          </code></p><p><code>1248</code><code>                                            &lt;/li&gt;</code></p><p><code>1249</code><code>          </code></p><p><code>1250</code><code>                                        </code></p><p><code>1251</code><code>                                            &lt;li class="c-navbar__item" role="menuitem"&gt;</code></p><p><code>1252</code><code>          </code></p><p><code>1253</code><code>                                                &lt;a class="c-navbar__link" data-track="click" data-track-category="Submission Guidelines" data-track-action="Clicked journal navigation link" href='/submission-guidelines'&gt;</code></p><p><code>1254</code><code>Submission Guidelines&lt;/a&gt;</code></p><p><code>1255</code><code>          </code></p><p><code>1256</code><code>                                            &lt;/li&gt;</code></p><p><code>1257</code><code>          </code></p><p><code>1258</code><code>                                        </code></p><p><code>1259</code><code>                                        </code></p><p><code>1260</code><code>                                            </code></p><p><code>1261</code><code>                                                &lt;li class="c-navbar__item" role="menuitem" data-test="journal-header-submit-button"&gt;</code></p><p><code>1262</code><code>          </code></p><p><code>1263</code><code>                                                    </code></p><p><code>1264</code><code>    </code></p><p><code>1265</code><code>          </code></p><p><code>1266</code><code>    </code></p><p><code>1267</code><code>        &lt;div class=""&gt;</code></p><p><code>1268</code><code>          </code></p><p><code>1269</code><code>            </code></p><p><code>1270</code><code>        &lt;a class="u-button u-button--tertiary u-button--alt-colour-on-mobile" href="https://submission.nature.com/new-submission/13058/3"</code></p><p><code>1271</code><code>           data-track="click"</code></p><p><code>1272</code><code>           data-track-action="manuscript submission"</code></p><p><code>1273</code><code>           </code></p><p><code>1274</code><code>           data-track-category="article"</code></p><p><code>1275</code><code>           data-track-label="button in journal nav"</code></p><p><code>1276</code><code>           </code></p><p><code>1277</code><code>           data-track-external</code></p><p><code>1278</code><code>           data-test="submit-manuscript-button"&gt;</code></p><p><code>1279</code><code>Submit manuscript&lt;svg class="u-ml-8" width="15" height="16" aria-hidden="true" focusable="false"&gt;</code></p><p><code>1280</code><code>&lt;use xlink:href="#icon-submit-open"&gt;</code></p><p><code>1281</code><code>&lt;/use&gt;</code></p><p><code>1282</code><code>&lt;/svg&gt;</code></p><p><code>1283</code><code>&lt;/a&gt;</code></p><p><code>1284</code><code>          </code></p><p><code>1285</code><code>    </code></p><p><code>1286</code><code>        &lt;/div&gt;</code></p><p><code>1287</code><code>          </code></p><p><code>1288</code><code>    </code></p><p><code>1289</code><code>          </code></p><p><code>1290</code><code>          </code></p><p><code>1291</code><code>                                                &lt;/li&gt;</code></p><p><code>1292</code><code>          </code></p><p><code>1293</code><code>                                            </code></p><p><code>1294</code><code>                                        </code></p><p><code>1295</code><code>                                    &lt;/ul&gt;</code></p><p><code>1296</code><code>          </code></p><p><code>1297</code><code>                                &lt;/nav&gt;</code></p><p><code>1298</code><code>          </code></p><p><code>1299</code><code>                            &lt;/div&gt;</code></p><p><code>1300</code><code>          </code></p><p><code>1301</code><code>                        </code></p><p><code>1302</code><code>                    &lt;/div&gt;</code></p><p><code>1303</code><code>          </code></p><p><code>1304</code><code>                &lt;/div&gt;</code></p><p><code>1305</code><code>          </code></p><p><code>1306</code><code>                &lt;div class="c-journal-header__identity c-journal-header__identity--midnight-purple"&gt;</code></p><p><code>1307</code><code>          </code></p><p><code>1308</code><code>                    </code></p><p><code>1309</code><code>                &lt;/div&gt;</code></p><p><code>1310</code><code>          </code></p><p><code>1311</code><code>            &lt;/header&gt;</code></p><p><code>1312</code><code>          </code></p><p><code>1313</code><code>            </code></p><p><code>1314</code><code>        </code></p><p><code>1315</code><code>          </code></p><p><code>1316</code><code>        &lt;div class="u-container u-mt-32 u-mb-32 u-clearfix" id="main-content" data-component="article-container"&gt;</code></p><p><code>1317</code><code>          </code></p><p><code>1318</code><code>            &lt;main class="c-article-main-column u-float-left js-main-column" data-track-component="article body"&gt;</code></p><p><code>1319</code><code>          </code></p><p><code>1320</code><code>                &lt;div class="c-context-bar u-hide"</code></p><p><code>1321</code><code>                     data-test="context-bar"</code></p><p><code>1322</code><code>                     data-context-bar</code></p><p><code>1323</code><code>                     aria-hidden="true"&gt;</code></p><p><code>1324</code><code>          </code></p><p><code>1325</code><code>                    &lt;div class="c-context-bar__container u-container"&gt;</code></p><p><code>1326</code><code>          </code></p><p><code>1327</code><code>                        &lt;div class="c-context-bar__title"&gt;</code></p><p><code>1328</code><code>          </code></p><p><code>1329</code><code>                            NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients</code></p><p><code>1330</code><code>                        &lt;/div&gt;</code></p><p><code>1331</code><code>          </code></p><p><code>1332</code><code>                        &lt;div class="c-pdf-container"&gt;</code></p><p><code>1333</code><code>          </code></p><p><code>1334</code><code>                            </code></p><p><code>1335</code><code>    &lt;div class="c-pdf-download u-clear-both"&gt;</code></p><p><code>1336</code><code>          </code></p><p><code>1337</code><code>        &lt;a href="//breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/s13058-018-1049-0.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true"  data-readcube-pdf-url="true" data-test="pdf-link" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-label="link" data-track-external download&gt;</code></p><p><code>1338</code><code>          </code></p><p><code>1339</code><code>            &lt;span class="c-pdf-download__text"&gt;</code></p><p><code>1340</code><code>Download PDF&lt;/span&gt;</code></p><p><code>1341</code><code>          </code></p><p><code>1342</code><code>            &lt;svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"&gt;</code></p><p><code>1343</code><code>&lt;use xlink:href="#icon-download"/&gt;</code></p><p><code>1344</code><code>&lt;/svg&gt;</code></p><p><code>1345</code><code>          </code></p><p><code>1346</code><code>        &lt;/a&gt;</code></p><p><code>1347</code><code>          </code></p><p><code>1348</code><code>    &lt;/div&gt;</code></p><p><code>1349</code><code>          </code></p><p><code>1350</code><code>          </code></p><p><code>1351</code><code>                            </code></p><p><code>1352</code><code>                        &lt;/div&gt;</code></p><p><code>1353</code><code>          </code></p><p><code>1354</code><code>                    &lt;/div&gt;</code></p><p><code>1355</code><code>          </code></p><p><code>1356</code><code>                &lt;/div&gt;</code></p><p><code>1357</code><code>          </code></p><p><code>1358</code><code>          </code></p><p><code>1359</code><code>                &lt;div class="c-pdf-button__container u-hide-at-lg js-context-bar-sticky-point-mobile"&gt;</code></p><p><code>1360</code><code>          </code></p><p><code>1361</code><code>                    &lt;div class="c-pdf-container"&gt;</code></p><p><code>1362</code><code>          </code></p><p><code>1363</code><code>                        </code></p><p><code>1364</code><code>    &lt;div class="c-pdf-download u-clear-both"&gt;</code></p><p><code>1365</code><code>          </code></p><p><code>1366</code><code>        &lt;a href="//breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/s13058-018-1049-0.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true"  data-readcube-pdf-url="true" data-test="pdf-link" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-label="link" data-track-external download&gt;</code></p><p><code>1367</code><code>          </code></p><p><code>1368</code><code>            &lt;span class="c-pdf-download__text"&gt;</code></p><p><code>1369</code><code>Download PDF&lt;/span&gt;</code></p><p><code>1370</code><code>          </code></p><p><code>1371</code><code>            &lt;svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"&gt;</code></p><p><code>1372</code><code>&lt;use xlink:href="#icon-download"/&gt;</code></p><p><code>1373</code><code>&lt;/svg&gt;</code></p><p><code>1374</code><code>          </code></p><p><code>1375</code><code>        &lt;/a&gt;</code></p><p><code>1376</code><code>          </code></p><p><code>1377</code><code>    &lt;/div&gt;</code></p><p><code>1378</code><code>          </code></p><p><code>1379</code><code>          </code></p><p><code>1380</code><code>                        </code></p><p><code>1381</code><code>                    &lt;/div&gt;</code></p><p><code>1382</code><code>          </code></p><p><code>1383</code><code>                &lt;/div&gt;</code></p><p><code>1384</code><code>          </code></p><p><code>1385</code><code>                &lt;article lang="en"&gt;</code></p><p><code>1386</code><code>          </code></p><p><code>1387</code><code>                    &lt;div class="c-article-header"&gt;</code></p><p><code>1388</code><code>          </code></p><p><code>1389</code><code>                        </code></p><p><code>1390</code><code>    </code></p><p><code>1391</code><code>          </code></p><p><code>1392</code><code>          </code></p><p><code>1393</code><code>                        &lt;ul class="c-article-identifiers" data-test="article-identifier"&gt;</code></p><p><code>1394</code><code>          </code></p><p><code>1395</code><code>                            &lt;li class="c-article-identifiers__item" data-test="article-category"&gt;</code></p><p><code>1396</code><code>Short report&lt;/li&gt;</code></p><p><code>1397</code><code>          </code></p><p><code>1398</code><code>                            </code></p><p><code>1399</code><code>    </code></p><p><code>1400</code><code>        &lt;li class="c-article-identifiers__item"&gt;</code></p><p><code>1401</code><code>          </code></p><p><code>1402</code><code>            &lt;a href="https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research" data-track="click" data-track-action="open access" data-track-label="link" class="u-color-open-access" data-test="open-access"&gt;</code></p><p><code>1403</code><code>Open Access&lt;/a&gt;</code></p><p><code>1404</code><code>          </code></p><p><code>1405</code><code>        &lt;/li&gt;</code></p><p><code>1406</code><code>          </code></p><p><code>1407</code><code>    </code></p><p><code>1408</code><code>    </code></p><p><code>1409</code><code>          </code></p><p><code>1410</code><code>                            &lt;li class="c-article-identifiers__item"&gt;</code></p><p><code>1411</code><code>&lt;a href="#article-info" data-track="click" data-track-action="publication date" data-track-label="link"&gt;</code></p><p><code>1412</code><code>Published: &lt;time datetime="2018-10-16"&gt;</code></p><p><code>1413</code><code>16 October 2018&lt;/time&gt;</code></p><p><code>1414</code><code>&lt;/a&gt;</code></p><p><code>1415</code><code>&lt;/li&gt;</code></p><p><code>1416</code><code>          </code></p><p><code>1417</code><code>                        &lt;/ul&gt;</code></p><p><code>1418</code><code>          </code></p><p><code>1419</code><code>          </code></p><p><code>1420</code><code>                        &lt;h1 class="c-article-title" data-test="article-title" data-article-title=""&gt;</code></p><p><code>1421</code><code>NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients&lt;/h1&gt;</code></p><p><code>1422</code><code>          </code></p><p><code>1423</code><code>                        &lt;ul class="c-article-author-list c-article-author-list--short" data-test="authors-list" data-component-authors-activator="authors-list"&gt;</code></p><p><code>1424</code><code>&lt;li class="c-article-author-list__item"&gt;</code></p><p><code>1425</code><code>&lt;a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Elin-Borgen-Aff1" data-author-popup="auth-Elin-Borgen-Aff1"&gt;</code></p><p><code>1426</code><code>Elin Borgen&lt;/a&gt;</code></p><p><code>1427</code><code>&lt;sup class="u-js-hide"&gt;</code></p><p><code>1428</code><code>&lt;a href="#Aff1"&gt;</code></p><p><code>1429</code><code>1&lt;/a&gt;</code></p><p><code>1430</code><code>&lt;/sup&gt;</code></p><p><code>1431</code><code>&lt;sup class="u-js-hide"&gt;</code></p><p><code>1432</code><code> &lt;a href="#na1"&gt;</code></p><p><code>1433</code><code>na1&lt;/a&gt;</code></p><p><code>1434</code><code>&lt;/sup&gt;</code></p><p><code>1435</code><code>, &lt;/li&gt;</code></p><p><code>1436</code><code>&lt;li class="c-article-author-list__item"&gt;</code></p><p><code>1437</code><code>&lt;a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Maria_C_-Rypdal-Aff1" data-author-popup="auth-Maria_C_-Rypdal-Aff1"&gt;</code></p><p><code>1438</code><code>Maria C. Rypdal&lt;/a&gt;</code></p><p><code>1439</code><code>&lt;sup class="u-js-hide"&gt;</code></p><p><code>1440</code><code>&lt;a href="#Aff1"&gt;</code></p><p><code>1441</code><code>1&lt;/a&gt;</code></p><p><code>1442</code><code>&lt;/sup&gt;</code></p><p><code>1443</code><code>&lt;sup class="u-js-hide"&gt;</code></p><p><code>1444</code><code> &lt;a href="#na1"&gt;</code></p><p><code>1445</code><code>na1&lt;/a&gt;</code></p><p><code>1446</code><code>&lt;/sup&gt;</code></p><p><code>1447</code><code>, &lt;/li&gt;</code></p><p><code>1448</code><code>&lt;li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"&gt;</code></p><p><code>1449</code><code>&lt;a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Maria_Soledad-Sosa-Aff2-Aff3" data-author-popup="auth-Maria_Soledad-Sosa-Aff2-Aff3"&gt;</code></p><p><code>1450</code><code>Maria Soledad Sosa&lt;/a&gt;</code></p><p><code>1451</code><code>&lt;sup class="u-js-hide"&gt;</code></p><p><code>1452</code><code>&lt;a href="#Aff2"&gt;</code></p><p><code>1453</code><code>2&lt;/a&gt;</code></p><p><code>1454</code><code>,&lt;a href="#Aff3"&gt;</code></p><p><code>1455</code><code>3&lt;/a&gt;</code></p><p><code>1456</code><code>&lt;/sup&gt;</code></p><p><code>1457</code><code>&lt;sup class="u-js-hide"&gt;</code></p><p><code>1458</code><code> &lt;a href="#na1"&gt;</code></p><p><code>1459</code><code>na1&lt;/a&gt;</code></p><p><code>1460</code><code>&lt;/sup&gt;</code></p><p><code>1461</code><code>, &lt;/li&gt;</code></p><p><code>1462</code><code>&lt;li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"&gt;</code></p><p><code>1463</code><code>&lt;a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Anne-Renolen-Aff1" data-author-popup="auth-Anne-Renolen-Aff1"&gt;</code></p><p><code>1464</code><code>Anne Renolen&lt;/a&gt;</code></p><p><code>1465</code><code>&lt;sup class="u-js-hide"&gt;</code></p><p><code>1466</code><code>&lt;a href="#Aff1"&gt;</code></p><p><code>1467</code><code>1&lt;/a&gt;</code></p><p><code>1468</code><code>&lt;/sup&gt;</code></p><p><code>1469</code><code>, &lt;/li&gt;</code></p><p><code>1470</code><code>&lt;li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"&gt;</code></p><p><code>1471</code><code>&lt;a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Ellen-Schlichting-Aff4" data-author-popup="auth-Ellen-Schlichting-Aff4"&gt;</code></p><p><code>1472</code><code>Ellen Schlichting&lt;/a&gt;</code></p><p><code>1473</code><code>&lt;sup class="u-js-hide"&gt;</code></p><p><code>1474</code><code>&lt;a href="#Aff4"&gt;</code></p><p><code>1475</code><code>4&lt;/a&gt;</code></p><p><code>1476</code><code>&lt;/sup&gt;</code></p><p><code>1477</code><code>, &lt;/li&gt;</code></p><p><code>1478</code><code>&lt;li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"&gt;</code></p><p><code>1479</code><code>&lt;a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Per_E_-L_nning-Aff5-Aff6" data-author-popup="auth-Per_E_-L_nning-Aff5-Aff6"&gt;</code></p><p><code>1480</code><code>Per E. Lønning&lt;/a&gt;</code></p><p><code>1481</code><code>&lt;sup class="u-js-hide"&gt;</code></p><p><code>1482</code><code>&lt;a href="#Aff5"&gt;</code></p><p><code>1483</code><code>5&lt;/a&gt;</code></p><p><code>1484</code><code>,&lt;a href="#Aff6"&gt;</code></p><p><code>1485</code><code>6&lt;/a&gt;</code></p><p><code>1486</code><code>&lt;/sup&gt;</code></p><p><code>1487</code><code>, &lt;/li&gt;</code></p><p><code>1488</code><code>&lt;li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"&gt;</code></p><p><code>1489</code><code>&lt;a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Marit-Synnestvedt-Aff7" data-author-popup="auth-Marit-Synnestvedt-Aff7"&gt;</code></p><p><code>1490</code><code>Marit Synnestvedt&lt;/a&gt;</code></p><p><code>1491</code><code>&lt;sup class="u-js-hide"&gt;</code></p><p><code>1492</code><code>&lt;a href="#Aff7"&gt;</code></p><p><code>1493</code><code>7&lt;/a&gt;</code></p><p><code>1494</code><code>&lt;/sup&gt;</code></p><p><code>1495</code><code>, &lt;/li&gt;</code></p><p><code>1496</code><code>&lt;li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"&gt;</code></p><p><code>1497</code><code>&lt;a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Julio_A_-Aguirre_Ghiso-Aff3" data-author-popup="auth-Julio_A_-Aguirre_Ghiso-Aff3" data-corresp-id="c1"&gt;</code></p><p><code>1498</code><code>Julio A. Aguirre-Ghiso&lt;svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"&gt;</code></p><p><code>1499</code><code>&lt;use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-email"&gt;</code></p><p><code>1500</code><code>&lt;/use&gt;</code></p><p><code>1501</code><code>&lt;/svg&gt;</code></p><p><code>1502</code><code>&lt;/a&gt;</code></p><p><code>1503</code><code>&lt;sup class="u-js-hide"&gt;</code></p><p><code>1504</code><code>&lt;a href="#Aff3"&gt;</code></p><p><code>1505</code><code>3&lt;/a&gt;</code></p><p><code>1506</code><code>&lt;/sup&gt;</code></p><p><code>1507</code><code>&lt;sup class="u-js-hide"&gt;</code></p><p><code>1508</code><code> &lt;a href="#na1"&gt;</code></p><p><code>1509</code><code>na1&lt;/a&gt;</code></p><p><code>1510</code><code>&lt;/sup&gt;</code></p><p><code>1511</code><code> &amp;amp; &lt;/li&gt;</code></p><p><code>1512</code><code>&lt;li class="c-article-author-list__show-more" aria-label="Show all 9 authors for this article" title="Show all 9 authors for this article"&gt;</code></p><p><code>1513</code><code>…&lt;/li&gt;</code></p><p><code>1514</code><code>&lt;li class="c-article-author-list__item"&gt;</code></p><p><code>1515</code><code>&lt;a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Bj_rn-Naume-Aff7-Aff8" data-author-popup="auth-Bj_rn-Naume-Aff7-Aff8" data-corresp-id="c2"&gt;</code></p><p><code>1516</code><code>Bjørn Naume&lt;svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"&gt;</code></p><p><code>1517</code><code>&lt;use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-email"&gt;</code></p><p><code>1518</code><code>&lt;/use&gt;</code></p><p><code>1519</code><code>&lt;/svg&gt;</code></p><p><code>1520</code><code>&lt;/a&gt;</code></p><p><code>1521</code><code>&lt;sup class="u-js-hide"&gt;</code></p><p><code>1522</code><code>&lt;a href="#Aff7"&gt;</code></p><p><code>1523</code><code>7&lt;/a&gt;</code></p><p><code>1524</code><code>,&lt;a href="#Aff8"&gt;</code></p><p><code>1525</code><code>8&lt;/a&gt;</code></p><p><code>1526</code><code>&lt;/sup&gt;</code></p><p><code>1527</code><code>&lt;sup class="u-js-hide"&gt;</code></p><p><code>1528</code><code> &lt;a href="#na1"&gt;</code></p><p><code>1529</code><code>na1&lt;/a&gt;</code></p><p><code>1530</code><code>&lt;/sup&gt;</code></p><p><code>1531</code><code> &lt;/li&gt;</code></p><p><code>1532</code><code>&lt;/ul&gt;</code></p><p><code>1533</code><code>&lt;button aria-expanded="false" class="c-article-author-list__button"&gt;</code></p><p><code>1534</code><code>&lt;svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"&gt;</code></p><p><code>1535</code><code>&lt;use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-plus"&gt;</code></p><p><code>1536</code><code>&lt;/use&gt;</code></p><p><code>1537</code><code>&lt;/svg&gt;</code></p><p><code>1538</code><code>&lt;span&gt;</code></p><p><code>1539</code><code>Show authors&lt;/span&gt;</code></p><p><code>1540</code><code>&lt;/button&gt;</code></p><p><code>1541</code><code>          </code></p><p><code>1542</code><code>                        &lt;p class="c-article-info-details" data-container-section="info"&gt;</code></p><p><code>1543</code><code>          </code></p><p><code>1544</code><code>                            </code></p><p><code>1545</code><code>    &lt;a data-test="journal-link" href="/" data-track="click" data-track-action="journal homepage" data-track-category="article body" data-track-label="link"&gt;</code></p><p><code>1546</code><code>&lt;i data-test="journal-title"&gt;</code></p><p><code>1547</code><code>Breast Cancer Research&lt;/i&gt;</code></p><p><code>1548</code><code>&lt;/a&gt;</code></p><p><code>1549</code><code>          </code></p><p><code>1550</code><code>          </code></p><p><code>1551</code><code>                            &lt;b data-test="journal-volume"&gt;</code></p><p><code>1552</code><code>&lt;span class="u-visually-hidden"&gt;</code></p><p><code>1553</code><code>volume&lt;/span&gt;</code></p><p><code>1554</code><code> 20&lt;/b&gt;</code></p><p><code>1555</code><code>, Article number: &lt;span data-test="article-number"&gt;</code></p><p><code>1556</code><code>120&lt;/span&gt;</code></p><p><code>1557</code><code> (&lt;span data-test="article-publication-year"&gt;</code></p><p><code>1558</code><code>2018&lt;/span&gt;</code></p><p><code>1559</code><code>)</code></p><p><code>1560</code><code>            &lt;a href="#citeas" class="c-article-info-details__cite-as u-hide-print" data-track="click" data-track-action="cite this article" data-track-label="link"&gt;</code></p><p><code>1561</code><code>Cite this article&lt;/a&gt;</code></p><p><code>1562</code><code>          </code></p><p><code>1563</code><code>                        &lt;/p&gt;</code></p><p><code>1564</code><code>          </code></p><p><code>1565</code><code>                        </code></p><p><code>1566</code><code>        &lt;div class="c-article-metrics-bar__wrapper u-clear-both"&gt;</code></p><p><code>1567</code><code>          </code></p><p><code>1568</code><code>            &lt;ul class="c-article-metrics-bar u-list-reset"&gt;</code></p><p><code>1569</code><code>          </code></p><p><code>1570</code><code>                </code></p><p><code>1571</code><code>                    &lt;li class=" c-article-metrics-bar__item"&gt;</code></p><p><code>1572</code><code>          </code></p><p><code>1573</code><code>                        &lt;p class="c-article-metrics-bar__count"&gt;</code></p><p><code>1574</code><code>6504 &lt;span class="c-article-metrics-bar__label"&gt;</code></p><p><code>1575</code><code>Accesses&lt;/span&gt;</code></p><p><code>1576</code><code>&lt;/p&gt;</code></p><p><code>1577</code><code>          </code></p><p><code>1578</code><code>                    &lt;/li&gt;</code></p><p><code>1579</code><code>          </code></p><p><code>1580</code><code>                </code></p><p><code>1581</code><code>                </code></p><p><code>1582</code><code>                    &lt;li class="c-article-metrics-bar__item"&gt;</code></p><p><code>1583</code><code>          </code></p><p><code>1584</code><code>                        &lt;p class="c-article-metrics-bar__count"&gt;</code></p><p><code>1585</code><code>60 &lt;span class="c-article-metrics-bar__label"&gt;</code></p><p><code>1586</code><code>Citations&lt;/span&gt;</code></p><p><code>1587</code><code>&lt;/p&gt;</code></p><p><code>1588</code><code>          </code></p><p><code>1589</code><code>                    &lt;/li&gt;</code></p><p><code>1590</code><code>          </code></p><p><code>1591</code><code>                </code></p><p><code>1592</code><code>                </code></p><p><code>1593</code><code>                    </code></p><p><code>1594</code><code>                        &lt;li class="c-article-metrics-bar__item"&gt;</code></p><p><code>1595</code><code>          </code></p><p><code>1596</code><code>                            &lt;p class="c-article-metrics-bar__count"&gt;</code></p><p><code>1597</code><code>86 &lt;span class="c-article-metrics-bar__label"&gt;</code></p><p><code>1598</code><code>Altmetric&lt;/span&gt;</code></p><p><code>1599</code><code>&lt;/p&gt;</code></p><p><code>1600</code><code>          </code></p><p><code>1601</code><code>                        &lt;/li&gt;</code></p><p><code>1602</code><code>          </code></p><p><code>1603</code><code>                    </code></p><p><code>1604</code><code>                </code></p><p><code>1605</code><code>                &lt;li class="c-article-metrics-bar__item"&gt;</code></p><p><code>1606</code><code>          </code></p><p><code>1607</code><code>                    &lt;p class="c-article-metrics-bar__details"&gt;</code></p><p><code>1608</code><code>&lt;a href="/articles/10.1186/s13058-018-1049-0/metrics" data-track="click" data-track-action="view metrics" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>1609</code><code>Metrics &lt;span class="u-visually-hidden"&gt;</code></p><p><code>1610</code><code>details&lt;/span&gt;</code></p><p><code>1611</code><code>&lt;/a&gt;</code></p><p><code>1612</code><code>&lt;/p&gt;</code></p><p><code>1613</code><code>          </code></p><p><code>1614</code><code>                &lt;/li&gt;</code></p><p><code>1615</code><code>          </code></p><p><code>1616</code><code>            &lt;/ul&gt;</code></p><p><code>1617</code><code>          </code></p><p><code>1618</code><code>        &lt;/div&gt;</code></p><p><code>1619</code><code>          </code></p><p><code>1620</code><code>    </code></p><p><code>1621</code><code>                        </code></p><p><code>1622</code><code>                        </code></p><p><code>1623</code><code>    </code></p><p><code>1624</code><code>          </code></p><p><code>1625</code><code>    </code></p><p><code>1626</code><code>          </code></p><p><code>1627</code><code>                        </code></p><p><code>1628</code><code>                    &lt;/div&gt;</code></p><p><code>1629</code><code>          </code></p><p><code>1630</code><code>          </code></p><p><code>1631</code><code>                    &lt;section aria-labelledby="Abs1" data-title="Abstract" lang="en"&gt;</code></p><p><code>1632</code><code>&lt;div class="c-article-section" id="Abs1-section"&gt;</code></p><p><code>1633</code><code>&lt;h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Abs1"&gt;</code></p><p><code>1634</code><code>Abstract&lt;/h2&gt;</code></p><p><code>1635</code><code>&lt;div class="c-article-section__content" id="Abs1-content"&gt;</code></p><p><code>1636</code><code>&lt;h3 class="c-article__sub-heading" data-test="abstract-sub-heading"&gt;</code></p><p><code>1637</code><code>Background&lt;/h3&gt;</code></p><p><code>1638</code><code>&lt;p&gt;</code></p><p><code>1639</code><code>The presence of disseminated tumor cells (DTCs) in bone marrow (BM) is an independent prognostic factor in early breast cancer but does not uniformly predict outcome. Tumor cells can persist in a quiescent state over time, but clinical studies of markers predicting the awakening potential of DTCs are lacking. Recently, experiments have shown that NR2F1 (COUP-TF1) plays a key role in dormancy signaling.&lt;/p&gt;</code></p><p><code>1640</code><code>&lt;h3 class="c-article__sub-heading" data-test="abstract-sub-heading"&gt;</code></p><p><code>1641</code><code>Methods&lt;/h3&gt;</code></p><p><code>1642</code><code>&lt;p&gt;</code></p><p><code>1643</code><code>We analyzed the NR2F1 expression in DTCs by double immunofluorescence (DIF) staining of extra cytospins prepared from 114 BM samples from 86 selected DTC-positive breast cancer patients. Samples collected at two or more time points were available for 24 patients. Fifteen samples were also analyzed for the proliferation marker Ki67.&lt;/p&gt;</code></p><p><code>1644</code><code>&lt;h3 class="c-article__sub-heading" data-test="abstract-sub-heading"&gt;</code></p><p><code>1645</code><code>Results&lt;/h3&gt;</code></p><p><code>1646</code><code>&lt;p&gt;</code></p><p><code>1647</code><code>Of the patients with detectable DTCs by DIF, 27% had ≥ 50% NR2F1&lt;sup&gt;</code></p><p><code>1648</code><code>high&lt;/sup&gt;</code></p><p><code>1649</code><code> DTCs, chosen a priori as the cut-off for “dormant profile” classification. All patients with systemic relapse within 12 months after BM aspiration carried ≤ 1% NR2F1&lt;sup&gt;</code></p><p><code>1650</code><code>high&lt;/sup&gt;</code></p><p><code>1651</code><code> DTCs, including patients who transitioned from having NR2F1&lt;sup&gt;</code></p><p><code>1652</code><code>high&lt;/sup&gt;</code></p><p><code>1653</code><code>-expressing DTCs in previous BM samples. Of the patients with serial samples, half of those with no relapse at follow-up had ≥ 50% NR2F1&lt;sup&gt;</code></p><p><code>1654</code><code>high&lt;/sup&gt;</code></p><p><code>1655</code><code> DTCs in the last BM aspiration analyzed. Among the 18 relapse-free patients at the time of the last DTC-positive BM aspiration with no subsequent BM analysis performed, distant disease-free intervals were favorable for patients carrying ≥ 50% NR2F1&lt;sup&gt;</code></p><p><code>1656</code><code>high&lt;/sup&gt;</code></p><p><code>1657</code><code> DTCs compared with those with predominantly NR2F1&lt;sup&gt;</code></p><p><code>1658</code><code>low&lt;/sup&gt;</code></p><p><code>1659</code><code> DTCs (&lt;i&gt;</code></p><p><code>1660</code><code>p&lt;/i&gt;</code></p><p><code>1661</code><code> = 0.007, log-rank). No survival difference was observed by classification according to Ki67-expressing DTCs (&lt;i&gt;</code></p><p><code>1662</code><code>p&lt;/i&gt;</code></p><p><code>1663</code><code> = 0.520).&lt;/p&gt;</code></p><p><code>1664</code><code>&lt;h3 class="c-article__sub-heading" data-test="abstract-sub-heading"&gt;</code></p><p><code>1665</code><code>Conclusions&lt;/h3&gt;</code></p><p><code>1666</code><code>&lt;p&gt;</code></p><p><code>1667</code><code>Our study translates findings from basic biological analysis of DTC dormancy to the clinical situation and supports further clinical studies of NR2F1 as a marker of dormancy.&lt;/p&gt;</code></p><p><code>1668</code><code>&lt;/div&gt;</code></p><p><code>1669</code><code>&lt;/div&gt;</code></p><p><code>1670</code><code>&lt;/section&gt;</code></p><p><code>1671</code><code>          </code></p><p><code>1672</code><code>                    </code></p><p><code>1673</code><code>    </code></p><p><code>1674</code><code>          </code></p><p><code>1675</code><code>          </code></p><p><code>1676</code><code>                    &lt;section data-title="Background"&gt;</code></p><p><code>1677</code><code>&lt;div class="c-article-section" id="Sec1-section"&gt;</code></p><p><code>1678</code><code>&lt;h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec1"&gt;</code></p><p><code>1679</code><code>Background&lt;/h2&gt;</code></p><p><code>1680</code><code>&lt;div class="c-article-section__content" id="Sec1-content"&gt;</code></p><p><code>1681</code><code>&lt;p&gt;</code></p><p><code>1682</code><code>Breast cancer patients may experience relapse and subsequent death from the disease many years after primary treatment. This indicates an ability of occult cancer cells to survive in a non- or slow-proliferating state, retaining a potential for progression and proliferation at a later time point [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Linde N, Fluegen G, Aguirre-Ghiso JA. The relationship between dormant cancer cells and their microenvironment. Adv Cancer Res. 2016;132:45–71." href="/articles/10.1186/s13058-018-1049-0#ref-CR1" id="ref-link-section-d33543424e961"&gt;</code></p><p><code>1683</code><code>1&lt;/a&gt;</code></p><p><code>1684</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Aguirre-Ghiso JA, Bragado P, Sosa MS. Metastasis awakening: targeting dormant cancer. Nat Med. 2013;19(3):276–7." href="/articles/10.1186/s13058-018-1049-0#ref-CR2" id="ref-link-section-d33543424e964"&gt;</code></p><p><code>1685</code><code>2&lt;/a&gt;</code></p><p><code>1686</code><code>]. The window of time represented by such minimal residual disease (MRD) represents a possibility for therapeutic intervention to prevent development of future metastasis rather than treat overt metastasis. However, the biology of the population of residual disseminated tumor cells (DTCs) is poorly understood. Large studies have shown the presence of DTCs in bone marrow (BM) to be a strong predictor of recurrence over the next 5 years [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med. 2005;353(8):793–802." href="/articles/10.1186/s13058-018-1049-0#ref-CR3" id="ref-link-section-d33543424e967"&gt;</code></p><p><code>1687</code><code>3&lt;/a&gt;</code></p><p><code>1688</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Janni W, Vogl FD, Wiedswang G, Synnestvedt M, Fehm T, Juckstock J, Borgen E, Rack B, Braun S, Sommer H, et al. Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse—a European pooled analysis. Clin Cancer Res. 2011;17(9):2967–76." href="/articles/10.1186/s13058-018-1049-0#ref-CR4" id="ref-link-section-d33543424e970"&gt;</code></p><p><code>1689</code><code>4&lt;/a&gt;</code></p><p><code>1690</code><code>]. However, about 60% of the DTC-positive patients remained relapse-free until the end of the follow-up period. Consequently, there is an urgent need for markers to disclose the functional state of DTCs and evaluate their progression potential. Such markers may help us to understand the biology of dormant DTCs in patients and as decision-making tools for current and new therapies.&lt;/p&gt;</code></p><p><code>1691</code><code>&lt;p&gt;</code></p><p><code>1692</code><code>Our experimental model studies of DTC dormancy revealed that NR2F1, an orphan nuclear receptor of the retinoic acid receptor family, is commonly downregulated in human cancer and metastatic tissues [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Adam AP, George A, Schewe D, Bragado P, Iglesias BV, Ranganathan AC, Kourtidis A, Conklin DS, Aguirre-Ghiso JA. Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence. Cancer Res. 2009;69(14):5664–72." href="#ref-CR5" id="ref-link-section-d33543424e976"&gt;</code></p><p><code>1693</code><code>5&lt;/a&gt;</code></p><p><code>1694</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="#ref-CR6" id="ref-link-section-d33543424e976_1"&gt;</code></p><p><code>1695</code><code>6&lt;/a&gt;</code></p><p><code>1696</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Sosa MS. Dormancy programs as emerging antimetastasis therapeutic alternatives. Mol Cell Oncol. 2016;3(1):e1029062." href="/articles/10.1186/s13058-018-1049-0#ref-CR7" id="ref-link-section-d33543424e979"&gt;</code></p><p><code>1697</code><code>7&lt;/a&gt;</code></p><p><code>1698</code><code>]. In contrast, in a PDX model of squamous carcinoma, NR2F1 was upregulated in the DTCs that entered spontaneous dormancy [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e982"&gt;</code></p><p><code>1699</code><code>6&lt;/a&gt;</code></p><p><code>1700</code><code>], and additional results suggested that NR2F1 may pinpoint dormant DTCs in different cancer types [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e985"&gt;</code></p><p><code>1701</code><code>6&lt;/a&gt;</code></p><p><code>1702</code><code>]. DTC analysis in the experimental models indicated that when 40–50% of DTCs displayed nuclear NR2F1, this correlated with quiescence markers, other dormancy markers such as DEC2 and SOX9, and lack of proliferation [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e988"&gt;</code></p><p><code>1703</code><code>6&lt;/a&gt;</code></p><p><code>1704</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Fluegen G, Avivar-Valderas A, Wang Y, Padgen MR, Williams JK, Nobre AR, Calvo V, Cheung JF, Bravo-Cordero JJ, Entenberg D, et al. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat Cell Biol. 2017;19(2):120–32." href="/articles/10.1186/s13058-018-1049-0#ref-CR8" id="ref-link-section-d33543424e992"&gt;</code></p><p><code>1705</code><code>8&lt;/a&gt;</code></p><p><code>1706</code><code>]. In addition, a frequency of less than 20% of DTCs positive for NR2F1 correlated with a lack of expression of the above markers of dormancy, quiescence, and proliferation. Metastatic and local recurrence samples in head and neck squamous cell carcinoma that clearly escaped dormancy showed less than 5% of tumor cells positive for NR2F1 (supplementing data in [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e995"&gt;</code></p><p><code>1707</code><code>6&lt;/a&gt;</code></p><p><code>1708</code><code>]). Furthermore, dormant DTCs upregulated genes linked to NR2F1 signaling, including several retinoic acid-regulated genes [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e998"&gt;</code></p><p><code>1709</code><code>6&lt;/a&gt;</code></p><p><code>1710</code><code>]. In prostate cancer samples, we found that 43–47% of DTCs from patients with no evidence of disease after many years of relapse-free follow-up showed NR2F1 mRNA upregulation, compared with 10% of the DTCs in advanced prostate cancer [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e1001"&gt;</code></p><p><code>1711</code><code>6&lt;/a&gt;</code></p><p><code>1712</code><code>]. Altogether, these results support further testing of NR2F1 as a dormancy marker in solitary DTCs from clinical samples, including assessment of cut-off values to classify patients according to NR2F1 expression.&lt;/p&gt;</code></p><p><code>1713</code><code>&lt;p&gt;</code></p><p><code>1714</code><code>Three Norwegian early breast cancer cohorts were previously analyzed for DTCs in the BM [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Mathiesen RR, Borgen E, Renolen A, Lokkevik E, Nesland JM, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, et al. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival. Breast Cancer Res. 2012;14(4):R117." href="#ref-CR9" id="ref-link-section-d33543424e1007"&gt;</code></p><p><code>1715</code><code>9&lt;/a&gt;</code></p><p><code>1716</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Wiedswang G, Borgen E, Karesen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol. 2003;21(18):3469–78." href="#ref-CR10" id="ref-link-section-d33543424e1007_1"&gt;</code></p><p><code>1717</code><code>10&lt;/a&gt;</code></p><p><code>1718</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Wiedswang G, Borgen E, Karesen R, Qvist H, Janbu J, Kvalheim G, Nesland JM, Naume B. Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome. Clin Cancer Res. 2004;10(16):5342–8." href="#ref-CR11" id="ref-link-section-d33543424e1007_2"&gt;</code></p><p><code>1719</code><code>11&lt;/a&gt;</code></p><p><code>1720</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Naume B, Synnestvedt M, Falk RS, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Sommer HH, et al. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer. J Clin Oncol. 2014;32(34):3848–57." href="#ref-CR12" id="ref-link-section-d33543424e1007_3"&gt;</code></p><p><code>1721</code><code>12&lt;/a&gt;</code></p><p><code>1722</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Chrisanthar R, Knappskog S, Lokkevik E, Anker G, Ostenstad B, Lundgren S, Berge EO, Risberg T, Mjaaland I, Maehle L, et al. CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer. PLoS One. 2008;3(8):e3062." href="#ref-CR13" id="ref-link-section-d33543424e1007_4"&gt;</code></p><p><code>1723</code><code>13&lt;/a&gt;</code></p><p><code>1724</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Chrisanthar R, Knappskog S, Lokkevik E, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Skjonsberg G, Aas T, et al. Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel. PLoS One. 2011;6(4):e19249." href="/articles/10.1186/s13058-018-1049-0#ref-CR14" id="ref-link-section-d33543424e1010"&gt;</code></p><p><code>1725</code><code>14&lt;/a&gt;</code></p><p><code>1726</code><code>] using the standard immunocytochemical method (standard ICC) [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Borgen E, Naume B, Nesland JM, Kvalheim G, Beiske K, Fodstad O, Diel I, Solomayer EF, Theocharous P, Coombes RC, et al. Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. Establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy. 1999;1(5):377–88." href="/articles/10.1186/s13058-018-1049-0#ref-CR15" id="ref-link-section-d33543424e1013"&gt;</code></p><p><code>1727</code><code>15&lt;/a&gt;</code></p><p><code>1728</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Fehm T, Braun S, Muller V, Janni W, Gebauer G, Marth C, Schindlbeck C, Wallwiener D, Borgen E, Naume B, et al. A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer. 2006;107(5):885–92." href="/articles/10.1186/s13058-018-1049-0#ref-CR16" id="ref-link-section-d33543424e1016"&gt;</code></p><p><code>1729</code><code>16&lt;/a&gt;</code></p><p><code>1730</code><code>]. Clinical follow-up identified the presence of DTCs to be a significant, independent predictor of unfavorable outcome [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Mathiesen RR, Borgen E, Renolen A, Lokkevik E, Nesland JM, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, et al. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival. Breast Cancer Res. 2012;14(4):R117." href="#ref-CR9" id="ref-link-section-d33543424e1019"&gt;</code></p><p><code>1731</code><code>9&lt;/a&gt;</code></p><p><code>1732</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Wiedswang G, Borgen E, Karesen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol. 2003;21(18):3469–78." href="#ref-CR10" id="ref-link-section-d33543424e1019_1"&gt;</code></p><p><code>1733</code><code>10&lt;/a&gt;</code></p><p><code>1734</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Wiedswang G, Borgen E, Karesen R, Qvist H, Janbu J, Kvalheim G, Nesland JM, Naume B. Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome. Clin Cancer Res. 2004;10(16):5342–8." href="#ref-CR11" id="ref-link-section-d33543424e1019_2"&gt;</code></p><p><code>1735</code><code>11&lt;/a&gt;</code></p><p><code>1736</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Naume B, Synnestvedt M, Falk RS, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Sommer HH, et al. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer. J Clin Oncol. 2014;32(34):3848–57." href="/articles/10.1186/s13058-018-1049-0#ref-CR12" id="ref-link-section-d33543424e1023"&gt;</code></p><p><code>1737</code><code>12&lt;/a&gt;</code></p><p><code>1738</code><code>]. To explore the functional state of the DTCs, we optimized double immunofluorescence (DIF) protocols for detection of NR2F1 and Ki67 on DTCs and analyzed selected BM samples from these three breast cancer cohorts with comparison to clinical parameters. Our study is the first to translate findings from basic biological mechanism analysis of DTC dormancy to the clinical situation.&lt;/p&gt;</code></p><p><code>1739</code><code>&lt;/div&gt;</code></p><p><code>1740</code><code>&lt;/div&gt;</code></p><p><code>1741</code><code>&lt;/section&gt;</code></p><p><code>1742</code><code>&lt;section data-title="Materials and methods"&gt;</code></p><p><code>1743</code><code>&lt;div class="c-article-section" id="Sec2-section"&gt;</code></p><p><code>1744</code><code>&lt;h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec2"&gt;</code></p><p><code>1745</code><code>Materials and methods&lt;/h2&gt;</code></p><p><code>1746</code><code>&lt;div class="c-article-section__content" id="Sec2-content"&gt;</code></p><p><code>1747</code><code>&lt;h3 class="c-article__sub-heading" id="Sec3"&gt;</code></p><p><code>1748</code><code>Breast cancer patient cohorts&lt;/h3&gt;</code></p><p><code>1749</code><code>&lt;p&gt;</code></p><p><code>1750</code><code>The patient material includes cytospins with BM mononuclear cells (MNCs) from breast cancer patients included in one of three different Norwegian studies in the period from 1995 to 2008. An overview of the studies and included patients is presented in Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig1"&gt;</code></p><p><code>1751</code><code>1&lt;/a&gt;</code></p><p><code>1752</code><code>, and below.&lt;/p&gt;</code></p><p><code>1753</code><code>&lt;div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-1" data-title="Fig. 1"&gt;</code></p><p><code>1754</code><code>&lt;figure&gt;</code></p><p><code>1755</code><code>&lt;figcaption&gt;</code></p><p><code>1756</code><code>&lt;b id="Fig1" class="c-article-section__figure-caption" data-test="figure-caption-text"&gt;</code></p><p><code>1757</code><code>Fig. 1&lt;/b&gt;</code></p><p><code>1758</code><code>&lt;/figcaption&gt;</code></p><p><code>1759</code><code>&lt;div class="c-article-section__figure-content"&gt;</code></p><p><code>1760</code><code>&lt;div class="c-article-section__figure-item"&gt;</code></p><p><code>1761</code><code>&lt;a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/s13058-018-1049-0/figures/1" rel="nofollow"&gt;</code></p><p><code>1762</code><code>&lt;picture&gt;</code></p><p><code>1763</code><code>&lt;source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_Fig1_HTML.png?as=webp"&gt;</code></p><p><code>1764</code><code>&lt;img aria-describedby="Fig1" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_Fig1_HTML.png" alt="figure 1" loading="lazy" width="685" height="470"&gt;</code></p><p><code>1765</code><code>&lt;/picture&gt;</code></p><p><code>1766</code><code>&lt;/a&gt;</code></p><p><code>1767</code><code>&lt;/div&gt;</code></p><p><code>1768</code><code>&lt;div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-1-desc"&gt;</code></p><p><code>1769</code><code>&lt;p&gt;</code></p><p><code>1770</code><code>Clinical studies overview. Overview of the clinical studies, number of patients, and number of samples analyzed by DIF in the present study. Bone marrow aspiration (BMA) time points are indicated, as well as therapy administered. *One patient had a BMA performed at an unknown time point; however not harboring any disseminated tumor cells (DTC) by DIF. ER estrogen receptor&lt;/p&gt;</code></p><p><code>1771</code><code>&lt;/div&gt;</code></p><p><code>1772</code><code>&lt;/div&gt;</code></p><p><code>1773</code><code>&lt;div class="u-text-right u-hide-print"&gt;</code></p><p><code>1774</code><code>&lt;a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/s13058-018-1049-0/figures/1" data-track-dest="link:Figure1 Full size image" aria-label="Full size image figure 1" rel="nofollow"&gt;</code></p><p><code>1775</code><code>&lt;span&gt;</code></p><p><code>1776</code><code>Full size image&lt;/span&gt;</code></p><p><code>1777</code><code>&lt;svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"&gt;</code></p><p><code>1778</code><code>&lt;use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-chevron-right"&gt;</code></p><p><code>1779</code><code>&lt;/use&gt;</code></p><p><code>1780</code><code>&lt;/svg&gt;</code></p><p><code>1781</code><code>&lt;/a&gt;</code></p><p><code>1782</code><code>&lt;/div&gt;</code></p><p><code>1783</code><code>&lt;/figure&gt;</code></p><p><code>1784</code><code>&lt;/div&gt;</code></p><p><code>1785</code><code>&lt;p&gt;</code></p><p><code>1786</code><code>The NeoTax study enrolled 260 patients with stage III/IV breast cancer between 1997 and 2003 and randomly allocated them to treatment with paclitaxel or epirubicin, with a crossover between treatment arms if there was no response [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Mathiesen RR, Borgen E, Renolen A, Lokkevik E, Nesland JM, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, et al. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival. Breast Cancer Res. 2012;14(4):R117." href="/articles/10.1186/s13058-018-1049-0#ref-CR9" id="ref-link-section-d33543424e1061"&gt;</code></p><p><code>1787</code><code>9&lt;/a&gt;</code></p><p><code>1788</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Chrisanthar R, Knappskog S, Lokkevik E, Anker G, Ostenstad B, Lundgren S, Berge EO, Risberg T, Mjaaland I, Maehle L, et al. CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer. PLoS One. 2008;3(8):e3062." href="/articles/10.1186/s13058-018-1049-0#ref-CR13" id="ref-link-section-d33543424e1064"&gt;</code></p><p><code>1789</code><code>13&lt;/a&gt;</code></p><p><code>1790</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Chrisanthar R, Knappskog S, Lokkevik E, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Skjonsberg G, Aas T, et al. Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel. PLoS One. 2011;6(4):e19249." href="/articles/10.1186/s13058-018-1049-0#ref-CR14" id="ref-link-section-d33543424e1067"&gt;</code></p><p><code>1791</code><code>14&lt;/a&gt;</code></p><p><code>1792</code><code>]. Stage IV patients were included only if they harbored a locally advanced disease (T3/T4 and/or N2/N3) with limited distant metastases. After chemotherapy, mastectomy with axillary clearance was performed, followed by radiotherapy and antihormonal therapy when estrogen receptor (ER)-positive. BM aspirations for DTC analysis were performed prior to the start of chemotherapy (BM1), at surgery (BM2), and 12 months after randomization (BM3).&lt;/p&gt;</code></p><p><code>1793</code><code>&lt;p&gt;</code></p><p><code>1794</code><code>The Oslo1 observational study enrolled 920 patients with stage I/II breast cancer between 1995 and 1998, and submitted them to standard adjuvant therapy, antihormonal therapy, and radiotherapy according to Norwegian guidelines at the time of the study. BM aspirations for DTC analysis were performed at surgery (BM1), and after 3 years of follow-up (for about one-third of the patients; BM2) [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="Wiedswang G, Borgen E, Karesen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol. 2003;21(18):3469–78." href="/articles/10.1186/s13058-018-1049-0#ref-CR10" id="ref-link-section-d33543424e1073"&gt;</code></p><p><code>1795</code><code>10&lt;/a&gt;</code></p><p><code>1796</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Wiedswang G, Borgen E, Karesen R, Qvist H, Janbu J, Kvalheim G, Nesland JM, Naume B. Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome. Clin Cancer Res. 2004;10(16):5342–8." href="/articles/10.1186/s13058-018-1049-0#ref-CR11" id="ref-link-section-d33543424e1076"&gt;</code></p><p><code>1797</code><code>11&lt;/a&gt;</code></p><p><code>1798</code><code>].&lt;/p&gt;</code></p><p><code>1799</code><code>&lt;p&gt;</code></p><p><code>1800</code><code>The SATT study [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Naume B, Synnestvedt M, Falk RS, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Sommer HH, et al. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer. J Clin Oncol. 2014;32(34):3848–57." href="/articles/10.1186/s13058-018-1049-0#ref-CR12" id="ref-link-section-d33543424e1082"&gt;</code></p><p><code>1801</code><code>12&lt;/a&gt;</code></p><p><code>1802</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Synnestvedt M, Borgen E, Wist E, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Schirmer C, et al. Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study. BMC Cancer. 2012;12:616." href="/articles/10.1186/s13058-018-1049-0#ref-CR17" id="ref-link-section-d33543424e1085"&gt;</code></p><p><code>1803</code><code>17&lt;/a&gt;</code></p><p><code>1804</code><code>] enrolled 1121 patients with operable breast cancer between 2003 and 2008. In addition to chemotherapy, patients received antihormonal therapy, radiotherapy, and from 2005 also herceptin if HER2-positive, according to Norwegian guidelines at the time of the study. Patients who had completed six cycles of standard adjuvant fluorouracil, epirubicin, and cyclophosphamide (FEC) chemotherapy underwent BM aspiration 2 to 3 months (BM1) and 8 to 9 months (BM2) after FEC. The presence of DTCs in BM was determined by immunocytochemistry. If one or more DTCs were present at BM2, six cycles of docetaxel (100 mg/m&lt;sup&gt;</code></p><p><code>1805</code><code>2&lt;/sup&gt;</code></p><p><code>1806</code><code>, once every 3 weeks) were administered, followed by DTC analysis 1 and 13 months after the last docetaxel infusion (BM3 and BM4).&lt;/p&gt;</code></p><p><code>1807</code><code>&lt;h3 class="c-article__sub-heading" id="Sec4"&gt;</code></p><p><code>1808</code><code>Preparation of bone marrow mononuclear cell samples and cytospins&lt;/h3&gt;</code></p><p><code>1809</code><code>&lt;p&gt;</code></p><p><code>1810</code><code>Bone marrow was aspirated in heparin (1000 IE/ml; 0.5 ml per 10 ml BM) from iliac crests bilaterally under local anesthesia (5–10 ml per site) and pooled into one tube. The samples were stored at room temperature until processing within 24 h. The aspirates were diluted 1:1 in phosphate-buffered saline (PBS; Gibco, Life Technologies) and separated by density centrifugation using Lymphoprep (Axis-Shield, Oslo, Norway). Mononuclear cells were collected from the interphase layer, washed in 1% fetal calf serum in PBS (Gibco), and resuspended to 1 × 10&lt;sup&gt;</code></p><p><code>1811</code><code>6&lt;/sup&gt;</code></p><p><code>1812</code><code> cells/mL. Cytospins were prepared by centrifugation of the BM MNCs down to poly-&lt;span class="u-small-caps"&gt;</code></p><p><code>1813</code><code>l&lt;/span&gt;</code></p><p><code>1814</code><code>-lysine-coated glass slides (5 × 10&lt;sup&gt;</code></p><p><code>1815</code><code>5&lt;/sup&gt;</code></p><p><code>1816</code><code> MNCs/slide) in a Hettich cytocentrifuge (Tutlingen, Germany), air-dried at room temperature overnight, and stored at −80 °C until immunostaining.&lt;/p&gt;</code></p><p><code>1817</code><code>&lt;h3 class="c-article__sub-heading" id="Sec5"&gt;</code></p><p><code>1818</code><code>Patient material&lt;/h3&gt;</code></p><p><code>1819</code><code>&lt;p&gt;</code></p><p><code>1820</code><code>For all the studies, the large majority of DTC-positive samples had only one detectable DTC in the original standard ICC analysis. A minority of the original samples contained ≥ 2–5 up to several thousand DTCs. For the present study, stored frozen cytospins prepared in parallel to the cytospins used for the initial (original) analysis were used when available. For some samples, viable BM MNCs stored in liquid nitrogen were thawed and new cytospins were prepared. To increase the chance of detecting DTCs in the study samples, we primarily selected patients having ≥ 3 DTCs per 2 × 10&lt;sup&gt;</code></p><p><code>1821</code><code>6&lt;/sup&gt;</code></p><p><code>1822</code><code> BM MNCs by the original DTC analysis. However, patients with 0–2 DTCs were also included. When available, we prioritized BM from patients where successive samples over time were available. For some patients, no more spare BM was available for the present analysis. Normally, two cytospins containing in total 1 × 10&lt;sup&gt;</code></p><p><code>1823</code><code>6&lt;/sup&gt;</code></p><p><code>1824</code><code> BM MNCs with adequate staining quality were analyzed for NR2F1 and for Ki67. The staining of samples and scoring of Ki67 and NR2F1 were performed by EB and MCR without access to the clinical database for the trials or information about time to relapse.&lt;/p&gt;</code></p><p><code>1825</code><code>&lt;p&gt;</code></p><p><code>1826</code><code>Based on this, the present study included cytospins of BM MNCs from a total of 86 patients categorized as DTC-positive by the original “gold standard” DTC analysis performed prospectively within the original studies (DTC-positivity in at least one original sample if more than one BM aspiration was performed; ICC APAAP technique, four cytospins, 2 × 10&lt;sup&gt;</code></p><p><code>1827</code><code>6&lt;/sup&gt;</code></p><p><code>1828</code><code> BM MNCs analyzed) [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Borgen E, Naume B, Nesland JM, Kvalheim G, Beiske K, Fodstad O, Diel I, Solomayer EF, Theocharous P, Coombes RC, et al. Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. Establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy. 1999;1(5):377–88." href="/articles/10.1186/s13058-018-1049-0#ref-CR15" id="ref-link-section-d33543424e1122"&gt;</code></p><p><code>1829</code><code>15&lt;/a&gt;</code></p><p><code>1830</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Fehm T, Braun S, Muller V, Janni W, Gebauer G, Marth C, Schindlbeck C, Wallwiener D, Borgen E, Naume B, et al. A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer. 2006;107(5):885–92." href="/articles/10.1186/s13058-018-1049-0#ref-CR16" id="ref-link-section-d33543424e1125"&gt;</code></p><p><code>1831</code><code>16&lt;/a&gt;</code></p><p><code>1832</code><code>], of which 13 were included in Oslo1, 38 in the NeoTax study, and 35 in the SATT study (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig1"&gt;</code></p><p><code>1833</code><code>1&lt;/a&gt;</code></p><p><code>1834</code><code>). For 24 of these patients, successive analyses from two or three time points were analyzed (20 at two time points and 4 at three time points). Samples from 11 patients with no detectable DTCs by the original DTC analysis were also included. In total, 127 samples were analyzed (all presented in Additional file &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM1"&gt;</code></p><p><code>1835</code><code>1&lt;/a&gt;</code></p><p><code>1836</code><code>: Table S1).&lt;/p&gt;</code></p><p><code>1837</code><code>&lt;h3 class="c-article__sub-heading" id="Sec6"&gt;</code></p><p><code>1838</code><code>NR2F1/Ki67 and AE1AE3 double immunofluorescence staining protocol&lt;/h3&gt;</code></p><p><code>1839</code><code>&lt;p&gt;</code></p><p><code>1840</code><code>Double immunofluorescence was performed using the broad-specter anticytokeratin (anti-CK) monoclonal antibodies (mAbs) AE1/AE3 combined with anti-COUP TF1/NR2F1 for expression of dormancy. From a selection of the samples, parallel (additional) cytospins were available and DIF was performed using anti-CK mAbs AE1/AE3 combined with the marker Ki67 for proliferation expression. Cytospins (0.5 × 10&lt;sup&gt;</code></p><p><code>1841</code><code>6&lt;/sup&gt;</code></p><p><code>1842</code><code> MNCs/slide) were fixed for 12 min in methanol/acetone (1:1) at room temperature and briefly air-dried, permeabilized in Triton X-100 (0.1% in PBS (DPBS Gibco-CaCl&lt;sub&gt;</code></p><p><code>1843</code><code>2&lt;/sub&gt;</code></p><p><code>1844</code><code>/MgCl&lt;sub&gt;</code></p><p><code>1845</code><code>2&lt;/sub&gt;</code></p><p><code>1846</code><code>)) for 7 min, followed by a wash in PBS. The slides were then incubated for 45 min with one of the following mAbs: NR2F1 Anti-COUP TF1 (Abcam Ab 41,858; 10 μg/mL) or anti-Ki67 clone MIB-1 (DAKO M7240; 1.15 μg/mL). They were subsequently labelled with Alexa Fluor 488 goat anti-mouse IgG (H + L) (Molecular Probes 11029; 4 μg/mL) and incubated for 45 min. To block for cross-reactions (Ki67) the slides were then incubated with a mouse mAb MOPC21 (Sigma-Aldrich M9269; 20 μg/mL) for 20 min. Finally, a combination of the two anti-CK mAbs AE1 and AE3 (Chemicon Millipore mAbs 1611/1612) were added, fluorescently labelled by Zenon 555 (2 μg of the AE1/AE3 combination per slide was labeled by the Zenon 555 mouse IgG labeling kit (Life technologies Molecular Probes, Z25005) diluted to 20 μg/mL), and the slides were incubated for 45 min. Slides were washed 2 × 5 min in PBS, then sealed with ProLong Gold antifade reagent with DAPI (Life technologies P36931) and cover-slipped. Throughout the protocol, the slides were washed 2 × 5 min in PBS after each antibody incubation step. All antibodies were diluted in PBS/ 0.5% Tween20/ 5% normal goat serum. Cytospins (0.5 × 10&lt;sup&gt;</code></p><p><code>1847</code><code>6&lt;/sup&gt;</code></p><p><code>1848</code><code> MNCs/slide) spiked with 1% MCF7 or SKBR3 breast cancer cell line cells were used as positive controls for the anti-CK staining and for optimization of the DIF protocols. Among the normal BM cells in the patient cytospins there were both Ki67-positive cells and cells with 0–5 small NR2F1 signals (see a more detailed description below), serving as internal positive controls for the NR2F1 staining.&lt;/p&gt;</code></p><p><code>1849</code><code>&lt;h3 class="c-article__sub-heading" id="Sec7"&gt;</code></p><p><code>1850</code><code>Scoring of individual DTCs and NR2F1/Ki67 expression&lt;/h3&gt;</code></p><p><code>1851</code><code>&lt;p&gt;</code></p><p><code>1852</code><code>Stained cells were identified by manual screening in a Leica Microsystems DMI6000B fluorescence microscope, using 20×, 40×, and 63× objectives. Only AE1/AE3-positive cells with a morphology compatible with tumor cells were scored as DTCs [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Borgen E, Naume B, Nesland JM, Kvalheim G, Beiske K, Fodstad O, Diel I, Solomayer EF, Theocharous P, Coombes RC, et al. Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. Establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy. 1999;1(5):377–88." href="/articles/10.1186/s13058-018-1049-0#ref-CR15" id="ref-link-section-d33543424e1159"&gt;</code></p><p><code>1853</code><code>15&lt;/a&gt;</code></p><p><code>1854</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Fehm T, Braun S, Muller V, Janni W, Gebauer G, Marth C, Schindlbeck C, Wallwiener D, Borgen E, Naume B, et al. A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer. 2006;107(5):885–92." href="/articles/10.1186/s13058-018-1049-0#ref-CR16" id="ref-link-section-d33543424e1162"&gt;</code></p><p><code>1855</code><code>16&lt;/a&gt;</code></p><p><code>1856</code><code>].&lt;/p&gt;</code></p><p><code>1857</code><code>&lt;p&gt;</code></p><p><code>1858</code><code>The definitions of DTC as either NR2F1&lt;sup&gt;</code></p><p><code>1859</code><code>low&lt;/sup&gt;</code></p><p><code>1860</code><code> or NR2F1&lt;sup&gt;</code></p><p><code>1861</code><code>high&lt;/sup&gt;</code></p><p><code>1862</code><code> used in this study were determined prior to starting the screening of the patient samples. When optimizing the AE1AE3/NR2F1 DIF protocol we observed that a large majority (&amp;gt; 99%) of normal blood and BM MNCs showed from zero up to two small NR2F1 nuclear localization signals (Additional file &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM2"&gt;</code></p><p><code>1863</code><code>2&lt;/a&gt;</code></p><p><code>1864</code><code>: Figure S1), and only occasionally did normal BM cells harbor up to five small signals. In contrast, in MCF7 and SKBR3 breast cancer cell line cells, and in test patient samples harboring many DTCs, a range from zero up to many, often large, irregular NR2F1 nuclear localization signals were observed, often with an appearance compatible with localization in the nucleoli (Additional file &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM2"&gt;</code></p><p><code>1865</code><code>2&lt;/a&gt;</code></p><p><code>1866</code><code>: Figure S1); in some DTCs cytoplasmic signals could also be observed. From our previous immunofluorescence experience in experimental models and cell lines in vivo [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e1178"&gt;</code></p><p><code>1867</code><code>6&lt;/a&gt;</code></p><p><code>1868</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Fluegen G, Avivar-Valderas A, Wang Y, Padgen MR, Williams JK, Nobre AR, Calvo V, Cheung JF, Bravo-Cordero JJ, Entenberg D, et al. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat Cell Biol. 2017;19(2):120–32." href="/articles/10.1186/s13058-018-1049-0#ref-CR8" id="ref-link-section-d33543424e1182"&gt;</code></p><p><code>1869</code><code>8&lt;/a&gt;</code></p><p><code>1870</code><code>] we have defined NR2F1&lt;sup&gt;</code></p><p><code>1871</code><code>high&lt;/sup&gt;</code></p><p><code>1872</code><code> cells as cells with a strong NR2F1 signal detected in all the nuclear area (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig2"&gt;</code></p><p><code>1873</code><code>2a&lt;/a&gt;</code></p><p><code>1874</code><code>, first row) or deposited as dotted or large irregular nucleolar-like signals (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig2"&gt;</code></p><p><code>1875</code><code>2a&lt;/a&gt;</code></p><p><code>1876</code><code>, second row). In proliferative human and experimental tumors, the NR2F1 signal is either negative (no signal at all) or a weak speckled signal, except in certain areas that are hypoxic [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Fluegen G, Avivar-Valderas A, Wang Y, Padgen MR, Williams JK, Nobre AR, Calvo V, Cheung JF, Bravo-Cordero JJ, Entenberg D, et al. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat Cell Biol. 2017;19(2):120–32." href="/articles/10.1186/s13058-018-1049-0#ref-CR8" id="ref-link-section-d33543424e1193"&gt;</code></p><p><code>1877</code><code>8&lt;/a&gt;</code></p><p><code>1878</code><code>]. Based on these data from both experimental studies and testing on MCF7 and SKBR3-spiked normal MNCs, we defined as NR2F1&lt;sup&gt;</code></p><p><code>1879</code><code>low&lt;/sup&gt;</code></p><p><code>1880</code><code>a range of NR2F1 immunostaining from entirely negative up to five small signals as seen in normal MNCs (Additional files &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM2"&gt;</code></p><p><code>1881</code><code>2&lt;/a&gt;</code></p><p><code>1882</code><code> and &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM3"&gt;</code></p><p><code>1883</code><code>3&lt;/a&gt;</code></p><p><code>1884</code><code>: Figures S1 and S2). A NR2F1 staining &amp;gt; 5 small signals and/or large signals (≥ 1), and/or the presence of signal clusters defined DTCs as NR2F1&lt;sup&gt;</code></p><p><code>1885</code><code>high&lt;/sup&gt;</code></p><p><code>1886</code><code> (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig2"&gt;</code></p><p><code>1887</code><code>2&lt;/a&gt;</code></p><p><code>1888</code><code>, Additional files &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM6"&gt;</code></p><p><code>1889</code><code>2&lt;/a&gt;</code></p><p><code>1890</code><code> and &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM3"&gt;</code></p><p><code>1891</code><code>7&lt;/a&gt;</code></p><p><code>1892</code><code>: Figures S1 and S2).&lt;/p&gt;</code></p><p><code>1893</code><code>&lt;div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-2" data-title="Fig. 2"&gt;</code></p><p><code>1894</code><code>&lt;figure&gt;</code></p><p><code>1895</code><code>&lt;figcaption&gt;</code></p><p><code>1896</code><code>&lt;b id="Fig2" class="c-article-section__figure-caption" data-test="figure-caption-text"&gt;</code></p><p><code>1897</code><code>Fig. 2&lt;/b&gt;</code></p><p><code>1898</code><code>&lt;/figcaption&gt;</code></p><p><code>1899</code><code>&lt;div class="c-article-section__figure-content"&gt;</code></p><p><code>1900</code><code>&lt;div class="c-article-section__figure-item"&gt;</code></p><p><code>1901</code><code>&lt;a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/s13058-018-1049-0/figures/2" rel="nofollow"&gt;</code></p><p><code>1902</code><code>&lt;picture&gt;</code></p><p><code>1903</code><code>&lt;source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_Fig2_HTML.png?as=webp"&gt;</code></p><p><code>1904</code><code>&lt;img aria-describedby="Fig2" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_Fig2_HTML.png" alt="figure 2" loading="lazy" width="685" height="320"&gt;</code></p><p><code>1905</code><code>&lt;/picture&gt;</code></p><p><code>1906</code><code>&lt;/a&gt;</code></p><p><code>1907</code><code>&lt;/div&gt;</code></p><p><code>1908</code><code>&lt;div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-2-desc"&gt;</code></p><p><code>1909</code><code>&lt;p&gt;</code></p><p><code>1910</code><code>Images of disseminated tumor cells (DTCs) stained by double immunofluorescence (AE1AE3/NR2F1 and AE1AE3/Ki67) and correlation between Ki67 and NR2F1 expression. &lt;b&gt;</code></p><p><code>1911</code><code>a&lt;/b&gt;</code></p><p><code>1912</code><code> DTCs from the BM of study patients analyzed by DIF. The strong and irregular cytoplasmic cytokeratin staining (AE1AE3 antibody, in red fluorescence) identifies these cells as DTCs among the normal BM MNCs (AE1AE3-negative). The two upper rows show NR2F1&lt;sup&gt;</code></p><p><code>1913</code><code>high&lt;/sup&gt;</code></p><p><code>1914</code><code> DTCs with the presence of nuclear NR2F1 signal clusters (in green fluorescence; first row) or one large size NR2F1 signal (i.e., larger than the size range observed in normal BM MNCs; second row). Third row shows two DTCs classified as NR2F1&lt;sup&gt;</code></p><p><code>1915</code><code>low&lt;/sup&gt;</code></p><p><code>1916</code><code> containing only two (lower cell) or three (upper cell) small NR2F1 signals, i.e., expression not exceeding what may be observed in normal BM MNCs. The bottom row shows two DTCs positive for Ki67 (in green). &lt;b&gt;</code></p><p><code>1917</code><code>b&lt;/b&gt;</code></p><p><code>1918</code><code> Comparison of the expression on DTC of NR2F1 versus the proliferation marker Ki67. Results from DIF analysis of Ki67/AE1AE3 versus NR2F1/AE1AE3, respectively, on 15 of the BM samples presented in Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/10.1186/s13058-018-1049-0#Tab1"&gt;</code></p><p><code>1919</code><code>1&lt;/a&gt;</code></p><p><code>1920</code><code>, where additional cytospins were available for both analyses&lt;/p&gt;</code></p><p><code>1921</code><code>&lt;/div&gt;</code></p><p><code>1922</code><code>&lt;/div&gt;</code></p><p><code>1923</code><code>&lt;div class="u-text-right u-hide-print"&gt;</code></p><p><code>1924</code><code>&lt;a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/s13058-018-1049-0/figures/2" data-track-dest="link:Figure2 Full size image" aria-label="Full size image figure 2" rel="nofollow"&gt;</code></p><p><code>1925</code><code>&lt;span&gt;</code></p><p><code>1926</code><code>Full size image&lt;/span&gt;</code></p><p><code>1927</code><code>&lt;svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"&gt;</code></p><p><code>1928</code><code>&lt;use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-chevron-right"&gt;</code></p><p><code>1929</code><code>&lt;/use&gt;</code></p><p><code>1930</code><code>&lt;/svg&gt;</code></p><p><code>1931</code><code>&lt;/a&gt;</code></p><p><code>1932</code><code>&lt;/div&gt;</code></p><p><code>1933</code><code>&lt;/figure&gt;</code></p><p><code>1934</code><code>&lt;/div&gt;</code></p><p><code>1935</code><code>&lt;p&gt;</code></p><p><code>1936</code><code>In accordance with the preclinical study data presented above, we chose to classify, a priori, samples with ≥ 50% NR2F1&lt;sup&gt;</code></p><p><code>1937</code><code>high&lt;/sup&gt;</code></p><p><code>1938</code><code> DTCs as “dormant” and samples with &amp;lt; 50% NR2F1&lt;sup&gt;</code></p><p><code>1939</code><code>high&lt;/sup&gt;</code></p><p><code>1940</code><code> DTCs as “non-dormant”.&lt;/p&gt;</code></p><p><code>1941</code><code>&lt;p&gt;</code></p><p><code>1942</code><code>One of the patients with DTC-negative status according to the original DTC analysis had one detectable DTC by the DIF analysis and was not classified according to “dormant” versus “non-dormant” status.&lt;/p&gt;</code></p><p><code>1943</code><code>&lt;p&gt;</code></p><p><code>1944</code><code>A Ki67-expressing DTC was defined as a cell exhibiting nuclear immunostaining of Ki67.&lt;/p&gt;</code></p><p><code>1945</code><code>&lt;h3 class="c-article__sub-heading" id="Sec8"&gt;</code></p><p><code>1946</code><code>Statistics&lt;/h3&gt;</code></p><p><code>1947</code><code>&lt;p&gt;</code></p><p><code>1948</code><code>The association between DTC status/characteristics and distant disease-free interval (DFI) was analyzed. Distant DFI was defined as survival without distant breast cancer recurrence or breast cancer death, and was constructed using Kaplan-Meier curves with accompanied &lt;i&gt;</code></p><p><code>1949</code><code>P&lt;/i&gt;</code></p><p><code>1950</code><code> values obtained from a log-rank test. SPSS software was used for statistical analysis.&lt;/p&gt;</code></p><p><code>1951</code><code>&lt;/div&gt;</code></p><p><code>1952</code><code>&lt;/div&gt;</code></p><p><code>1953</code><code>&lt;/section&gt;</code></p><p><code>1954</code><code>&lt;section data-title="Results"&gt;</code></p><p><code>1955</code><code>&lt;div class="c-article-section" id="Sec9-section"&gt;</code></p><p><code>1956</code><code>&lt;h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec9"&gt;</code></p><p><code>1957</code><code>Results&lt;/h2&gt;</code></p><p><code>1958</code><code>&lt;div class="c-article-section__content" id="Sec9-content"&gt;</code></p><p><code>1959</code><code>&lt;p&gt;</code></p><p><code>1960</code><code>Bone marrow cytospins from 86 DTC-positive patients identified by the original DTC staining procedure were analyzed by DIF for cytokeratin (AE1/AE3) and NR2F1 expression as described in &lt;a data-track="click" data-track-label="link" data-track-action="section anchor" href="/articles/10.1186/s13058-018-1049-0#Sec2"&gt;</code></p><p><code>1961</code><code>Materials and methods&lt;/a&gt;</code></p><p><code>1962</code><code>. An overview of the BM aspiration (BMA) time points for the included patients is presented in Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig1"&gt;</code></p><p><code>1963</code><code>1&lt;/a&gt;</code></p><p><code>1964</code><code>. From 24 of these patients, BM samples at ≥ 2 time points were available for DIF analysis.&lt;/p&gt;</code></p><p><code>1965</code><code>&lt;p&gt;</code></p><p><code>1966</code><code>Cytokeratin-positive cells were classified as either NR2F1&lt;sup&gt;</code></p><p><code>1967</code><code>high&lt;/sup&gt;</code></p><p><code>1968</code><code> or NR2F1&lt;sup&gt;</code></p><p><code>1969</code><code>low&lt;/sup&gt;</code></p><p><code>1970</code><code> according to the level and pattern of expression (see &lt;a data-track="click" data-track-label="link" data-track-action="section anchor" href="/articles/10.1186/s13058-018-1049-0#Sec2"&gt;</code></p><p><code>1971</code><code>Materials and methods&lt;/a&gt;</code></p><p><code>1972</code><code>, Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig2"&gt;</code></p><p><code>1973</code><code>2&lt;/a&gt;</code></p><p><code>1974</code><code>, and Additional files &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM2"&gt;</code></p><p><code>1975</code><code>2&lt;/a&gt;</code></p><p><code>1976</code><code> and &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM3"&gt;</code></p><p><code>1977</code><code>3&lt;/a&gt;</code></p><p><code>1978</code><code>: Figures S1 and S2).&lt;/p&gt;</code></p><p><code>1979</code><code>&lt;p&gt;</code></p><p><code>1980</code><code>Expression of Ki67 was analyzed in parallel with the NR2F1 analyses on additional available cytospins from 15 DTC-positive patients (Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/10.1186/s13058-018-1049-0#Tab1"&gt;</code></p><p><code>1981</code><code>1&lt;/a&gt;</code></p><p><code>1982</code><code> and Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig2"&gt;</code></p><p><code>1983</code><code>2b&lt;/a&gt;</code></p><p><code>1984</code><code>). Of the total 103 samples found to be DTC-positive (i.e., ≥ 1 detectable DTC) by the original DTC staining procedure (of 2 × 10&lt;sup&gt;</code></p><p><code>1985</code><code>6&lt;/sup&gt;</code></p><p><code>1986</code><code> BM MNCs), 32 (31%) had cytokeratin-detectable DTCs in the DIF analysis (of 1 × 10&lt;sup&gt;</code></p><p><code>1987</code><code>6&lt;/sup&gt;</code></p><p><code>1988</code><code> BM MNCs) (Additional file &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM4"&gt;</code></p><p><code>1989</code><code>4&lt;/a&gt;</code></p><p><code>1990</code><code>: Table S2), in accordance with an expected lower sensitivity of this analysis. Twenty-four samples submitted to DIF had been concluded as DTC-negative by the original DTC analysis. These included 13 samples from 11 patients with no original detectable DTCs. One of the samples had one detectable DTC by DIF, and the remaining 23 were DTC-negative (Additional file &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM4"&gt;</code></p><p><code>1991</code><code>4&lt;/a&gt;</code></p><p><code>1992</code><code>: Table S2). Data on the original DTC-positive patients with DIF-positive results and available clinicopathological characteristics are presented in Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/10.1186/s13058-018-1049-0#Tab1"&gt;</code></p><p><code>1993</code><code>1&lt;/a&gt;</code></p><p><code>1994</code><code>.&lt;/p&gt;</code></p><p><code>1995</code><code>&lt;div class="c-article-table" data-test="inline-table" data-container-section="table" id="table-1"&gt;</code></p><p><code>1996</code><code>&lt;figure&gt;</code></p><p><code>1997</code><code>&lt;figcaption class="c-article-table__figcaption"&gt;</code></p><p><code>1998</code><code>&lt;b id="Tab1" data-test="table-caption"&gt;</code></p><p><code>1999</code><code>Table 1 Overview of all originally disseminated tumor cell (DTC)-positive patients with detectable DTCs by double immunofluorescence technique and clinicopathological parameters&lt;/b&gt;</code></p><p><code>2000</code><code>&lt;/figcaption&gt;</code></p><p><code>2001</code><code>&lt;div class="u-text-right u-hide-print"&gt;</code></p><p><code>2002</code><code>&lt;a class="c-article__pill-button" data-test="table-link" data-track="click" data-track-action="view table" data-track-label="button" rel="nofollow" href="/articles/10.1186/s13058-018-1049-0/tables/1" aria-label="Full size table 1"&gt;</code></p><p><code>2003</code><code>&lt;span&gt;</code></p><p><code>2004</code><code>Full size table&lt;/span&gt;</code></p><p><code>2005</code><code>&lt;svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"&gt;</code></p><p><code>2006</code><code>&lt;use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-chevron-right"&gt;</code></p><p><code>2007</code><code>&lt;/use&gt;</code></p><p><code>2008</code><code>&lt;/svg&gt;</code></p><p><code>2009</code><code>&lt;/a&gt;</code></p><p><code>2010</code><code>&lt;/div&gt;</code></p><p><code>2011</code><code>&lt;/figure&gt;</code></p><p><code>2012</code><code>&lt;/div&gt;</code></p><p><code>2013</code><code>&lt;p&gt;</code></p><p><code>2014</code><code>The DIF analysis revealed that most of the analyzed patients (24 out of 26) with CK-positive DTCs had ≥ 3 detectable cells and 16 had ≥ 10 DTCs in at least one BM sample, representing a patient group with high risk of metastasis (Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/10.1186/s13058-018-1049-0#Tab1"&gt;</code></p><p><code>2015</code><code>1&lt;/a&gt;</code></p><p><code>2016</code><code>, Additional file &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM5"&gt;</code></p><p><code>2017</code><code>5&lt;/a&gt;</code></p><p><code>2018</code><code>: Table S3). Indeed, 81% of the DTC-positive patients developed metastasis after the BMA (&lt;i&gt;</code></p><p><code>2019</code><code>n&lt;/i&gt;</code></p><p><code>2020</code><code> = 17) or had metastasis at time of the BM aspiration (&lt;i&gt;</code></p><p><code>2021</code><code>n&lt;/i&gt;</code></p><p><code>2022</code><code> = 4) (Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/10.1186/s13058-018-1049-0#Tab1"&gt;</code></p><p><code>2023</code><code>1&lt;/a&gt;</code></p><p><code>2024</code><code>). Half (&lt;i&gt;</code></p><p><code>2025</code><code>n&lt;/i&gt;</code></p><p><code>2026</code><code> = 13) of the patients had &amp;gt; 1% of NR2F1&lt;sup&gt;</code></p><p><code>2027</code><code>high&lt;/sup&gt;</code></p><p><code>2028</code><code> DTCs in at least one BM sample and 26.9% (&lt;i&gt;</code></p><p><code>2029</code><code>n&lt;/i&gt;</code></p><p><code>2030</code><code> = 7) had ≥ 50% NR2F1&lt;sup&gt;</code></p><p><code>2031</code><code>high&lt;/sup&gt;</code></p><p><code>2032</code><code> DTCs. The latter parameter (≥ 50% NR2F1&lt;sup&gt;</code></p><p><code>2033</code><code>high&lt;/sup&gt;</code></p><p><code>2034</code><code> DTCs) was chosen as the a priori cut-off for classifying the patient as having a “dormant profile” in accordance with previous experimental studies [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e3639"&gt;</code></p><p><code>2035</code><code>6&lt;/a&gt;</code></p><p><code>2036</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Fluegen G, Avivar-Valderas A, Wang Y, Padgen MR, Williams JK, Nobre AR, Calvo V, Cheung JF, Bravo-Cordero JJ, Entenberg D, et al. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat Cell Biol. 2017;19(2):120–32." href="/articles/10.1186/s13058-018-1049-0#ref-CR8" id="ref-link-section-d33543424e3643"&gt;</code></p><p><code>2037</code><code>8&lt;/a&gt;</code></p><p><code>2038</code><code>]. Of the samples with detectable NR2F1&lt;sup&gt;</code></p><p><code>2039</code><code>high&lt;/sup&gt;</code></p><p><code>2040</code><code> DTCs, the median proportion of NR2F1&lt;sup&gt;</code></p><p><code>2041</code><code>high&lt;/sup&gt;</code></p><p><code>2042</code><code> DTCs was 50%.&lt;/p&gt;</code></p><p><code>2043</code><code>&lt;p&gt;</code></p><p><code>2044</code><code>To explore changes in the expression of NR2F1 over time and during treatment, DIF analysis was performed on the 24 cases classified as DTC-positive in the original DTC staining procedure and with available samples from BM aspiration at two time points (see Additional file &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM6"&gt;</code></p><p><code>2045</code><code>6&lt;/a&gt;</code></p><p><code>2046</code><code>: Figure S3 for the original DTC staining results). Of the cases analyzed, 16 received chemotherapy (± endocrine treatment), 5 endocrine treatment only, and 3 no systemic treatment between the BM aspirations (Additional file &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM7"&gt;</code></p><p><code>2047</code><code>7&lt;/a&gt;</code></p><p><code>2048</code><code>: Table S4). The number of DIF-detected CK-positive DTCs and proportion of NR2F1&lt;sup&gt;</code></p><p><code>2049</code><code>high&lt;/sup&gt;</code></p><p><code>2050</code><code> DTCs are presented in Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig3"&gt;</code></p><p><code>2051</code><code>3&lt;/a&gt;</code></p><p><code>2052</code><code>. The results showed different patterns of change and did not appear to be related to the type of adjuvant treatment (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig3"&gt;</code></p><p><code>2053</code><code>3&lt;/a&gt;</code></p><p><code>2054</code><code>). Three of the six patients with ≥ 50% NR2F1&lt;sup&gt;</code></p><p><code>2055</code><code>high&lt;/sup&gt;</code></p><p><code>2056</code><code> DTCs at the last BM analysis did not experience relapse. In contrast, 7 of 8 patients with ≤ 1% NR2F1&lt;sup&gt;</code></p><p><code>2057</code><code>high&lt;/sup&gt;</code></p><p><code>2058</code><code> DTCs at the last BM analysis had systemic relapse or breast cancer death within 12 months (i.e., &amp;lt; 8 months) (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig3"&gt;</code></p><p><code>2059</code><code>3b, c&lt;/a&gt;</code></p><p><code>2060</code><code>). Additional information on the original DTC status, NR2F1 expression, and Ki67 expression of these patients are presented in Additional file &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM8"&gt;</code></p><p><code>2061</code><code>8&lt;/a&gt;</code></p><p><code>2062</code><code> (Table S5). All patients with systemic relapse or breast cancer death within 12 months had ≤ 1% NR2F1&lt;sup&gt;</code></p><p><code>2063</code><code>high&lt;/sup&gt;</code></p><p><code>2064</code><code> DTCs (Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/10.1186/s13058-018-1049-0#Tab1"&gt;</code></p><p><code>2065</code><code>1&lt;/a&gt;</code></p><p><code>2066</code><code>).&lt;/p&gt;</code></p><p><code>2067</code><code>&lt;div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-3" data-title="Fig. 3"&gt;</code></p><p><code>2068</code><code>&lt;figure&gt;</code></p><p><code>2069</code><code>&lt;figcaption&gt;</code></p><p><code>2070</code><code>&lt;b id="Fig3" class="c-article-section__figure-caption" data-test="figure-caption-text"&gt;</code></p><p><code>2071</code><code>Fig. 3&lt;/b&gt;</code></p><p><code>2072</code><code>&lt;/figcaption&gt;</code></p><p><code>2073</code><code>&lt;div class="c-article-section__figure-content"&gt;</code></p><p><code>2074</code><code>&lt;div class="c-article-section__figure-item"&gt;</code></p><p><code>2075</code><code>&lt;a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/s13058-018-1049-0/figures/3" rel="nofollow"&gt;</code></p><p><code>2076</code><code>&lt;picture&gt;</code></p><p><code>2077</code><code>&lt;source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_Fig3_HTML.png?as=webp"&gt;</code></p><p><code>2078</code><code>&lt;img aria-describedby="Fig3" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_Fig3_HTML.png" alt="figure 3" loading="lazy" width="685" height="384"&gt;</code></p><p><code>2079</code><code>&lt;/picture&gt;</code></p><p><code>2080</code><code>&lt;/a&gt;</code></p><p><code>2081</code><code>&lt;/div&gt;</code></p><p><code>2082</code><code>&lt;div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-3-desc"&gt;</code></p><p><code>2083</code><code>&lt;p&gt;</code></p><p><code>2084</code><code>Disseminated tumor cell (DTC) status by DIF and NR2F1 expression in patients with bone marrow (BM) samples available at two time points. Results of AE1AE3/NR2F1 DIF analysis performed on 24 patients classified as DTC-positive in the original DTC analysis, and with available BM samples from two aspiration time points. The number of DIF cytokeratin-positive DTCs (&lt;b&gt;</code></p><p><code>2085</code><code>a&lt;/b&gt;</code></p><p><code>2086</code><code>), the proportion of NR2F1&lt;sup&gt;</code></p><p><code>2087</code><code>high&lt;/sup&gt;</code></p><p><code>2088</code><code> DTCs in patients with DIF DTC-positive status at both BM aspiration (BMA) time points (&lt;b&gt;</code></p><p><code>2089</code><code>b&lt;/b&gt;</code></p><p><code>2090</code><code>), and the proportion of NR2F1&lt;sup&gt;</code></p><p><code>2091</code><code>high&lt;/sup&gt;</code></p><p><code>2092</code><code> DTCs in patients with DIF DTC-positive status in the second but not the first BMA (&lt;b&gt;</code></p><p><code>2093</code><code>c&lt;/b&gt;</code></p><p><code>2094</code><code>) are presented. The right sections of &lt;b&gt;</code></p><p><code>2095</code><code>b&lt;/b&gt;</code></p><p><code>2096</code><code> and &lt;b&gt;</code></p><p><code>2097</code><code>c&lt;/b&gt;</code></p><p><code>2098</code><code> show time to relapse or last observation and additional clinical information for the patients presented in &lt;b&gt;</code></p><p><code>2099</code><code>b&lt;/b&gt;</code></p><p><code>2100</code><code> and &lt;b&gt;</code></p><p><code>2101</code><code>c&lt;/b&gt;</code></p><p><code>2102</code><code>. Chemo chemotherapy, N/A not applicable, neg negative, pos positive, Pt patient&lt;/p&gt;</code></p><p><code>2103</code><code>&lt;/div&gt;</code></p><p><code>2104</code><code>&lt;/div&gt;</code></p><p><code>2105</code><code>&lt;div class="u-text-right u-hide-print"&gt;</code></p><p><code>2106</code><code>&lt;a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/s13058-018-1049-0/figures/3" data-track-dest="link:Figure3 Full size image" aria-label="Full size image figure 3" rel="nofollow"&gt;</code></p><p><code>2107</code><code>&lt;span&gt;</code></p><p><code>2108</code><code>Full size image&lt;/span&gt;</code></p><p><code>2109</code><code>&lt;svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"&gt;</code></p><p><code>2110</code><code>&lt;use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-chevron-right"&gt;</code></p><p><code>2111</code><code>&lt;/use&gt;</code></p><p><code>2112</code><code>&lt;/svg&gt;</code></p><p><code>2113</code><code>&lt;/a&gt;</code></p><p><code>2114</code><code>&lt;/div&gt;</code></p><p><code>2115</code><code>&lt;/figure&gt;</code></p><p><code>2116</code><code>&lt;/div&gt;</code></p><p><code>2117</code><code>&lt;p&gt;</code></p><p><code>2118</code><code>Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/10.1186/s13058-018-1049-0#Tab2"&gt;</code></p><p><code>2119</code><code>2&lt;/a&gt;</code></p><p><code>2120</code><code> presents the systemic relapse status among the patients with 1 and ≥ 2 BM aspiration time points in combination, according to the proportion of NR2F1-expressing cells in the DTC-positive cases (last positive BM aspiration time point if &amp;gt; 1 performed). Of the patients with predominantly NR2F1&lt;sup&gt;</code></p><p><code>2121</code><code>low&lt;/sup&gt;</code></p><p><code>2122</code><code> DTCs, 90% had, or  experienced, systemic relapse or breast cancer death and 67% were recorded with bone metastasis. Similar figures were observed for those with ≤ 1 NR2F1&lt;sup&gt;</code></p><p><code>2123</code><code>high&lt;/sup&gt;</code></p><p><code>2124</code><code> DTCs. In contrast, in those patients with ≥ 50% NR2F1&lt;sup&gt;</code></p><p><code>2125</code><code>high&lt;/sup&gt;</code></p><p><code>2126</code><code> expressing DTCs, 57% had, or experienced, systemic relapse and 29% were recorded with bone metastasis. Survival analysis of all nonmetastatic patients at the time of last DIF DTC-positive BM aspiration revealed a difference in distant DFI (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig4"&gt;</code></p><p><code>2127</code><code>4a&lt;/a&gt;</code></p><p><code>2128</code><code>; &lt;i&gt;</code></p><p><code>2129</code><code>p&lt;/i&gt;</code></p><p><code>2130</code><code> = 0.023). Excluding patients analyzed for DIF-positive DTCs (with a negative result) at a subsequent BMA time point (&lt;i&gt;</code></p><p><code>2131</code><code>n&lt;/i&gt;</code></p><p><code>2132</code><code> = 18), 93% experienced systemic relapse/breast cancer death and 75% bone metastasis among the patients with a “non-dormant” DTC classification. One of the four patients with ≥ 50% NR2F1&lt;sup&gt;</code></p><p><code>2133</code><code>high&lt;/sup&gt;</code></p><p><code>2134</code><code> DTCs (a “dormant” DTC classification) experienced bone metastasis. Analysis of distant DFI among these 18 patients indicated a survival difference between the patients classified by DTCs as having &amp;lt; 50% versus ≥ 50% NR2F1&lt;sup&gt;</code></p><p><code>2135</code><code>high&lt;/sup&gt;</code></p><p><code>2136</code><code> expressing cells (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig4"&gt;</code></p><p><code>2137</code><code>4c&lt;/a&gt;</code></p><p><code>2138</code><code>; &lt;i&gt;</code></p><p><code>2139</code><code>p&lt;/i&gt;</code></p><p><code>2140</code><code> = 0.007). A few patients had exceptionally high DTC numbers. A survival analysis without the patients with ≥ 500 DTCs gave similar results (&lt;i&gt;</code></p><p><code>2141</code><code>p&lt;/i&gt;</code></p><p><code>2142</code><code> = 0.014; Additional file &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM9"&gt;</code></p><p><code>2143</code><code>9&lt;/a&gt;</code></p><p><code>2144</code><code>: Figure S4A). The patients included in the NeoTax study had higher stages (all with locally advanced disease) than the two other cohorts. Excluding these patients from the survival analysis did not change the results (&lt;i&gt;</code></p><p><code>2145</code><code>p&lt;/i&gt;</code></p><p><code>2146</code><code> = 0.022; Additional file &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM9"&gt;</code></p><p><code>2147</code><code>9&lt;/a&gt;</code></p><p><code>2148</code><code>: Figure S4B).&lt;/p&gt;</code></p><p><code>2149</code><code>&lt;div class="c-article-table" data-test="inline-table" data-container-section="table" id="table-2"&gt;</code></p><p><code>2150</code><code>&lt;figure&gt;</code></p><p><code>2151</code><code>&lt;figcaption class="c-article-table__figcaption"&gt;</code></p><p><code>2152</code><code>&lt;b id="Tab2" data-test="table-caption"&gt;</code></p><p><code>2153</code><code>Table 2 NR2F1 expression and clinical outcome&lt;/b&gt;</code></p><p><code>2154</code><code>&lt;/figcaption&gt;</code></p><p><code>2155</code><code>&lt;div class="u-text-right u-hide-print"&gt;</code></p><p><code>2156</code><code>&lt;a class="c-article__pill-button" data-test="table-link" data-track="click" data-track-action="view table" data-track-label="button" rel="nofollow" href="/articles/10.1186/s13058-018-1049-0/tables/2" aria-label="Full size table 2"&gt;</code></p><p><code>2157</code><code>&lt;span&gt;</code></p><p><code>2158</code><code>Full size table&lt;/span&gt;</code></p><p><code>2159</code><code>&lt;svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"&gt;</code></p><p><code>2160</code><code>&lt;use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-chevron-right"&gt;</code></p><p><code>2161</code><code>&lt;/use&gt;</code></p><p><code>2162</code><code>&lt;/svg&gt;</code></p><p><code>2163</code><code>&lt;/a&gt;</code></p><p><code>2164</code><code>&lt;/div&gt;</code></p><p><code>2165</code><code>&lt;/figure&gt;</code></p><p><code>2166</code><code>&lt;/div&gt;</code></p><p><code>2167</code><code>&lt;div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-4" data-title="Fig. 4"&gt;</code></p><p><code>2168</code><code>&lt;figure&gt;</code></p><p><code>2169</code><code>&lt;figcaption&gt;</code></p><p><code>2170</code><code>&lt;b id="Fig4" class="c-article-section__figure-caption" data-test="figure-caption-text"&gt;</code></p><p><code>2171</code><code>Fig. 4&lt;/b&gt;</code></p><p><code>2172</code><code>&lt;/figcaption&gt;</code></p><p><code>2173</code><code>&lt;div class="c-article-section__figure-content"&gt;</code></p><p><code>2174</code><code>&lt;div class="c-article-section__figure-item"&gt;</code></p><p><code>2175</code><code>&lt;a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/s13058-018-1049-0/figures/4" rel="nofollow"&gt;</code></p><p><code>2176</code><code>&lt;picture&gt;</code></p><p><code>2177</code><code>&lt;source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_Fig4_HTML.png?as=webp"&gt;</code></p><p><code>2178</code><code>&lt;img aria-describedby="Fig4" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_Fig4_HTML.png" alt="figure 4" loading="lazy" width="685" height="695"&gt;</code></p><p><code>2179</code><code>&lt;/picture&gt;</code></p><p><code>2180</code><code>&lt;/a&gt;</code></p><p><code>2181</code><code>&lt;/div&gt;</code></p><p><code>2182</code><code>&lt;div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-4-desc"&gt;</code></p><p><code>2183</code><code>&lt;p&gt;</code></p><p><code>2184</code><code>Survival analyses in relation to DTC dormancy profile and Ki67 status. Survival analyses (time to systemic relapse/breast cancer death) in relation to NR2F1 (&lt;b&gt;</code></p><p><code>2185</code><code>a&lt;/b&gt;</code></p><p><code>2186</code><code>,&lt;b&gt;</code></p><p><code>2187</code><code>c&lt;/b&gt;</code></p><p><code>2188</code><code>) and Ki67 profile (&lt;b&gt;</code></p><p><code>2189</code><code>b&lt;/b&gt;</code></p><p><code>2190</code><code>,&lt;b&gt;</code></p><p><code>2191</code><code>d&lt;/b&gt;</code></p><p><code>2192</code><code>) of DTCs (at last DIF DTC-positive bone marrow (BM) aspiration). &lt;b&gt;</code></p><p><code>2193</code><code>a&lt;/b&gt;</code></p><p><code>2194</code><code>,&lt;b&gt;</code></p><p><code>2195</code><code>b&lt;/b&gt;</code></p><p><code>2196</code><code> Patients being nonmetastatic at last DIF DTC-positive BMA. &lt;b&gt;</code></p><p><code>2197</code><code>c&lt;/b&gt;</code></p><p><code>2198</code><code>,&lt;b&gt;</code></p><p><code>2199</code><code>d&lt;/b&gt;</code></p><p><code>2200</code><code> Patients being  nonmetastatic at last DIF DTC-positive BMA with no subsequent BM analysis performed. Cum cumulative&lt;/p&gt;</code></p><p><code>2201</code><code>&lt;/div&gt;</code></p><p><code>2202</code><code>&lt;/div&gt;</code></p><p><code>2203</code><code>&lt;div class="u-text-right u-hide-print"&gt;</code></p><p><code>2204</code><code>&lt;a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/s13058-018-1049-0/figures/4" data-track-dest="link:Figure4 Full size image" aria-label="Full size image figure 4" rel="nofollow"&gt;</code></p><p><code>2205</code><code>&lt;span&gt;</code></p><p><code>2206</code><code>Full size image&lt;/span&gt;</code></p><p><code>2207</code><code>&lt;svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"&gt;</code></p><p><code>2208</code><code>&lt;use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-chevron-right"&gt;</code></p><p><code>2209</code><code>&lt;/use&gt;</code></p><p><code>2210</code><code>&lt;/svg&gt;</code></p><p><code>2211</code><code>&lt;/a&gt;</code></p><p><code>2212</code><code>&lt;/div&gt;</code></p><p><code>2213</code><code>&lt;/figure&gt;</code></p><p><code>2214</code><code>&lt;/div&gt;</code></p><p><code>2215</code><code>&lt;p&gt;</code></p><p><code>2216</code><code>Limiting the analysis to only those with no chemotherapy after the last BMA revealed similar results, although the interpretation is restricted by the low number of patients with ≥ 50% NR2F1&lt;sup&gt;</code></p><p><code>2217</code><code>high&lt;/sup&gt;</code></p><p><code>2218</code><code> DTCs (&lt;i&gt;</code></p><p><code>2219</code><code>n&lt;/i&gt;</code></p><p><code>2220</code><code> = 2) (Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/10.1186/s13058-018-1049-0#Tab2"&gt;</code></p><p><code>2221</code><code>2&lt;/a&gt;</code></p><p><code>2222</code><code> and Additional file &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM10"&gt;</code></p><p><code>2223</code><code>10&lt;/a&gt;</code></p><p><code>2224</code><code>: Figure S5; &lt;i&gt;</code></p><p><code>2225</code><code>p&lt;/i&gt;</code></p><p><code>2226</code><code> = 0.091).&lt;/p&gt;</code></p><p><code>2227</code><code>&lt;p&gt;</code></p><p><code>2228</code><code>To compare the expression of NR2F1 and the proliferation marker Ki67, 1–2 additional cytospins from 15 of the BM samples presented in Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/10.1186/s13058-018-1049-0#Tab1"&gt;</code></p><p><code>2229</code><code>1&lt;/a&gt;</code></p><p><code>2230</code><code> were analyzed by Ki67/pan-cytokeratin DIF. NR2F1 and Ki67 expression were not examined in the same DTCs (cytospins), and therefore the combined expression pattern at the single DTC level could not be addressed. The results showed that the proportion of Ki67-positive DTCs was weakly negatively correlated with the proportion of NR2F1&lt;sup&gt;</code></p><p><code>2231</code><code>high&lt;/sup&gt;</code></p><p><code>2232</code><code> DTCs (ρ = −0.466; &lt;i&gt;</code></p><p><code>2233</code><code>p&lt;/i&gt;</code></p><p><code>2234</code><code> = 0.08; Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig2"&gt;</code></p><p><code>2235</code><code>2b&lt;/a&gt;</code></p><p><code>2236</code><code>), bearing in mind the low number of cases analyzed for both Ki67 and NR2F1. Survival was not different for patients classified into subgroups by Ki67 expression in DTCs using median dichotomization (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig4"&gt;</code></p><p><code>2237</code><code>4b&lt;/a&gt;</code></p><p><code>2238</code><code>, &lt;i&gt;</code></p><p><code>2239</code><code>p&lt;/i&gt;</code></p><p><code>2240</code><code> = 0.520; Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig4"&gt;</code></p><p><code>2241</code><code>4d&lt;/a&gt;</code></p><p><code>2242</code><code>, &lt;i&gt;</code></p><p><code>2243</code><code>p&lt;/i&gt;</code></p><p><code>2244</code><code> = 0.464), or by the same cut-off value as for NR2F1 (&lt;i&gt;</code></p><p><code>2245</code><code>p&lt;/i&gt;</code></p><p><code>2246</code><code> = 0.753, data not shown). The survival difference between patients with NR2F1&lt;sup&gt;</code></p><p><code>2247</code><code>high&lt;/sup&gt;</code></p><p><code>2248</code><code> and NR2F1&lt;sup&gt;</code></p><p><code>2249</code><code>low&lt;/sup&gt;</code></p><p><code>2250</code><code> expressing DTCs were similar if the analysis was restricted to only the patients with samples analyzed for Ki67 (Additional file &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM11"&gt;</code></p><p><code>2251</code><code>11&lt;/a&gt;</code></p><p><code>2252</code><code>: Figure S6; &lt;i&gt;</code></p><p><code>2253</code><code>p&lt;/i&gt;</code></p><p><code>2254</code><code> = 0.019 and &lt;i&gt;</code></p><p><code>2255</code><code>p&lt;/i&gt;</code></p><p><code>2256</code><code> = 0.026 for the same patient categories as presented in Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig4"&gt;</code></p><p><code>2257</code><code>4&lt;/a&gt;</code></p><p><code>2258</code><code>).&lt;/p&gt;</code></p><p><code>2259</code><code>&lt;/div&gt;</code></p><p><code>2260</code><code>&lt;/div&gt;</code></p><p><code>2261</code><code>&lt;/section&gt;</code></p><p><code>2262</code><code>&lt;section data-title="Discussion"&gt;</code></p><p><code>2263</code><code>&lt;div class="c-article-section" id="Sec10-section"&gt;</code></p><p><code>2264</code><code>&lt;h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec10"&gt;</code></p><p><code>2265</code><code>Discussion&lt;/h2&gt;</code></p><p><code>2266</code><code>&lt;div class="c-article-section__content" id="Sec10-content"&gt;</code></p><p><code>2267</code><code>&lt;p&gt;</code></p><p><code>2268</code><code>To further improve curative treatment of breast cancer, we need to identify patients with MRD and characterize the potential for MRD progression. To the best of our knowledge, this is the first report exploring dormancy marker profiling in DTCs in breast cancer patients. The analysis of NR2F1 expression, a critical node in tumor dormancy induction, can potentially differentiate between active occult tumor cells giving a risk for early metastasis development and more long-term quiescent DTCs. Such information may potentially contribute to future clinical decisions based on minimal residual cancer detection and its state of activation.&lt;/p&gt;</code></p><p><code>2269</code><code>&lt;p&gt;</code></p><p><code>2270</code><code>We observed that the samples from patients with very early systemic relapse (within 12 months) carried only NR2F1&lt;sup&gt;</code></p><p><code>2271</code><code>low&lt;/sup&gt;</code></p><p><code>2272</code><code> (non-dormant) DTCs in the last BM sample (≤ 1% NR2F1&lt;sup&gt;</code></p><p><code>2273</code><code>high&lt;/sup&gt;</code></p><p><code>2274</code><code> DTCs). This included patients that transitioned from having NR2F1&lt;sup&gt;</code></p><p><code>2275</code><code>high&lt;/sup&gt;</code></p><p><code>2276</code><code> expressing DTCs to a NR2F1&lt;sup&gt;</code></p><p><code>2277</code><code>low&lt;/sup&gt;</code></p><p><code>2278</code><code> DTC state in consecutive samples (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig3"&gt;</code></p><p><code>2279</code><code>3&lt;/a&gt;</code></p><p><code>2280</code><code>). Likewise, longer disease-free interval/no detectable metastases were indicated among patients with a presence of predominantly NR2F1&lt;sup&gt;</code></p><p><code>2281</code><code>high&lt;/sup&gt;</code></p><p><code>2282</code><code> DTCs. This was further supported by the result from survival analysis of nonmetastatic patients showing a difference in metastasis-free interval in subgroups according to NR2F1&lt;sup&gt;</code></p><p><code>2283</code><code>high&lt;/sup&gt;</code></p><p><code>2284</code><code> expression (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig4"&gt;</code></p><p><code>2285</code><code>4a&lt;/a&gt;</code></p><p><code>2286</code><code>). However, the results should be interpreted with caution due to the restricted number of patients analyzed and the heterogeneity in patient population and treatment. Nevertheless, the data provide clinical support to the abundant previous experimental and some clinical data (mRNA measurements) identifying NR2F1 as a candidate marker for clinically relevant characterization of MRD [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e4205"&gt;</code></p><p><code>2287</code><code>6&lt;/a&gt;</code></p><p><code>2288</code><code>], and that NR2F1 may serve to identify DTC long-term dormancy candidates even among patients harboring larger number of DTCs. Indeed, the patients studied were not selected to be obvious DTC dormancy candidates by a long (many years) relapse-free follow-up period. Most of the BM samples were collected ≤ 3 years after diagnosis and were enriched for cases with ≥ 5 DTCs, a known poor prognostic feature [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med. 2005;353(8):793–802." href="/articles/10.1186/s13058-018-1049-0#ref-CR3" id="ref-link-section-d33543424e4208"&gt;</code></p><p><code>2289</code><code>3&lt;/a&gt;</code></p><p><code>2290</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Janni W, Vogl FD, Wiedswang G, Synnestvedt M, Fehm T, Juckstock J, Borgen E, Rack B, Braun S, Sommer H, et al. Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse—a European pooled analysis. Clin Cancer Res. 2011;17(9):2967–76." href="/articles/10.1186/s13058-018-1049-0#ref-CR4" id="ref-link-section-d33543424e4211"&gt;</code></p><p><code>2291</code><code>4&lt;/a&gt;</code></p><p><code>2292</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Mathiesen RR, Borgen E, Renolen A, Lokkevik E, Nesland JM, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, et al. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival. Breast Cancer Res. 2012;14(4):R117." href="#ref-CR9" id="ref-link-section-d33543424e4215"&gt;</code></p><p><code>2293</code><code>9&lt;/a&gt;</code></p><p><code>2294</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Wiedswang G, Borgen E, Karesen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol. 2003;21(18):3469–78." href="#ref-CR10" id="ref-link-section-d33543424e4215_1"&gt;</code></p><p><code>2295</code><code>10&lt;/a&gt;</code></p><p><code>2296</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Wiedswang G, Borgen E, Karesen R, Qvist H, Janbu J, Kvalheim G, Nesland JM, Naume B. Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome. Clin Cancer Res. 2004;10(16):5342–8." href="#ref-CR11" id="ref-link-section-d33543424e4215_2"&gt;</code></p><p><code>2297</code><code>11&lt;/a&gt;</code></p><p><code>2298</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Naume B, Synnestvedt M, Falk RS, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Sommer HH, et al. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer. J Clin Oncol. 2014;32(34):3848–57." href="/articles/10.1186/s13058-018-1049-0#ref-CR12" id="ref-link-section-d33543424e4218"&gt;</code></p><p><code>2299</code><code>12&lt;/a&gt;</code></p><p><code>2300</code><code>]. Moreover, although the DTC Ki67 expression showed a weak negative correlation with NR2F1&lt;sup&gt;</code></p><p><code>2301</code><code>high&lt;/sup&gt;</code></p><p><code>2302</code><code> DTCs (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig2"&gt;</code></p><p><code>2303</code><code>2b&lt;/a&gt;</code></p><p><code>2304</code><code>), no significant association with clinical outcome was observed. This indicates that a proliferation marker such as Ki67 is insufficient to characterize the MRD cell population.&lt;/p&gt;</code></p><p><code>2305</code><code>&lt;p&gt;</code></p><p><code>2306</code><code>Since Ki67 detects all phases of the cell cycle, except G0, it is possible that it may not accurately pinpoint true dormant cells. In our experience, retinoblastoma protein (pRb) and P-H3-negative, p27-positive cells are better indicators of a quiescent NR2F1-positive DTC [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e4229"&gt;</code></p><p><code>2307</code><code>6&lt;/a&gt;</code></p><p><code>2308</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Fluegen G, Avivar-Valderas A, Wang Y, Padgen MR, Williams JK, Nobre AR, Calvo V, Cheung JF, Bravo-Cordero JJ, Entenberg D, et al. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat Cell Biol. 2017;19(2):120–32." href="/articles/10.1186/s13058-018-1049-0#ref-CR8" id="ref-link-section-d33543424e4232"&gt;</code></p><p><code>2309</code><code>8&lt;/a&gt;</code></p><p><code>2310</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Bragado P, Estrada Y, Parikh F, Krause S, Capobianco C, Farina HG, Schewe DM, Aguirre-Ghiso JA. TGF-beta2 dictates disseminated tumour cell fate in target organs through TGF-beta-RIII and p38alpha/beta signalling. Nat Cell Biol. 2013;15(11):1351–61." href="/articles/10.1186/s13058-018-1049-0#ref-CR18" id="ref-link-section-d33543424e4235"&gt;</code></p><p><code>2311</code><code>18&lt;/a&gt;</code></p><p><code>2312</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Harper KL, Sosa MS, Entenberg D, Hosseini H, Cheung JF, Nobre R, Avivar-Valderas A, Nagi C, Girnius N, Davis RJ, et al. Mechanism of early dissemination and metastasis in Her2+ mammary cancer. Nature. 2016. &amp;#xA;                    https://doi.org/10.1038/nature20609&amp;#xA;                    &amp;#xA;                  ." href="/articles/10.1186/s13058-018-1049-0#ref-CR19" id="ref-link-section-d33543424e4238"&gt;</code></p><p><code>2313</code><code>19&lt;/a&gt;</code></p><p><code>2314</code><code>]. The Ki67 result may place into the proliferative population bin, cells that are in a G0/G1 boundary and arrested or slow cycling. Furthermore, it may classify nonarrested cells transiting through G0 as nonproliferative. In contrast, NR2F1 expression is remarkably stable, epigenetically controlled, and associated with a repressive chromatin state observed in terminally senescent or differentiated cells [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e4241"&gt;</code></p><p><code>2315</code><code>6&lt;/a&gt;</code></p><p><code>2316</code><code>]. These data suggest that NR2F1 marks a durable, more long-lived phenotype of growth arrest. The presented data and results from our experimental models also suggest that NR2F1 is associated with cellular dormancy (quiescence) and not tumor mass dormancy (representing a small cancer cell mass that cannot surpass a certain size) characterized by a balance between proliferation and apoptosis where arrest is never observed. [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14(9):611–22." href="/articles/10.1186/s13058-018-1049-0#ref-CR20" id="ref-link-section-d33543424e4245"&gt;</code></p><p><code>2317</code><code>20&lt;/a&gt;</code></p><p><code>2318</code><code>]. In our experience and that of other investigators, the latter phenomenon is not observed in solitary DTC dormancy [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e4248"&gt;</code></p><p><code>2319</code><code>6&lt;/a&gt;</code></p><p><code>2320</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Fluegen G, Avivar-Valderas A, Wang Y, Padgen MR, Williams JK, Nobre AR, Calvo V, Cheung JF, Bravo-Cordero JJ, Entenberg D, et al. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat Cell Biol. 2017;19(2):120–32." href="/articles/10.1186/s13058-018-1049-0#ref-CR8" id="ref-link-section-d33543424e4251"&gt;</code></p><p><code>2321</code><code>8&lt;/a&gt;</code></p><p><code>2322</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Bragado P, Estrada Y, Parikh F, Krause S, Capobianco C, Farina HG, Schewe DM, Aguirre-Ghiso JA. TGF-beta2 dictates disseminated tumour cell fate in target organs through TGF-beta-RIII and p38alpha/beta signalling. Nat Cell Biol. 2013;15(11):1351–61." href="/articles/10.1186/s13058-018-1049-0#ref-CR18" id="ref-link-section-d33543424e4254"&gt;</code></p><p><code>2323</code><code>18&lt;/a&gt;</code></p><p><code>2324</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Harper KL, Sosa MS, Entenberg D, Hosseini H, Cheung JF, Nobre R, Avivar-Valderas A, Nagi C, Girnius N, Davis RJ, et al. Mechanism of early dissemination and metastasis in Her2+ mammary cancer. Nature. 2016. &amp;#xA;                    https://doi.org/10.1038/nature20609&amp;#xA;                    &amp;#xA;                  ." href="/articles/10.1186/s13058-018-1049-0#ref-CR19" id="ref-link-section-d33543424e4257"&gt;</code></p><p><code>2325</code><code>19&lt;/a&gt;</code></p><p><code>2326</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y, de Stanchina E, Massague J. Metastatic latency and immune evasion through autocrine inhibition of WNT. Cell. 2016;165(1):45–60." href="/articles/10.1186/s13058-018-1049-0#ref-CR21" id="ref-link-section-d33543424e4260"&gt;</code></p><p><code>2327</code><code>21&lt;/a&gt;</code></p><p><code>2328</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Gao H, Chakraborty G, Lee-Lim AP, Mo Q, Decker M, Vonica A, Shen R, Brogi E, Brivanlou AH, Giancotti FG. The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell. 2012;150(4):764–79." href="/articles/10.1186/s13058-018-1049-0#ref-CR22" id="ref-link-section-d33543424e4264"&gt;</code></p><p><code>2329</code><code>22&lt;/a&gt;</code></p><p><code>2330</code><code>]. Published data also suggest that the mechanisms driving solitary DTCs share a significant overlap with those regulating adult stem cell quiescence [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e4267"&gt;</code></p><p><code>2331</code><code>6&lt;/a&gt;</code></p><p><code>2332</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14(9):611–22." href="/articles/10.1186/s13058-018-1049-0#ref-CR20" id="ref-link-section-d33543424e4270"&gt;</code></p><p><code>2333</code><code>20&lt;/a&gt;</code></p><p><code>2334</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Cabezas-Wallscheid N, Buettner F, Sommerkamp P, Klimmeck D, Ladel L, Thalheimer FB, Pastor-Flores D, Roma LP, Renders S, Zeisberger P, et al. Vitamin A-retinoic acid signaling regulates hematopoietic stem cell dormancy. Cell. 2017;169(5):807–823.e819." href="/articles/10.1186/s13058-018-1049-0#ref-CR23" id="ref-link-section-d33543424e4273"&gt;</code></p><p><code>2335</code><code>23&lt;/a&gt;</code></p><p><code>2336</code><code>], which is a cellular dormancy mechanism. These mechanisms may explain the divergence between Ki67 and NR2F1, although additional validation is needed because these markers were not analyzed for in the same DTCs. Nevertheless, results presented in this study and prior results strongly support the concept [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14(9):611–22." href="/articles/10.1186/s13058-018-1049-0#ref-CR20" id="ref-link-section-d33543424e4276"&gt;</code></p><p><code>2337</code><code>20&lt;/a&gt;</code></p><p><code>2338</code><code>] that lack of proliferation is not the same as dormancy, but rather that proliferative arrest is one characteristic of the dormancy program. This underpins the need for markers that can identify the biological key mechanisms for dormancy-associated quiescence that are different from the absence of cell cycle phase markers.&lt;/p&gt;</code></p><p><code>2339</code><code>&lt;p&gt;</code></p><p><code>2340</code><code>Improved techniques to assess the MRD population and their dormant or reactivating state will be key to identifying the risk of future metastasis despite undergoing standard treatment. This opens the way for testing new treatments that prevent metastasis by inducing/enforcing dormancy, and/or to eradicate MRD [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Aguirre-Ghiso JA, Bragado P, Sosa MS. Metastasis awakening: targeting dormant cancer. Nat Med. 2013;19(3):276–7." href="/articles/10.1186/s13058-018-1049-0#ref-CR2" id="ref-link-section-d33543424e4282"&gt;</code></p><p><code>2341</code><code>2&lt;/a&gt;</code></p><p><code>2342</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e4285"&gt;</code></p><p><code>2343</code><code>6&lt;/a&gt;</code></p><p><code>2344</code><code>]. Dormant cancer cells can evade chemotherapy and also express pluripotency genes that keep them in a long-term reawakening probability state [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e4288"&gt;</code></p><p><code>2345</code><code>6&lt;/a&gt;</code></p><p><code>2346</code><code>]. Retinoic acid and 5-azacitidine are examples of dormancy-inducing/sustaining treatment strategies, showing the ability to reprogram malignant cells into dormancy and enforce dormancy programs in already quiescent tumor cells [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e4291"&gt;</code></p><p><code>2347</code><code>6&lt;/a&gt;</code></p><p><code>2348</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Sosa MS. Dormancy programs as emerging antimetastasis therapeutic alternatives. Mol Cell Oncol. 2016;3(1):e1029062." href="/articles/10.1186/s13058-018-1049-0#ref-CR7" id="ref-link-section-d33543424e4294"&gt;</code></p><p><code>2349</code><code>7&lt;/a&gt;</code></p><p><code>2350</code><code>]. These drugs will be tested in a clinical trial of prostate cancer patients at risk of developing metastasis (Mount Sinai IRB no. 18–00226; ClinicalTrials.gov identifier, NCT03572387).&lt;/p&gt;</code></p><p><code>2351</code><code>&lt;p&gt;</code></p><p><code>2352</code><code>Sustaining a dormancy phenotype could have life-saving consequences. In line with this, patients with NR2F1 expression in a few DTCs appeared to have longer disease-free survival in our study. This may suggest that those few DTCs are indicative of at least two parameters that need to be further investigated: first, that residual DTCs not detected in the test clearly share the same phenotype as those detected, and second, that the test seems to also inform on patients that may have niches that are pro-dormant and thus support dormancy of the residual DTCs for longer time periods. The first possibility is supported by abundant experimental evidence for a role of NR2F1 in DTC dormancy through a microenvironmental and epigenetic program of regulation [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170." href="/articles/10.1186/s13058-018-1049-0#ref-CR6" id="ref-link-section-d33543424e4301"&gt;</code></p><p><code>2353</code><code>6&lt;/a&gt;</code></p><p><code>2354</code><code>]. The second is less explored, but it is possible that some patients may be better producers of dormancy-inducing cues as these are commonly signals involved in adult stem cell quiescence. Furthermore, androgen deprivation treatment in prostate cancer has been linked to upregulation of NR2F1 [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Thompson VC, Day TK, Bianco-Miotto T, Selth LA, Han G, Thomas M, Buchanan G, Scher HI, Nelson CC, Greenberg NM, et al. A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease. Int J Cancer. 2012;131(3):662–72." href="/articles/10.1186/s13058-018-1049-0#ref-CR24" id="ref-link-section-d33543424e4304"&gt;</code></p><p><code>2355</code><code>24&lt;/a&gt;</code></p><p><code>2356</code><code>], suggesting that certain commonly used therapies may induce dormancy and cooperate in a long-term response by affecting the DTCs and the host to enter a pro-dormancy state. In breast cancer, response to tamoxifen was reported to be associated with the presence of transforming growth factor (TGF)β2, a dormancy-inducing factor [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Kopp A, Jonat W, Schmahl M, Knabbe C. Transforming growth factor beta 2 (TGF-beta 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen. Cancer Res. 1995;55(20):4512–5." href="/articles/10.1186/s13058-018-1049-0#ref-CR25" id="ref-link-section-d33543424e4307"&gt;</code></p><p><code>2357</code><code>25&lt;/a&gt;</code></p><p><code>2358</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Buck MB, Coller JK, Murdter TE, Eichelbaum M, Knabbe C. TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells. Breast Cancer Res Treat. 2008;107(1):15–24." href="/articles/10.1186/s13058-018-1049-0#ref-CR26" id="ref-link-section-d33543424e4310"&gt;</code></p><p><code>2359</code><code>26&lt;/a&gt;</code></p><p><code>2360</code><code>]. Furthermore, a reduced androgen receptor signaling resulted in TGFβ2 upregulation in the prostate and seminal gland tissue [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Lucia MS, Sporn MB, Roberts AB, Stewart LV, Danielpour D. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells. J Cell Physiol. 1998;175(2):184–92." href="/articles/10.1186/s13058-018-1049-0#ref-CR27" id="ref-link-section-d33543424e4313"&gt;</code></p><p><code>2361</code><code>27&lt;/a&gt;</code></p><p><code>2362</code><code>]. Thus, future studies may not only focus on detection of dormant DTCs, but also investigation of whether the host is producing pro-dormancy cues.&lt;/p&gt;</code></p><p><code>2363</code><code>&lt;p&gt;</code></p><p><code>2364</code><code>Among all the patients included in the studies used as the source for the current project [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Mathiesen RR, Borgen E, Renolen A, Lokkevik E, Nesland JM, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, et al. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival. Breast Cancer Res. 2012;14(4):R117." href="#ref-CR9" id="ref-link-section-d33543424e4319"&gt;</code></p><p><code>2365</code><code>9&lt;/a&gt;</code></p><p><code>2366</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Wiedswang G, Borgen E, Karesen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol. 2003;21(18):3469–78." href="#ref-CR10" id="ref-link-section-d33543424e4319_1"&gt;</code></p><p><code>2367</code><code>10&lt;/a&gt;</code></p><p><code>2368</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Wiedswang G, Borgen E, Karesen R, Qvist H, Janbu J, Kvalheim G, Nesland JM, Naume B. Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome. Clin Cancer Res. 2004;10(16):5342–8." href="#ref-CR11" id="ref-link-section-d33543424e4319_2"&gt;</code></p><p><code>2369</code><code>11&lt;/a&gt;</code></p><p><code>2370</code><code>,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Naume B, Synnestvedt M, Falk RS, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Sommer HH, et al. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer. J Clin Oncol. 2014;32(34):3848–57." href="/articles/10.1186/s13058-018-1049-0#ref-CR12" id="ref-link-section-d33543424e4322"&gt;</code></p><p><code>2371</code><code>12&lt;/a&gt;</code></p><p><code>2372</code><code>] the majority of those identified as DTC-positive had only one or two detectable DTCs across the BMA time points (based on the original analysis; NeoTax ≥ 75%, Oslo1 ≥ 87%, SATT ≥ 75%). The group of patients with such low numbers of DTCs has the most favorable survival among the DTC-positive cases [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Mathiesen RR, Borgen E, Renolen A, Lokkevik E, Nesland JM, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, et al. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival. Breast Cancer Res. 2012;14(4):R117." href="/articles/10.1186/s13058-018-1049-0#ref-CR9" id="ref-link-section-d33543424e4325"&gt;</code></p><p><code>2373</code><code>9&lt;/a&gt;</code></p><p><code>2374</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Naume B, Wiedswang G, Borgen E, Kvalheim G, Karesen R, Qvist H, Janbu J, Harbitz T, Nesland JM. The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells. Clin Cancer Res. 2004;10(9):3091–7." href="/articles/10.1186/s13058-018-1049-0#ref-CR28" id="ref-link-section-d33543424e4328"&gt;</code></p><p><code>2375</code><code>28&lt;/a&gt;</code></p><p><code>2376</code><code>] and would also be expected to be enriched in cases with quiescent DTCs. We attempted to include both patients with originally high and low numbers of DTCs in our analysis. However, in the majority of the samples, no DTCs were detectable by DIF from patients with low DTC burden. In addition to the Poisson distribution effect, this may be for several reasons. Firstly, a reduced sensitivity of the DIF technique compared with the standard (original) APAAP ICC technique can be expected due to a stronger amplification of the signals by the APAAP (three layers) than the direct Xenon-labeling of the anti-CK antibody used in the DIF protocol. Secondly, half the number of BM MNCs (1 × 10&lt;sup&gt;</code></p><p><code>2377</code><code>6&lt;/sup&gt;</code></p><p><code>2378</code><code>) were available for the DIF analysis. Thirdly, some of the DIF samples were prepared from liquid nitrogen-frozen MNC suspensions, which in our experience results in loss of tumor cells in some patients compared with cytospins prepared from fresh BM. Further assessment and characterization of dormancy in patients with very infrequent DTCs (i.e., below the detection level for our analysis) requires analysis of larger BM volumes in future studies, preferably using enrichment techniques [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Naume B, Borgen E, Nesland JM, Beiske K, Gilen E, Renolen A, Ravnas G, Qvist H, Karesen R, Kvalheim G. Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation. Int J Cancer. 1998;78(5):556–60." href="/articles/10.1186/s13058-018-1049-0#ref-CR29" id="ref-link-section-d33543424e4334"&gt;</code></p><p><code>2379</code><code>29&lt;/a&gt;</code></p><p><code>2380</code><code>] or automated scanning systems (&lt;a href="http://rarecyte.com"&gt;</code></p><p><code>2381</code><code>http://rarecyte.com&lt;/a&gt;</code></p><p><code>2382</code><code>) combined with multimarker analysis. In parallel with DTC analysis, capturing functional characteristics of circulating tumor cells (CTCs) from high volumes of peripheral blood, for instance by a multitube CellSearch analysis (&lt;a href="https://www.cellsearchctc.com/"&gt;</code></p><p><code>2383</code><code>https://www.cellsearchctc.com/&lt;/a&gt;</code></p><p><code>2384</code><code>), leukapheresis-related techniques [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Stoecklein NH, Fischer JC, Niederacher D, Terstappen LW. Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution. Expert Rev Mol Diagn. 2016;16(2):147–64." href="/articles/10.1186/s13058-018-1049-0#ref-CR30" id="ref-link-section-d33543424e4351"&gt;</code></p><p><code>2385</code><code>30&lt;/a&gt;</code></p><p><code>2386</code><code>], or intravascular capturing devices [&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="Theil G, Fischer K, Weber E, Medek R, Hoda R, Lucke K, Fornara P. The use of a new cell collector to isolate circulating tumor cells from the blood of patients with different stages of prostate cancer and clinical outcomes—a proof-of-concept study. PLoS One. 2016;11(8):e0158354." href="/articles/10.1186/s13058-018-1049-0#ref-CR31" id="ref-link-section-d33543424e4354"&gt;</code></p><p><code>2387</code><code>31&lt;/a&gt;</code></p><p><code>2388</code><code>, &lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Gorges TM, Penkalla N, Schalk T, Joosse SA, Riethdorf S, Tucholski J, Lucke K, Wikman H, Jackson S, Brychta N, et al. Enumeration and molecular characterization of tumor cells in lung cancer patients using a novel in vivo device for capturing circulating tumor cells. Clin Cancer Res. 2016;22(9):2197–206." href="/articles/10.1186/s13058-018-1049-0#ref-CR32" id="ref-link-section-d33543424e4357"&gt;</code></p><p><code>2389</code><code>32&lt;/a&gt;</code></p><p><code>2390</code><code>], would clarify whether assessment of CTCs may be used for future dormancy studies.&lt;/p&gt;</code></p><p><code>2391</code><code>&lt;/div&gt;</code></p><p><code>2392</code><code>&lt;/div&gt;</code></p><p><code>2393</code><code>&lt;/section&gt;</code></p><p><code>2394</code><code>&lt;section data-title="Conclusions"&gt;</code></p><p><code>2395</code><code>&lt;div class="c-article-section" id="Sec11-section"&gt;</code></p><p><code>2396</code><code>&lt;h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec11"&gt;</code></p><p><code>2397</code><code>Conclusions&lt;/h2&gt;</code></p><p><code>2398</code><code>&lt;div class="c-article-section__content" id="Sec11-content"&gt;</code></p><p><code>2399</code><code>&lt;p&gt;</code></p><p><code>2400</code><code>Overall, we conclude that NR2F1 detection in BM DTCs may be a promising tool to determine the phenotype of DTCs and the prognosis of breast cancer patients. For decades, DTC biology has been relegated primarily to the area of enumeration and subsequent prognosis. Our bench-to-bedside work reveals the first potential dormancy marker that informs on the behavior of DTCs and suggests that enumeration should be followed by phenotype information. Markers such as NR2F1 coupled to DTC genetics and other host-derived indicators may provide a breakthrough in the management of MRD and metastasis prevention.&lt;/p&gt;</code></p><p><code>2401</code><code>&lt;/div&gt;</code></p><p><code>2402</code><code>&lt;/div&gt;</code></p><p><code>2403</code><code>&lt;/section&gt;</code></p><p><code>2404</code><code>          </code></p><p><code>2405</code><code>                    &lt;section data-title="Abbreviations"&gt;</code></p><p><code>2406</code><code>&lt;div class="c-article-section" id="abbreviations-section"&gt;</code></p><p><code>2407</code><code>&lt;h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="abbreviations"&gt;</code></p><p><code>2408</code><code>Abbreviations&lt;/h2&gt;</code></p><p><code>2409</code><code>&lt;div class="c-article-section__content" id="abbreviations-content"&gt;</code></p><p><code>2410</code><code>&lt;dl class="c-abbreviation_list"&gt;</code></p><p><code>2411</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2412</code><code>&lt;dfn&gt;</code></p><p><code>2413</code><code>APAAP:&lt;/dfn&gt;</code></p><p><code>2414</code><code>&lt;/dt&gt;</code></p><p><code>2415</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2416</code><code>          </code></p><p><code>2417</code><code>                    &lt;p&gt;</code></p><p><code>2418</code><code>Alkaline phosphatase–anti-alkaline phosphatase&lt;/p&gt;</code></p><p><code>2419</code><code>          </code></p><p><code>2420</code><code>                  &lt;/dd&gt;</code></p><p><code>2421</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2422</code><code>&lt;dfn&gt;</code></p><p><code>2423</code><code>BM:&lt;/dfn&gt;</code></p><p><code>2424</code><code>&lt;/dt&gt;</code></p><p><code>2425</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2426</code><code>          </code></p><p><code>2427</code><code>                    &lt;p&gt;</code></p><p><code>2428</code><code>Bone marrow&lt;/p&gt;</code></p><p><code>2429</code><code>          </code></p><p><code>2430</code><code>                  &lt;/dd&gt;</code></p><p><code>2431</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2432</code><code>&lt;dfn&gt;</code></p><p><code>2433</code><code>BMA:&lt;/dfn&gt;</code></p><p><code>2434</code><code>&lt;/dt&gt;</code></p><p><code>2435</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2436</code><code>          </code></p><p><code>2437</code><code>                    &lt;p&gt;</code></p><p><code>2438</code><code>Bone marrow aspiration&lt;/p&gt;</code></p><p><code>2439</code><code>          </code></p><p><code>2440</code><code>                  &lt;/dd&gt;</code></p><p><code>2441</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2442</code><code>&lt;dfn&gt;</code></p><p><code>2443</code><code>CK:&lt;/dfn&gt;</code></p><p><code>2444</code><code>&lt;/dt&gt;</code></p><p><code>2445</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2446</code><code>          </code></p><p><code>2447</code><code>                    &lt;p&gt;</code></p><p><code>2448</code><code>Cytokeratin&lt;/p&gt;</code></p><p><code>2449</code><code>          </code></p><p><code>2450</code><code>                  &lt;/dd&gt;</code></p><p><code>2451</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2452</code><code>&lt;dfn&gt;</code></p><p><code>2453</code><code>Coup TF1:&lt;/dfn&gt;</code></p><p><code>2454</code><code>&lt;/dt&gt;</code></p><p><code>2455</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2456</code><code>          </code></p><p><code>2457</code><code>                    &lt;p&gt;</code></p><p><code>2458</code><code>Chicken ovalbumin upstream promoter transcription factor 1&lt;/p&gt;</code></p><p><code>2459</code><code>          </code></p><p><code>2460</code><code>                  &lt;/dd&gt;</code></p><p><code>2461</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2462</code><code>&lt;dfn&gt;</code></p><p><code>2463</code><code>CTC:&lt;/dfn&gt;</code></p><p><code>2464</code><code>&lt;/dt&gt;</code></p><p><code>2465</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2466</code><code>          </code></p><p><code>2467</code><code>                    &lt;p&gt;</code></p><p><code>2468</code><code>Circulating tumor cell&lt;/p&gt;</code></p><p><code>2469</code><code>          </code></p><p><code>2470</code><code>                  &lt;/dd&gt;</code></p><p><code>2471</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2472</code><code>&lt;dfn&gt;</code></p><p><code>2473</code><code>DFI:&lt;/dfn&gt;</code></p><p><code>2474</code><code>&lt;/dt&gt;</code></p><p><code>2475</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2476</code><code>          </code></p><p><code>2477</code><code>                    &lt;p&gt;</code></p><p><code>2478</code><code>Disease-free interval&lt;/p&gt;</code></p><p><code>2479</code><code>          </code></p><p><code>2480</code><code>                  &lt;/dd&gt;</code></p><p><code>2481</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2482</code><code>&lt;dfn&gt;</code></p><p><code>2483</code><code>DIF:&lt;/dfn&gt;</code></p><p><code>2484</code><code>&lt;/dt&gt;</code></p><p><code>2485</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2486</code><code>          </code></p><p><code>2487</code><code>                    &lt;p&gt;</code></p><p><code>2488</code><code>Double immunofluorescence&lt;/p&gt;</code></p><p><code>2489</code><code>          </code></p><p><code>2490</code><code>                  &lt;/dd&gt;</code></p><p><code>2491</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2492</code><code>&lt;dfn&gt;</code></p><p><code>2493</code><code>DTC:&lt;/dfn&gt;</code></p><p><code>2494</code><code>&lt;/dt&gt;</code></p><p><code>2495</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2496</code><code>          </code></p><p><code>2497</code><code>                    &lt;p&gt;</code></p><p><code>2498</code><code>Disseminated tumor cell&lt;/p&gt;</code></p><p><code>2499</code><code>          </code></p><p><code>2500</code><code>                  &lt;/dd&gt;</code></p><p><code>2501</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2502</code><code>&lt;dfn&gt;</code></p><p><code>2503</code><code>ER:&lt;/dfn&gt;</code></p><p><code>2504</code><code>&lt;/dt&gt;</code></p><p><code>2505</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2506</code><code>          </code></p><p><code>2507</code><code>                    &lt;p&gt;</code></p><p><code>2508</code><code>Estrogen receptor&lt;/p&gt;</code></p><p><code>2509</code><code>          </code></p><p><code>2510</code><code>                  &lt;/dd&gt;</code></p><p><code>2511</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2512</code><code>&lt;dfn&gt;</code></p><p><code>2513</code><code>FEC:&lt;/dfn&gt;</code></p><p><code>2514</code><code>&lt;/dt&gt;</code></p><p><code>2515</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2516</code><code>          </code></p><p><code>2517</code><code>                    &lt;p&gt;</code></p><p><code>2518</code><code>Fluorouracil, epirubicin, and cyclophosphamide&lt;/p&gt;</code></p><p><code>2519</code><code>          </code></p><p><code>2520</code><code>                  &lt;/dd&gt;</code></p><p><code>2521</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2522</code><code>&lt;dfn&gt;</code></p><p><code>2523</code><code>ICC:&lt;/dfn&gt;</code></p><p><code>2524</code><code>&lt;/dt&gt;</code></p><p><code>2525</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2526</code><code>          </code></p><p><code>2527</code><code>                    &lt;p&gt;</code></p><p><code>2528</code><code>Immunocytochemical&lt;/p&gt;</code></p><p><code>2529</code><code>          </code></p><p><code>2530</code><code>                  &lt;/dd&gt;</code></p><p><code>2531</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2532</code><code>&lt;dfn&gt;</code></p><p><code>2533</code><code>mAb:&lt;/dfn&gt;</code></p><p><code>2534</code><code>&lt;/dt&gt;</code></p><p><code>2535</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2536</code><code>          </code></p><p><code>2537</code><code>                    &lt;p&gt;</code></p><p><code>2538</code><code>Monoclonal antibody&lt;/p&gt;</code></p><p><code>2539</code><code>          </code></p><p><code>2540</code><code>                  &lt;/dd&gt;</code></p><p><code>2541</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2542</code><code>&lt;dfn&gt;</code></p><p><code>2543</code><code>MNC:&lt;/dfn&gt;</code></p><p><code>2544</code><code>&lt;/dt&gt;</code></p><p><code>2545</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2546</code><code>          </code></p><p><code>2547</code><code>                    &lt;p&gt;</code></p><p><code>2548</code><code>Mononuclear cell&lt;/p&gt;</code></p><p><code>2549</code><code>          </code></p><p><code>2550</code><code>                  &lt;/dd&gt;</code></p><p><code>2551</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2552</code><code>&lt;dfn&gt;</code></p><p><code>2553</code><code>MRD:&lt;/dfn&gt;</code></p><p><code>2554</code><code>&lt;/dt&gt;</code></p><p><code>2555</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2556</code><code>          </code></p><p><code>2557</code><code>                    &lt;p&gt;</code></p><p><code>2558</code><code>Minimal residual disease&lt;/p&gt;</code></p><p><code>2559</code><code>          </code></p><p><code>2560</code><code>                  &lt;/dd&gt;</code></p><p><code>2561</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2562</code><code>&lt;dfn&gt;</code></p><p><code>2563</code><code>NR2F1:&lt;/dfn&gt;</code></p><p><code>2564</code><code>&lt;/dt&gt;</code></p><p><code>2565</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2566</code><code>          </code></p><p><code>2567</code><code>                    &lt;p&gt;</code></p><p><code>2568</code><code>Nuclear receptor subfamily 2, group F, member 1&lt;/p&gt;</code></p><p><code>2569</code><code>          </code></p><p><code>2570</code><code>                  &lt;/dd&gt;</code></p><p><code>2571</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2572</code><code>&lt;dfn&gt;</code></p><p><code>2573</code><code>PBS:&lt;/dfn&gt;</code></p><p><code>2574</code><code>&lt;/dt&gt;</code></p><p><code>2575</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2576</code><code>          </code></p><p><code>2577</code><code>                    &lt;p&gt;</code></p><p><code>2578</code><code>Phosphate-buffered saline&lt;/p&gt;</code></p><p><code>2579</code><code>          </code></p><p><code>2580</code><code>                  &lt;/dd&gt;</code></p><p><code>2581</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2582</code><code>&lt;dfn&gt;</code></p><p><code>2583</code><code>pRb:&lt;/dfn&gt;</code></p><p><code>2584</code><code>&lt;/dt&gt;</code></p><p><code>2585</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2586</code><code>          </code></p><p><code>2587</code><code>                    &lt;p&gt;</code></p><p><code>2588</code><code>Retinoblastoma protein&lt;/p&gt;</code></p><p><code>2589</code><code>          </code></p><p><code>2590</code><code>                  &lt;/dd&gt;</code></p><p><code>2591</code><code>&lt;dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"&gt;</code></p><p><code>2592</code><code>&lt;dfn&gt;</code></p><p><code>2593</code><code>TGF:&lt;/dfn&gt;</code></p><p><code>2594</code><code>&lt;/dt&gt;</code></p><p><code>2595</code><code>&lt;dd class="c-abbreviation_list__description u-mb-24"&gt;</code></p><p><code>2596</code><code>          </code></p><p><code>2597</code><code>                    &lt;p&gt;</code></p><p><code>2598</code><code>Transforming growth factor&lt;/p&gt;</code></p><p><code>2599</code><code>          </code></p><p><code>2600</code><code>                  &lt;/dd&gt;</code></p><p><code>2601</code><code>&lt;/dl&gt;</code></p><p><code>2602</code><code>&lt;/div&gt;</code></p><p><code>2603</code><code>&lt;/div&gt;</code></p><p><code>2604</code><code>&lt;/section&gt;</code></p><p><code>2605</code><code>&lt;div id="MagazineFulltextArticleBodySuffix"&gt;</code></p><p><code>2606</code><code>&lt;section aria-labelledby="Bib1" data-title="References"&gt;</code></p><p><code>2607</code><code>&lt;div class="c-article-section" id="Bib1-section"&gt;</code></p><p><code>2608</code><code>&lt;h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Bib1"&gt;</code></p><p><code>2609</code><code>References&lt;/h2&gt;</code></p><p><code>2610</code><code>&lt;div class="c-article-section__content" id="Bib1-content"&gt;</code></p><p><code>2611</code><code>&lt;div data-container-section="references"&gt;</code></p><p><code>2612</code><code>&lt;ol class="c-article-references" data-track-component="outbound reference"&gt;</code></p><p><code>2613</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1."&gt;</code></p><p><code>2614</code><code>&lt;p class="c-article-references__text" id="ref-CR1"&gt;</code></p><p><code>2615</code><code>Linde N, Fluegen G, Aguirre-Ghiso JA. The relationship between dormant cancer cells and their microenvironment. Adv Cancer Res. 2016;132:45–71.&lt;/p&gt;</code></p><p><code>2616</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2617</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1016/bs.acr.2016.07.002" data-track-action="article reference" href="https://doi.org/10.1016%2Fbs.acr.2016.07.002" aria-label="Article reference 1" data-doi="10.1016/bs.acr.2016.07.002"&gt;</code></p><p><code>2618</code><code>Article&lt;/a&gt;</code></p><p><code>2619</code><code> </code></p><p><code>2620</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DC%2BC2szpt12mtQ%3D%3D" aria-label="CAS reference 1"&gt;</code></p><p><code>2621</code><code>CAS&lt;/a&gt;</code></p><p><code>2622</code><code> </code></p><p><code>2623</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20relationship%20between%20dormant%20cancer%20cells%20and%20their%20microenvironment&amp;amp;journal=Adv%20Cancer%20Res&amp;amp;doi=10.1016%2Fbs.acr.2016.07.002&amp;amp;volume=132&amp;amp;pages=45-71&amp;amp;publication_year=2016&amp;amp;author=Linde%2CN&amp;amp;author=Fluegen%2CG&amp;amp;author=Aguirre-Ghiso%2CJA"&gt;</code></p><p><code>2624</code><code>          </code></p><p><code>2625</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2626</code><code> </code></p><p><code>2627</code><code>                &lt;/p&gt;</code></p><p><code>2628</code><code>&lt;/li&gt;</code></p><p><code>2629</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2."&gt;</code></p><p><code>2630</code><code>&lt;p class="c-article-references__text" id="ref-CR2"&gt;</code></p><p><code>2631</code><code>Aguirre-Ghiso JA, Bragado P, Sosa MS. Metastasis awakening: targeting dormant cancer. Nat Med. 2013;19(3):276–7.&lt;/p&gt;</code></p><p><code>2632</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2633</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1038/nm.3120" data-track-action="article reference" href="https://doi.org/10.1038%2Fnm.3120" aria-label="Article reference 2" data-doi="10.1038/nm.3120"&gt;</code></p><p><code>2634</code><code>Article&lt;/a&gt;</code></p><p><code>2635</code><code> </code></p><p><code>2636</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXjsVKqtLc%3D" aria-label="CAS reference 2"&gt;</code></p><p><code>2637</code><code>CAS&lt;/a&gt;</code></p><p><code>2638</code><code> </code></p><p><code>2639</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Metastasis%20awakening%3A%20targeting%20dormant%20cancer&amp;amp;journal=Nat%20Med&amp;amp;doi=10.1038%2Fnm.3120&amp;amp;volume=19&amp;amp;issue=3&amp;amp;pages=276-277&amp;amp;publication_year=2013&amp;amp;author=Aguirre-Ghiso%2CJA&amp;amp;author=Bragado%2CP&amp;amp;author=Sosa%2CMS"&gt;</code></p><p><code>2640</code><code>          </code></p><p><code>2641</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2642</code><code> </code></p><p><code>2643</code><code>                &lt;/p&gt;</code></p><p><code>2644</code><code>&lt;/li&gt;</code></p><p><code>2645</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3."&gt;</code></p><p><code>2646</code><code>&lt;p class="c-article-references__text" id="ref-CR3"&gt;</code></p><p><code>2647</code><code>Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med. 2005;353(8):793–802.&lt;/p&gt;</code></p><p><code>2648</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2649</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1056/NEJMoa050434" data-track-action="article reference" href="https://doi.org/10.1056%2FNEJMoa050434" aria-label="Article reference 3" data-doi="10.1056/NEJMoa050434"&gt;</code></p><p><code>2650</code><code>Article&lt;/a&gt;</code></p><p><code>2651</code><code> </code></p><p><code>2652</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXovVKlu7s%3D" aria-label="CAS reference 3"&gt;</code></p><p><code>2653</code><code>CAS&lt;/a&gt;</code></p><p><code>2654</code><code> </code></p><p><code>2655</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20pooled%20analysis%20of%20bone%20marrow%20micrometastasis%20in%20breast%20cancer&amp;amp;journal=N%20Engl%20J%20Med&amp;amp;doi=10.1056%2FNEJMoa050434&amp;amp;volume=353&amp;amp;issue=8&amp;amp;pages=793-802&amp;amp;publication_year=2005&amp;amp;author=Braun%2CS&amp;amp;author=Vogl%2CFD&amp;amp;author=Naume%2CB&amp;amp;author=Janni%2CW&amp;amp;author=Osborne%2CMP&amp;amp;author=Coombes%2CRC&amp;amp;author=Schlimok%2CG&amp;amp;author=Diel%2CIJ&amp;amp;author=Gerber%2CB&amp;amp;author=Gebauer%2CG"&gt;</code></p><p><code>2656</code><code>          </code></p><p><code>2657</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2658</code><code> </code></p><p><code>2659</code><code>                &lt;/p&gt;</code></p><p><code>2660</code><code>&lt;/li&gt;</code></p><p><code>2661</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4."&gt;</code></p><p><code>2662</code><code>&lt;p class="c-article-references__text" id="ref-CR4"&gt;</code></p><p><code>2663</code><code>Janni W, Vogl FD, Wiedswang G, Synnestvedt M, Fehm T, Juckstock J, Borgen E, Rack B, Braun S, Sommer H, et al. Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse—a European pooled analysis. Clin Cancer Res. 2011;17(9):2967–76.&lt;/p&gt;</code></p><p><code>2664</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2665</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1158/1078-0432.CCR-10-2515" data-track-action="article reference" href="https://doi.org/10.1158%2F1078-0432.CCR-10-2515" aria-label="Article reference 4" data-doi="10.1158/1078-0432.CCR-10-2515"&gt;</code></p><p><code>2666</code><code>Article&lt;/a&gt;</code></p><p><code>2667</code><code> </code></p><p><code>2668</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Persistence%20of%20disseminated%20tumor%20cells%20in%20the%20bone%20marrow%20of%20breast%20cancer%20patients%20predicts%20increased%20risk%20for%20relapse%E2%80%94a%20European%20pooled%20analysis&amp;amp;journal=Clin%20Cancer%20Res&amp;amp;doi=10.1158%2F1078-0432.CCR-10-2515&amp;amp;volume=17&amp;amp;issue=9&amp;amp;pages=2967-2976&amp;amp;publication_year=2011&amp;amp;author=Janni%2CW&amp;amp;author=Vogl%2CFD&amp;amp;author=Wiedswang%2CG&amp;amp;author=Synnestvedt%2CM&amp;amp;author=Fehm%2CT&amp;amp;author=Juckstock%2CJ&amp;amp;author=Borgen%2CE&amp;amp;author=Rack%2CB&amp;amp;author=Braun%2CS&amp;amp;author=Sommer%2CH"&gt;</code></p><p><code>2669</code><code>          </code></p><p><code>2670</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2671</code><code> </code></p><p><code>2672</code><code>                &lt;/p&gt;</code></p><p><code>2673</code><code>&lt;/li&gt;</code></p><p><code>2674</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5."&gt;</code></p><p><code>2675</code><code>&lt;p class="c-article-references__text" id="ref-CR5"&gt;</code></p><p><code>2676</code><code>Adam AP, George A, Schewe D, Bragado P, Iglesias BV, Ranganathan AC, Kourtidis A, Conklin DS, Aguirre-Ghiso JA. Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence. Cancer Res. 2009;69(14):5664–72.&lt;/p&gt;</code></p><p><code>2677</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2678</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1158/0008-5472.CAN-08-3820" data-track-action="article reference" href="https://doi.org/10.1158%2F0008-5472.CAN-08-3820" aria-label="Article reference 5" data-doi="10.1158/0008-5472.CAN-08-3820"&gt;</code></p><p><code>2679</code><code>Article&lt;/a&gt;</code></p><p><code>2680</code><code> </code></p><p><code>2681</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXosV2ms7w%3D" aria-label="CAS reference 5"&gt;</code></p><p><code>2682</code><code>CAS&lt;/a&gt;</code></p><p><code>2683</code><code> </code></p><p><code>2684</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Computational%20identification%20of%20a%20p38SAPK-regulated%20transcription%20factor%20network%20required%20for%20tumor%20cell%20quiescence&amp;amp;journal=Cancer%20Res&amp;amp;doi=10.1158%2F0008-5472.CAN-08-3820&amp;amp;volume=69&amp;amp;issue=14&amp;amp;pages=5664-5672&amp;amp;publication_year=2009&amp;amp;author=Adam%2CAP&amp;amp;author=George%2CA&amp;amp;author=Schewe%2CD&amp;amp;author=Bragado%2CP&amp;amp;author=Iglesias%2CBV&amp;amp;author=Ranganathan%2CAC&amp;amp;author=Kourtidis%2CA&amp;amp;author=Conklin%2CDS&amp;amp;author=Aguirre-Ghiso%2CJA"&gt;</code></p><p><code>2685</code><code>          </code></p><p><code>2686</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2687</code><code> </code></p><p><code>2688</code><code>                &lt;/p&gt;</code></p><p><code>2689</code><code>&lt;/li&gt;</code></p><p><code>2690</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6."&gt;</code></p><p><code>2691</code><code>&lt;p class="c-article-references__text" id="ref-CR6"&gt;</code></p><p><code>2692</code><code>Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170.&lt;/p&gt;</code></p><p><code>2693</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2694</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1038/ncomms7170" data-track-action="article reference" href="https://doi.org/10.1038%2Fncomms7170" aria-label="Article reference 6" data-doi="10.1038/ncomms7170"&gt;</code></p><p><code>2695</code><code>Article&lt;/a&gt;</code></p><p><code>2696</code><code> </code></p><p><code>2697</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtF2itLjI" aria-label="CAS reference 6"&gt;</code></p><p><code>2698</code><code>CAS&lt;/a&gt;</code></p><p><code>2699</code><code> </code></p><p><code>2700</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NR2F1%20controls%20tumour%20cell%20dormancy%20via%20SOX9-%20and%20RARbeta-driven%20quiescence%20programmes&amp;amp;journal=Nat%20Commun&amp;amp;doi=10.1038%2Fncomms7170&amp;amp;volume=6&amp;amp;publication_year=2015&amp;amp;author=Sosa%2CMS&amp;amp;author=Parikh%2CF&amp;amp;author=Maia%2CAG&amp;amp;author=Estrada%2CY&amp;amp;author=Bosch%2CA&amp;amp;author=Bragado%2CP&amp;amp;author=Ekpin%2CE&amp;amp;author=George%2CA&amp;amp;author=Zheng%2CY&amp;amp;author=Lam%2CHM"&gt;</code></p><p><code>2701</code><code>          </code></p><p><code>2702</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2703</code><code> </code></p><p><code>2704</code><code>                &lt;/p&gt;</code></p><p><code>2705</code><code>&lt;/li&gt;</code></p><p><code>2706</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7."&gt;</code></p><p><code>2707</code><code>&lt;p class="c-article-references__text" id="ref-CR7"&gt;</code></p><p><code>2708</code><code>Sosa MS. Dormancy programs as emerging antimetastasis therapeutic alternatives. Mol Cell Oncol. 2016;3(1):e1029062.&lt;/p&gt;</code></p><p><code>2709</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2710</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1080/23723556.2015.1029062" data-track-action="article reference" href="https://doi.org/10.1080%2F23723556.2015.1029062" aria-label="Article reference 7" data-doi="10.1080/23723556.2015.1029062"&gt;</code></p><p><code>2711</code><code>Article&lt;/a&gt;</code></p><p><code>2712</code><code> </code></p><p><code>2713</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Dormancy%20programs%20as%20emerging%20antimetastasis%20therapeutic%20alternatives&amp;amp;journal=Mol%20Cell%20Oncol&amp;amp;doi=10.1080%2F23723556.2015.1029062&amp;amp;volume=3&amp;amp;issue=1&amp;amp;publication_year=2016&amp;amp;author=Sosa%2CMS"&gt;</code></p><p><code>2714</code><code>          </code></p><p><code>2715</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2716</code><code> </code></p><p><code>2717</code><code>                &lt;/p&gt;</code></p><p><code>2718</code><code>&lt;/li&gt;</code></p><p><code>2719</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8."&gt;</code></p><p><code>2720</code><code>&lt;p class="c-article-references__text" id="ref-CR8"&gt;</code></p><p><code>2721</code><code>Fluegen G, Avivar-Valderas A, Wang Y, Padgen MR, Williams JK, Nobre AR, Calvo V, Cheung JF, Bravo-Cordero JJ, Entenberg D, et al. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat Cell Biol. 2017;19(2):120–32.&lt;/p&gt;</code></p><p><code>2722</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2723</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1038/ncb3465" data-track-action="article reference" href="https://doi.org/10.1038%2Fncb3465" aria-label="Article reference 8" data-doi="10.1038/ncb3465"&gt;</code></p><p><code>2724</code><code>Article&lt;/a&gt;</code></p><p><code>2725</code><code> </code></p><p><code>2726</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhsVKitrw%3D" aria-label="CAS reference 8"&gt;</code></p><p><code>2727</code><code>CAS&lt;/a&gt;</code></p><p><code>2728</code><code> </code></p><p><code>2729</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Phenotypic%20heterogeneity%20of%20disseminated%20tumour%20cells%20is%20preset%20by%20primary%20tumour%20hypoxic%20microenvironments&amp;amp;journal=Nat%20Cell%20Biol&amp;amp;doi=10.1038%2Fncb3465&amp;amp;volume=19&amp;amp;issue=2&amp;amp;pages=120-132&amp;amp;publication_year=2017&amp;amp;author=Fluegen%2CG&amp;amp;author=Avivar-Valderas%2CA&amp;amp;author=Wang%2CY&amp;amp;author=Padgen%2CMR&amp;amp;author=Williams%2CJK&amp;amp;author=Nobre%2CAR&amp;amp;author=Calvo%2CV&amp;amp;author=Cheung%2CJF&amp;amp;author=Bravo-Cordero%2CJJ&amp;amp;author=Entenberg%2CD"&gt;</code></p><p><code>2730</code><code>          </code></p><p><code>2731</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2732</code><code> </code></p><p><code>2733</code><code>                &lt;/p&gt;</code></p><p><code>2734</code><code>&lt;/li&gt;</code></p><p><code>2735</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9."&gt;</code></p><p><code>2736</code><code>&lt;p class="c-article-references__text" id="ref-CR9"&gt;</code></p><p><code>2737</code><code>Mathiesen RR, Borgen E, Renolen A, Lokkevik E, Nesland JM, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, et al. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival. Breast Cancer Res. 2012;14(4):R117.&lt;/p&gt;</code></p><p><code>2738</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2739</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1186/bcr3242" data-track-action="article reference" href="https://doi.org/10.1186%2Fbcr3242" aria-label="Article reference 9" data-doi="10.1186/bcr3242"&gt;</code></p><p><code>2740</code><code>Article&lt;/a&gt;</code></p><p><code>2741</code><code> </code></p><p><code>2742</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Persistence%20of%20disseminated%20tumor%20cells%20after%20neoadjuvant%20treatment%20for%20locally%20advanced%20breast%20cancer%20predicts%20poor%20survival&amp;amp;journal=Breast%20Cancer%20Res&amp;amp;doi=10.1186%2Fbcr3242&amp;amp;volume=14&amp;amp;issue=4&amp;amp;publication_year=2012&amp;amp;author=Mathiesen%2CRR&amp;amp;author=Borgen%2CE&amp;amp;author=Renolen%2CA&amp;amp;author=Lokkevik%2CE&amp;amp;author=Nesland%2CJM&amp;amp;author=Anker%2CG&amp;amp;author=Ostenstad%2CB&amp;amp;author=Lundgren%2CS&amp;amp;author=Risberg%2CT&amp;amp;author=Mjaaland%2CI"&gt;</code></p><p><code>2743</code><code>          </code></p><p><code>2744</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2745</code><code> </code></p><p><code>2746</code><code>                &lt;/p&gt;</code></p><p><code>2747</code><code>&lt;/li&gt;</code></p><p><code>2748</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10."&gt;</code></p><p><code>2749</code><code>&lt;p class="c-article-references__text" id="ref-CR10"&gt;</code></p><p><code>2750</code><code>Wiedswang G, Borgen E, Karesen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol. 2003;21(18):3469–78.&lt;/p&gt;</code></p><p><code>2751</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2752</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1200/JCO.2003.02.009" data-track-action="article reference" href="https://doi.org/10.1200%2FJCO.2003.02.009" aria-label="Article reference 10" data-doi="10.1200/JCO.2003.02.009"&gt;</code></p><p><code>2753</code><code>Article&lt;/a&gt;</code></p><p><code>2754</code><code> </code></p><p><code>2755</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DC%2BD3svjtFyksQ%3D%3D" aria-label="CAS reference 10"&gt;</code></p><p><code>2756</code><code>CAS&lt;/a&gt;</code></p><p><code>2757</code><code> </code></p><p><code>2758</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Detection%20of%20isolated%20tumor%20cells%20in%20bone%20marrow%20is%20an%20independent%20prognostic%20factor%20in%20breast%20cancer&amp;amp;journal=J%20Clin%20Oncol&amp;amp;doi=10.1200%2FJCO.2003.02.009&amp;amp;volume=21&amp;amp;issue=18&amp;amp;pages=3469-3478&amp;amp;publication_year=2003&amp;amp;author=Wiedswang%2CG&amp;amp;author=Borgen%2CE&amp;amp;author=Karesen%2CR&amp;amp;author=Kvalheim%2CG&amp;amp;author=Nesland%2CJM&amp;amp;author=Qvist%2CH&amp;amp;author=Schlichting%2CE&amp;amp;author=Sauer%2CT&amp;amp;author=Janbu%2CJ&amp;amp;author=Harbitz%2CT"&gt;</code></p><p><code>2759</code><code>          </code></p><p><code>2760</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2761</code><code> </code></p><p><code>2762</code><code>                &lt;/p&gt;</code></p><p><code>2763</code><code>&lt;/li&gt;</code></p><p><code>2764</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11."&gt;</code></p><p><code>2765</code><code>&lt;p class="c-article-references__text" id="ref-CR11"&gt;</code></p><p><code>2766</code><code>Wiedswang G, Borgen E, Karesen R, Qvist H, Janbu J, Kvalheim G, Nesland JM, Naume B. Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome. Clin Cancer Res. 2004;10(16):5342–8.&lt;/p&gt;</code></p><p><code>2767</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2768</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1158/1078-0432.CCR-04-0245" data-track-action="article reference" href="https://doi.org/10.1158%2F1078-0432.CCR-04-0245" aria-label="Article reference 11" data-doi="10.1158/1078-0432.CCR-04-0245"&gt;</code></p><p><code>2769</code><code>Article&lt;/a&gt;</code></p><p><code>2770</code><code> </code></p><p><code>2771</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Isolated%20tumor%20cells%20in%20bone%20marrow%20three%20years%20after%20diagnosis%20in%20disease-free%20breast%20cancer%20patients%20predict%20unfavorable%20clinical%20outcome&amp;amp;journal=Clin%20Cancer%20Res&amp;amp;doi=10.1158%2F1078-0432.CCR-04-0245&amp;amp;volume=10&amp;amp;issue=16&amp;amp;pages=5342-5348&amp;amp;publication_year=2004&amp;amp;author=Wiedswang%2CG&amp;amp;author=Borgen%2CE&amp;amp;author=Karesen%2CR&amp;amp;author=Qvist%2CH&amp;amp;author=Janbu%2CJ&amp;amp;author=Kvalheim%2CG&amp;amp;author=Nesland%2CJM&amp;amp;author=Naume%2CB"&gt;</code></p><p><code>2772</code><code>          </code></p><p><code>2773</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2774</code><code> </code></p><p><code>2775</code><code>                &lt;/p&gt;</code></p><p><code>2776</code><code>&lt;/li&gt;</code></p><p><code>2777</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12."&gt;</code></p><p><code>2778</code><code>&lt;p class="c-article-references__text" id="ref-CR12"&gt;</code></p><p><code>2779</code><code>Naume B, Synnestvedt M, Falk RS, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Sommer HH, et al. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer. J Clin Oncol. 2014;32(34):3848–57.&lt;/p&gt;</code></p><p><code>2780</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2781</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1200/JCO.2014.56.9327" data-track-action="article reference" href="https://doi.org/10.1200%2FJCO.2014.56.9327" aria-label="Article reference 12" data-doi="10.1200/JCO.2014.56.9327"&gt;</code></p><p><code>2782</code><code>Article&lt;/a&gt;</code></p><p><code>2783</code><code> </code></p><p><code>2784</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Clinical%20outcome%20with%20correlation%20to%20disseminated%20tumor%20cell%20%28DTC%29%20status%20after%20DTC-guided%20secondary%20adjuvant%20treatment%20with%20docetaxel%20in%20early%20breast%20cancer&amp;amp;journal=J%20Clin%20Oncol&amp;amp;doi=10.1200%2FJCO.2014.56.9327&amp;amp;volume=32&amp;amp;issue=34&amp;amp;pages=3848-3857&amp;amp;publication_year=2014&amp;amp;author=Naume%2CB&amp;amp;author=Synnestvedt%2CM&amp;amp;author=Falk%2CRS&amp;amp;author=Wiedswang%2CG&amp;amp;author=Weyde%2CK&amp;amp;author=Risberg%2CT&amp;amp;author=Kersten%2CC&amp;amp;author=Mjaaland%2CI&amp;amp;author=Vindi%2CL&amp;amp;author=Sommer%2CHH"&gt;</code></p><p><code>2785</code><code>          </code></p><p><code>2786</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2787</code><code> </code></p><p><code>2788</code><code>                &lt;/p&gt;</code></p><p><code>2789</code><code>&lt;/li&gt;</code></p><p><code>2790</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13."&gt;</code></p><p><code>2791</code><code>&lt;p class="c-article-references__text" id="ref-CR13"&gt;</code></p><p><code>2792</code><code>Chrisanthar R, Knappskog S, Lokkevik E, Anker G, Ostenstad B, Lundgren S, Berge EO, Risberg T, Mjaaland I, Maehle L, et al. CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer. PLoS One. 2008;3(8):e3062.&lt;/p&gt;</code></p><p><code>2793</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2794</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1371/journal.pone.0003062" data-track-action="article reference" href="https://doi.org/10.1371%2Fjournal.pone.0003062" aria-label="Article reference 13" data-doi="10.1371/journal.pone.0003062"&gt;</code></p><p><code>2795</code><code>Article&lt;/a&gt;</code></p><p><code>2796</code><code> </code></p><p><code>2797</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=CHEK2%20mutations%20affecting%20kinase%20activity%20together%20with%20mutations%20in%20TP53%20indicate%20a%20functional%20pathway%20associated%20with%20resistance%20to%20epirubicin%20in%20primary%20breast%20cancer&amp;amp;journal=PLoS%20One&amp;amp;doi=10.1371%2Fjournal.pone.0003062&amp;amp;volume=3&amp;amp;issue=8&amp;amp;publication_year=2008&amp;amp;author=Chrisanthar%2CR&amp;amp;author=Knappskog%2CS&amp;amp;author=Lokkevik%2CE&amp;amp;author=Anker%2CG&amp;amp;author=Ostenstad%2CB&amp;amp;author=Lundgren%2CS&amp;amp;author=Berge%2CEO&amp;amp;author=Risberg%2CT&amp;amp;author=Mjaaland%2CI&amp;amp;author=Maehle%2CL"&gt;</code></p><p><code>2798</code><code>          </code></p><p><code>2799</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2800</code><code> </code></p><p><code>2801</code><code>                &lt;/p&gt;</code></p><p><code>2802</code><code>&lt;/li&gt;</code></p><p><code>2803</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14."&gt;</code></p><p><code>2804</code><code>&lt;p class="c-article-references__text" id="ref-CR14"&gt;</code></p><p><code>2805</code><code>Chrisanthar R, Knappskog S, Lokkevik E, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Skjonsberg G, Aas T, et al. Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel. PLoS One. 2011;6(4):e19249.&lt;/p&gt;</code></p><p><code>2806</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2807</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1371/journal.pone.0019249" data-track-action="article reference" href="https://doi.org/10.1371%2Fjournal.pone.0019249" aria-label="Article reference 14" data-doi="10.1371/journal.pone.0019249"&gt;</code></p><p><code>2808</code><code>Article&lt;/a&gt;</code></p><p><code>2809</code><code> </code></p><p><code>2810</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXls1Sntbk%3D" aria-label="CAS reference 14"&gt;</code></p><p><code>2811</code><code>CAS&lt;/a&gt;</code></p><p><code>2812</code><code> </code></p><p><code>2813</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Predictive%20and%20prognostic%20impact%20of%20TP53%20mutations%20and%20MDM2%20promoter%20genotype%20in%20primary%20breast%20cancer%20patients%20treated%20with%20epirubicin%20or%20paclitaxel&amp;amp;journal=PLoS%20One&amp;amp;doi=10.1371%2Fjournal.pone.0019249&amp;amp;volume=6&amp;amp;issue=4&amp;amp;publication_year=2011&amp;amp;author=Chrisanthar%2CR&amp;amp;author=Knappskog%2CS&amp;amp;author=Lokkevik%2CE&amp;amp;author=Anker%2CG&amp;amp;author=Ostenstad%2CB&amp;amp;author=Lundgren%2CS&amp;amp;author=Risberg%2CT&amp;amp;author=Mjaaland%2CI&amp;amp;author=Skjonsberg%2CG&amp;amp;author=Aas%2CT"&gt;</code></p><p><code>2814</code><code>          </code></p><p><code>2815</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2816</code><code> </code></p><p><code>2817</code><code>                &lt;/p&gt;</code></p><p><code>2818</code><code>&lt;/li&gt;</code></p><p><code>2819</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15."&gt;</code></p><p><code>2820</code><code>&lt;p class="c-article-references__text" id="ref-CR15"&gt;</code></p><p><code>2821</code><code>Borgen E, Naume B, Nesland JM, Kvalheim G, Beiske K, Fodstad O, Diel I, Solomayer EF, Theocharous P, Coombes RC, et al. Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. Establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy. 1999;1(5):377–88.&lt;/p&gt;</code></p><p><code>2822</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2823</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1080/0032472031000141283" data-track-action="article reference" href="https://doi.org/10.1080%2F0032472031000141283" aria-label="Article reference 15" data-doi="10.1080/0032472031000141283"&gt;</code></p><p><code>2824</code><code>Article&lt;/a&gt;</code></p><p><code>2825</code><code> </code></p><p><code>2826</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DC%2BC3c3ps1Cjtw%3D%3D" aria-label="CAS reference 15"&gt;</code></p><p><code>2827</code><code>CAS&lt;/a&gt;</code></p><p><code>2828</code><code> </code></p><p><code>2829</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Standardization%20of%20the%20immunocytochemical%20detection%20of%20cancer%20cells%20in%20BM%20and%20blood%3A%20I.%20Establishment%20of%20objective%20criteria%20for%20the%20evaluation%20of%20immunostained%20cells&amp;amp;journal=Cytotherapy&amp;amp;doi=10.1080%2F0032472031000141283&amp;amp;volume=1&amp;amp;issue=5&amp;amp;pages=377-388&amp;amp;publication_year=1999&amp;amp;author=Borgen%2CE&amp;amp;author=Naume%2CB&amp;amp;author=Nesland%2CJM&amp;amp;author=Kvalheim%2CG&amp;amp;author=Beiske%2CK&amp;amp;author=Fodstad%2CO&amp;amp;author=Diel%2CI&amp;amp;author=Solomayer%2CEF&amp;amp;author=Theocharous%2CP&amp;amp;author=Coombes%2CRC"&gt;</code></p><p><code>2830</code><code>          </code></p><p><code>2831</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2832</code><code> </code></p><p><code>2833</code><code>                &lt;/p&gt;</code></p><p><code>2834</code><code>&lt;/li&gt;</code></p><p><code>2835</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16."&gt;</code></p><p><code>2836</code><code>&lt;p class="c-article-references__text" id="ref-CR16"&gt;</code></p><p><code>2837</code><code>Fehm T, Braun S, Muller V, Janni W, Gebauer G, Marth C, Schindlbeck C, Wallwiener D, Borgen E, Naume B, et al. A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer. 2006;107(5):885–92.&lt;/p&gt;</code></p><p><code>2838</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2839</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1002/cncr.22076" data-track-action="article reference" href="https://doi.org/10.1002%2Fcncr.22076" aria-label="Article reference 16" data-doi="10.1002/cncr.22076"&gt;</code></p><p><code>2840</code><code>Article&lt;/a&gt;</code></p><p><code>2841</code><code> </code></p><p><code>2842</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20concept%20for%20the%20standardized%20detection%20of%20disseminated%20tumor%20cells%20in%20bone%20marrow%20from%20patients%20with%20primary%20breast%20cancer%20and%20its%20clinical%20implementation&amp;amp;journal=Cancer&amp;amp;doi=10.1002%2Fcncr.22076&amp;amp;volume=107&amp;amp;issue=5&amp;amp;pages=885-892&amp;amp;publication_year=2006&amp;amp;author=Fehm%2CT&amp;amp;author=Braun%2CS&amp;amp;author=Muller%2CV&amp;amp;author=Janni%2CW&amp;amp;author=Gebauer%2CG&amp;amp;author=Marth%2CC&amp;amp;author=Schindlbeck%2CC&amp;amp;author=Wallwiener%2CD&amp;amp;author=Borgen%2CE&amp;amp;author=Naume%2CB"&gt;</code></p><p><code>2843</code><code>          </code></p><p><code>2844</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2845</code><code> </code></p><p><code>2846</code><code>                &lt;/p&gt;</code></p><p><code>2847</code><code>&lt;/li&gt;</code></p><p><code>2848</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17."&gt;</code></p><p><code>2849</code><code>&lt;p class="c-article-references__text" id="ref-CR17"&gt;</code></p><p><code>2850</code><code>Synnestvedt M, Borgen E, Wist E, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Schirmer C, et al. Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study. BMC Cancer. 2012;12:616.&lt;/p&gt;</code></p><p><code>2851</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2852</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1186/1471-2407-12-616" data-track-action="article reference" href="https://doi.org/10.1186%2F1471-2407-12-616" aria-label="Article reference 17" data-doi="10.1186/1471-2407-12-616"&gt;</code></p><p><code>2853</code><code>Article&lt;/a&gt;</code></p><p><code>2854</code><code> </code></p><p><code>2855</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXjs12mt74%3D" aria-label="CAS reference 17"&gt;</code></p><p><code>2856</code><code>CAS&lt;/a&gt;</code></p><p><code>2857</code><code> </code></p><p><code>2858</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Disseminated%20tumor%20cells%20as%20selection%20marker%20and%20monitoring%20tool%20for%20secondary%20adjuvant%20treatment%20in%20early%20breast%20cancer.%20Descriptive%20results%20from%20an%20intervention%20study&amp;amp;journal=BMC%20Cancer&amp;amp;doi=10.1186%2F1471-2407-12-616&amp;amp;volume=12&amp;amp;publication_year=2012&amp;amp;author=Synnestvedt%2CM&amp;amp;author=Borgen%2CE&amp;amp;author=Wist%2CE&amp;amp;author=Wiedswang%2CG&amp;amp;author=Weyde%2CK&amp;amp;author=Risberg%2CT&amp;amp;author=Kersten%2CC&amp;amp;author=Mjaaland%2CI&amp;amp;author=Vindi%2CL&amp;amp;author=Schirmer%2CC"&gt;</code></p><p><code>2859</code><code>          </code></p><p><code>2860</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2861</code><code> </code></p><p><code>2862</code><code>                &lt;/p&gt;</code></p><p><code>2863</code><code>&lt;/li&gt;</code></p><p><code>2864</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18."&gt;</code></p><p><code>2865</code><code>&lt;p class="c-article-references__text" id="ref-CR18"&gt;</code></p><p><code>2866</code><code>Bragado P, Estrada Y, Parikh F, Krause S, Capobianco C, Farina HG, Schewe DM, Aguirre-Ghiso JA. TGF-beta2 dictates disseminated tumour cell fate in target organs through TGF-beta-RIII and p38alpha/beta signalling. Nat Cell Biol. 2013;15(11):1351–61.&lt;/p&gt;</code></p><p><code>2867</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2868</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1038/ncb2861" data-track-action="article reference" href="https://doi.org/10.1038%2Fncb2861" aria-label="Article reference 18" data-doi="10.1038/ncb2861"&gt;</code></p><p><code>2869</code><code>Article&lt;/a&gt;</code></p><p><code>2870</code><code> </code></p><p><code>2871</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXhs1yiurrP" aria-label="CAS reference 18"&gt;</code></p><p><code>2872</code><code>CAS&lt;/a&gt;</code></p><p><code>2873</code><code> </code></p><p><code>2874</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=TGF-beta2%20dictates%20disseminated%20tumour%20cell%20fate%20in%20target%20organs%20through%20TGF-beta-RIII%20and%20p38alpha%2Fbeta%20signalling&amp;amp;journal=Nat%20Cell%20Biol&amp;amp;doi=10.1038%2Fncb2861&amp;amp;volume=15&amp;amp;issue=11&amp;amp;pages=1351-1361&amp;amp;publication_year=2013&amp;amp;author=Bragado%2CP&amp;amp;author=Estrada%2CY&amp;amp;author=Parikh%2CF&amp;amp;author=Krause%2CS&amp;amp;author=Capobianco%2CC&amp;amp;author=Farina%2CHG&amp;amp;author=Schewe%2CDM&amp;amp;author=Aguirre-Ghiso%2CJA"&gt;</code></p><p><code>2875</code><code>          </code></p><p><code>2876</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2877</code><code> </code></p><p><code>2878</code><code>                &lt;/p&gt;</code></p><p><code>2879</code><code>&lt;/li&gt;</code></p><p><code>2880</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19."&gt;</code></p><p><code>2881</code><code>&lt;p class="c-article-references__text" id="ref-CR19"&gt;</code></p><p><code>2882</code><code>Harper KL, Sosa MS, Entenberg D, Hosseini H, Cheung JF, Nobre R, Avivar-Valderas A, Nagi C, Girnius N, Davis RJ, et al. Mechanism of early dissemination and metastasis in Her2+ mammary cancer. Nature. 2016. &lt;a href="https://doi.org/10.1038/nature20609" data-track="click" data-track-action="external reference" data-track-label="10.1038/nature20609"&gt;</code></p><p><code>2883</code><code>https://doi.org/10.1038/nature20609&lt;/a&gt;</code></p><p><code>2884</code><code>.&lt;/p&gt;</code></p><p><code>2885</code><code>&lt;/li&gt;</code></p><p><code>2886</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20."&gt;</code></p><p><code>2887</code><code>&lt;p class="c-article-references__text" id="ref-CR20"&gt;</code></p><p><code>2888</code><code>Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14(9):611–22.&lt;/p&gt;</code></p><p><code>2889</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2890</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1038/nrc3793" data-track-action="article reference" href="https://doi.org/10.1038%2Fnrc3793" aria-label="Article reference 20" data-doi="10.1038/nrc3793"&gt;</code></p><p><code>2891</code><code>Article&lt;/a&gt;</code></p><p><code>2892</code><code> </code></p><p><code>2893</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXhtlGnt7%2FP" aria-label="CAS reference 20"&gt;</code></p><p><code>2894</code><code>CAS&lt;/a&gt;</code></p><p><code>2895</code><code> </code></p><p><code>2896</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Mechanisms%20of%20disseminated%20cancer%20cell%20dormancy%3A%20an%20awakening%20field&amp;amp;journal=Nat%20Rev%20Cancer&amp;amp;doi=10.1038%2Fnrc3793&amp;amp;volume=14&amp;amp;issue=9&amp;amp;pages=611-622&amp;amp;publication_year=2014&amp;amp;author=Sosa%2CMS&amp;amp;author=Bragado%2CP&amp;amp;author=Aguirre-Ghiso%2CJA"&gt;</code></p><p><code>2897</code><code>          </code></p><p><code>2898</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2899</code><code> </code></p><p><code>2900</code><code>                &lt;/p&gt;</code></p><p><code>2901</code><code>&lt;/li&gt;</code></p><p><code>2902</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21."&gt;</code></p><p><code>2903</code><code>&lt;p class="c-article-references__text" id="ref-CR21"&gt;</code></p><p><code>2904</code><code>Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y, de Stanchina E, Massague J. Metastatic latency and immune evasion through autocrine inhibition of WNT. Cell. 2016;165(1):45–60.&lt;/p&gt;</code></p><p><code>2905</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2906</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1016/j.cell.2016.02.025" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2016.02.025" aria-label="Article reference 21" data-doi="10.1016/j.cell.2016.02.025"&gt;</code></p><p><code>2907</code><code>Article&lt;/a&gt;</code></p><p><code>2908</code><code> </code></p><p><code>2909</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XltVamu7g%3D" aria-label="CAS reference 21"&gt;</code></p><p><code>2910</code><code>CAS&lt;/a&gt;</code></p><p><code>2911</code><code> </code></p><p><code>2912</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Metastatic%20latency%20and%20immune%20evasion%20through%20autocrine%20inhibition%20of%20WNT&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2016.02.025&amp;amp;volume=165&amp;amp;issue=1&amp;amp;pages=45-60&amp;amp;publication_year=2016&amp;amp;author=Malladi%2CS&amp;amp;author=Macalinao%2CDG&amp;amp;author=Jin%2CX&amp;amp;author=He%2CL&amp;amp;author=Basnet%2CH&amp;amp;author=Zou%2CY&amp;amp;author=de%20Stanchina%2CE&amp;amp;author=Massague%2CJ"&gt;</code></p><p><code>2913</code><code>          </code></p><p><code>2914</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2915</code><code> </code></p><p><code>2916</code><code>                &lt;/p&gt;</code></p><p><code>2917</code><code>&lt;/li&gt;</code></p><p><code>2918</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22."&gt;</code></p><p><code>2919</code><code>&lt;p class="c-article-references__text" id="ref-CR22"&gt;</code></p><p><code>2920</code><code>Gao H, Chakraborty G, Lee-Lim AP, Mo Q, Decker M, Vonica A, Shen R, Brogi E, Brivanlou AH, Giancotti FG. The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell. 2012;150(4):764–79.&lt;/p&gt;</code></p><p><code>2921</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2922</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1016/j.cell.2012.06.035" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2012.06.035" aria-label="Article reference 22" data-doi="10.1016/j.cell.2012.06.035"&gt;</code></p><p><code>2923</code><code>Article&lt;/a&gt;</code></p><p><code>2924</code><code> </code></p><p><code>2925</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38Xht1aksbrK" aria-label="CAS reference 22"&gt;</code></p><p><code>2926</code><code>CAS&lt;/a&gt;</code></p><p><code>2927</code><code> </code></p><p><code>2928</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20BMP%20inhibitor%20Coco%20reactivates%20breast%20cancer%20cells%20at%20lung%20metastatic%20sites&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2012.06.035&amp;amp;volume=150&amp;amp;issue=4&amp;amp;pages=764-779&amp;amp;publication_year=2012&amp;amp;author=Gao%2CH&amp;amp;author=Chakraborty%2CG&amp;amp;author=Lee-Lim%2CAP&amp;amp;author=Mo%2CQ&amp;amp;author=Decker%2CM&amp;amp;author=Vonica%2CA&amp;amp;author=Shen%2CR&amp;amp;author=Brogi%2CE&amp;amp;author=Brivanlou%2CAH&amp;amp;author=Giancotti%2CFG"&gt;</code></p><p><code>2929</code><code>          </code></p><p><code>2930</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2931</code><code> </code></p><p><code>2932</code><code>                &lt;/p&gt;</code></p><p><code>2933</code><code>&lt;/li&gt;</code></p><p><code>2934</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23."&gt;</code></p><p><code>2935</code><code>&lt;p class="c-article-references__text" id="ref-CR23"&gt;</code></p><p><code>2936</code><code>Cabezas-Wallscheid N, Buettner F, Sommerkamp P, Klimmeck D, Ladel L, Thalheimer FB, Pastor-Flores D, Roma LP, Renders S, Zeisberger P, et al. Vitamin A-retinoic acid signaling regulates hematopoietic stem cell dormancy. Cell. 2017;169(5):807–823.e819.&lt;/p&gt;</code></p><p><code>2937</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2938</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1016/j.cell.2017.04.018" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2017.04.018" aria-label="Article reference 23" data-doi="10.1016/j.cell.2017.04.018"&gt;</code></p><p><code>2939</code><code>Article&lt;/a&gt;</code></p><p><code>2940</code><code> </code></p><p><code>2941</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXntFerurc%3D" aria-label="CAS reference 23"&gt;</code></p><p><code>2942</code><code>CAS&lt;/a&gt;</code></p><p><code>2943</code><code> </code></p><p><code>2944</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Vitamin%20A-retinoic%20acid%20signaling%20regulates%20hematopoietic%20stem%20cell%20dormancy&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2017.04.018&amp;amp;volume=169&amp;amp;issue=5&amp;amp;pages=807-823.e819&amp;amp;publication_year=2017&amp;amp;author=Cabezas-Wallscheid%2CN&amp;amp;author=Buettner%2CF&amp;amp;author=Sommerkamp%2CP&amp;amp;author=Klimmeck%2CD&amp;amp;author=Ladel%2CL&amp;amp;author=Thalheimer%2CFB&amp;amp;author=Pastor-Flores%2CD&amp;amp;author=Roma%2CLP&amp;amp;author=Renders%2CS&amp;amp;author=Zeisberger%2CP"&gt;</code></p><p><code>2945</code><code>          </code></p><p><code>2946</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2947</code><code> </code></p><p><code>2948</code><code>                &lt;/p&gt;</code></p><p><code>2949</code><code>&lt;/li&gt;</code></p><p><code>2950</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24."&gt;</code></p><p><code>2951</code><code>&lt;p class="c-article-references__text" id="ref-CR24"&gt;</code></p><p><code>2952</code><code>Thompson VC, Day TK, Bianco-Miotto T, Selth LA, Han G, Thomas M, Buchanan G, Scher HI, Nelson CC, Greenberg NM, et al. A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease. Int J Cancer. 2012;131(3):662–72.&lt;/p&gt;</code></p><p><code>2953</code><code>&lt;/li&gt;</code></p><p><code>2954</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25."&gt;</code></p><p><code>2955</code><code>&lt;p class="c-article-references__text" id="ref-CR25"&gt;</code></p><p><code>2956</code><code>Kopp A, Jonat W, Schmahl M, Knabbe C. Transforming growth factor beta 2 (TGF-beta 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen. Cancer Res. 1995;55(20):4512–5.&lt;/p&gt;</code></p><p><code>2957</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2958</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK2MXoslWmsro%3D" aria-label="CAS reference 25"&gt;</code></p><p><code>2959</code><code>CAS&lt;/a&gt;</code></p><p><code>2960</code><code> </code></p><p><code>2961</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=7553618" aria-label="PubMed reference 25"&gt;</code></p><p><code>2962</code><code>PubMed&lt;/a&gt;</code></p><p><code>2963</code><code> </code></p><p><code>2964</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Transforming%20growth%20factor%20beta%202%20%28TGF-beta%202%29%20levels%20in%20plasma%20of%20patients%20with%20metastatic%20breast%20cancer%20treated%20with%20tamoxifen&amp;amp;journal=Cancer%20Res&amp;amp;volume=55&amp;amp;issue=20&amp;amp;pages=4512-4515&amp;amp;publication_year=1995&amp;amp;author=Kopp%2CA&amp;amp;author=Jonat%2CW&amp;amp;author=Schmahl%2CM&amp;amp;author=Knabbe%2CC"&gt;</code></p><p><code>2965</code><code>          </code></p><p><code>2966</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2967</code><code> </code></p><p><code>2968</code><code>                &lt;/p&gt;</code></p><p><code>2969</code><code>&lt;/li&gt;</code></p><p><code>2970</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26."&gt;</code></p><p><code>2971</code><code>&lt;p class="c-article-references__text" id="ref-CR26"&gt;</code></p><p><code>2972</code><code>Buck MB, Coller JK, Murdter TE, Eichelbaum M, Knabbe C. TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells. Breast Cancer Res Treat. 2008;107(1):15–24.&lt;/p&gt;</code></p><p><code>2973</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2974</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1007/s10549-007-9526-7" data-track-action="article reference" href="https://doi.org/10.1007%2Fs10549-007-9526-7" aria-label="Article reference 26" data-doi="10.1007/s10549-007-9526-7"&gt;</code></p><p><code>2975</code><code>Article&lt;/a&gt;</code></p><p><code>2976</code><code> </code></p><p><code>2977</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXhtlGrtbrE" aria-label="CAS reference 26"&gt;</code></p><p><code>2978</code><code>CAS&lt;/a&gt;</code></p><p><code>2979</code><code> </code></p><p><code>2980</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=TGFbeta2%20and%20TbetaRII%20are%20valid%20molecular%20biomarkers%20for%20the%20antiproliferative%20effects%20of%20tamoxifen%20and%20tamoxifen%20metabolites%20in%20breast%20cancer%20cells&amp;amp;journal=Breast%20Cancer%20Res%20Treat&amp;amp;doi=10.1007%2Fs10549-007-9526-7&amp;amp;volume=107&amp;amp;issue=1&amp;amp;pages=15-24&amp;amp;publication_year=2008&amp;amp;author=Buck%2CMB&amp;amp;author=Coller%2CJK&amp;amp;author=Murdter%2CTE&amp;amp;author=Eichelbaum%2CM&amp;amp;author=Knabbe%2CC"&gt;</code></p><p><code>2981</code><code>          </code></p><p><code>2982</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2983</code><code> </code></p><p><code>2984</code><code>                &lt;/p&gt;</code></p><p><code>2985</code><code>&lt;/li&gt;</code></p><p><code>2986</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27."&gt;</code></p><p><code>2987</code><code>&lt;p class="c-article-references__text" id="ref-CR27"&gt;</code></p><p><code>2988</code><code>Lucia MS, Sporn MB, Roberts AB, Stewart LV, Danielpour D. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells. J Cell Physiol. 1998;175(2):184–92.&lt;/p&gt;</code></p><p><code>2989</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>2990</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1002/(SICI)1097-4652(199805)175:2&lt;184::AID-JCP8&amp;gt;3.0.CO;2-K" data-track-action="article reference" href="https://doi.org/10.1002%2F%28SICI%291097-4652%28199805%29175%3A2%3C184%3A%3AAID-JCP8%3E3.0.CO%3B2-K" aria-label="Article reference 27" data-doi="10.1002/(SICI)1097-4652(199805)175:2&lt;184::AID-JCP8&amp;gt;3.0.CO;2-K"&gt;</code></p><p><code>2991</code><code>Article&lt;/a&gt;</code></p><p><code>2992</code><code> </code></p><p><code>2993</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK1cXit1Wls7s%3D" aria-label="CAS reference 27"&gt;</code></p><p><code>2994</code><code>CAS&lt;/a&gt;</code></p><p><code>2995</code><code> </code></p><p><code>2996</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20role%20of%20transforming%20growth%20factor-beta1%2C%20-beta2%2C%20and%20-beta3%20in%20androgen-responsive%20growth%20of%20NRP-152%20rat%20prostatic%20epithelial%20cells&amp;amp;journal=J%20Cell%20Physiol&amp;amp;doi=10.1002%2F%28SICI%291097-4652%28199805%29175%3A2%3C184%3A%3AAID-JCP8%3E3.0.CO%3B2-K&amp;amp;volume=175&amp;amp;issue=2&amp;amp;pages=184-192&amp;amp;publication_year=1998&amp;amp;author=Lucia%2CMS&amp;amp;author=Sporn%2CMB&amp;amp;author=Roberts%2CAB&amp;amp;author=Stewart%2CLV&amp;amp;author=Danielpour%2CD"&gt;</code></p><p><code>2997</code><code>          </code></p><p><code>2998</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>2999</code><code> </code></p><p><code>3000</code><code>                &lt;/p&gt;</code></p><p><code>3001</code><code>&lt;/li&gt;</code></p><p><code>3002</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28."&gt;</code></p><p><code>3003</code><code>&lt;p class="c-article-references__text" id="ref-CR28"&gt;</code></p><p><code>3004</code><code>Naume B, Wiedswang G, Borgen E, Kvalheim G, Karesen R, Qvist H, Janbu J, Harbitz T, Nesland JM. The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells. Clin Cancer Res. 2004;10(9):3091–7.&lt;/p&gt;</code></p><p><code>3005</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>3006</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1158/1078-0432.CCR-03-0373" data-track-action="article reference" href="https://doi.org/10.1158%2F1078-0432.CCR-03-0373" aria-label="Article reference 28" data-doi="10.1158/1078-0432.CCR-03-0373"&gt;</code></p><p><code>3007</code><code>Article&lt;/a&gt;</code></p><p><code>3008</code><code> </code></p><p><code>3009</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20prognostic%20value%20of%20isolated%20tumor%20cells%20in%20bone%20marrow%20in%20breast%20cancer%20patients%3A%20evaluation%20of%20morphological%20categories%20and%20the%20number%20of%20clinically%20significant%20cells&amp;amp;journal=Clin%20Cancer%20Res&amp;amp;doi=10.1158%2F1078-0432.CCR-03-0373&amp;amp;volume=10&amp;amp;issue=9&amp;amp;pages=3091-3097&amp;amp;publication_year=2004&amp;amp;author=Naume%2CB&amp;amp;author=Wiedswang%2CG&amp;amp;author=Borgen%2CE&amp;amp;author=Kvalheim%2CG&amp;amp;author=Karesen%2CR&amp;amp;author=Qvist%2CH&amp;amp;author=Janbu%2CJ&amp;amp;author=Harbitz%2CT&amp;amp;author=Nesland%2CJM"&gt;</code></p><p><code>3010</code><code>          </code></p><p><code>3011</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>3012</code><code> </code></p><p><code>3013</code><code>                &lt;/p&gt;</code></p><p><code>3014</code><code>&lt;/li&gt;</code></p><p><code>3015</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29."&gt;</code></p><p><code>3016</code><code>&lt;p class="c-article-references__text" id="ref-CR29"&gt;</code></p><p><code>3017</code><code>Naume B, Borgen E, Nesland JM, Beiske K, Gilen E, Renolen A, Ravnas G, Qvist H, Karesen R, Kvalheim G. Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation. Int J Cancer. 1998;78(5):556–60.&lt;/p&gt;</code></p><p><code>3018</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>3019</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1002/(SICI)1097-0215(19981123)78:5&lt;556::AID-IJC5&amp;gt;3.0.CO;2-G" data-track-action="article reference" href="https://doi.org/10.1002%2F%28SICI%291097-0215%2819981123%2978%3A5%3C556%3A%3AAID-IJC5%3E3.0.CO%3B2-G" aria-label="Article reference 29" data-doi="10.1002/(SICI)1097-0215(19981123)78:5&lt;556::AID-IJC5&amp;gt;3.0.CO;2-G"&gt;</code></p><p><code>3020</code><code>Article&lt;/a&gt;</code></p><p><code>3021</code><code> </code></p><p><code>3022</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK1cXns1CgsLc%3D" aria-label="CAS reference 29"&gt;</code></p><p><code>3023</code><code>CAS&lt;/a&gt;</code></p><p><code>3024</code><code> </code></p><p><code>3025</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Increased%20sensitivity%20for%20detection%20of%20micrometastases%20in%20bone-marrow%2Fperipheral-blood%20stem-cell%20products%20from%20breast-cancer%20patients%20by%20negative%20immunomagnetic%20separation&amp;amp;journal=Int%20J%20Cancer&amp;amp;doi=10.1002%2F%28SICI%291097-0215%2819981123%2978%3A5%3C556%3A%3AAID-IJC5%3E3.0.CO%3B2-G&amp;amp;volume=78&amp;amp;issue=5&amp;amp;pages=556-560&amp;amp;publication_year=1998&amp;amp;author=Naume%2CB&amp;amp;author=Borgen%2CE&amp;amp;author=Nesland%2CJM&amp;amp;author=Beiske%2CK&amp;amp;author=Gilen%2CE&amp;amp;author=Renolen%2CA&amp;amp;author=Ravnas%2CG&amp;amp;author=Qvist%2CH&amp;amp;author=Karesen%2CR&amp;amp;author=Kvalheim%2CG"&gt;</code></p><p><code>3026</code><code>          </code></p><p><code>3027</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>3028</code><code> </code></p><p><code>3029</code><code>                &lt;/p&gt;</code></p><p><code>3030</code><code>&lt;/li&gt;</code></p><p><code>3031</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30."&gt;</code></p><p><code>3032</code><code>&lt;p class="c-article-references__text" id="ref-CR30"&gt;</code></p><p><code>3033</code><code>Stoecklein NH, Fischer JC, Niederacher D, Terstappen LW. Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution. Expert Rev Mol Diagn. 2016;16(2):147–64.&lt;/p&gt;</code></p><p><code>3034</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>3035</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1586/14737159.2016.1123095" data-track-action="article reference" href="https://doi.org/10.1586%2F14737159.2016.1123095" aria-label="Article reference 30" data-doi="10.1586/14737159.2016.1123095"&gt;</code></p><p><code>3036</code><code>Article&lt;/a&gt;</code></p><p><code>3037</code><code> </code></p><p><code>3038</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXitVCksLbJ" aria-label="CAS reference 30"&gt;</code></p><p><code>3039</code><code>CAS&lt;/a&gt;</code></p><p><code>3040</code><code> </code></p><p><code>3041</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Challenges%20for%20CTC-based%20liquid%20biopsies%3A%20low%20CTC%20frequency%20and%20diagnostic%20leukapheresis%20as%20a%20potential%20solution&amp;amp;journal=Expert%20Rev%20Mol%20Diagn&amp;amp;doi=10.1586%2F14737159.2016.1123095&amp;amp;volume=16&amp;amp;issue=2&amp;amp;pages=147-164&amp;amp;publication_year=2016&amp;amp;author=Stoecklein%2CNH&amp;amp;author=Fischer%2CJC&amp;amp;author=Niederacher%2CD&amp;amp;author=Terstappen%2CLW"&gt;</code></p><p><code>3042</code><code>          </code></p><p><code>3043</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>3044</code><code> </code></p><p><code>3045</code><code>                &lt;/p&gt;</code></p><p><code>3046</code><code>&lt;/li&gt;</code></p><p><code>3047</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31."&gt;</code></p><p><code>3048</code><code>&lt;p class="c-article-references__text" id="ref-CR31"&gt;</code></p><p><code>3049</code><code>Theil G, Fischer K, Weber E, Medek R, Hoda R, Lucke K, Fornara P. The use of a new cell collector to isolate circulating tumor cells from the blood of patients with different stages of prostate cancer and clinical outcomes—a proof-of-concept study. PLoS One. 2016;11(8):e0158354.&lt;/p&gt;</code></p><p><code>3050</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>3051</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1371/journal.pone.0158354" data-track-action="article reference" href="https://doi.org/10.1371%2Fjournal.pone.0158354" aria-label="Article reference 31" data-doi="10.1371/journal.pone.0158354"&gt;</code></p><p><code>3052</code><code>Article&lt;/a&gt;</code></p><p><code>3053</code><code> </code></p><p><code>3054</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20use%20of%20a%20new%20cell%20collector%20to%20isolate%20circulating%20tumor%20cells%20from%20the%20blood%20of%20patients%20with%20different%20stages%20of%20prostate%20cancer%20and%20clinical%20outcomes%E2%80%94a%20proof-of-concept%20study&amp;amp;journal=PLoS%20One&amp;amp;doi=10.1371%2Fjournal.pone.0158354&amp;amp;volume=11&amp;amp;issue=8&amp;amp;publication_year=2016&amp;amp;author=Theil%2CG&amp;amp;author=Fischer%2CK&amp;amp;author=Weber%2CE&amp;amp;author=Medek%2CR&amp;amp;author=Hoda%2CR&amp;amp;author=Lucke%2CK&amp;amp;author=Fornara%2CP"&gt;</code></p><p><code>3055</code><code>          </code></p><p><code>3056</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>3057</code><code> </code></p><p><code>3058</code><code>                &lt;/p&gt;</code></p><p><code>3059</code><code>&lt;/li&gt;</code></p><p><code>3060</code><code>&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32."&gt;</code></p><p><code>3061</code><code>&lt;p class="c-article-references__text" id="ref-CR32"&gt;</code></p><p><code>3062</code><code>Gorges TM, Penkalla N, Schalk T, Joosse SA, Riethdorf S, Tucholski J, Lucke K, Wikman H, Jackson S, Brychta N, et al. Enumeration and molecular characterization of tumor cells in lung cancer patients using a novel in vivo device for capturing circulating tumor cells. Clin Cancer Res. 2016;22(9):2197–206.&lt;/p&gt;</code></p><p><code>3063</code><code>&lt;p class="c-article-references__links u-hide-print"&gt;</code></p><p><code>3064</code><code>&lt;a data-track="click" rel="nofollow noopener" data-track-label="10.1158/1078-0432.CCR-15-1416" data-track-action="article reference" href="https://doi.org/10.1158%2F1078-0432.CCR-15-1416" aria-label="Article reference 32" data-doi="10.1158/1078-0432.CCR-15-1416"&gt;</code></p><p><code>3065</code><code>Article&lt;/a&gt;</code></p><p><code>3066</code><code> </code></p><p><code>3067</code><code>    &lt;a data-track="click" rel="nofollow noopener" data-track-label="link" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XntlOrsbs%3D" aria-label="CAS reference 32"&gt;</code></p><p><code>3068</code><code>CAS&lt;/a&gt;</code></p><p><code>3069</code><code> </code></p><p><code>3070</code><code>    &lt;a data-track="click" data-track-action="google scholar reference" data-track-label="link" rel="nofollow noopener" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Enumeration%20and%20molecular%20characterization%20of%20tumor%20cells%20in%20lung%20cancer%20patients%20using%20a%20novel%20in%20vivo%20device%20for%20capturing%20circulating%20tumor%20cells&amp;amp;journal=Clin%20Cancer%20Res&amp;amp;doi=10.1158%2F1078-0432.CCR-15-1416&amp;amp;volume=22&amp;amp;issue=9&amp;amp;pages=2197-2206&amp;amp;publication_year=2016&amp;amp;author=Gorges%2CTM&amp;amp;author=Penkalla%2CN&amp;amp;author=Schalk%2CT&amp;amp;author=Joosse%2CSA&amp;amp;author=Riethdorf%2CS&amp;amp;author=Tucholski%2CJ&amp;amp;author=Lucke%2CK&amp;amp;author=Wikman%2CH&amp;amp;author=Jackson%2CS&amp;amp;author=Brychta%2CN"&gt;</code></p><p><code>3071</code><code>          </code></p><p><code>3072</code><code>                    Google Scholar&lt;/a&gt;</code></p><p><code>3073</code><code> </code></p><p><code>3074</code><code>                &lt;/p&gt;</code></p><p><code>3075</code><code>&lt;/li&gt;</code></p><p><code>3076</code><code>&lt;/ol&gt;</code></p><p><code>3077</code><code>&lt;p class="c-article-references__download u-hide-print"&gt;</code></p><p><code>3078</code><code>&lt;a data-track="click" data-track-action="download citation references" data-track-label="link" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1186/s13058-018-1049-0?format=refman&amp;amp;flavour=references"&gt;</code></p><p><code>3079</code><code>Download references&lt;svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"&gt;</code></p><p><code>3080</code><code>&lt;use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-download"&gt;</code></p><p><code>3081</code><code>&lt;/use&gt;</code></p><p><code>3082</code><code>&lt;/svg&gt;</code></p><p><code>3083</code><code>&lt;/a&gt;</code></p><p><code>3084</code><code>&lt;/p&gt;</code></p><p><code>3085</code><code>&lt;/div&gt;</code></p><p><code>3086</code><code>&lt;/div&gt;</code></p><p><code>3087</code><code>&lt;/div&gt;</code></p><p><code>3088</code><code>&lt;/section&gt;</code></p><p><code>3089</code><code>&lt;/div&gt;</code></p><p><code>3090</code><code>&lt;section data-title="Acknowledgements"&gt;</code></p><p><code>3091</code><code>&lt;div class="c-article-section" id="Ack1-section"&gt;</code></p><p><code>3092</code><code>&lt;h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Ack1"&gt;</code></p><p><code>3093</code><code>Acknowledgements&lt;/h2&gt;</code></p><p><code>3094</code><code>&lt;div class="c-article-section__content" id="Ack1-content"&gt;</code></p><p><code>3095</code><code>&lt;p&gt;</code></p><p><code>3096</code><code>We thank the patients who have participated in the studies.&lt;/p&gt;</code></p><p><code>3097</code><code>          </code></p><p><code>3098</code><code>                &lt;h3 class="c-article__sub-heading" id="FPar1"&gt;</code></p><p><code>3099</code><code>Funding&lt;/h3&gt;</code></p><p><code>3100</code><code>          </code></p><p><code>3101</code><code>                &lt;p&gt;</code></p><p><code>3102</code><code>Funding was provided to BN by the Research Council of Norway, South-Eastern Norway Regional Health Authority, and the Norwegian Cancer Society. Funding was provided to JAA-G by the National Cancer Institute (US), US Department of Defense, and the Samuel Waxman Cancer Research Foundation. Funding was provided to MSS by the Melanoma Research Alliance, Susan G. Komen (US), and the National Cancer Institute (US).&lt;/p&gt;</code></p><p><code>3103</code><code>          </code></p><p><code>3104</code><code>              </code></p><p><code>3105</code><code>                &lt;h3 class="c-article__sub-heading" id="FPar2"&gt;</code></p><p><code>3106</code><code>Availability of data and materials&lt;/h3&gt;</code></p><p><code>3107</code><code>          </code></p><p><code>3108</code><code>                &lt;p&gt;</code></p><p><code>3109</code><code>A complete overview of data is presented in Additional file &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM1"&gt;</code></p><p><code>3110</code><code>1&lt;/a&gt;</code></p><p><code>3111</code><code> (Table S1). Further data sharing is not applicable to this article. Please contact the author for data questions&lt;b&gt;</code></p><p><code>3112</code><code>.&lt;/b&gt;</code></p><p><code>3113</code><code>&lt;/p&gt;</code></p><p><code>3114</code><code>          </code></p><p><code>3115</code><code>              &lt;/div&gt;</code></p><p><code>3116</code><code>&lt;/div&gt;</code></p><p><code>3117</code><code>&lt;/section&gt;</code></p><p><code>3118</code><code>&lt;section aria-labelledby="author-information" data-title="Author information"&gt;</code></p><p><code>3119</code><code>&lt;div class="c-article-section" id="author-information-section"&gt;</code></p><p><code>3120</code><code>&lt;h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="author-information"&gt;</code></p><p><code>3121</code><code>Author information&lt;/h2&gt;</code></p><p><code>3122</code><code>&lt;div class="c-article-section__content" id="author-information-content"&gt;</code></p><p><code>3123</code><code>&lt;span class="c-article-author-information__subtitle u-visually-hidden" id="author-notes"&gt;</code></p><p><code>3124</code><code>Author notes&lt;/span&gt;</code></p><p><code>3125</code><code>&lt;ol class="c-article-author-information__list"&gt;</code></p><p><code>3126</code><code>&lt;li class="c-article-author-information__item" id="na1"&gt;</code></p><p><code>3127</code><code>&lt;p&gt;</code></p><p><code>3128</code><code>Elin Borgen, Maria C. Rypdal and Maria Soledad Sosa contributed equally as first authors, and Julio A. Aguirre-Ghiso and Bjørn Naume contributed equally as last authors to this work.&lt;/p&gt;</code></p><p><code>3129</code><code>&lt;/li&gt;</code></p><p><code>3130</code><code>&lt;/ol&gt;</code></p><p><code>3131</code><code>&lt;h3 class="c-article__sub-heading" id="affiliations"&gt;</code></p><p><code>3132</code><code>Authors and Affiliations&lt;/h3&gt;</code></p><p><code>3133</code><code>&lt;ol class="c-article-author-affiliation__list"&gt;</code></p><p><code>3134</code><code>&lt;li id="Aff1"&gt;</code></p><p><code>3135</code><code>&lt;p class="c-article-author-affiliation__address"&gt;</code></p><p><code>3136</code><code>Department of Pathology, Oslo University Hospital, Oslo, Norway&lt;/p&gt;</code></p><p><code>3137</code><code>&lt;p class="c-article-author-affiliation__authors-list"&gt;</code></p><p><code>3138</code><code>Elin Borgen, Maria C. Rypdal &amp;amp; Anne Renolen&lt;/p&gt;</code></p><p><code>3139</code><code>&lt;/li&gt;</code></p><p><code>3140</code><code>&lt;li id="Aff2"&gt;</code></p><p><code>3141</code><code>&lt;p class="c-article-author-affiliation__address"&gt;</code></p><p><code>3142</code><code>Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA&lt;/p&gt;</code></p><p><code>3143</code><code>&lt;p class="c-article-author-affiliation__authors-list"&gt;</code></p><p><code>3144</code><code>Maria Soledad Sosa&lt;/p&gt;</code></p><p><code>3145</code><code>&lt;/li&gt;</code></p><p><code>3146</code><code>&lt;li id="Aff3"&gt;</code></p><p><code>3147</code><code>&lt;p class="c-article-author-affiliation__address"&gt;</code></p><p><code>3148</code><code>Division of Hematology and Oncology, Department of Medicine, Department of Otolaryngology, Tisch Cancer Institute, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA&lt;/p&gt;</code></p><p><code>3149</code><code>&lt;p class="c-article-author-affiliation__authors-list"&gt;</code></p><p><code>3150</code><code>Maria Soledad Sosa &amp;amp; Julio A. Aguirre-Ghiso&lt;/p&gt;</code></p><p><code>3151</code><code>&lt;/li&gt;</code></p><p><code>3152</code><code>&lt;li id="Aff4"&gt;</code></p><p><code>3153</code><code>&lt;p class="c-article-author-affiliation__address"&gt;</code></p><p><code>3154</code><code>Department of Surgery, Oslo University Hospital, Oslo, Norway&lt;/p&gt;</code></p><p><code>3155</code><code>&lt;p class="c-article-author-affiliation__authors-list"&gt;</code></p><p><code>3156</code><code>Ellen Schlichting&lt;/p&gt;</code></p><p><code>3157</code><code>&lt;/li&gt;</code></p><p><code>3158</code><code>&lt;li id="Aff5"&gt;</code></p><p><code>3159</code><code>&lt;p class="c-article-author-affiliation__address"&gt;</code></p><p><code>3160</code><code>Department of Oncology, Haukeland University Hospital, Bergen, Norway&lt;/p&gt;</code></p><p><code>3161</code><code>&lt;p class="c-article-author-affiliation__authors-list"&gt;</code></p><p><code>3162</code><code>Per E. Lønning&lt;/p&gt;</code></p><p><code>3163</code><code>&lt;/li&gt;</code></p><p><code>3164</code><code>&lt;li id="Aff6"&gt;</code></p><p><code>3165</code><code>&lt;p class="c-article-author-affiliation__address"&gt;</code></p><p><code>3166</code><code>Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway&lt;/p&gt;</code></p><p><code>3167</code><code>&lt;p class="c-article-author-affiliation__authors-list"&gt;</code></p><p><code>3168</code><code>Per E. Lønning&lt;/p&gt;</code></p><p><code>3169</code><code>&lt;/li&gt;</code></p><p><code>3170</code><code>&lt;li id="Aff7"&gt;</code></p><p><code>3171</code><code>&lt;p class="c-article-author-affiliation__address"&gt;</code></p><p><code>3172</code><code>Department of Oncology, Oslo University Hospital, Oslo, Norway&lt;/p&gt;</code></p><p><code>3173</code><code>&lt;p class="c-article-author-affiliation__authors-list"&gt;</code></p><p><code>3174</code><code>Marit Synnestvedt &amp;amp; Bjørn Naume&lt;/p&gt;</code></p><p><code>3175</code><code>&lt;/li&gt;</code></p><p><code>3176</code><code>&lt;li id="Aff8"&gt;</code></p><p><code>3177</code><code>&lt;p class="c-article-author-affiliation__address"&gt;</code></p><p><code>3178</code><code>Institute of Clinical Medicine, University of Oslo, Oslo, Norway&lt;/p&gt;</code></p><p><code>3179</code><code>&lt;p class="c-article-author-affiliation__authors-list"&gt;</code></p><p><code>3180</code><code>Bjørn Naume&lt;/p&gt;</code></p><p><code>3181</code><code>&lt;/li&gt;</code></p><p><code>3182</code><code>&lt;/ol&gt;</code></p><p><code>3183</code><code>&lt;div class="u-js-hide u-hide-print" data-test="author-info"&gt;</code></p><p><code>3184</code><code>&lt;span class="c-article__sub-heading"&gt;</code></p><p><code>3185</code><code>Authors&lt;/span&gt;</code></p><p><code>3186</code><code>&lt;ol class="c-article-authors-search u-list-reset"&gt;</code></p><p><code>3187</code><code>&lt;li id="auth-Elin-Borgen-Aff1"&gt;</code></p><p><code>3188</code><code>&lt;span class="c-article-authors-search__title u-h3 js-search-name"&gt;</code></p><p><code>3189</code><code>Elin Borgen&lt;/span&gt;</code></p><p><code>3190</code><code>&lt;div class="c-article-authors-search__list"&gt;</code></p><p><code>3191</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--left"&gt;</code></p><p><code>3192</code><code>&lt;a href="https://www.biomedcentral.com/search?query=author%23Elin%20Borgen" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3193</code><code>View author publications&lt;/a&gt;</code></p><p><code>3194</code><code>&lt;/div&gt;</code></p><p><code>3195</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--right"&gt;</code></p><p><code>3196</code><code>&lt;p class="search-in-title-js c-article-authors-search__text"&gt;</code></p><p><code>3197</code><code>You can also search for this author in</code></p><p><code>3198</code><code>                        &lt;span class="c-article-identifiers"&gt;</code></p><p><code>3199</code><code>&lt;a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;amp;term=Elin%20Borgen" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3200</code><code>PubMed&lt;/a&gt;</code></p><p><code>3201</code><code>&lt;span class="u-hide"&gt;</code></p><p><code>3202</code><code> &lt;/span&gt;</code></p><p><code>3203</code><code>&lt;a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;amp;num=10&amp;amp;btnG=Search+Scholar&amp;amp;as_epq=&amp;amp;as_oq=&amp;amp;as_eq=&amp;amp;as_occt=any&amp;amp;as_sauthors=%22Elin%20Borgen%22&amp;amp;as_publication=&amp;amp;as_ylo=&amp;amp;as_yhi=&amp;amp;as_allsubj=all&amp;amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3204</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3205</code><code>&lt;/span&gt;</code></p><p><code>3206</code><code>&lt;/p&gt;</code></p><p><code>3207</code><code>&lt;/div&gt;</code></p><p><code>3208</code><code>&lt;/div&gt;</code></p><p><code>3209</code><code>&lt;/li&gt;</code></p><p><code>3210</code><code>&lt;li id="auth-Maria_C_-Rypdal-Aff1"&gt;</code></p><p><code>3211</code><code>&lt;span class="c-article-authors-search__title u-h3 js-search-name"&gt;</code></p><p><code>3212</code><code>Maria C. Rypdal&lt;/span&gt;</code></p><p><code>3213</code><code>&lt;div class="c-article-authors-search__list"&gt;</code></p><p><code>3214</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--left"&gt;</code></p><p><code>3215</code><code>&lt;a href="https://www.biomedcentral.com/search?query=author%23Maria%20C.%20Rypdal" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3216</code><code>View author publications&lt;/a&gt;</code></p><p><code>3217</code><code>&lt;/div&gt;</code></p><p><code>3218</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--right"&gt;</code></p><p><code>3219</code><code>&lt;p class="search-in-title-js c-article-authors-search__text"&gt;</code></p><p><code>3220</code><code>You can also search for this author in</code></p><p><code>3221</code><code>                        &lt;span class="c-article-identifiers"&gt;</code></p><p><code>3222</code><code>&lt;a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;amp;term=Maria%20C.%20Rypdal" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3223</code><code>PubMed&lt;/a&gt;</code></p><p><code>3224</code><code>&lt;span class="u-hide"&gt;</code></p><p><code>3225</code><code> &lt;/span&gt;</code></p><p><code>3226</code><code>&lt;a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;amp;num=10&amp;amp;btnG=Search+Scholar&amp;amp;as_epq=&amp;amp;as_oq=&amp;amp;as_eq=&amp;amp;as_occt=any&amp;amp;as_sauthors=%22Maria%20C.%20Rypdal%22&amp;amp;as_publication=&amp;amp;as_ylo=&amp;amp;as_yhi=&amp;amp;as_allsubj=all&amp;amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3227</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3228</code><code>&lt;/span&gt;</code></p><p><code>3229</code><code>&lt;/p&gt;</code></p><p><code>3230</code><code>&lt;/div&gt;</code></p><p><code>3231</code><code>&lt;/div&gt;</code></p><p><code>3232</code><code>&lt;/li&gt;</code></p><p><code>3233</code><code>&lt;li id="auth-Maria_Soledad-Sosa-Aff2-Aff3"&gt;</code></p><p><code>3234</code><code>&lt;span class="c-article-authors-search__title u-h3 js-search-name"&gt;</code></p><p><code>3235</code><code>Maria Soledad Sosa&lt;/span&gt;</code></p><p><code>3236</code><code>&lt;div class="c-article-authors-search__list"&gt;</code></p><p><code>3237</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--left"&gt;</code></p><p><code>3238</code><code>&lt;a href="https://www.biomedcentral.com/search?query=author%23Maria%20Soledad%20Sosa" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3239</code><code>View author publications&lt;/a&gt;</code></p><p><code>3240</code><code>&lt;/div&gt;</code></p><p><code>3241</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--right"&gt;</code></p><p><code>3242</code><code>&lt;p class="search-in-title-js c-article-authors-search__text"&gt;</code></p><p><code>3243</code><code>You can also search for this author in</code></p><p><code>3244</code><code>                        &lt;span class="c-article-identifiers"&gt;</code></p><p><code>3245</code><code>&lt;a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;amp;term=Maria%20Soledad%20Sosa" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3246</code><code>PubMed&lt;/a&gt;</code></p><p><code>3247</code><code>&lt;span class="u-hide"&gt;</code></p><p><code>3248</code><code> &lt;/span&gt;</code></p><p><code>3249</code><code>&lt;a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;amp;num=10&amp;amp;btnG=Search+Scholar&amp;amp;as_epq=&amp;amp;as_oq=&amp;amp;as_eq=&amp;amp;as_occt=any&amp;amp;as_sauthors=%22Maria%20Soledad%20Sosa%22&amp;amp;as_publication=&amp;amp;as_ylo=&amp;amp;as_yhi=&amp;amp;as_allsubj=all&amp;amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3250</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3251</code><code>&lt;/span&gt;</code></p><p><code>3252</code><code>&lt;/p&gt;</code></p><p><code>3253</code><code>&lt;/div&gt;</code></p><p><code>3254</code><code>&lt;/div&gt;</code></p><p><code>3255</code><code>&lt;/li&gt;</code></p><p><code>3256</code><code>&lt;li id="auth-Anne-Renolen-Aff1"&gt;</code></p><p><code>3257</code><code>&lt;span class="c-article-authors-search__title u-h3 js-search-name"&gt;</code></p><p><code>3258</code><code>Anne Renolen&lt;/span&gt;</code></p><p><code>3259</code><code>&lt;div class="c-article-authors-search__list"&gt;</code></p><p><code>3260</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--left"&gt;</code></p><p><code>3261</code><code>&lt;a href="https://www.biomedcentral.com/search?query=author%23Anne%20Renolen" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3262</code><code>View author publications&lt;/a&gt;</code></p><p><code>3263</code><code>&lt;/div&gt;</code></p><p><code>3264</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--right"&gt;</code></p><p><code>3265</code><code>&lt;p class="search-in-title-js c-article-authors-search__text"&gt;</code></p><p><code>3266</code><code>You can also search for this author in</code></p><p><code>3267</code><code>                        &lt;span class="c-article-identifiers"&gt;</code></p><p><code>3268</code><code>&lt;a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;amp;term=Anne%20Renolen" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3269</code><code>PubMed&lt;/a&gt;</code></p><p><code>3270</code><code>&lt;span class="u-hide"&gt;</code></p><p><code>3271</code><code> &lt;/span&gt;</code></p><p><code>3272</code><code>&lt;a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;amp;num=10&amp;amp;btnG=Search+Scholar&amp;amp;as_epq=&amp;amp;as_oq=&amp;amp;as_eq=&amp;amp;as_occt=any&amp;amp;as_sauthors=%22Anne%20Renolen%22&amp;amp;as_publication=&amp;amp;as_ylo=&amp;amp;as_yhi=&amp;amp;as_allsubj=all&amp;amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3273</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3274</code><code>&lt;/span&gt;</code></p><p><code>3275</code><code>&lt;/p&gt;</code></p><p><code>3276</code><code>&lt;/div&gt;</code></p><p><code>3277</code><code>&lt;/div&gt;</code></p><p><code>3278</code><code>&lt;/li&gt;</code></p><p><code>3279</code><code>&lt;li id="auth-Ellen-Schlichting-Aff4"&gt;</code></p><p><code>3280</code><code>&lt;span class="c-article-authors-search__title u-h3 js-search-name"&gt;</code></p><p><code>3281</code><code>Ellen Schlichting&lt;/span&gt;</code></p><p><code>3282</code><code>&lt;div class="c-article-authors-search__list"&gt;</code></p><p><code>3283</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--left"&gt;</code></p><p><code>3284</code><code>&lt;a href="https://www.biomedcentral.com/search?query=author%23Ellen%20Schlichting" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3285</code><code>View author publications&lt;/a&gt;</code></p><p><code>3286</code><code>&lt;/div&gt;</code></p><p><code>3287</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--right"&gt;</code></p><p><code>3288</code><code>&lt;p class="search-in-title-js c-article-authors-search__text"&gt;</code></p><p><code>3289</code><code>You can also search for this author in</code></p><p><code>3290</code><code>                        &lt;span class="c-article-identifiers"&gt;</code></p><p><code>3291</code><code>&lt;a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;amp;term=Ellen%20Schlichting" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3292</code><code>PubMed&lt;/a&gt;</code></p><p><code>3293</code><code>&lt;span class="u-hide"&gt;</code></p><p><code>3294</code><code> &lt;/span&gt;</code></p><p><code>3295</code><code>&lt;a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;amp;num=10&amp;amp;btnG=Search+Scholar&amp;amp;as_epq=&amp;amp;as_oq=&amp;amp;as_eq=&amp;amp;as_occt=any&amp;amp;as_sauthors=%22Ellen%20Schlichting%22&amp;amp;as_publication=&amp;amp;as_ylo=&amp;amp;as_yhi=&amp;amp;as_allsubj=all&amp;amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3296</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3297</code><code>&lt;/span&gt;</code></p><p><code>3298</code><code>&lt;/p&gt;</code></p><p><code>3299</code><code>&lt;/div&gt;</code></p><p><code>3300</code><code>&lt;/div&gt;</code></p><p><code>3301</code><code>&lt;/li&gt;</code></p><p><code>3302</code><code>&lt;li id="auth-Per_E_-L_nning-Aff5-Aff6"&gt;</code></p><p><code>3303</code><code>&lt;span class="c-article-authors-search__title u-h3 js-search-name"&gt;</code></p><p><code>3304</code><code>Per E. Lønning&lt;/span&gt;</code></p><p><code>3305</code><code>&lt;div class="c-article-authors-search__list"&gt;</code></p><p><code>3306</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--left"&gt;</code></p><p><code>3307</code><code>&lt;a href="https://www.biomedcentral.com/search?query=author%23Per%20E.%20L%C3%B8nning" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3308</code><code>View author publications&lt;/a&gt;</code></p><p><code>3309</code><code>&lt;/div&gt;</code></p><p><code>3310</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--right"&gt;</code></p><p><code>3311</code><code>&lt;p class="search-in-title-js c-article-authors-search__text"&gt;</code></p><p><code>3312</code><code>You can also search for this author in</code></p><p><code>3313</code><code>                        &lt;span class="c-article-identifiers"&gt;</code></p><p><code>3314</code><code>&lt;a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;amp;term=Per%20E.%20L%C3%B8nning" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3315</code><code>PubMed&lt;/a&gt;</code></p><p><code>3316</code><code>&lt;span class="u-hide"&gt;</code></p><p><code>3317</code><code> &lt;/span&gt;</code></p><p><code>3318</code><code>&lt;a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;amp;num=10&amp;amp;btnG=Search+Scholar&amp;amp;as_epq=&amp;amp;as_oq=&amp;amp;as_eq=&amp;amp;as_occt=any&amp;amp;as_sauthors=%22Per%20E.%20L%C3%B8nning%22&amp;amp;as_publication=&amp;amp;as_ylo=&amp;amp;as_yhi=&amp;amp;as_allsubj=all&amp;amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3319</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3320</code><code>&lt;/span&gt;</code></p><p><code>3321</code><code>&lt;/p&gt;</code></p><p><code>3322</code><code>&lt;/div&gt;</code></p><p><code>3323</code><code>&lt;/div&gt;</code></p><p><code>3324</code><code>&lt;/li&gt;</code></p><p><code>3325</code><code>&lt;li id="auth-Marit-Synnestvedt-Aff7"&gt;</code></p><p><code>3326</code><code>&lt;span class="c-article-authors-search__title u-h3 js-search-name"&gt;</code></p><p><code>3327</code><code>Marit Synnestvedt&lt;/span&gt;</code></p><p><code>3328</code><code>&lt;div class="c-article-authors-search__list"&gt;</code></p><p><code>3329</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--left"&gt;</code></p><p><code>3330</code><code>&lt;a href="https://www.biomedcentral.com/search?query=author%23Marit%20Synnestvedt" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3331</code><code>View author publications&lt;/a&gt;</code></p><p><code>3332</code><code>&lt;/div&gt;</code></p><p><code>3333</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--right"&gt;</code></p><p><code>3334</code><code>&lt;p class="search-in-title-js c-article-authors-search__text"&gt;</code></p><p><code>3335</code><code>You can also search for this author in</code></p><p><code>3336</code><code>                        &lt;span class="c-article-identifiers"&gt;</code></p><p><code>3337</code><code>&lt;a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;amp;term=Marit%20Synnestvedt" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3338</code><code>PubMed&lt;/a&gt;</code></p><p><code>3339</code><code>&lt;span class="u-hide"&gt;</code></p><p><code>3340</code><code> &lt;/span&gt;</code></p><p><code>3341</code><code>&lt;a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;amp;num=10&amp;amp;btnG=Search+Scholar&amp;amp;as_epq=&amp;amp;as_oq=&amp;amp;as_eq=&amp;amp;as_occt=any&amp;amp;as_sauthors=%22Marit%20Synnestvedt%22&amp;amp;as_publication=&amp;amp;as_ylo=&amp;amp;as_yhi=&amp;amp;as_allsubj=all&amp;amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3342</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3343</code><code>&lt;/span&gt;</code></p><p><code>3344</code><code>&lt;/p&gt;</code></p><p><code>3345</code><code>&lt;/div&gt;</code></p><p><code>3346</code><code>&lt;/div&gt;</code></p><p><code>3347</code><code>&lt;/li&gt;</code></p><p><code>3348</code><code>&lt;li id="auth-Julio_A_-Aguirre_Ghiso-Aff3"&gt;</code></p><p><code>3349</code><code>&lt;span class="c-article-authors-search__title u-h3 js-search-name"&gt;</code></p><p><code>3350</code><code>Julio A. Aguirre-Ghiso&lt;/span&gt;</code></p><p><code>3351</code><code>&lt;div class="c-article-authors-search__list"&gt;</code></p><p><code>3352</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--left"&gt;</code></p><p><code>3353</code><code>&lt;a href="https://www.biomedcentral.com/search?query=author%23Julio%20A.%20Aguirre-Ghiso" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3354</code><code>View author publications&lt;/a&gt;</code></p><p><code>3355</code><code>&lt;/div&gt;</code></p><p><code>3356</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--right"&gt;</code></p><p><code>3357</code><code>&lt;p class="search-in-title-js c-article-authors-search__text"&gt;</code></p><p><code>3358</code><code>You can also search for this author in</code></p><p><code>3359</code><code>                        &lt;span class="c-article-identifiers"&gt;</code></p><p><code>3360</code><code>&lt;a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;amp;term=Julio%20A.%20Aguirre-Ghiso" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3361</code><code>PubMed&lt;/a&gt;</code></p><p><code>3362</code><code>&lt;span class="u-hide"&gt;</code></p><p><code>3363</code><code> &lt;/span&gt;</code></p><p><code>3364</code><code>&lt;a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;amp;num=10&amp;amp;btnG=Search+Scholar&amp;amp;as_epq=&amp;amp;as_oq=&amp;amp;as_eq=&amp;amp;as_occt=any&amp;amp;as_sauthors=%22Julio%20A.%20Aguirre-Ghiso%22&amp;amp;as_publication=&amp;amp;as_ylo=&amp;amp;as_yhi=&amp;amp;as_allsubj=all&amp;amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3365</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3366</code><code>&lt;/span&gt;</code></p><p><code>3367</code><code>&lt;/p&gt;</code></p><p><code>3368</code><code>&lt;/div&gt;</code></p><p><code>3369</code><code>&lt;/div&gt;</code></p><p><code>3370</code><code>&lt;/li&gt;</code></p><p><code>3371</code><code>&lt;li id="auth-Bj_rn-Naume-Aff7-Aff8"&gt;</code></p><p><code>3372</code><code>&lt;span class="c-article-authors-search__title u-h3 js-search-name"&gt;</code></p><p><code>3373</code><code>Bjørn Naume&lt;/span&gt;</code></p><p><code>3374</code><code>&lt;div class="c-article-authors-search__list"&gt;</code></p><p><code>3375</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--left"&gt;</code></p><p><code>3376</code><code>&lt;a href="https://www.biomedcentral.com/search?query=author%23Bj%C3%B8rn%20Naume" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3377</code><code>View author publications&lt;/a&gt;</code></p><p><code>3378</code><code>&lt;/div&gt;</code></p><p><code>3379</code><code>&lt;div class="c-article-authors-search__item c-article-authors-search__list-item--right"&gt;</code></p><p><code>3380</code><code>&lt;p class="search-in-title-js c-article-authors-search__text"&gt;</code></p><p><code>3381</code><code>You can also search for this author in</code></p><p><code>3382</code><code>                        &lt;span class="c-article-identifiers"&gt;</code></p><p><code>3383</code><code>&lt;a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;amp;term=Bj%C3%B8rn%20Naume" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3384</code><code>PubMed&lt;/a&gt;</code></p><p><code>3385</code><code>&lt;span class="u-hide"&gt;</code></p><p><code>3386</code><code> &lt;/span&gt;</code></p><p><code>3387</code><code>&lt;a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;amp;num=10&amp;amp;btnG=Search+Scholar&amp;amp;as_epq=&amp;amp;as_oq=&amp;amp;as_eq=&amp;amp;as_occt=any&amp;amp;as_sauthors=%22Bj%C3%B8rn%20Naume%22&amp;amp;as_publication=&amp;amp;as_ylo=&amp;amp;as_yhi=&amp;amp;as_allsubj=all&amp;amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow"&gt;</code></p><p><code>3388</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>3389</code><code>&lt;/span&gt;</code></p><p><code>3390</code><code>&lt;/p&gt;</code></p><p><code>3391</code><code>&lt;/div&gt;</code></p><p><code>3392</code><code>&lt;/div&gt;</code></p><p><code>3393</code><code>&lt;/li&gt;</code></p><p><code>3394</code><code>&lt;/ol&gt;</code></p><p><code>3395</code><code>&lt;/div&gt;</code></p><p><code>3396</code><code>&lt;h3 class="c-article__sub-heading" id="contributions"&gt;</code></p><p><code>3397</code><code>Contributions&lt;/h3&gt;</code></p><p><code>3398</code><code>&lt;p&gt;</code></p><p><code>3399</code><code>Initiation and planning of the study: BN and JAA-G. Writing and revision of the manuscript and analyses of results: BN, JAA-G, MCR, MSS, and EB. Revision of the manuscript, patient inclusion and patient management: BN, PEL, MS, and ES. Double immunofluorescence staining and screening of samples: MCR. Laboratory administration and supervision: AR. All authors read and approved the final manuscript.&lt;/p&gt;</code></p><p><code>3400</code><code>&lt;h3 class="c-article__sub-heading" id="corresponding-author"&gt;</code></p><p><code>3401</code><code>Corresponding authors&lt;/h3&gt;</code></p><p><code>3402</code><code>&lt;p id="corresponding-author-list"&gt;</code></p><p><code>3403</code><code>Correspondence to</code></p><p><code>3404</code><code>                &lt;a id="corresp-c1" href="mailto:julio.aguirre-ghiso@mssm.edu"&gt;</code></p><p><code>3405</code><code>Julio A. Aguirre-Ghiso&lt;/a&gt;</code></p><p><code>3406</code><code> or &lt;a id="corresp-c2" href="mailto:BNA@ous-hf.no"&gt;</code></p><p><code>3407</code><code>Bjørn Naume&lt;/a&gt;</code></p><p><code>3408</code><code>.&lt;/p&gt;</code></p><p><code>3409</code><code>&lt;/div&gt;</code></p><p><code>3410</code><code>&lt;/div&gt;</code></p><p><code>3411</code><code>&lt;/section&gt;</code></p><p><code>3412</code><code>&lt;section data-title="Ethics declarations"&gt;</code></p><p><code>3413</code><code>&lt;div class="c-article-section" id="ethics-section"&gt;</code></p><p><code>3414</code><code>&lt;h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="ethics"&gt;</code></p><p><code>3415</code><code>Ethics declarations&lt;/h2&gt;</code></p><p><code>3416</code><code>&lt;div class="c-article-section__content" id="ethics-content"&gt;</code></p><p><code>3417</code><code>          </code></p><p><code>3418</code><code>              </code></p><p><code>3419</code><code>                &lt;h3 class="c-article__sub-heading" id="FPar3"&gt;</code></p><p><code>3420</code><code>Ethics approval and consent to participate&lt;/h3&gt;</code></p><p><code>3421</code><code>          </code></p><p><code>3422</code><code>                &lt;p&gt;</code></p><p><code>3423</code><code>NeoTax Study: Norwegian Regional Ethics Committee approval number 273/96–82.96 REK Helseregion III. Oslo1 Study: Norwegian Regional Ethics Committee approval number S-97103. SATT Study: Norwegian Regional Ethics Committee approval number S-03032. Informed consent to participate was given by all patients.&lt;/p&gt;</code></p><p><code>3424</code><code>          </code></p><p><code>3425</code><code>              </code></p><p><code>3426</code><code>              </code></p><p><code>3427</code><code>                &lt;h3 class="c-article__sub-heading" id="FPar4"&gt;</code></p><p><code>3428</code><code>Competing interests&lt;/h3&gt;</code></p><p><code>3429</code><code>          </code></p><p><code>3430</code><code>                &lt;p&gt;</code></p><p><code>3431</code><code>The authors declare that they have no competing interests.&lt;/p&gt;</code></p><p><code>3432</code><code>          </code></p><p><code>3433</code><code>              </code></p><p><code>3434</code><code>              </code></p><p><code>3435</code><code>                &lt;h3 class="c-article__sub-heading" id="FPar5"&gt;</code></p><p><code>3436</code><code>Publisher’s Note&lt;/h3&gt;</code></p><p><code>3437</code><code>          </code></p><p><code>3438</code><code>                &lt;p&gt;</code></p><p><code>3439</code><code>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.&lt;/p&gt;</code></p><p><code>3440</code><code>          </code></p><p><code>3441</code><code>              </code></p><p><code>3442</code><code>            &lt;/div&gt;</code></p><p><code>3443</code><code>&lt;/div&gt;</code></p><p><code>3444</code><code>&lt;/section&gt;</code></p><p><code>3445</code><code>&lt;section data-title="Additional files"&gt;</code></p><p><code>3446</code><code>&lt;div class="c-article-section" id="Sec12-section"&gt;</code></p><p><code>3447</code><code>&lt;h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec12"&gt;</code></p><p><code>3448</code><code>Additional files&lt;/h2&gt;</code></p><p><code>3449</code><code>&lt;div class="c-article-section__content" id="Sec12-content"&gt;</code></p><p><code>3450</code><code>&lt;div data-test="supplementary-info"&gt;</code></p><p><code>3451</code><code>&lt;div id="figshareContainer" class="c-article-figshare-container" data-test="figshare-container"&gt;</code></p><p><code>3452</code><code>&lt;/div&gt;</code></p><p><code>3453</code><code>&lt;div class="c-article-supplementary__item" data-test="supp-item" id="MOESM1"&gt;</code></p><p><code>3454</code><code>&lt;h3 class="c-article-supplementary__title u-h3"&gt;</code></p><p><code>3455</code><code>&lt;a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="additional file 1:" href="https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_MOESM1_ESM.xlsx" data-supp-info-image=""&gt;</code></p><p><code>3456</code><code>Additional file 1:&lt;/a&gt;</code></p><p><code>3457</code><code>&lt;/h3&gt;</code></p><p><code>3458</code><code>&lt;div class="c-article-supplementary__description" data-component="thumbnail-container"&gt;</code></p><p><code>3459</code><code>&lt;p&gt;</code></p><p><code>3460</code><code>&lt;b&gt;</code></p><p><code>3461</code><code>Table S1.&lt;/b&gt;</code></p><p><code>3462</code><code> Descriptive data from all tested patients. (XLSX 15 kb)&lt;/p&gt;</code></p><p><code>3463</code><code>&lt;/div&gt;</code></p><p><code>3464</code><code>&lt;/div&gt;</code></p><p><code>3465</code><code>&lt;div class="c-article-supplementary__item" data-test="supp-item" id="MOESM2"&gt;</code></p><p><code>3466</code><code>&lt;h3 class="c-article-supplementary__title u-h3"&gt;</code></p><p><code>3467</code><code>&lt;a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="additional file 2:" href="https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_MOESM2_ESM.pdf" data-supp-info-image=""&gt;</code></p><p><code>3468</code><code>Additional file 2:&lt;/a&gt;</code></p><p><code>3469</code><code>&lt;/h3&gt;</code></p><p><code>3470</code><code>&lt;div class="c-article-supplementary__description" data-component="thumbnail-container"&gt;</code></p><p><code>3471</code><code>&lt;p&gt;</code></p><p><code>3472</code><code>&lt;b&gt;</code></p><p><code>3473</code><code>Figure S1.&lt;/b&gt;</code></p><p><code>3474</code><code> AE1AE3/NR2F1 DIF staining on normal MNCs spiked with breast cancer cell line cells. The first row shows normal MNCs (AE1AE2-negative) and one breast cancer cell line cell (MCF7; AE1AE3-positive). The MNCs contain 0–3 small/weak NR2F1 signals per nucleus and the cancer cell two similarly small signals. These cells are all defined as being NR2F1&lt;sup&gt;</code></p><p><code>3475</code><code>low&lt;/sup&gt;</code></p><p><code>3476</code><code> cells in the present study. Occasionally, normal BM cells harbored up to 5 small signals (not shown in the figure). The second row shows MNCs with a cluster of four breast cancer cell line cells (SKBR3), of which the lower left cell does not contain any NR2F1 signals and is therefore defined as NR2F1&lt;sup&gt;</code></p><p><code>3477</code><code>low&lt;/sup&gt;</code></p><p><code>3478</code><code>. The third cell from the left contains 7–8 small signals, with a tendency to signal clustering, and satisfies the criteria for an NR2F1&lt;sup&gt;</code></p><p><code>3479</code><code>high&lt;/sup&gt;</code></p><p><code>3480</code><code> cell. In cell numbers 2 and 4 from the left, 4–5 small signals are seen. Although the signals of these cells tend to melt together in clusters/larger signals they still represent expressions below the cut-off for NR2F1&lt;sup&gt;</code></p><p><code>3481</code><code>high&lt;/sup&gt;</code></p><p><code>3482</code><code> classification, but are approaching the cut-off level. The cells in the second row of this figure therefore illustrate the a priori defined cut-off between NR2F1-positive and -negative cells. (NR2F1 signals in MNCs in the second row are out of focus and therefore not visible on the images). For illustration of the NR2F1 classification of DTCs within the study, see Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig2"&gt;</code></p><p><code>3483</code><code>2a&lt;/a&gt;</code></p><p><code>3484</code><code> and Additional file &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/s13058-018-1049-0#MOESM7"&gt;</code></p><p><code>3485</code><code>7&lt;/a&gt;</code></p><p><code>3486</code><code>: Figure S2. (PDF 684 kb)&lt;/p&gt;</code></p><p><code>3487</code><code>&lt;/div&gt;</code></p><p><code>3488</code><code>&lt;/div&gt;</code></p><p><code>3489</code><code>&lt;div class="c-article-supplementary__item" data-test="supp-item" id="MOESM3"&gt;</code></p><p><code>3490</code><code>&lt;h3 class="c-article-supplementary__title u-h3"&gt;</code></p><p><code>3491</code><code>&lt;a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="additional file 3:" href="https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_MOESM3_ESM.pdf" data-supp-info-image=""&gt;</code></p><p><code>3492</code><code>Additional file 3:&lt;/a&gt;</code></p><p><code>3493</code><code>&lt;/h3&gt;</code></p><p><code>3494</code><code>&lt;div class="c-article-supplementary__description" data-component="thumbnail-container"&gt;</code></p><p><code>3495</code><code>&lt;p&gt;</code></p><p><code>3496</code><code>&lt;b&gt;</code></p><p><code>3497</code><code>Figure S2.&lt;/b&gt;</code></p><p><code>3498</code><code> Illustration of the classification system for NR2F1 expression of DTC prospectively chosen for the present study. NR2F1&lt;sup&gt;</code></p><p><code>3499</code><code>low&lt;/sup&gt;</code></p><p><code>3500</code><code> DTC (A–C). (A) Cluster of three DTCs identified by AE1AE3 in red fluorescence and a morphology compatible with tumor cells. Two of the DTCs have no NR2F1 signals and one has one small NR2F1 signal. Surrounding BM MNCs have 0–1 NR2F1 signals of a similar size. (B, C) One DTC with 2–3 small NR2F1 signals. Adjacent normal BM MNCs with 0–1 small NR2F1 signals. NR2F1&lt;sup&gt;</code></p><p><code>3501</code><code>high&lt;/sup&gt;</code></p><p><code>3502</code><code> DTC (D, E): (D) Cluster of two DTCs with coarse, partly confluent NR2F1 signals of varying sizes (signals in BM MNCs not visualized because of not being in focus). (E) Cluster of 5 DTCs, three of them defined as NR2F1&lt;sup&gt;</code></p><p><code>3503</code><code>high&lt;/sup&gt;</code></p><p><code>3504</code><code> because of &amp;gt; 5 NR2F1 signals, partly of large signal size. The remaining two DTCs, with no NR2F1 signals, are assigned NR2F1&lt;sup&gt;</code></p><p><code>3505</code><code>low&lt;/sup&gt;</code></p><p><code>3506</code><code>, as well as the adjacent normal BM MNCs with 0–1 small NR2F1 signals. (PDF 337 kb)&lt;/p&gt;</code></p><p><code>3507</code><code>&lt;/div&gt;</code></p><p><code>3508</code><code>&lt;/div&gt;</code></p><p><code>3509</code><code>&lt;div class="c-article-supplementary__item" data-test="supp-item" id="MOESM4"&gt;</code></p><p><code>3510</code><code>&lt;h3 class="c-article-supplementary__title u-h3"&gt;</code></p><p><code>3511</code><code>&lt;a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="additional file 4:" href="https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_MOESM4_ESM.docx" data-supp-info-image=""&gt;</code></p><p><code>3512</code><code>Additional file 4:&lt;/a&gt;</code></p><p><code>3513</code><code>&lt;/h3&gt;</code></p><p><code>3514</code><code>&lt;div class="c-article-supplementary__description" data-component="thumbnail-container"&gt;</code></p><p><code>3515</code><code>&lt;p&gt;</code></p><p><code>3516</code><code>&lt;b&gt;</code></p><p><code>3517</code><code>Table S2.&lt;/b&gt;</code></p><p><code>3518</code><code> Overview of patient material and DTC results. (DOCX 34 kb)&lt;/p&gt;</code></p><p><code>3519</code><code>&lt;/div&gt;</code></p><p><code>3520</code><code>&lt;/div&gt;</code></p><p><code>3521</code><code>&lt;div class="c-article-supplementary__item" data-test="supp-item" id="MOESM5"&gt;</code></p><p><code>3522</code><code>&lt;h3 class="c-article-supplementary__title u-h3"&gt;</code></p><p><code>3523</code><code>&lt;a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="additional file 5:" href="https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_MOESM5_ESM.docx" data-supp-info-image=""&gt;</code></p><p><code>3524</code><code>Additional file 5:&lt;/a&gt;</code></p><p><code>3525</code><code>&lt;/h3&gt;</code></p><p><code>3526</code><code>&lt;div class="c-article-supplementary__description" data-component="thumbnail-container"&gt;</code></p><p><code>3527</code><code>&lt;p&gt;</code></p><p><code>3528</code><code>&lt;b&gt;</code></p><p><code>3529</code><code>Table S3.&lt;/b&gt;</code></p><p><code>3530</code><code> Characteristics of the DTC-positive cases by double immunofluorescence (DIF). (DOCX 33 kb)&lt;/p&gt;</code></p><p><code>3531</code><code>&lt;/div&gt;</code></p><p><code>3532</code><code>&lt;/div&gt;</code></p><p><code>3533</code><code>&lt;div class="c-article-supplementary__item" data-test="supp-item" id="MOESM6"&gt;</code></p><p><code>3534</code><code>&lt;h3 class="c-article-supplementary__title u-h3"&gt;</code></p><p><code>3535</code><code>&lt;a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="additional file 6:" href="https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_MOESM6_ESM.pptx" data-supp-info-image=""&gt;</code></p><p><code>3536</code><code>Additional file 6:&lt;/a&gt;</code></p><p><code>3537</code><code>&lt;/h3&gt;</code></p><p><code>3538</code><code>&lt;div class="c-article-supplementary__description" data-component="thumbnail-container"&gt;</code></p><p><code>3539</code><code>&lt;p&gt;</code></p><p><code>3540</code><code>&lt;b&gt;</code></p><p><code>3541</code><code>Figure S3.&lt;/b&gt;</code></p><p><code>3542</code><code> Serial BM samples: number of DTCs detected in the original DTC analysis (APAAP-ICC technique). (PPTX 128 kb)&lt;/p&gt;</code></p><p><code>3543</code><code>&lt;/div&gt;</code></p><p><code>3544</code><code>&lt;/div&gt;</code></p><p><code>3545</code><code>&lt;div class="c-article-supplementary__item" data-test="supp-item" id="MOESM7"&gt;</code></p><p><code>3546</code><code>&lt;h3 class="c-article-supplementary__title u-h3"&gt;</code></p><p><code>3547</code><code>&lt;a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="additional file 7:" href="https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_MOESM7_ESM.docx" data-supp-info-image=""&gt;</code></p><p><code>3548</code><code>Additional file 7:&lt;/a&gt;</code></p><p><code>3549</code><code>&lt;/h3&gt;</code></p><p><code>3550</code><code>&lt;div class="c-article-supplementary__description" data-component="thumbnail-container"&gt;</code></p><p><code>3551</code><code>&lt;p&gt;</code></p><p><code>3552</code><code>&lt;b&gt;</code></p><p><code>3553</code><code>Table S4.&lt;/b&gt;</code></p><p><code>3554</code><code> Overview of received treatment between the two BM aspiration time points for the patients presented in Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig3"&gt;</code></p><p><code>3555</code><code>3&lt;/a&gt;</code></p><p><code>3556</code><code>. (DOCX 33 kb)&lt;/p&gt;</code></p><p><code>3557</code><code>&lt;/div&gt;</code></p><p><code>3558</code><code>&lt;/div&gt;</code></p><p><code>3559</code><code>&lt;div class="c-article-supplementary__item" data-test="supp-item" id="MOESM8"&gt;</code></p><p><code>3560</code><code>&lt;h3 class="c-article-supplementary__title u-h3"&gt;</code></p><p><code>3561</code><code>&lt;a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="additional file 8:" href="https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_MOESM8_ESM.docx" data-supp-info-image=""&gt;</code></p><p><code>3562</code><code>Additional file 8:&lt;/a&gt;</code></p><p><code>3563</code><code>&lt;/h3&gt;</code></p><p><code>3564</code><code>&lt;div class="c-article-supplementary__description" data-component="thumbnail-container"&gt;</code></p><p><code>3565</code><code>&lt;p&gt;</code></p><p><code>3566</code><code>&lt;b&gt;</code></p><p><code>3567</code><code>Table S5.&lt;/b&gt;</code></p><p><code>3568</code><code> Additional results from the serial DTC analyses on samples presented in Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig3"&gt;</code></p><p><code>3569</code><code>3b&lt;/a&gt;</code></p><p><code>3570</code><code> and &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/s13058-018-1049-0#Fig3"&gt;</code></p><p><code>3571</code><code>c&lt;/a&gt;</code></p><p><code>3572</code><code> (in the same order). (DOCX 39 kb)&lt;/p&gt;</code></p><p><code>3573</code><code>&lt;/div&gt;</code></p><p><code>3574</code><code>&lt;/div&gt;</code></p><p><code>3575</code><code>&lt;div class="c-article-supplementary__item" data-test="supp-item" id="MOESM9"&gt;</code></p><p><code>3576</code><code>&lt;h3 class="c-article-supplementary__title u-h3"&gt;</code></p><p><code>3577</code><code>&lt;a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="additional file 9:" href="https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_MOESM9_ESM.pptx" data-supp-info-image=""&gt;</code></p><p><code>3578</code><code>Additional file 9:&lt;/a&gt;</code></p><p><code>3579</code><code>&lt;/h3&gt;</code></p><p><code>3580</code><code>&lt;div class="c-article-supplementary__description" data-component="thumbnail-container"&gt;</code></p><p><code>3581</code><code>&lt;p&gt;</code></p><p><code>3582</code><code>&lt;b&gt;</code></p><p><code>3583</code><code>Figure S4.&lt;/b&gt;</code></p><p><code>3584</code><code> (A) Survival analyses (time to systemic relapse/breast cancer death) in relation to NR2F1 profile of DTCs for patients being nonmetastatic at the time point of last DIF DTC-positive BMA and having no subsequent BM analyzed; patients harboring ≥ 500 DTC excluded. (B) Survival analyses (time to systemic relapse/breast cancer death) in relation to NR2F1 profile of DTCs for patients being nonmetastatic at time point of last DIF DTC-positive BMA and having no subsequent BM analyzed; NeoTax study patients excluded. (PPTX 114 kb)&lt;/p&gt;</code></p><p><code>3585</code><code>&lt;/div&gt;</code></p><p><code>3586</code><code>&lt;/div&gt;</code></p><p><code>3587</code><code>&lt;div class="c-article-supplementary__item" data-test="supp-item" id="MOESM10"&gt;</code></p><p><code>3588</code><code>&lt;h3 class="c-article-supplementary__title u-h3"&gt;</code></p><p><code>3589</code><code>&lt;a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="additional file 10:" href="https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_MOESM10_ESM.pptx" data-supp-info-image=""&gt;</code></p><p><code>3590</code><code>Additional file 10:&lt;/a&gt;</code></p><p><code>3591</code><code>&lt;/h3&gt;</code></p><p><code>3592</code><code>&lt;div class="c-article-supplementary__description" data-component="thumbnail-container"&gt;</code></p><p><code>3593</code><code>&lt;p&gt;</code></p><p><code>3594</code><code>&lt;b&gt;</code></p><p><code>3595</code><code>Figure S5.&lt;/b&gt;</code></p><p><code>3596</code><code> Survival analyses according to NR2F1 and Ki67 DTC profiles of patients being nonmetastatic at the time of last DIF DTC-positive BMA, having no subsequent BM analyzed, and no chemotherapy after last BMA. (PPTX 120 kb)&lt;/p&gt;</code></p><p><code>3597</code><code>&lt;/div&gt;</code></p><p><code>3598</code><code>&lt;/div&gt;</code></p><p><code>3599</code><code>&lt;div class="c-article-supplementary__item" data-test="supp-item" id="MOESM11"&gt;</code></p><p><code>3600</code><code>&lt;h3 class="c-article-supplementary__title u-h3"&gt;</code></p><p><code>3601</code><code>&lt;a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="additional file 11:" href="https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-018-1049-0/MediaObjects/13058_2018_1049_MOESM11_ESM.pptx" data-supp-info-image=""&gt;</code></p><p><code>3602</code><code>Additional file 11:&lt;/a&gt;</code></p><p><code>3603</code><code>&lt;/h3&gt;</code></p><p><code>3604</code><code>&lt;div class="c-article-supplementary__description" data-component="thumbnail-container"&gt;</code></p><p><code>3605</code><code>&lt;p&gt;</code></p><p><code>3606</code><code>&lt;b&gt;</code></p><p><code>3607</code><code>Figure S6.&lt;/b&gt;</code></p><p><code>3608</code><code> (A) Survival analyses (time to systemic relapse/breast cancer death) in relation to NR2F1 profile at last DIF DTC-positive BMA, restricted to those with Ki67 DTC analysis available (only patients being nonmetastatic at last DIF DTC-positive BMA included). (B) As A, but analysis restricted to patients having no subsequent BMA analyzed. (PPTX 68 kb)&lt;/p&gt;</code></p><p><code>3609</code><code>&lt;/div&gt;</code></p><p><code>3610</code><code>&lt;/div&gt;</code></p><p><code>3611</code><code>&lt;/div&gt;</code></p><p><code>3612</code><code>&lt;/div&gt;</code></p><p><code>3613</code><code>&lt;/div&gt;</code></p><p><code>3614</code><code>&lt;/section&gt;</code></p><p><code>3615</code><code>&lt;section data-title="Rights and permissions"&gt;</code></p><p><code>3616</code><code>&lt;div class="c-article-section" id="rightslink-section"&gt;</code></p><p><code>3617</code><code>&lt;h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="rightslink"&gt;</code></p><p><code>3618</code><code>Rights and permissions&lt;/h2&gt;</code></p><p><code>3619</code><code>&lt;div class="c-article-section__content" id="rightslink-content"&gt;</code></p><p><code>3620</code><code>          </code></p><p><code>3621</code><code>                &lt;p&gt;</code></p><p><code>3622</code><code>&lt;b&gt;</code></p><p><code>3623</code><code>Open Access&lt;/b&gt;</code></p><p><code>3624</code><code> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (&lt;a href="http://creativecommons.org/licenses/by/4.0/" rel="license"&gt;</code></p><p><code>3625</code><code>http://creativecommons.org/licenses/by/4.0/&lt;/a&gt;</code></p><p><code>3626</code><code>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (&lt;a href="http://creativecommons.org/publicdomain/zero/1.0/" rel="license"&gt;</code></p><p><code>3627</code><code>http://creativecommons.org/publicdomain/zero/1.0/&lt;/a&gt;</code></p><p><code>3628</code><code>) applies to the data made available in this article, unless otherwise stated.&lt;/p&gt;</code></p><p><code>3629</code><code>          </code></p><p><code>3630</code><code>              &lt;p class="c-article-rights"&gt;</code></p><p><code>3631</code><code>&lt;a data-track="click" data-track-action="view rights and permissions" data-track-label="link" href="https://s100.copyright.com/AppDispatchServlet?title=NR2F1%20stratifies%20dormant%20disseminated%20tumor%20cells%20in%20breast%20cancer%20patients&amp;amp;author=Elin%20Borgen%20et%20al&amp;amp;contentID=10.1186%2Fs13058-018-1049-0&amp;amp;copyright=The%20Author%28s%29.&amp;amp;publication=1465-542X&amp;amp;publicationDate=2018-10-16&amp;amp;publisherName=SpringerNature&amp;amp;orderBeanReset=true&amp;amp;oa=CC%20BY%20%2B%20CC0"&gt;</code></p><p><code>3632</code><code>Reprints and Permissions&lt;/a&gt;</code></p><p><code>3633</code><code>&lt;/p&gt;</code></p><p><code>3634</code><code>&lt;/div&gt;</code></p><p><code>3635</code><code>&lt;/div&gt;</code></p><p><code>3636</code><code>&lt;/section&gt;</code></p><p><code>3637</code><code>&lt;section aria-labelledby="article-info" data-title="About this article"&gt;</code></p><p><code>3638</code><code>&lt;div class="c-article-section" id="article-info-section"&gt;</code></p><p><code>3639</code><code>&lt;h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="article-info"&gt;</code></p><p><code>3640</code><code>About this article&lt;/h2&gt;</code></p><p><code>3641</code><code>&lt;div class="c-article-section__content" id="article-info-content"&gt;</code></p><p><code>3642</code><code>&lt;div class="c-bibliographic-information"&gt;</code></p><p><code>3643</code><code>&lt;div class="u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border"&gt;</code></p><p><code>3644</code><code>&lt;a data-crossmark="10.1186/s13058-018-1049-0" target="_blank" rel="noopener" href="https://crossmark.crossref.org/dialog/?doi=10.1186/s13058-018-1049-0" data-track="click" data-track-action="Click Crossmark" data-track-label="link" data-test="crossmark"&gt;</code></p><p><code>3645</code><code>&lt;img width="57" height="81" alt="Check for updates. Verify currency and authenticity via CrossMark" src="data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>"&gt;</code></p><p><code>3646</code><code>&lt;/a&gt;</code></p><p><code>3647</code><code>&lt;/div&gt;</code></p><p><code>3648</code><code>&lt;div class="c-bibliographic-information__column"&gt;</code></p><p><code>3649</code><code>&lt;h3 class="c-article__sub-heading" id="citeas"&gt;</code></p><p><code>3650</code><code>Cite this article&lt;/h3&gt;</code></p><p><code>3651</code><code>&lt;p class="c-bibliographic-information__citation"&gt;</code></p><p><code>3652</code><code>Borgen, E., Rypdal, M.C., Sosa, M.S. &lt;i&gt;</code></p><p><code>3653</code><code>et al.&lt;/i&gt;</code></p><p><code>3654</code><code> NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients.</code></p><p><code>3655</code><code>                    &lt;i&gt;</code></p><p><code>3656</code><code>Breast Cancer Res&lt;/i&gt;</code></p><p><code>3657</code><code> &lt;b&gt;</code></p><p><code>3658</code><code>20&lt;/b&gt;</code></p><p><code>3659</code><code>, 120 (2018). https://doi.org/10.1186/s13058-018-1049-0&lt;/p&gt;</code></p><p><code>3660</code><code>&lt;p class="c-bibliographic-information__download-citation u-hide-print"&gt;</code></p><p><code>3661</code><code>&lt;a data-test="citation-link" data-track="click" data-track-action="download article citation" data-track-label="link" data-track-external="" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1186/s13058-018-1049-0?format=refman&amp;amp;flavour=citation"&gt;</code></p><p><code>3662</code><code>Download citation&lt;svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"&gt;</code></p><p><code>3663</code><code>&lt;use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-download"&gt;</code></p><p><code>3664</code><code>&lt;/use&gt;</code></p><p><code>3665</code><code>&lt;/svg&gt;</code></p><p><code>3666</code><code>&lt;/a&gt;</code></p><p><code>3667</code><code>&lt;/p&gt;</code></p><p><code>3668</code><code>&lt;ul class="c-bibliographic-information__list" data-test="publication-history"&gt;</code></p><p><code>3669</code><code>&lt;li class="c-bibliographic-information__list-item"&gt;</code></p><p><code>3670</code><code>&lt;p&gt;</code></p><p><code>3671</code><code>Published&lt;span class="u-hide"&gt;</code></p><p><code>3672</code><code>: &lt;/span&gt;</code></p><p><code>3673</code><code>&lt;span class="c-bibliographic-information__value"&gt;</code></p><p><code>3674</code><code>&lt;time datetime="2018-10-16"&gt;</code></p><p><code>3675</code><code>16 October 2018&lt;/time&gt;</code></p><p><code>3676</code><code>&lt;/span&gt;</code></p><p><code>3677</code><code>&lt;/p&gt;</code></p><p><code>3678</code><code>&lt;/li&gt;</code></p><p><code>3679</code><code>&lt;li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--full-width"&gt;</code></p><p><code>3680</code><code>&lt;p&gt;</code></p><p><code>3681</code><code>&lt;abbr title="Digital Object Identifier"&gt;</code></p><p><code>3682</code><code>DOI&lt;/abbr&gt;</code></p><p><code>3683</code><code>&lt;span class="u-hide"&gt;</code></p><p><code>3684</code><code>: &lt;/span&gt;</code></p><p><code>3685</code><code>&lt;span class="c-bibliographic-information__value"&gt;</code></p><p><code>3686</code><code>https://doi.org/10.1186/s13058-018-1049-0&lt;/span&gt;</code></p><p><code>3687</code><code>&lt;/p&gt;</code></p><p><code>3688</code><code>&lt;/li&gt;</code></p><p><code>3689</code><code>&lt;/ul&gt;</code></p><p><code>3690</code><code>&lt;div data-component="share-box"&gt;</code></p><p><code>3691</code><code>&lt;div class="c-article-share-box u-display-none" hidden=""&gt;</code></p><p><code>3692</code><code>&lt;h3 class="c-article__sub-heading"&gt;</code></p><p><code>3693</code><code>Share this article&lt;/h3&gt;</code></p><p><code>3694</code><code>&lt;p class="c-article-share-box__description"&gt;</code></p><p><code>3695</code><code>Anyone you share the following link with will be able to read this content:&lt;/p&gt;</code></p><p><code>3696</code><code>&lt;button class="js-get-share-url c-article-share-box__button" type="button" id="get-share-url" data-track="click" data-track-label="button" data-track-external="" data-track-action="get shareable link"&gt;</code></p><p><code>3697</code><code>Get shareable link&lt;/button&gt;</code></p><p><code>3698</code><code>&lt;div class="js-no-share-url-container u-display-none" hidden=""&gt;</code></p><p><code>3699</code><code>&lt;p class="js-c-article-share-box__no-sharelink-info c-article-share-box__no-sharelink-info"&gt;</code></p><p><code>3700</code><code>Sorry, a shareable link is not currently available for this article.&lt;/p&gt;</code></p><p><code>3701</code><code>&lt;/div&gt;</code></p><p><code>3702</code><code>&lt;div class="js-share-url-container u-display-none" hidden=""&gt;</code></p><p><code>3703</code><code>&lt;p class="js-share-url c-article-share-box__only-read-input" id="share-url" data-track="click" data-track-label="button" data-track-action="select share url"&gt;</code></p><p><code>3704</code><code>&lt;/p&gt;</code></p><p><code>3705</code><code>&lt;button class="js-copy-share-url c-article-share-box__button--link-like" type="button" id="copy-share-url" data-track="click" data-track-label="button" data-track-action="copy share url" data-track-external=""&gt;</code></p><p><code>3706</code><code>Copy to clipboard&lt;/button&gt;</code></p><p><code>3707</code><code>&lt;/div&gt;</code></p><p><code>3708</code><code>&lt;p class="js-c-article-share-box__additional-info c-article-share-box__additional-info"&gt;</code></p><p><code>3709</code><code>          </code></p><p><code>3710</code><code>                            Provided by the Springer Nature SharedIt content-sharing initiative</code></p><p><code>3711</code><code>                        &lt;/p&gt;</code></p><p><code>3712</code><code>&lt;/div&gt;</code></p><p><code>3713</code><code>&lt;/div&gt;</code></p><p><code>3714</code><code>&lt;h3 class="c-article__sub-heading"&gt;</code></p><p><code>3715</code><code>Keywords&lt;/h3&gt;</code></p><p><code>3716</code><code>&lt;ul class="c-article-subject-list"&gt;</code></p><p><code>3717</code><code>&lt;li class="c-article-subject-list__subject"&gt;</code></p><p><code>3718</code><code>&lt;span&gt;</code></p><p><code>3719</code><code>Disseminated tumor cells&lt;/span&gt;</code></p><p><code>3720</code><code>&lt;/li&gt;</code></p><p><code>3721</code><code>&lt;li class="c-article-subject-list__subject"&gt;</code></p><p><code>3722</code><code>&lt;span&gt;</code></p><p><code>3723</code><code>DTC&lt;/span&gt;</code></p><p><code>3724</code><code>&lt;/li&gt;</code></p><p><code>3725</code><code>&lt;li class="c-article-subject-list__subject"&gt;</code></p><p><code>3726</code><code>&lt;span&gt;</code></p><p><code>3727</code><code>Dormancy&lt;/span&gt;</code></p><p><code>3728</code><code>&lt;/li&gt;</code></p><p><code>3729</code><code>&lt;li class="c-article-subject-list__subject"&gt;</code></p><p><code>3730</code><code>&lt;span&gt;</code></p><p><code>3731</code><code>NR2F1&lt;/span&gt;</code></p><p><code>3732</code><code>&lt;/li&gt;</code></p><p><code>3733</code><code>&lt;li class="c-article-subject-list__subject"&gt;</code></p><p><code>3734</code><code>&lt;span&gt;</code></p><p><code>3735</code><code>Bone marrow&lt;/span&gt;</code></p><p><code>3736</code><code>&lt;/li&gt;</code></p><p><code>3737</code><code>&lt;li class="c-article-subject-list__subject"&gt;</code></p><p><code>3738</code><code>&lt;span&gt;</code></p><p><code>3739</code><code>Breast cancer&lt;/span&gt;</code></p><p><code>3740</code><code>&lt;/li&gt;</code></p><p><code>3741</code><code>&lt;li class="c-article-subject-list__subject"&gt;</code></p><p><code>3742</code><code>&lt;span&gt;</code></p><p><code>3743</code><code>Occult disease&lt;/span&gt;</code></p><p><code>3744</code><code>&lt;/li&gt;</code></p><p><code>3745</code><code>&lt;li class="c-article-subject-list__subject"&gt;</code></p><p><code>3746</code><code>&lt;span&gt;</code></p><p><code>3747</code><code>Micrometastasis&lt;/span&gt;</code></p><p><code>3748</code><code>&lt;/li&gt;</code></p><p><code>3749</code><code>&lt;/ul&gt;</code></p><p><code>3750</code><code>&lt;div data-component="article-info-list"&gt;</code></p><p><code>3751</code><code>&lt;/div&gt;</code></p><p><code>3752</code><code>&lt;/div&gt;</code></p><p><code>3753</code><code>&lt;/div&gt;</code></p><p><code>3754</code><code>&lt;/div&gt;</code></p><p><code>3755</code><code>&lt;/div&gt;</code></p><p><code>3756</code><code>&lt;/section&gt;</code></p><p><code>3757</code><code>          </code></p><p><code>3758</code><code>          </code></p><p><code>3759</code><code>                    </code></p><p><code>3760</code><code>          </code></p><p><code>3761</code><code>          </code></p><p><code>3762</code><code>                &lt;/article&gt;</code></p><p><code>3763</code><code>          </code></p><p><code>3764</code><code>            &lt;/main&gt;</code></p><p><code>3765</code><code>          </code></p><p><code>3766</code><code>          </code></p><p><code>3767</code><code>            &lt;div class="c-article-extras u-text-sm u-hide-print" data-container-type="reading-companion" data-track-component="reading companion"&gt;</code></p><p><code>3768</code><code>          </code></p><p><code>3769</code><code>                &lt;aside&gt;</code></p><p><code>3770</code><code>          </code></p><p><code>3771</code><code>                    &lt;div data-test="download-article-link-wrapper" class="js-context-bar-sticky-point-desktop"&gt;</code></p><p><code>3772</code><code>          </code></p><p><code>3773</code><code>                        </code></p><p><code>3774</code><code>    &lt;div class="c-pdf-download u-clear-both"&gt;</code></p><p><code>3775</code><code>          </code></p><p><code>3776</code><code>        &lt;a href="//breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/s13058-018-1049-0.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true"  data-readcube-pdf-url="true" data-test="pdf-link" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-label="link" data-track-external download&gt;</code></p><p><code>3777</code><code>          </code></p><p><code>3778</code><code>            &lt;span class="c-pdf-download__text"&gt;</code></p><p><code>3779</code><code>Download PDF&lt;/span&gt;</code></p><p><code>3780</code><code>          </code></p><p><code>3781</code><code>            &lt;svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"&gt;</code></p><p><code>3782</code><code>&lt;use xlink:href="#icon-download"/&gt;</code></p><p><code>3783</code><code>&lt;/svg&gt;</code></p><p><code>3784</code><code>          </code></p><p><code>3785</code><code>        &lt;/a&gt;</code></p><p><code>3786</code><code>          </code></p><p><code>3787</code><code>    &lt;/div&gt;</code></p><p><code>3788</code><code>          </code></p><p><code>3789</code><code>          </code></p><p><code>3790</code><code>                        </code></p><p><code>3791</code><code>                    &lt;/div&gt;</code></p><p><code>3792</code><code>          </code></p><p><code>3793</code><code>          </code></p><p><code>3794</code><code>                    </code></p><p><code>3795</code><code>    </code></p><p><code>3796</code><code>          </code></p><p><code>3797</code><code>          </code></p><p><code>3798</code><code>                    &lt;div class="c-reading-companion"&gt;</code></p><p><code>3799</code><code>          </code></p><p><code>3800</code><code>                        &lt;div class="c-reading-companion__sticky" data-component="reading-companion-sticky" data-test="reading-companion-sticky"&gt;</code></p><p><code>3801</code><code>          </code></p><p><code>3802</code><code>                            &lt;div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id="tabpanel-sections"&gt;</code></p><p><code>3803</code><code>          </code></p><p><code>3804</code><code>                                &lt;div class="js-ad u-lazy-ad-wrapper u-mt-16 u-hide" data-component-mpu&gt;</code></p><p><code>3805</code><code>          </code></p><p><code>3806</code><code>                                    </code></p><p><code>3807</code><code>    </code></p><p><code>3808</code><code>    &lt;aside class="adsbox c-ad c-ad--300x250 u-mt-16" data-component-mpu&gt;</code></p><p><code>3809</code><code>          </code></p><p><code>3810</code><code>        &lt;div class="c-ad__inner" &gt;</code></p><p><code>3811</code><code>          </code></p><p><code>3812</code><code>            &lt;p class="c-ad__label"&gt;</code></p><p><code>3813</code><code>Advertisement&lt;/p&gt;</code></p><p><code>3814</code><code>          </code></p><p><code>3815</code><code>            &lt;div id="div-gpt-ad-MPU1"</code></p><p><code>3816</code><code>                data-ad-type="MPU1"</code></p><p><code>3817</code><code>                data-test="MPU1-ad"</code></p><p><code>3818</code><code>                data-pa11y-ignore</code></p><p><code>3819</code><code>                data-gpt</code></p><p><code>3820</code><code>                data-gpt-unitpath="/270604982/bmc/breast-cancer-research/articles"</code></p><p><code>3821</code><code>                data-gpt-sizes="300x250"</code></p><p><code>3822</code><code>                data-gpt-targeting="pos=MPU1;doi=10.1186/s13058-018-1049-0;type=article;kwrd=Disseminated tumor cells,DTC,Dormancy,NR2F1,Bone marrow,Breast cancer,Occult disease,Micrometastasis;pmc=B11001,H33160,H59150;"</code></p><p><code>3823</code><code>            &gt;</code></p><p><code>3824</code><code>          </code></p><p><code>3825</code><code>                &lt;noscript&gt;</code></p><p><code>3826</code><code>          </code></p><p><code>3827</code><code>                    &lt;a href="//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/breast-cancer-research/articles&amp;amp;sz=300x250&amp;amp;pos=MPU1&amp;amp;doi=10.1186/s13058-018-1049-0&amp;amp;type=article&amp;amp;kwrd=Disseminated tumor cells,DTC,Dormancy,NR2F1,Bone marrow,Breast cancer,Occult disease,Micrometastasis&amp;amp;pmc=B11001,H33160,H59150&amp;amp;"&gt;</code></p><p><code>3828</code><code>          </code></p><p><code>3829</code><code>                        &lt;img data-test="gpt-advert-fallback-img"</code></p><p><code>3830</code><code>                            src="//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/breast-cancer-research/articles&amp;amp;sz=300x250&amp;amp;pos=MPU1&amp;amp;doi=10.1186/s13058-018-1049-0&amp;amp;type=article&amp;amp;kwrd=Disseminated tumor cells,DTC,Dormancy,NR2F1,Bone marrow,Breast cancer,Occult disease,Micrometastasis&amp;amp;pmc=B11001,H33160,H59150&amp;amp;"</code></p><p><code>3831</code><code>                            alt="Advertisement"</code></p><p><code>3832</code><code>                            width="300"</code></p><p><code>3833</code><code>                            height="250"&gt;</code></p><p><code>3834</code><code>          </code></p><p><code>3835</code><code>                    &lt;/a&gt;</code></p><p><code>3836</code><code>          </code></p><p><code>3837</code><code>                &lt;/noscript&gt;</code></p><p><code>3838</code><code>          </code></p><p><code>3839</code><code>            &lt;/div&gt;</code></p><p><code>3840</code><code>          </code></p><p><code>3841</code><code>        &lt;/div&gt;</code></p><p><code>3842</code><code>          </code></p><p><code>3843</code><code>    &lt;/aside&gt;</code></p><p><code>3844</code><code>          </code></p><p><code>3845</code><code>          </code></p><p><code>3846</code><code>                                &lt;/div&gt;</code></p><p><code>3847</code><code>          </code></p><p><code>3848</code><code>                            &lt;/div&gt;</code></p><p><code>3849</code><code>          </code></p><p><code>3850</code><code>                            &lt;div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width" id="tabpanel-figures"&gt;</code></p><p><code>3851</code><code>&lt;/div&gt;</code></p><p><code>3852</code><code>          </code></p><p><code>3853</code><code>                            &lt;div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width" id="tabpanel-references"&gt;</code></p><p><code>3854</code><code>&lt;/div&gt;</code></p><p><code>3855</code><code>          </code></p><p><code>3856</code><code>                        &lt;/div&gt;</code></p><p><code>3857</code><code>          </code></p><p><code>3858</code><code>                    &lt;/div&gt;</code></p><p><code>3859</code><code>          </code></p><p><code>3860</code><code>                &lt;/aside&gt;</code></p><p><code>3861</code><code>          </code></p><p><code>3862</code><code>            &lt;/div&gt;</code></p><p><code>3863</code><code>          </code></p><p><code>3864</code><code>        &lt;/div&gt;</code></p><p><code>3865</code><code>          </code></p><p><code>3866</code><code>          </code></p><p><code>3867</code><code>        </code></p><p><code>3868</code><code>            &lt;div class="c-journal-footer"&gt;</code></p><p><code>3869</code><code>          </code></p><p><code>3870</code><code>                &lt;div class="c-journal-footer__inner"&gt;</code></p><p><code>3871</code><code>          </code></p><p><code>3872</code><code>                    &lt;div class="c-journal-footer__summary"&gt;</code></p><p><code>3873</code><code>          </code></p><p><code>3874</code><code>                        &lt;h4 class="c-journal-title c-journal-title--footer"&gt;</code></p><p><code>3875</code><code>          </code></p><p><code>3876</code><code>                            </code></p><p><code>3877</code><code>                            &lt;span class="c-journal-title__text"&gt;</code></p><p><code>3878</code><code>Breast Cancer Research&lt;/span&gt;</code></p><p><code>3879</code><code>          </code></p><p><code>3880</code><code>                        &lt;/h4&gt;</code></p><p><code>3881</code><code>          </code></p><p><code>3882</code><code>                         &lt;p class="c-journal-footer__issn"&gt;</code></p><p><code>3883</code><code>ISSN: 1465-542X&lt;/p&gt;</code></p><p><code>3884</code><code>          </code></p><p><code>3885</code><code>                    &lt;/div&gt;</code></p><p><code>3886</code><code>          </code></p><p><code>3887</code><code>                    </code></p><p><code>3888</code><code>                        &lt;div class="c-journal-footer__contact"&gt;</code></p><p><code>3889</code><code>          </code></p><p><code>3890</code><code>                            &lt;h4 class="c-journal-footer__contact-title "&gt;</code></p><p><code>3891</code><code>Contact us&lt;/h4&gt;</code></p><p><code>3892</code><code>          </code></p><p><code>3893</code><code>                            &lt;ul class="c-journal-footer__contact-list"&gt;</code></p><p><code>3894</code><code>          </code></p><p><code>3895</code><code>                                </code></p><p><code>3896</code><code>                                    &lt;li class="c-journal-footer__contact-item"&gt;</code></p><p><code>3897</code><code>Submission enquiries: &lt;a href="mailto:maritess.reyes@springernature.com"&gt;</code></p><p><code>3898</code><code>maritess.reyes@springernature.com&lt;/a&gt;</code></p><p><code>3899</code><code>&lt;/li&gt;</code></p><p><code>3900</code><code>          </code></p><p><code>3901</code><code>                                </code></p><p><code>3902</code><code>                                </code></p><p><code>3903</code><code>                                    &lt;li class="c-journal-footer__contact-item"&gt;</code></p><p><code>3904</code><code>General enquiries: &lt;a href="mailto:info@biomedcentral.com"&gt;</code></p><p><code>3905</code><code>info@biomedcentral.com&lt;/a&gt;</code></p><p><code>3906</code><code>&lt;/li&gt;</code></p><p><code>3907</code><code>          </code></p><p><code>3908</code><code>                                </code></p><p><code>3909</code><code>                            &lt;/ul&gt;</code></p><p><code>3910</code><code>          </code></p><p><code>3911</code><code>                        &lt;/div&gt;</code></p><p><code>3912</code><code>          </code></p><p><code>3913</code><code>                    </code></p><p><code>3914</code><code>                &lt;/div&gt;</code></p><p><code>3915</code><code>          </code></p><p><code>3916</code><code>            &lt;/div&gt;</code></p><p><code>3917</code><code>          </code></p><p><code>3918</code><code>        </code></p><p><code>3919</code><code>        </code></p><p><code>3920</code><code>    &lt;img rel="nofollow" class='tracker' style='display:none' src='/track/article/10.1186/s13058-018-1049-0' alt=""/&gt;</code></p><p><code>3921</code><code>          </code></p><p><code>3922</code><code>          </code></p><p><code>3923</code><code>         </code></p><p><code>3924</code><code>    &lt;footer&gt;</code></p><p><code>3925</code><code>          </code></p><p><code>3926</code><code>        </code></p><p><code>3927</code><code>            &lt;div class="c-publisher-footer u-color-inherit" data-test="publisher-footer"&gt;</code></p><p><code>3928</code><code>          </code></p><p><code>3929</code><code>    &lt;div class="u-container"&gt;</code></p><p><code>3930</code><code>          </code></p><p><code>3931</code><code>        &lt;div class="u-display-flex u-flex-wrap u-justify-content-space-between" data-test="publisher-footer-menu"&gt;</code></p><p><code>3932</code><code>          </code></p><p><code>3933</code><code>            &lt;div class="u-display-flex"&gt;</code></p><p><code>3934</code><code>          </code></p><p><code>3935</code><code>                </code></p><p><code>3936</code><code>                    </code></p><p><code>3937</code><code>                        &lt;ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16"&gt;</code></p><p><code>3938</code><code>          </code></p><p><code>3939</code><code>                            </code></p><p><code>3940</code><code>                                &lt;li class="c-list-group__item"&gt;</code></p><p><code>3941</code><code>          </code></p><p><code>3942</code><code>                                    &lt;a class="u-gray-link" href="https://blogs.biomedcentral.com/"&gt;</code></p><p><code>3943</code><code>Read more on our blogs&lt;/a&gt;</code></p><p><code>3944</code><code>          </code></p><p><code>3945</code><code>                                &lt;/li&gt;</code></p><p><code>3946</code><code>          </code></p><p><code>3947</code><code>                            </code></p><p><code>3948</code><code>                                &lt;li class="c-list-group__item"&gt;</code></p><p><code>3949</code><code>          </code></p><p><code>3950</code><code>                                    &lt;a class="u-gray-link" href="//www.biomedcentral.com/login"&gt;</code></p><p><code>3951</code><code>Receive BMC newsletters&lt;/a&gt;</code></p><p><code>3952</code><code>          </code></p><p><code>3953</code><code>                                &lt;/li&gt;</code></p><p><code>3954</code><code>          </code></p><p><code>3955</code><code>                            </code></p><p><code>3956</code><code>                                &lt;li class="c-list-group__item"&gt;</code></p><p><code>3957</code><code>          </code></p><p><code>3958</code><code>                                    &lt;a class="u-gray-link" href="//www.biomedcentral.com/account"&gt;</code></p><p><code>3959</code><code>Manage article alerts&lt;/a&gt;</code></p><p><code>3960</code><code>          </code></p><p><code>3961</code><code>                                &lt;/li&gt;</code></p><p><code>3962</code><code>          </code></p><p><code>3963</code><code>                            </code></p><p><code>3964</code><code>                                &lt;li class="c-list-group__item"&gt;</code></p><p><code>3965</code><code>          </code></p><p><code>3966</code><code>                                    &lt;a class="u-gray-link" href="https://authorservices.springernature.com/go/sn/?utm_source&amp;#x3D;Website&amp;amp;utm_medium&amp;#x3D;BMC&amp;amp;utm_campaign&amp;#x3D;SNAS+Referrals+2022&amp;amp;utm_id&amp;#x3D;ref2022"&gt;</code></p><p><code>3967</code><code>Language editing for authors&lt;/a&gt;</code></p><p><code>3968</code><code>          </code></p><p><code>3969</code><code>                                &lt;/li&gt;</code></p><p><code>3970</code><code>          </code></p><p><code>3971</code><code>                            </code></p><p><code>3972</code><code>                                &lt;li class="c-list-group__item"&gt;</code></p><p><code>3973</code><code>          </code></p><p><code>3974</code><code>                                    &lt;a class="u-gray-link" href="https://authorservices.springernature.com/go/sn/?utm_source&amp;#x3D;Website&amp;amp;utm_medium&amp;#x3D;BMC&amp;amp;utm_campaign&amp;#x3D;SNAS+Referrals+2022&amp;amp;utm_id&amp;#x3D;ref2022"&gt;</code></p><p><code>3975</code><code>Scientific editing for authors&lt;/a&gt;</code></p><p><code>3976</code><code>          </code></p><p><code>3977</code><code>                                &lt;/li&gt;</code></p><p><code>3978</code><code>          </code></p><p><code>3979</code><code>                            </code></p><p><code>3980</code><code>                        &lt;/ul&gt;</code></p><p><code>3981</code><code>          </code></p><p><code>3982</code><code>                    </code></p><p><code>3983</code><code>                        &lt;ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16"&gt;</code></p><p><code>3984</code><code>          </code></p><p><code>3985</code><code>                            </code></p><p><code>3986</code><code>                                &lt;li class="c-list-group__item"&gt;</code></p><p><code>3987</code><code>          </code></p><p><code>3988</code><code>                                    &lt;a class="u-gray-link" href="//www.biomedcentral.com/about/policies"&gt;</code></p><p><code>3989</code><code>Policies&lt;/a&gt;</code></p><p><code>3990</code><code>          </code></p><p><code>3991</code><code>                                &lt;/li&gt;</code></p><p><code>3992</code><code>          </code></p><p><code>3993</code><code>                            </code></p><p><code>3994</code><code>                                &lt;li class="c-list-group__item"&gt;</code></p><p><code>3995</code><code>          </code></p><p><code>3996</code><code>                                    &lt;a class="u-gray-link" href="//www.biomedcentral.com/accessibility"&gt;</code></p><p><code>3997</code><code>Accessibility&lt;/a&gt;</code></p><p><code>3998</code><code>          </code></p><p><code>3999</code><code>                                &lt;/li&gt;</code></p><p><code>4000</code><code>          </code></p><p><code>4001</code><code>                            </code></p><p><code>4002</code><code>                                &lt;li class="c-list-group__item"&gt;</code></p><p><code>4003</code><code>          </code></p><p><code>4004</code><code>                                    &lt;a class="u-gray-link" href="//www.biomedcentral.com/about/press-centre"&gt;</code></p><p><code>4005</code><code>Press center&lt;/a&gt;</code></p><p><code>4006</code><code>          </code></p><p><code>4007</code><code>                                &lt;/li&gt;</code></p><p><code>4008</code><code>          </code></p><p><code>4009</code><code>                            </code></p><p><code>4010</code><code>                        &lt;/ul&gt;</code></p><p><code>4011</code><code>          </code></p><p><code>4012</code><code>                    </code></p><p><code>4013</code><code>                        &lt;ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16"&gt;</code></p><p><code>4014</code><code>          </code></p><p><code>4015</code><code>                            </code></p><p><code>4016</code><code>                                &lt;li class="c-list-group__item"&gt;</code></p><p><code>4017</code><code>          </code></p><p><code>4018</code><code>                                    &lt;a class="u-gray-link" href="https://support.biomedcentral.com/support/home"&gt;</code></p><p><code>4019</code><code>Support and Contact&lt;/a&gt;</code></p><p><code>4020</code><code>          </code></p><p><code>4021</code><code>                                &lt;/li&gt;</code></p><p><code>4022</code><code>          </code></p><p><code>4023</code><code>                            </code></p><p><code>4024</code><code>                                &lt;li class="c-list-group__item"&gt;</code></p><p><code>4025</code><code>          </code></p><p><code>4026</code><code>                                    &lt;a class="u-gray-link" href="https://biomedcentral.typeform.com/to/VLXboo"&gt;</code></p><p><code>4027</code><code>Leave feedback&lt;/a&gt;</code></p><p><code>4028</code><code>          </code></p><p><code>4029</code><code>                                &lt;/li&gt;</code></p><p><code>4030</code><code>          </code></p><p><code>4031</code><code>                            </code></p><p><code>4032</code><code>                                &lt;li class="c-list-group__item"&gt;</code></p><p><code>4033</code><code>          </code></p><p><code>4034</code><code>                                    &lt;a class="u-gray-link" href="//www.biomedcentral.com/about/jobs"&gt;</code></p><p><code>4035</code><code>Careers&lt;/a&gt;</code></p><p><code>4036</code><code>          </code></p><p><code>4037</code><code>                                &lt;/li&gt;</code></p><p><code>4038</code><code>          </code></p><p><code>4039</code><code>                            </code></p><p><code>4040</code><code>                        &lt;/ul&gt;</code></p><p><code>4041</code><code>          </code></p><p><code>4042</code><code>                    </code></p><p><code>4043</code><code>                </code></p><p><code>4044</code><code>            &lt;/div&gt;</code></p><p><code>4045</code><code>          </code></p><p><code>4046</code><code>            &lt;div class="u-mb-24"&gt;</code></p><p><code>4047</code><code>          </code></p><p><code>4048</code><code>                &lt;h3 id="social-menu" class="u-text-sm u-reset-margin u-text-normal"&gt;</code></p><p><code>4049</code><code>Follow BMC&lt;/h3&gt;</code></p><p><code>4050</code><code>          </code></p><p><code>4051</code><code>                &lt;ul class="u-display-flex u-list-reset" data-test="footer-social-links"&gt;</code></p><p><code>4052</code><code>          </code></p><p><code>4053</code><code>                    </code></p><p><code>4054</code><code>                        &lt;li class="u-mt-8 u-mr-8"&gt;</code></p><p><code>4055</code><code>          </code></p><p><code>4056</code><code>                            &lt;a href="https://twitter.com/biomedcentral"</code></p><p><code>4057</code><code>                               data-track="click"</code></p><p><code>4058</code><code>                               data-track-category="Social"</code></p><p><code>4059</code><code>                               data-track-action="Clicked BMC Twitter"</code></p><p><code>4060</code><code>                               class="u-gray-link"&gt;</code></p><p><code>4061</code><code>          </code></p><p><code>4062</code><code>                                &lt;span class="u-visually-hidden"&gt;</code></p><p><code>4063</code><code>BMC Twitter page&lt;/span&gt;</code></p><p><code>4064</code><code>          </code></p><p><code>4065</code><code>                                &lt;svg class="u-icon u-text-lg" width="24" height="24" aria-hidden="true" focusable="false"&gt;</code></p><p><code>4066</code><code>          </code></p><p><code>4067</code><code>                                    &lt;use xlink:href="#icon-twitter-bordered"&gt;</code></p><p><code>4068</code><code>&lt;/use&gt;</code></p><p><code>4069</code><code>          </code></p><p><code>4070</code><code>                                &lt;/svg&gt;</code></p><p><code>4071</code><code>          </code></p><p><code>4072</code><code>                            &lt;/a&gt;</code></p><p><code>4073</code><code>          </code></p><p><code>4074</code><code>                        &lt;/li&gt;</code></p><p><code>4075</code><code>          </code></p><p><code>4076</code><code>                    </code></p><p><code>4077</code><code>                        &lt;li class="u-mt-8 u-mr-8"&gt;</code></p><p><code>4078</code><code>          </code></p><p><code>4079</code><code>                            &lt;a href="https://www.facebook.com/BioMedCentral"</code></p><p><code>4080</code><code>                               data-track="click"</code></p><p><code>4081</code><code>                               data-track-category="Social"</code></p><p><code>4082</code><code>                               data-track-action="Clicked BMC Facebook"</code></p><p><code>4083</code><code>                               class="u-gray-link"&gt;</code></p><p><code>4084</code><code>          </code></p><p><code>4085</code><code>                                &lt;span class="u-visually-hidden"&gt;</code></p><p><code>4086</code><code>BMC Facebook page&lt;/span&gt;</code></p><p><code>4087</code><code>          </code></p><p><code>4088</code><code>                                &lt;svg class="u-icon u-text-lg" width="24" height="24" aria-hidden="true" focusable="false"&gt;</code></p><p><code>4089</code><code>          </code></p><p><code>4090</code><code>                                    &lt;use xlink:href="#icon-facebook-bordered"&gt;</code></p><p><code>4091</code><code>&lt;/use&gt;</code></p><p><code>4092</code><code>          </code></p><p><code>4093</code><code>                                &lt;/svg&gt;</code></p><p><code>4094</code><code>          </code></p><p><code>4095</code><code>                            &lt;/a&gt;</code></p><p><code>4096</code><code>          </code></p><p><code>4097</code><code>                        &lt;/li&gt;</code></p><p><code>4098</code><code>          </code></p><p><code>4099</code><code>                    </code></p><p><code>4100</code><code>                        &lt;li class="u-mt-8 u-mr-8"&gt;</code></p><p><code>4101</code><code>          </code></p><p><code>4102</code><code>                            &lt;a href="http://www.weibo.com/biomedcentral"</code></p><p><code>4103</code><code>                               data-track="click"</code></p><p><code>4104</code><code>                               data-track-category="Social"</code></p><p><code>4105</code><code>                               data-track-action="Clicked BMC Weibo"</code></p><p><code>4106</code><code>                               class="u-gray-link"&gt;</code></p><p><code>4107</code><code>          </code></p><p><code>4108</code><code>                                &lt;span class="u-visually-hidden"&gt;</code></p><p><code>4109</code><code>BMC Weibo page&lt;/span&gt;</code></p><p><code>4110</code><code>          </code></p><p><code>4111</code><code>                                &lt;svg class="u-icon u-text-lg" width="24" height="24" aria-hidden="true" focusable="false"&gt;</code></p><p><code>4112</code><code>          </code></p><p><code>4113</code><code>                                    &lt;use xlink:href="#icon-weibo-bordered"&gt;</code></p><p><code>4114</code><code>&lt;/use&gt;</code></p><p><code>4115</code><code>          </code></p><p><code>4116</code><code>                                &lt;/svg&gt;</code></p><p><code>4117</code><code>          </code></p><p><code>4118</code><code>                            &lt;/a&gt;</code></p><p><code>4119</code><code>          </code></p><p><code>4120</code><code>                        &lt;/li&gt;</code></p><p><code>4121</code><code>          </code></p><p><code>4122</code><code>                    </code></p><p><code>4123</code><code>                &lt;/ul&gt;</code></p><p><code>4124</code><code>          </code></p><p><code>4125</code><code>            &lt;/div&gt;</code></p><p><code>4126</code><code>          </code></p><p><code>4127</code><code>        &lt;/div&gt;</code></p><p><code>4128</code><code>          </code></p><p><code>4129</code><code>        &lt;p class="u-reset-margin"&gt;</code></p><p><code>4130</code><code>          </code></p><p><code>4131</code><code>            By using this website, you agree to our</code></p><p><code>4132</code><code>            &lt;a class="u-gray-link" href="//www.biomedcentral.com/terms-and-conditions"&gt;</code></p><p><code>4133</code><code>Terms and Conditions&lt;/a&gt;</code></p><p><code>4134</code><code>,</code></p><p><code>4135</code><code>            &lt;a class="u-gray-link" href="https://www.springernature.com/ccpa"&gt;</code></p><p><code>4136</code><code>Your US state privacy rights&lt;/a&gt;</code></p><p><code>4137</code><code>,</code></p><p><code>4138</code><code>            &lt;a class="u-gray-link" href="//www.biomedcentral.com/privacy-statement"&gt;</code></p><p><code>4139</code><code>Privacy</code></p><p><code>4140</code><code>                statement&lt;/a&gt;</code></p><p><code>4141</code><code> and</code></p><p><code>4142</code><code>            &lt;a class="u-gray-link" href="//www.biomedcentral.com/cookies" data-test="cookie-link"&gt;</code></p><p><code>4143</code><code>Cookies&lt;/a&gt;</code></p><p><code>4144</code><code> policy.</code></p><p><code>4145</code><code>            </code></p><p><code>4146</code><code>                &lt;a class="optanon-toggle-display u-gray-link" data-cc-action="preferences" href="javascript:void(0);"&gt;</code></p><p><code>4147</code><code>Your privacy choices/Manage cookies&lt;/a&gt;</code></p><p><code>4148</code><code> we use in the preference centre.</code></p><p><code>4149</code><code>            </code></p><p><code>4150</code><code>        &lt;/p&gt;</code></p><p><code>4151</code><code>          </code></p><p><code>4152</code><code>    &lt;/div&gt;</code></p><p><code>4153</code><code>          </code></p><p><code>4154</code><code>&lt;/div&gt;</code></p><p><code>4155</code><code>          </code></p><p><code>4156</code><code>          </code></p><p><code>4157</code><code>        </code></p><p><code>4158</code><code>        &lt;div class="c-corporate-footer"&gt;</code></p><p><code>4159</code><code>          </code></p><p><code>4160</code><code>    &lt;div class="u-container"&gt;</code></p><p><code>4161</code><code>          </code></p><p><code>4162</code><code>        &lt;img src=/static/images/logo-springernature-acb40b85fb.svg class="c-corporate-footer__logo" alt="Springer Nature" itemprop="logo" role="img"&gt;</code></p><p><code>4163</code><code>          </code></p><p><code>4164</code><code>        &lt;p class="c-corporate-footer__legal" data-test="copyright"&gt;</code></p><p><code>4165</code><code> &amp;#169; 2023 BioMed Central Ltd unless otherwise stated. Part of</code></p><p><code>4166</code><code>            &lt;a class="c-corporate-footer__link" href="https://www.springernature.com" itemscope itemtype="http://schema.org/Organization" itemid="#parentOrganization"&gt;</code></p><p><code>4167</code><code>Springer Nature&lt;/a&gt;</code></p><p><code>4168</code><code>.</code></p><p><code>4169</code><code>        &lt;/p&gt;</code></p><p><code>4170</code><code>          </code></p><p><code>4171</code><code>    &lt;/div&gt;</code></p><p><code>4172</code><code>          </code></p><p><code>4173</code><code>&lt;/div&gt;</code></p><p><code>4174</code><code>          </code></p><p><code>4175</code><code>          </code></p><p><code>4176</code><code>    &lt;/footer&gt;</code></p><p><code>4177</code><code>          </code></p><p><code>4178</code><code>          </code></p><p><code>4179</code><code>    &lt;/div&gt;</code></p><p><code>4180</code><code>          </code></p><p><code>4181</code><code>          </code></p><p><code>4182</code><code>          </code></p><p><code>4183</code><code>          </code></p><p><code>4184</code><code>        &lt;div class="u-visually-hidden" aria-hidden="true"&gt;</code></p><p><code>4185</code><code>          </code></p><p><code>4186</code><code>    </code></p><p><code>4187</code><code>    &lt;?xml version="1.0" encoding="UTF-8"?&gt;</code></p><p><code>4188</code><code>&lt;!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd"&gt;</code></p><p><code>4189</code><code>&lt;svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"&gt;</code></p><p><code>4190</code><code>&lt;defs&gt;</code></p><p><code>4191</code><code>&lt;path id="a" d="M0 .74h56.72v55.24H0z"/&gt;</code></p><p><code>4192</code><code>&lt;/defs&gt;</code></p><p><code>4193</code><code>&lt;symbol id="icon-access" viewBox="0 0 18 18"&gt;</code></p><p><code>4194</code><code>&lt;path d="m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z" fill-rule="evenodd"/&gt;</code></p><p><code>4195</code><code>&lt;/symbol&gt;</code></p><p><code>4196</code><code>&lt;symbol id="icon-account" viewBox="0 0 18 18"&gt;</code></p><p><code>4197</code><code>&lt;path d="m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/&gt;</code></p><p><code>4198</code><code>&lt;/symbol&gt;</code></p><p><code>4199</code><code>&lt;symbol id="icon-alert" viewBox="0 0 18 18"&gt;</code></p><p><code>4200</code><code>&lt;path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill-rule="evenodd"/&gt;</code></p><p><code>4201</code><code>&lt;/symbol&gt;</code></p><p><code>4202</code><code>&lt;symbol id="icon-arrow-broad" viewBox="0 0 16 16"&gt;</code></p><p><code>4203</code><code>&lt;path d="m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 14 15)"/&gt;</code></p><p><code>4204</code><code>&lt;/symbol&gt;</code></p><p><code>4205</code><code>&lt;symbol id="icon-arrow-down" viewBox="0 0 16 16"&gt;</code></p><p><code>4206</code><code>&lt;path d="m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z" fill-rule="evenodd"/&gt;</code></p><p><code>4207</code><code>&lt;/symbol&gt;</code></p><p><code>4208</code><code>&lt;symbol id="icon-arrow-left" viewBox="0 0 16 16"&gt;</code></p><p><code>4209</code><code>&lt;path d="m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z" fill-rule="evenodd"/&gt;</code></p><p><code>4210</code><code>&lt;/symbol&gt;</code></p><p><code>4211</code><code>&lt;symbol id="icon-arrow-right" viewBox="0 0 16 16"&gt;</code></p><p><code>4212</code><code>&lt;path d="m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z" fill-rule="evenodd"/&gt;</code></p><p><code>4213</code><code>&lt;/symbol&gt;</code></p><p><code>4214</code><code>&lt;symbol id="icon-arrow-sub" viewBox="0 0 16 16"&gt;</code></p><p><code>4215</code><code>&lt;path d="m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z" fill-rule="evenodd"/&gt;</code></p><p><code>4216</code><code>&lt;/symbol&gt;</code></p><p><code>4217</code><code>&lt;symbol id="icon-arrow-up" viewBox="0 0 16 16"&gt;</code></p><p><code>4218</code><code>&lt;path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule="evenodd"/&gt;</code></p><p><code>4219</code><code>&lt;/symbol&gt;</code></p><p><code>4220</code><code>&lt;symbol id="icon-article" viewBox="0 0 18 18"&gt;</code></p><p><code>4221</code><code>&lt;path d="m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z" fill-rule="evenodd"/&gt;</code></p><p><code>4222</code><code>&lt;/symbol&gt;</code></p><p><code>4223</code><code>&lt;symbol id="icon-audio" viewBox="0 0 18 18"&gt;</code></p><p><code>4224</code><code>&lt;path d="m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z" fill-rule="evenodd"/&gt;</code></p><p><code>4225</code><code>&lt;/symbol&gt;</code></p><p><code>4226</code><code>&lt;symbol id="icon-block" viewBox="0 0 24 24"&gt;</code></p><p><code>4227</code><code>&lt;path d="m0 0h24v24h-24z" fill-rule="evenodd"/&gt;</code></p><p><code>4228</code><code>&lt;/symbol&gt;</code></p><p><code>4229</code><code>&lt;symbol id="icon-book" viewBox="0 0 18 18"&gt;</code></p><p><code>4230</code><code>&lt;path d="m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/&gt;</code></p><p><code>4231</code><code>&lt;/symbol&gt;</code></p><p><code>4232</code><code>&lt;symbol id="icon-broad" viewBox="0 0 24 24"&gt;</code></p><p><code>4233</code><code>&lt;path d="m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 20.182742 24.805206)"/&gt;</code></p><p><code>4234</code><code>&lt;/symbol&gt;</code></p><p><code>4235</code><code>&lt;symbol id="icon-calendar" viewBox="0 0 18 18"&gt;</code></p><p><code>4236</code><code>&lt;path d="m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z" fill-rule="evenodd"/&gt;</code></p><p><code>4237</code><code>&lt;/symbol&gt;</code></p><p><code>4238</code><code>&lt;symbol id="icon-cart" viewBox="0 0 18 18"&gt;</code></p><p><code>4239</code><code>&lt;path d="m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z"/&gt;</code></p><p><code>4240</code><code>&lt;/symbol&gt;</code></p><p><code>4241</code><code>&lt;symbol id="icon-chevron-less" viewBox="0 0 10 10"&gt;</code></p><p><code>4242</code><code>&lt;path d="m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 -1 -1 0 9 9)"/&gt;</code></p><p><code>4243</code><code>&lt;/symbol&gt;</code></p><p><code>4244</code><code>&lt;symbol id="icon-chevron-more" viewBox="0 0 10 10"&gt;</code></p><p><code>4245</code><code>&lt;path d="m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"/&gt;</code></p><p><code>4246</code><code>&lt;/symbol&gt;</code></p><p><code>4247</code><code>&lt;symbol id="icon-chevron-right" viewBox="0 0 10 10"&gt;</code></p><p><code>4248</code><code>&lt;path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/&gt;</code></p><p><code>4249</code><code>&lt;/symbol&gt;</code></p><p><code>4250</code><code>&lt;symbol id="icon-circle-fill" viewBox="0 0 16 16"&gt;</code></p><p><code>4251</code><code>&lt;path d="m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"/&gt;</code></p><p><code>4252</code><code>&lt;/symbol&gt;</code></p><p><code>4253</code><code>&lt;symbol id="icon-circle" viewBox="0 0 16 16"&gt;</code></p><p><code>4254</code><code>&lt;path d="m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"/&gt;</code></p><p><code>4255</code><code>&lt;/symbol&gt;</code></p><p><code>4256</code><code>&lt;symbol id="icon-citation" viewBox="0 0 18 18"&gt;</code></p><p><code>4257</code><code>&lt;path d="m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z" fill-rule="evenodd"/&gt;</code></p><p><code>4258</code><code>&lt;/symbol&gt;</code></p><p><code>4259</code><code>&lt;symbol id="icon-close" viewBox="0 0 16 16"&gt;</code></p><p><code>4260</code><code>&lt;path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"/&gt;</code></p><p><code>4261</code><code>&lt;/symbol&gt;</code></p><p><code>4262</code><code>&lt;symbol id="icon-collections" viewBox="0 0 18 18"&gt;</code></p><p><code>4263</code><code>&lt;path d="m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/&gt;</code></p><p><code>4264</code><code>&lt;/symbol&gt;</code></p><p><code>4265</code><code>&lt;symbol id="icon-compare" viewBox="0 0 18 18"&gt;</code></p><p><code>4266</code><code>&lt;path d="m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z" fill-rule="evenodd"/&gt;</code></p><p><code>4267</code><code>&lt;/symbol&gt;</code></p><p><code>4268</code><code>&lt;symbol id="icon-download-file" viewBox="0 0 18 18"&gt;</code></p><p><code>4269</code><code>&lt;path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z" fill-rule="evenodd"/&gt;</code></p><p><code>4270</code><code>&lt;/symbol&gt;</code></p><p><code>4271</code><code>&lt;symbol id="icon-download" viewBox="0 0 16 16"&gt;</code></p><p><code>4272</code><code>&lt;path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"/&gt;</code></p><p><code>4273</code><code>&lt;/symbol&gt;</code></p><p><code>4274</code><code>&lt;symbol id="icon-editors" viewBox="0 0 18 18"&gt;</code></p><p><code>4275</code><code>&lt;path d="m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z" fill-rule="evenodd"/&gt;</code></p><p><code>4276</code><code>&lt;/symbol&gt;</code></p><p><code>4277</code><code>&lt;symbol id="icon-email" viewBox="0 0 18 18"&gt;</code></p><p><code>4278</code><code>&lt;path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z" fill-rule="evenodd"/&gt;</code></p><p><code>4279</code><code>&lt;/symbol&gt;</code></p><p><code>4280</code><code>&lt;symbol id="icon-error" viewBox="0 0 18 18"&gt;</code></p><p><code>4281</code><code>&lt;path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill-rule="evenodd"/&gt;</code></p><p><code>4282</code><code>&lt;/symbol&gt;</code></p><p><code>4283</code><code>&lt;symbol id="icon-ethics" viewBox="0 0 18 18"&gt;</code></p><p><code>4284</code><code>&lt;path d="m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z" fill-rule="evenodd"/&gt;</code></p><p><code>4285</code><code>&lt;/symbol&gt;</code></p><p><code>4286</code><code>&lt;symbol id="icon-expand"&gt;</code></p><p><code>4287</code><code>&lt;path d="M7.498 11.918a.997.997 0 0 0-.003-1.411.995.995 0 0 0-1.412-.003l-4.102 4.102v-3.51A1 1 0 0 0 .98 10.09.992.992 0 0 0 0 11.092V17c0 .554.448 1.002 1.002 1.002h5.907c.554 0 1.002-.45 1.002-1.003 0-.539-.45-.978-1.006-.978h-3.51zm3.005-5.835a.997.997 0 0 0 .003 1.412.995.995 0 0 0 1.411.003l4.103-4.103v3.51a1 1 0 0 0 1.001 1.006A.992.992 0 0 0 18 6.91V1.002A1 1 0 0 0 17 0h-5.907a1.003 1.003 0 0 0-1.002 1.003c0 .539.45.978 1.006.978h3.51z" fill-rule="evenodd"/&gt;</code></p><p><code>4288</code><code>&lt;/symbol&gt;</code></p><p><code>4289</code><code>&lt;symbol id="icon-explore" viewBox="0 0 18 18"&gt;</code></p><p><code>4290</code><code>&lt;path d="m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z" fill-rule="evenodd"/&gt;</code></p><p><code>4291</code><code>&lt;/symbol&gt;</code></p><p><code>4292</code><code>&lt;symbol id="icon-filter" viewBox="0 0 16 16"&gt;</code></p><p><code>4293</code><code>&lt;path d="m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z"/&gt;</code></p><p><code>4294</code><code>&lt;/symbol&gt;</code></p><p><code>4295</code><code>&lt;symbol id="icon-home" viewBox="0 0 18 18"&gt;</code></p><p><code>4296</code><code>&lt;path d="m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z" fill-rule="evenodd"/&gt;</code></p><p><code>4297</code><code>&lt;/symbol&gt;</code></p><p><code>4298</code><code>&lt;symbol id="icon-image" viewBox="0 0 18 18"&gt;</code></p><p><code>4299</code><code>&lt;path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z" fill-rule="evenodd"/&gt;</code></p><p><code>4300</code><code>&lt;/symbol&gt;</code></p><p><code>4301</code><code>&lt;symbol id="icon-info" viewBox="0 0 18 18"&gt;</code></p><p><code>4302</code><code>&lt;path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"/&gt;</code></p><p><code>4303</code><code>&lt;/symbol&gt;</code></p><p><code>4304</code><code>&lt;symbol id="icon-institution" viewBox="0 0 18 18"&gt;</code></p><p><code>4305</code><code>&lt;path d="m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z" fill-rule="evenodd"/&gt;</code></p><p><code>4306</code><code>&lt;/symbol&gt;</code></p><p><code>4307</code><code>&lt;symbol id="icon-location" viewBox="0 0 18 18"&gt;</code></p><p><code>4308</code><code>&lt;path d="m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z" fill-rule="evenodd"/&gt;</code></p><p><code>4309</code><code>&lt;/symbol&gt;</code></p><p><code>4310</code><code>&lt;symbol id="icon-minus" viewBox="0 0 16 16"&gt;</code></p><p><code>4311</code><code>&lt;path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/&gt;</code></p><p><code>4312</code><code>&lt;/symbol&gt;</code></p><p><code>4313</code><code>&lt;symbol id="icon-newsletter" viewBox="0 0 18 18"&gt;</code></p><p><code>4314</code><code>&lt;path d="m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z" fill-rule="evenodd"/&gt;</code></p><p><code>4315</code><code>&lt;/symbol&gt;</code></p><p><code>4316</code><code>&lt;symbol id="icon-orcid" viewBox="0 0 18 18"&gt;</code></p><p><code>4317</code><code>&lt;path d="m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z" fill-rule="evenodd"/&gt;</code></p><p><code>4318</code><code>&lt;/symbol&gt;</code></p><p><code>4319</code><code>&lt;symbol id="icon-plus" viewBox="0 0 16 16"&gt;</code></p><p><code>4320</code><code>&lt;path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/&gt;</code></p><p><code>4321</code><code>&lt;/symbol&gt;</code></p><p><code>4322</code><code>&lt;symbol id="icon-print" viewBox="0 0 18 18"&gt;</code></p><p><code>4323</code><code>&lt;path d="m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z" fill-rule="evenodd"/&gt;</code></p><p><code>4324</code><code>&lt;/symbol&gt;</code></p><p><code>4325</code><code>&lt;symbol id="icon-search" viewBox="0 0 22 22"&gt;</code></p><p><code>4326</code><code>&lt;path d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z" fill-rule="evenodd"/&gt;</code></p><p><code>4327</code><code>&lt;/symbol&gt;</code></p><p><code>4328</code><code>&lt;symbol id="icon-social-facebook" viewBox="0 0 24 24"&gt;</code></p><p><code>4329</code><code>&lt;path d="m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z" fill-rule="evenodd"/&gt;</code></p><p><code>4330</code><code>&lt;/symbol&gt;</code></p><p><code>4331</code><code>&lt;symbol id="icon-social-twitter" viewBox="0 0 24 24"&gt;</code></p><p><code>4332</code><code>&lt;path d="m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z" fill-rule="evenodd"/&gt;</code></p><p><code>4333</code><code>&lt;/symbol&gt;</code></p><p><code>4334</code><code>&lt;symbol id="icon-social-youtube" viewBox="0 0 24 24"&gt;</code></p><p><code>4335</code><code>&lt;path d="m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z" fill-rule="evenodd"/&gt;</code></p><p><code>4336</code><code>&lt;/symbol&gt;</code></p><p><code>4337</code><code>&lt;symbol id="icon-subject-medicine" viewBox="0 0 18 18"&gt;</code></p><p><code>4338</code><code>&lt;path d="m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/&gt;</code></p><p><code>4339</code><code>&lt;/symbol&gt;</code></p><p><code>4340</code><code>&lt;symbol id="icon-success" viewBox="0 0 18 18"&gt;</code></p><p><code>4341</code><code>&lt;path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z" fill-rule="evenodd"/&gt;</code></p><p><code>4342</code><code>&lt;/symbol&gt;</code></p><p><code>4343</code><code>&lt;symbol id="icon-table" viewBox="0 0 18 18"&gt;</code></p><p><code>4344</code><code>&lt;path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z" fill-rule="evenodd"/&gt;</code></p><p><code>4345</code><code>&lt;/symbol&gt;</code></p><p><code>4346</code><code>&lt;symbol id="icon-tick-circle" viewBox="0 0 24 24"&gt;</code></p><p><code>4347</code><code>&lt;path d="m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z" fill-rule="evenodd"/&gt;</code></p><p><code>4348</code><code>&lt;/symbol&gt;</code></p><p><code>4349</code><code>&lt;symbol id="icon-tick" viewBox="0 0 16 16"&gt;</code></p><p><code>4350</code><code>&lt;path d="m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z" fill-rule="evenodd"/&gt;</code></p><p><code>4351</code><code>&lt;/symbol&gt;</code></p><p><code>4352</code><code>&lt;symbol id="icon-update" viewBox="0 0 18 18"&gt;</code></p><p><code>4353</code><code>&lt;path d="m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z" fill-rule="evenodd"/&gt;</code></p><p><code>4354</code><code>&lt;/symbol&gt;</code></p><p><code>4355</code><code>&lt;symbol id="icon-upload" viewBox="0 0 18 18"&gt;</code></p><p><code>4356</code><code>&lt;path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z" fill-rule="evenodd"/&gt;</code></p><p><code>4357</code><code>&lt;/symbol&gt;</code></p><p><code>4358</code><code>&lt;symbol id="icon-video" viewBox="0 0 18 18"&gt;</code></p><p><code>4359</code><code>&lt;path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z" fill-rule="evenodd"/&gt;</code></p><p><code>4360</code><code>&lt;/symbol&gt;</code></p><p><code>4361</code><code>&lt;symbol id="icon-warning" viewBox="0 0 18 18"&gt;</code></p><p><code>4362</code><code>&lt;path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/&gt;</code></p><p><code>4363</code><code>&lt;/symbol&gt;</code></p><p><code>4364</code><code>&lt;symbol id="icon-altmetric"&gt;</code></p><p><code>4365</code><code>&lt;path fill-rule="nonzero" d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm-1.886 9.684-1.101 1.845a1 1 0 0 1-.728.479l-.13.008H3.056a9.001 9.001 0 0 0 17.886 0l-4.564-.001-2.779 4.156c-.454.68-1.467.55-1.758-.179l-.038-.113-1.69-6.195ZM12 3a9.001 9.001 0 0 0-8.947 8.016h4.533l2.017-3.375c.452-.757 1.592-.6 1.824.25l1.73 6.345 1.858-2.777a1 1 0 0 1 .707-.436l.124-.008h5.1A9.001 9.001 0 0 0 12 3Z"/&gt;</code></p><p><code>4366</code><code>&lt;/symbol&gt;</code></p><p><code>4367</code><code>&lt;symbol id="icon-checklist-banner" viewBox="0 0 56.69 56.69"&gt;</code></p><p><code>4368</code><code>&lt;path style="fill:none" d="M0 0h56.69v56.69H0z"/&gt;</code></p><p><code>4369</code><code>&lt;clipPath id="b"&gt;</code></p><p><code>4370</code><code>&lt;use xlink:href="#a" style="overflow:visible"/&gt;</code></p><p><code>4371</code><code>&lt;/clipPath&gt;</code></p><p><code>4372</code><code>&lt;path d="M21.14 34.46c0-6.77 5.48-12.26 12.24-12.26s12.24 5.49 12.24 12.26-5.48 12.26-12.24 12.26c-6.76-.01-12.24-5.49-12.24-12.26zm19.33 10.66 10.23 9.22s1.21 1.09 2.3-.12l2.09-2.32s1.09-1.21-.12-2.3l-10.23-9.22m-19.29-5.92c0-4.38 3.55-7.94 7.93-7.94s7.93 3.55 7.93 7.94c0 4.38-3.55 7.94-7.93 7.94-4.38-.01-7.93-3.56-7.93-7.94zm17.58 12.99 4.14-4.81" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round"/&gt;</code></p><p><code>4373</code><code>&lt;path d="M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5m14.42-5.2V4.86s0-2.93-2.93-2.93H4.13s-2.93 0-2.93 2.93v37.57s0 2.93 2.93 2.93h15.01M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round;stroke-linejoin:round"/&gt;</code></p><p><code>4374</code><code>&lt;/symbol&gt;</code></p><p><code>4375</code><code>&lt;symbol id="icon-chevron-down" viewBox="0 0 16 16"&gt;</code></p><p><code>4376</code><code>&lt;path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"/&gt;</code></p><p><code>4377</code><code>&lt;/symbol&gt;</code></p><p><code>4378</code><code>&lt;symbol id="icon-citations"&gt;</code></p><p><code>4379</code><code>&lt;path fill-rule="evenodd" d="M15.59 1a1 1 0 0 1 .706.291l5.41 5.385a1 1 0 0 1 .294.709v13.077c0 .674-.269 1.32-.747 1.796a2.549 2.549 0 0 1-1.798.742h-5.843a1 1 0 1 1 0-2h5.843a.549.549 0 0 0 .387-.16.535.535 0 0 0 .158-.378V7.8L15.178 3H5.545a.543.543 0 0 0-.538.451L5 3.538v8.607a1 1 0 0 1-2 0V3.538A2.542 2.542 0 0 1 5.545 1h10.046ZM5.483 14.35c.197.26.17.62-.049.848l-.095.083-.016.011c-.36.24-.628.45-.804.634-.393.409-.59.93-.59 1.562.077-.019.192-.028.345-.028.442 0 .84.158 1.195.474.355.316.532.716.532 1.2 0 .501-.173.9-.518 1.198-.345.298-.767.446-1.266.446-.672 0-1.209-.195-1.612-.585-.403-.39-.604-.976-.604-1.757 0-.744.11-1.39.33-1.938.222-.549.49-1.009.807-1.38a4.28 4.28 0 0 1 .992-.88c.07-.043.148-.087.232-.133a.881.881 0 0 1 1.121.245Zm5 0c.197.26.17.62-.049.848l-.095.083-.016.011c-.36.24-.628.45-.804.634-.393.409-.59.93-.59 1.562.077-.019.192-.028.345-.028.442 0 .84.158 1.195.474.355.316.532.716.532 1.2 0 .501-.173.9-.518 1.198-.345.298-.767.446-1.266.446-.672 0-1.209-.195-1.612-.585-.403-.39-.604-.976-.604-1.757 0-.744.11-1.39.33-1.938.222-.549.49-1.009.807-1.38a4.28 4.28 0 0 1 .992-.88c.07-.043.148-.087.232-.133a.881.881 0 0 1 1.121.245Z"/&gt;</code></p><p><code>4380</code><code>&lt;/symbol&gt;</code></p><p><code>4381</code><code>&lt;symbol id="icon-eds-checklist" viewBox="0 0 32 32"&gt;</code></p><p><code>4382</code><code>&lt;path d="M19.2 1.333a3.468 3.468 0 0 1 3.381 2.699L24.667 4C26.515 4 28 5.52 28 7.38v19.906c0 1.86-1.485 3.38-3.333 3.38H7.333c-1.848 0-3.333-1.52-3.333-3.38V7.38C4 5.52 5.485 4 7.333 4h2.093A3.468 3.468 0 0 1 12.8 1.333h6.4ZM9.426 6.667H7.333c-.36 0-.666.312-.666.713v19.906c0 .401.305.714.666.714h17.334c.36 0 .666-.313.666-.714V7.38c0-.4-.305-.713-.646-.714l-2.121.033A3.468 3.468 0 0 1 19.2 9.333h-6.4a3.468 3.468 0 0 1-3.374-2.666Zm12.715 5.606c.586.446.7 1.283.253 1.868l-7.111 9.334a1.333 1.333 0 0 1-1.792.306l-3.556-2.333a1.333 1.333 0 1 1 1.463-2.23l2.517 1.651 6.358-8.344a1.333 1.333 0 0 1 1.868-.252ZM19.2 4h-6.4a.8.8 0 0 0-.8.8v1.067a.8.8 0 0 0 .8.8h6.4a.8.8 0 0 0 .8-.8V4.8a.8.8 0 0 0-.8-.8Z"/&gt;</code></p><p><code>4383</code><code>&lt;/symbol&gt;</code></p><p><code>4384</code><code>&lt;symbol id="icon-eds-menu" viewBox="0 0 24 24"&gt;</code></p><p><code>4385</code><code>&lt;path d="M21.09 5c.503 0 .91.448.91 1s-.407 1-.91 1H2.91C2.406 7 2 6.552 2 6s.407-1 .91-1h18.18Zm-3.817 6c.401 0 .727.448.727 1s-.326 1-.727 1H2.727C2.326 13 2 12.552 2 12s.326-1 .727-1h14.546Zm3.818 6c.502 0 .909.448.909 1s-.407 1-.91 1H2.91c-.503 0-.91-.448-.91-1s.407-1 .91-1h18.18Z" fill-rule="nonzero"/&gt;</code></p><p><code>4386</code><code>&lt;/symbol&gt;</code></p><p><code>4387</code><code>&lt;symbol id="icon-eds-search" viewBox="0 0 24 24"&gt;</code></p><p><code>4388</code><code>&lt;path d="M11 1c5.523 0 10 4.477 10 10 0 2.4-.846 4.604-2.256 6.328l3.963 3.965a1 1 0 0 1-1.414 1.414l-3.965-3.963A9.959 9.959 0 0 1 11 21C5.477 21 1 16.523 1 11S5.477 1 11 1Zm0 2a8 8 0 1 0 0 16 8 8 0 0 0 0-16Z" fill-rule="nonzero"/&gt;</code></p><p><code>4389</code><code>&lt;/symbol&gt;</code></p><p><code>4390</code><code>&lt;symbol id="icon-eds-small-arrow-right" viewBox="0 0 16 16"&gt;</code></p><p><code>4391</code><code>&lt;g fill-rule="evenodd" stroke="currentColor" stroke-linecap="round" stroke-linejoin="round" stroke-width="2"&gt;</code></p><p><code>4392</code><code>&lt;path d="M2 8.092h12M8 2l6 6.092M8 14.127l6-6.035"/&gt;</code></p><p><code>4393</code><code>&lt;/g&gt;</code></p><p><code>4394</code><code>&lt;/symbol&gt;</code></p><p><code>4395</code><code>&lt;symbol id="icon-eds-user-single" viewBox="0 0 24 24"&gt;</code></p><p><code>4396</code><code>&lt;path fill-rule="nonzero" d="M12 12c5.498 0 10 4.001 10 9a1 1 0 0 1-2 0c0-3.838-3.557-7-8-7s-8 3.162-8 7a1 1 0 0 1-2 0c0-4.999 4.502-9 10-9Zm0-11a5 5 0 1 0 0 10 5 5 0 0 0 0-10Zm0 2a3 3 0 1 1 0 6 3 3 0 0 1 0-6Z"/&gt;</code></p><p><code>4397</code><code>&lt;/symbol&gt;</code></p><p><code>4398</code><code>&lt;symbol id="icon-expand-image" viewBox="0 0 18 18"&gt;</code></p><p><code>4399</code><code>&lt;path d="m7.49754099 11.9178212c.38955542-.3895554.38761957-1.0207846-.00290473-1.4113089-.39324695-.3932469-1.02238878-.3918247-1.41130883-.0029047l-4.10273549 4.1027355.00055454-3.5103985c.00008852-.5603185-.44832171-1.006032-1.00155062-1.0059446-.53903074.0000852-.97857527.4487442-.97866268 1.0021075l-.00093318 5.9072465c-.00008751.553948.44841131 1.001882 1.00174994 1.0017946l5.906983-.0009331c.5539233-.0000875 1.00197907-.4486389 1.00206646-1.0018679.00008515-.5390307-.45026621-.9784332-1.00588841-.9783454l-3.51010549.0005545zm3.00571741-5.83449376c-.3895554.38955541-.3876196 1.02078454.0029047 1.41130883.393247.39324696 1.0223888.39182478 1.4113089.00290473l4.1027355-4.10273549-.0005546 3.5103985c-.0000885.56031852.4483217 1.006032 1.0015506 1.00594461.5390308-.00008516.9785753-.44874418.9786627-1.00210749l.0009332-5.9072465c.0000875-.553948-.4484113-1.00188204-1.0017499-1.00179463l-5.906983.00093313c-.5539233.00008751-1.0019791.44863892-1.0020665 1.00186784-.0000852.53903074.4502662.97843325 1.0058884.97834547l3.5101055-.00055449z" fill-rule="evenodd"/&gt;</code></p><p><code>4400</code><code>&lt;/symbol&gt;</code></p><p><code>4401</code><code>&lt;symbol id="icon-github" viewBox="0 0 100 100"&gt;</code></p><p><code>4402</code><code>&lt;path fill-rule="evenodd" clip-rule="evenodd" d="M48.854 0C21.839 0 0 22 0 49.217c0 21.756 13.993 40.172 33.405 46.69 2.427.49 3.316-1.059 3.316-2.362 0-1.141-.08-5.052-.08-9.127-13.59 2.934-16.42-5.867-16.42-5.867-2.184-5.704-5.42-7.17-5.42-7.17-4.448-3.015.324-3.015.324-3.015 4.934.326 7.523 5.052 7.523 5.052 4.367 7.496 11.404 5.378 14.235 4.074.404-3.178 1.699-5.378 3.074-6.6-10.839-1.141-22.243-5.378-22.243-24.283 0-5.378 1.94-9.778 5.014-13.2-.485-1.222-2.184-6.275.486-13.038 0 0 4.125-1.304 13.426 5.052a46.97 46.97 0 0 1 12.214-1.63c4.125 0 8.33.571 12.213 1.63 9.302-6.356 13.427-5.052 13.427-5.052 2.67 6.763.97 11.816.485 13.038 3.155 3.422 5.015 7.822 5.015 13.2 0 18.905-11.404 23.06-22.324 24.283 1.78 1.548 3.316 4.481 3.316 9.126 0 6.6-.08 11.897-.08 13.526 0 1.304.89 2.853 3.316 2.364 19.412-6.52 33.405-24.935 33.405-46.691C97.707 22 75.788 0 48.854 0z"/&gt;</code></p><p><code>4403</code><code>&lt;/symbol&gt;</code></p><p><code>4404</code><code>&lt;symbol id="icon-mentions"&gt;</code></p><p><code>4405</code><code>&lt;g fill-rule="evenodd" stroke="#000" stroke-linecap="round" stroke-linejoin="round" stroke-width="2"&gt;</code></p><p><code>4406</code><code>&lt;path d="M22 15.255A9.373 9.373 0 0 1 8.745 2L22 15.255ZM15.477 8.523l4.215-4.215"/&gt;</code></p><p><code>4407</code><code>&lt;path d="m7 13-5 9h10l-1-5"/&gt;</code></p><p><code>4408</code><code>&lt;/g&gt;</code></p><p><code>4409</code><code>&lt;/symbol&gt;</code></p><p><code>4410</code><code>&lt;symbol id="icon-metrics-accesses"&gt;</code></p><p><code>4411</code><code>&lt;path fill-rule="nonzero" d="M15.59 1a1 1 0 0 1 .706.291l5.41 5.385a1 1 0 0 1 .294.709v13.077c0 .674-.269 1.32-.747 1.796a2.549 2.549 0 0 1-1.798.742h-5.843a1 1 0 1 1 0-2h5.843a.549.549 0 0 0 .387-.16.535.535 0 0 0 .158-.378V7.8L15.178 3H5.545a.543.543 0 0 0-.538.451L5 3.538v8.607a1 1 0 0 1-2 0V3.538A2.542 2.542 0 0 1 5.545 1h10.046ZM7.708 13.308c2.004 0 3.969 1.198 5.802 2.995l.23.23a2.285 2.285 0 0 1 .009 3.233C11.853 21.693 9.799 23 7.707 23c-2.091 0-4.14-1.305-6.033-3.226a2.285 2.285 0 0 1-.007-3.233c1.9-1.93 3.949-3.233 6.04-3.233Zm0 2c-1.396 0-3.064 1.062-4.623 2.644a.285.285 0 0 0 .007.41C4.642 19.938 6.311 21 7.707 21c1.397 0 3.069-1.065 4.623-2.644a.285.285 0 0 0 0-.404l-.23-.229c-1.487-1.451-3.064-2.415-4.393-2.415Zm-.036 1.077a1.77 1.77 0 1 1 .126 3.537 1.77 1.77 0 0 1-.126-3.537Zm.072 1.538a.23.23 0 1 0-.017.461.23.23 0 0 0 .017-.46Z"/&gt;</code></p><p><code>4412</code><code>&lt;/symbol&gt;</code></p><p><code>4413</code><code>&lt;symbol id="icon-metrics"&gt;</code></p><p><code>4414</code><code>&lt;path fill-rule="nonzero" d="M3 22a1 1 0 0 1-1-1V3a1 1 0 0 1 1-1h6a1 1 0 0 1 1 1v7h4V8a1 1 0 0 1 1-1h6a1 1 0 0 1 1 1v13a1 1 0 0 1-.883.993L21 22H3Zm17-2V9h-4v11h4Zm-6-8h-4v8h4v-8ZM8 4H4v16h4V4Z"/&gt;</code></p><p><code>4415</code><code>&lt;/symbol&gt;</code></p><p><code>4416</code><code>&lt;symbol id="icon-springer-arrow-left"&gt;</code></p><p><code>4417</code><code>&lt;path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"/&gt;</code></p><p><code>4418</code><code>&lt;/symbol&gt;</code></p><p><code>4419</code><code>&lt;symbol id="icon-springer-arrow-right"&gt;</code></p><p><code>4420</code><code>&lt;path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"/&gt;</code></p><p><code>4421</code><code>&lt;/symbol&gt;</code></p><p><code>4422</code><code>&lt;symbol id="icon-submit-open" viewBox="0 0 16 17"&gt;</code></p><p><code>4423</code><code>&lt;path d="M12 0c1.10457 0 2 .895431 2 2v5c0 .276142-.223858.5-.5.5S13 7.276142 13 7V2c0-.512836-.38604-.935507-.883379-.993272L12 1H6v3c0 1.10457-.89543 2-2 2H1v8c0 .512836.38604.935507.883379.993272L2 15h6.5c.276142 0 .5.223858.5.5s-.223858.5-.5.5H2c-1.104569 0-2-.89543-2-2V5.828427c0-.530433.210714-1.039141.585786-1.414213L4.414214.585786C4.789286.210714 5.297994 0 5.828427 0H12Zm3.41 11.14c.250899.250899.250274.659726 0 .91-.242954.242954-.649606.245216-.9-.01l-1.863671-1.900337.001043 5.869492c0 .356992-.289839.637138-.647372.637138-.347077 0-.647371-.285256-.647371-.637138l-.001043-5.869492L9.5 12.04c-.253166.258042-.649726.260274-.9.01-.242954-.242954-.252269-.657731 0-.91l2.942184-2.951303c.250908-.250909.66127-.252277.91353-.000017L15.41 11.14ZM5 1.413 1.413 5H4c.552285 0 1-.447715 1-1V1.413ZM11 3c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Zm0 2c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Z" fill-rule="nonzero"/&gt;</code></p><p><code>4424</code><code>&lt;/symbol&gt;</code></p><p><code>4425</code><code>&lt;/svg&gt;</code></p><p><code>4426</code><code>          </code></p><p><code>4427</code><code>&lt;/div&gt;</code></p><p><code>4428</code><code>          </code></p><p><code>4429</code><code>    &lt;/body&gt;</code></p><p><code>4430</code><code>          </code></p><p><code>4431</code><code>&lt;/html&gt;</code></p><p><code>4432</code><code>          </code></p><p><code>4433</code><code>          </code></p><div></div></main><iframe hidden="hidden" title="Hidden frame for spell checking" src="about:blank" id="iframeSpelling"></iframe></body></html>